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Tis a lesson you should heed: 
Try, try, try again. 
If at first you don't succeed, 
Try, try, try again 
 
(Thomas H. Palmer) 
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Introduction 
 
Patients with acute abdominal pain due to acute colonic diverticulitis (ACD) impose an 
impressive burden to healthcare.
1
 In the Netherlands, patients with ACD account for over 
18,000 admissions and expenditures exceed 80 million euro per year. In the past years, a 
rise in the number of hospitalizations for ACD has been noted in the Netherlands. In 2009, 
18,355 patients were hospitalized with ACD as compared to 13,655 patients in 2006.
2, 3
 
This significant rise in hospital admissions is also notable in other countries. A recent study 
from the United States showed an increase in hospital admissions during the period 1998-
2005 of 26%, with the largest increase in the age between 18 and 44 years.
1
 In the 
Netherlands, 60% of patients admitted to the hospital for ACD are women.
2
 This overall 
difference in incidence of ACD between men and women has also been reported in other 
countries.
4
 Patients younger than 50 years of age with ACD are predominantly men, 
whereas in the age group of 50-70 years there is a preference for women.
4-8
 Patients with 
mild (recurrent) diverticulitis are usually treated by the general practitioner or on an 
outpatient basis, which makes it difficult to accurately determine the true incidence and 
recurrence rates of diverticulitis. It is estimated that approximately 20 to 25% of patients 
with diverticulosis coli develop ACD.
9
 
 
 
Pathogenesis of diverticulosis 
 
Diverticula are sac-like outpouchings of the colonic wall. Diverticula arise where the vasa 
recta penetrate the colonic wall to supply blood to the mucosa of the colon. This is a weak 
spot and prone for protrusion of the mucosa and submucosa through the muscle layer of 
the colonic wall. Because colonic diverticula exist of mucosa, and submucosa, which is 
covered by serosa, they are referred to as false diverticula. This is in contrast to true 
diverticula, which are diverticula that encompass the complete bowel wall, e.g., a 
Meckel’s diverticulum. Diverticula generally occur in parallel rows along the mesenteric 
side of the antimesenteric taeniae. With progression, an additional row of diverticula may 
be found between the antimesenteric taeniae.
10
 The common theory, with respect to the 
development of diverticulosis, focuses on three aspects: structural abnormalities of the 
colonic wall, motility disorders of the colon, and the role of dietary fiber.
11
 In pathological 
examination of colon specimen, changes in collagen structure, increased deposition of 
elastin and thickening of the colonic wall were found in patients with diverticulosis 
coli.
12, 13
 Wess et al.
12
 analyzed colonic collagen content in an attempt to determine if a 
lack of collagen is responsible for this apparent weakness of the muscular wall. As the 
collagen content does not change with age or the presence of diverticula, the changes are 
more likely to be qualitative than quantitative. Collagen fibrils demonstrate increased 
cross-linking with increased age; this process seems to increase most dramatically after 40 
years of age, the age at which the incidence of diverticulosis also appears to increase. This 
same study demonstrated that patients with diverticulosis have an abnormally high 
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amount of collagen cross-linkage in the colon wall. This increased cross-linkage likely 
causes the tissues to become stiffer, less resistant to stretching and results in wall 
thickening. Wall thickening leads to reduction of the intraluminal volume and increase in 
intraluminal pressure, which probably is the key factor in the development of 
diverticula.
14, 15
  
 
It has also been suggested that the colon in patients with diverticulosis functions not as a 
tube, but as individual compartments generating high pressures, a process called 
segmentation. The high pressures resulting from segmentation may lead to the focal 
muscular atrophy and subsequent mucosal herniation.
16
 Diverticula occur most frequently 
in the sigmoid colon because the lumen of the colon is the narrowest resulting in the 
generation of the highest pressures. 
 
Diverticulosis coli is often called a disease of Western civilization because of the relation 
between lack of fiber in the diet and the pathogenesis of the disease. Dietary fibers are 
not digested and stimulate and activate the peristalsis of the colon to create voluminous 
stool. Subsequently the colon has to deal with larger amounts of stool and dilates leading 
to less segmentation, with a decrease of the intracolonic pressure as a result. A large 
population based study supports the positive effect of the use of dietary fiber to prevent 
the development of diverticulosis coli. The risk of the development of diverticulosis coli 
was inversely associated with insoluble dietary fiber intake.
17
 
 
 
Definitions 
 
The term ‘diverticular disease’ used in Anglo Saxon literature comprises a spectrum of 
conditions that are all related to diverticulosis of the colon. Some use the term diverticular 
disease for patients having symptoms associated with diverticulosis and distinguish 
diverticulitis as a different entity, whereas others include diverticulitis and diverticular 
bleeding in the term ‘diverticular disease’. The lack of uniformity in terminology results in 
difficulties interpreting and comparing findings between studies. It seems best to use the 
term ‘diverticulosis coli’ and to distinguish between uncomplicated and complicated 
diverticulosis.  
 
Uncomplicated diverticulosis 
Patients with uncomplicated diverticulosis coli have no symptoms, which makes it difficult 
to determine the true prevalence. Based on autopsy reports from the 60s diverticulosis is 
present in about 50% of patients older than 80 years.
15, 18
 The prevalence of diverticulosis 
coli depends on age and increases from about 5% around the age of forty to 30% around 
sixty and 65% around eighty-five years without gender differences.  
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Complicated diverticulosis coli 
Complicated diverticulosis coli encompasses the complete spectrum of symptoms that can 
arise in patients with diverticulosis coli. This includes patients with (chronic) persistent 
abdominal pain, acute colonic diverticulitis and diverticular bleeding. 
 
Acute colonic diverticulitis (ACD) 
Acute colonic diverticulitis refers to inflammation of diverticula and has a wide variety of 
clinical presentations varying from mild to severe complicated disease. Uncomplicated 
diverticulitis is referred to when the inflammation of one or more diverticula leads to an 
inflammatory process without perforation or abscess formation. Complicated diverticulitis 
is associated with abscess formation, perforation or fistula formation. Recurrent episodes 
of diverticulitis can result in stenosis and obstruction or fistula to nearby organs (mostly 
bladder) or the skin.  
 
 
Pathogenesis of acute colonic diverticulitis 
 
There are several theories about the pathogenesis of ACD of which no one has been 
evidently confirmed. It was believed that obstructive fecal matter in the diverticulum 
leads to an increased pressure of the diverticular sac, resulting in vascular compromise 
with necrosis and micro or macro perforation of the diverticulum. Due to the localization 
of the diverticula on the mesenteric side of the bowel, this gives rise to the inflammation 
of the pericolonic mesenteric fat. Why some patients with diverticulosis will remain 
asymptomatic, while others develop diverticulitis is unknown. More recent studies suggest 
changes in colonic flora and the existence of a local low-grade mucosal infection in 
patients with diverticulitis.
21
 This low-grade infection is an explanation for the histological 
findings of chronic inflammation in patients operated for recurrent episodes of 
diverticulitis. Additionally, low grade infection may be an explanation for patients who 
experience persistent abdominal pain after an episode of diverticulitis, comparable with 
periods of exacerbation and remission in patients with inflammatory bowel disease.  
 
 
Classification of acute colonic diverticulitis 
 
Hinchey proposed a clinical scoring system in 1978 to classify acute colonic diverticulitis 
and a modified version is still used in clinical practice.
22, 23
 (Table 1) 
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Table 1: Modified Hinchey classification and accompanying CT findings according to Kaiser 
 
Modified Hinchey classification Accompanying CT findings 
Stage 0 Clinically mild diverticulitis Diverticuli with or without colonic wall 
thickening 
Stage Ia Confined pericolic inflammation or 
phlegmon 
Colonic wall thickening with inflammatory 
reaction in pericolic fatty tissue 
Stage Ib Abscess formation (<5cm) in the proximity 
of the primary inflammatory process 
Alterations as stage Ia + pericolic or mesocolic 
abscess 
Stage II Intra-abdominal abscess, pelvic or 
retroperitoneal abscess, abscess distant 
from the primary inflammatory process 
Alteration as stage Ia + distant abscess 
formation (mostly pelvic or interloop 
abscesses) 
Stage III Generalized purulent peritonitis Free gas with localized or generalized free 
fluid and possible thickening of the 
peritoneum 
Stage IV Generalized faecal peritonitis Similar findings to stage III 
 
 
Clinical diagnosis and imaging 
 
Patients with acute abdominal pain in the lower left abdomen, fever and an elevated 
white blood cell count are suspected of having ACD. Clinical evaluation alone seems 
inadequate to make the diagnosis; several studies show that the clinical diagnosis of ACD 
is wrong in 34% to 68% of suspected cases.
24-26
 The lack of specific signs and symptoms for 
accurately establishing the clinical diagnosis of patients with ACD and the discrepancy 
between the clinical and perioperative findings in patients with the presumptive diagnosis 
ACD, demanded for good imaging modalities to diagnose ACD. The radiological 
investigations that have been used for the diagnosis of acute diverticulitis are plain water-
soluble contrast enema, ultrasound (US), computed tomography (CT) and magnetic 
resonance imaging (MRI). Colonoscopy is rarely used for diagnostic purposes in the acute 
setting. 
 
The use of water-soluble contrast enema is considered an obsolete imaging technique of 
depicting ACD. Although proven a safe and feasible technique in the past, water-soluble 
enema only depicts intraluminal details, whereas ACD is mainly characterized by 
extramural inflammation. 
 
The most common US technique used to examine patients with suspected ACD is the 
graded compression technique. With this technique interposing fat and bowel can be 
displaced or compressed to show underlying structures. If the bowel cannot be 
compressed, the non-compressibility itself is a sign of inflammation.
27
 US is a real-time 
dynamic examination with wide availability and easy accessibility. Graded-compression 
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ultrasound has been widely used to diagnose ACD. Potential drawback is the inter-
operator variability.
28, 29
 
 
The use of CT in the evaluation of patients suspected of ACD has increased to a large 
extent. Modern CT imaging techniques allow us to visualize high-resolution images with a 
mean scanning time of less than 15 minutes. Exposure to radiation is a well-known 
disadvantage of CT. One out of 4 patients with diverticulitis will suffer from recurrent 
episodes of ACD and risk multiple CT scans over time. With the increasing use of CT in 
patients with diverticulitis the risk of radiation exposure and radiation induced 
malignancies may be a real concern.
27
 With the introduction of CT, radiological 
classifications for ACD were introduced. Kaiser et al. correlated findings on CT to the 
modified Hinchey scores, to standardize the reporting of CT imaging in patients with acute 
colonic diverticulitis.
30
 (Table 1) 
 
MRI is not widely used in the diagnostic work-up of patients suspected of ACD. Although 
MRI has demonstrated promising results in terms of sensitivity and specificity in 
diagnosing ACD, availability and expertise with this examination around the clock are 
more limited than US and CT.
31
 
 
Whether or not the process of diagnostic decision-making and the role of additional 
imaging in patients suspected of having ACD can be improved is topic of this thesis and 
addressed at the end of this chapter. 
 
 
Treatment 
 
Treatment of ACD depends on the severity of the disease. The majority of patients have 
uncomplicated ACD and can be treated conservatively. The conservative treatment of 
uncomplicated diverticulitis is successful in more than 90% of patients with Hinchey 0 and 
Ia stage of diverticulitis.
30, 32-34
 Usually a diet high in fibers, laxatives and bed rest are 
advised, but none of these treatments is evidence based. Almost all studies in which 
conservative treatment of patients with Hinchey 0 or Ia diverticulitis is investigated report 
the use of antibiotics, again without any supporting evidence of clinical effect. Dutch 
patients with uncomplicated ACD are not routinely treated with antibiotics. The use of 
antibiotic treatment is reserved for patients with a body temperature >38.5 degrees 
Celsius, with a clinical deterioration or with signs of bacteremia or sepsis.
35, 36
 In about 
15%-20% of patients with ACD, complications such as an abscess (Hinchey Ib or II), fistula 
formation and perforation occurs.
37, 38
 Antibiotic treatment of abscesses up to 4-5cm is 
successful in 73% of the patients.
30, 39-43
 If the abscess is larger or antibiotic treatment fails, 
there is an indication for percutaneous drainage. Antibiotic treatment with percutaneous 
treatment is successful in 81% of the patients with complicated ACD. Surgical drainage is 
only indicated when this strategy fails. Perforation of a diverticulum or abscess into the 
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free abdominal cavity leads to peritonitis with an overall mortality of 14% (Hinchey III or 
IV). It is a relatively rare complication with a prevalence of approximately 3,5 per 100,000 
per year.
37, 38
 Peritonitis is a medical emergency and needs urgent treatment. Prevention 
of sepsis and multiple organ failure by means of rapid resuscitation, the immediate 
administration of intravenous antibiotics and eliminating the disease process are 
measures that should be immediately taken.
44
 Several studies have shown that resection 
of the affected portion of the colon has better results than a diverting ileostomy or 
colostomy alone.
45
 In patients who are not seriously ill, are not haemodynamically 
unstable, and have no serious comorbidity a primary anastomosis after resection is usually 
safe.
46-48
 In other cases a Hartmann’s procedure, in which the affected colonic segment is 
resected with closure of the rectal stump and formation of an end colostomy is 
performed. Recently, good results of laparoscopic lavage and drainage of the abdominal 
cavity in patients with a purulent peritonitis (Hinchey III) without resection of the bowel 
and without applying a diverting ileo- or colostomy have been described. This operative 
strategy combined with the use of intravenous antibiotics, seems a promising alternative 
in patients with Hinchey III diverticulitis, although this technique should be evaluated in a 
randomized trial.
49, 50
 Stenosis and fistula formation are late complications of diverticulitis 
and are an indication for surgery. 
 
The American Society of Colon and Rectal Surgeons (ASCRS) state in their most recent 
guideline that elective sigmoid resection after recovery from acute diverticulitis should be 
made on a case-by-case basis.
51
 This advice differed significantly from the advice given six 
years earlier, in which a plea for elective surgery after two episodes of diverticulitis was 
proposed.
52
 Recent data on the natural history of diverticulitis has shown that recurrent 
episodes of diverticulitis mostly run a benign course and only 5.5% of the patients with 
recurrent hospitalizations for diverticulitis end up with emergency surgery.
38
 Moreover, 
most patients who present with complicated diverticulitis do so at the time of their first 
attack.
37, 53-55
 Therefore, a policy of elective sigmoid resection after recovery from 
uncomplicated ACD might not decrease the likelihood of later emergency surgery and the 
number of previous episodes itself seems no longer an indication for elective sigmoid 
resection.
56
 Persistent colonic symptoms, particularly abdominal pain, have been reported 
in patients after episodes of diverticulitis. It has been suggested that this pain represents 
increased visceral sensitivity.
57
 These patients might benefit from early colonic resection. 
 
Elective sigmoid resection for complicated diverticulosis can be performed either with an 
open or laparoscopic approach. Two randomized trials favor laparoscopic surgery over 
open surgery. In the ‘Sigma trial’ significantly more complications, higher pain scores and 
longer hospital stay were found among patients with open surgery. Operating time was 
significantly longer in the laparoscopic group, with a conversion rate of 19%. Quality of life 
was significantly better after six weeks, but did not differ after 6 months.
58
 The Gervaz 
study also had equal long-term results, except the cosmetic outcome, which was better in 
the laparoscopic group. No difference was found considering ventral hernia, patient 
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satisfaction, quality of life or total costs.
59
 Laparoscopic surgery provides a faster func-
tional recovery than an open sigmoid resection and a possibly less risk of complications, 
but the long-term advantages of laparoscopic sigmoid resection are not evident.  
 
Recently, new theories about similarities between diverticulitis and inflammatory bowel 
disease have been proposed and good results with medical therapy are being reported. 
The use of 5-aminosalicylic acid in combination with a non-absorbable antibiotic and the 
use of probiotics have been described in the reduction of persistent abdominal 
complaints. Medical treatment has not been proven to reduce recurrent diverticulitis.
60-62
 
 
The role and timing of elective surgery in patients with recurrent ACD is still evolving and 
remains subject of debate. Whether or not patients with recurrent episodes of diver-
ticulitis or persistent abdominal pain benefit from early surgery or benefit from new 
medical treatment protocols is addressed in this thesis. 
 
 
Outline of the thesis 
 
This thesis is divided into three parts. The first part of this thesis (Chapter 2, 3, 4 and 5) 
addresses clinical decision making in patients with suspected ACD. Chapter 2, 3 and 4 
discuss the clinical decision-making in patients with left-sided diverticulitis, while 
Chapter 5 discusses the potential pitfalls in diagnosing right-sided diverticulitis. The 
second part of the thesis (Chapter 6, 7 and 8) describes different treatment strategies in 
patients with recurrent episodes of ACD. The incidence and risk factors of recurrence after 
surgical treated ACD are discussed separately in chapter 8. In the third part of the thesis, 
the Dutch National guidelines for diagnosis and treatment of acute colonic diverticulitis 
are summarized (Chapter 9), and future perspectives are described (Chapter 10). 
 
Part one 
Clinical evaluation in patients with ACD seems to be wrong in almost two third of the 
patients suspected of ACD.
24-26
 This led to the idea that the diagnostic process in 
diverticulitis might be improved by a clinical scoring system, similar to scoring systems 
that have been proposed for example for patients with acute appendicitis
63
 Such a scoring 
system may ultimately lead to the reduction of additional imaging, especially reducing the 
number of CT scans. Approximately 25% of the patients with ACD, risk multiple episodes 
of ACD, and therefore multiple CT scans with an increased risk of radiation-induced 
malignancies. This widespread use of imaging can probably be reduced to some extent, 
since approximately 90% of patients with ACD can be managed conservatively.
30
 
Additional imaging in patients with uncomplicated diverticulitis rarely leads to alterations 
in management.
50
 A scoring system based on clinical symptoms and signs, and basic 
laboratory parameters, might also reduce costs associated with imaging. In Chapter 2, the 
development of such a scoring system for diverticulitis is described. The diagnostic value 
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of elements of disease history, physical examination, and routine laboratory tests in 
patients suspected of ACD were assessed and compared and based on these findings a 
clinical scoring system, that could predict ACD in clinical practice, was constructed. A letter 
to the editor with valuable comments and our response are added to this manuscript. 
 
Before any scoring system can be propagated for widespread use it should be tested in 
other data than in those it was developed (external validation).
64, 65
 External validation 
enhances the general applicability and takes into account historical, geographic and 
methodological differences.
66
 In Chapter 3 an external validation of the model is done 
with a comparative Dutch cohort of patients suspected of ACD and with a third 
independent dataset with patients with acute abdominal pain from a large Swedish 
database.
67
  
 
The added value of imaging after clinical evaluation, particularly its effect on diagnostic 
accuracy and certainty and patient treatment, is important and needs to be well defined in 
the diagnostic work-up of patients suspected of ACD. Additional imaging improves 
decision making, but there is no consensus on which radiological procedure is preferable. 
Chapter 4 describes the complete diagnostic process of patients suspected of ACD at an 
emergency department or during hospitalization. We systematically reviewed the 
published literature on clinical decision-making and imaging techniques in patients 
suspected of ACD and provide an evidence-based step up approach to diagnose 
diverticulitis. 
 
Right-sided colonic diverticulitis (RCD) is rare in Western patients and is considered a more 
aggressive disease than left-sided diverticulitis, probably based on a different etiology. 
RCD most often proved to be an unexpected finding during intended appendectomy in the 
era before the widespread use of imaging, since the clinical picture of RCD resembles that 
of acute appendicitis. A colonic resection is normally performed to treat the inflamed 
colon or exclude a carcinoma. In the last two decades, radiological imaging is standardized 
in the diagnostic work-up of patients with acute abdominal pain. This resulted in a pivotal 
shift for left-sided diverticulitis from a clinical to a radiological diagnosis, and for RCD from 
a surgical to a radiological diagnosis. There are no clinical guidelines for the diagnosis and 
treatment of Western patients with RCD, but we hypothesized that the natural course of 
patients with RCD would be similar to patients with acute left-sided diverticulitis. 
Chapter 5 describes the clinical course and potential differences in a retrospective cohort 
of patients with RCD and left-sided diverticulitis. 
  
Part two 
Morbidity and mortality rates of operative treatment of diverticulitis and a better 
understanding of complicated diverticulitis caused a shift towards a more conservative 
approach in patients with recurrent diverticulitis. However, the optimal treatment 
strategy for patients with recurrent episodes of diverticulitis remains unclear. The results 
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of new treatment options in patients with recurrent episodes of diverticulitis might play a 
more prominent role in the decision whether or not to operate. In Chapter 6, a Markov 
model was designed in which different (surgical and non-surgical) treatment strategies in 
patients with recurrent episodes of ACD were compared. In the Markov model we aim to 
determine whether patients would benefit from colonic resection after two or three 
episodes of diverticulitis, or that conservative or medical treatment after the third episode 
would be preferable in terms of Quality Adjusted Life Years (QALYs). 
 
Assessment of early morbidity and mortality is not sufficient to establish the optimal 
treatment strategy in patients with recurrent episodes of ACD. Quality of life (QoL) and 
other patient reported outcomes (PROs) are increasingly recognized as crucial when 
determining clinical outcome after medical interventions. Nowadays, PROs should be 
included in the choice of treatment modality.
68
 In Chapter 7, the impact of conservative 
versus operative treatment on QoL and other PROs in patients with recurrent episodes of 
ACD has been reviewed. In Chapter 8, the incidence and risk factors associated with 
recurrent ACD is addressed in patients who underwent surgery for uncomplicated or 
complicated diverticulitis. Identifying patients at risk for failure of resectional therapy 
would help to better select patients for elective surgery.  
 
Part three 
A multidisciplinary working group initiated by the Dutch Society of Surgery developed 
national guidelines concerning the epidemiology, classification, diagnosis and treatment of 
ACD in all its aspects. This work was inspired by the fact that there is a lot of inconsistent 
evidence and publications concerning ACD, a disease with a high incidence, but wherein 
the treatment is merely based on the doctor’s personal preference. The guidelines are 
based on an evidence-based review of the literature and recommendations are based on 
current scientific evidence. Chapter 9 summarizes the Dutch National Guidelines for 
diagnosis and treatment of acute colonic diverticulitis, which can be generalized to all 
Western countries because the guidelines are based upon international medical literature. 
In Chapter 10, the results and conclusions are summarized in the English and Dutch 
language, respectively, and future perspectives are described.  
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Abstract 
 
Objective 
The aim of this study was to assess and compare the diagnostic value of elements of the 
disease history, physical examination and routine laboratory tests in patients with 
suspected acute left-sided colonic diverticulitis (ALCD). 
 
Summary background data 
Misdiagnosis rates for diverticulitis vary in literature between 34% and 68% which needs 
improvement. Because of the frequent misdiagnosis, liberal use of imaging has been 
recommended. Before making a plea for routine imaging, the diagnostic accuracy of 
different variables of disease history, physical examination and routine laboratory tests 
needs to be specified. 
 
Methods 
All patients seen on the emergency department because of acute abdominal pain 
suspected of ALCD in whom an abdominal computed tomography was performed, 
between January 2002 and March 2006, were studied. Univariate logistic regression was 
used to study differences in patients’ characteristics and symptoms, findings at physical 
examination and routine laboratory tests between patients with and without ALCD. 
Independent predictors to the risk of ALCD were identified using multivariate logistic 
regression and used to create a clinical scoring system.  
 
Results 
Of 1290 patients with acute abdominal pain, 287 patients were eligible for analysis. ALCD 
was the final diagnosis in 124 patients (43%). ALCD was the final diagnosis in 124 patients 
(43%). Age, one or more previous episodes, localization of symptoms in the lower left 
abdomen, aggravation of pain on movement, the absence of vomiting, localization of 
abdominal tenderness in the lower left abdomen and C-reactive protein 50 or more were 
found to be independent predictors of ALCD. A nomogram was constructed based on 
these independent predictors with a diagnostic accuracy of 86%. 
 
Conclusions 
This study showed that the clinical diagnosis diverticulitis is difficult to make but can be 
improved using a clinical scoring system. In case of a high chance of ALCD based on the 
nomogram, additional imaging may not be needed. 
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Introduction 
 
Colonic diverticular disease affects approximately 35% to 50% of the Western population 
and increases in prevalence with advancing age.
1
 Acute left-sided colonic diverticulitis 
(ALCD) occurs in 10% to 25% of patients and is a frequently suspected diagnosis in patients 
presenting with acute abdominal pain.
2
 It is a challenge to correctly identify patients with 
ALCD, because numerous other acute abdominal conditions mimic its clinical picture. A 
false clinical diagnosis of ALCD may lead to delayed or inadequate treatment, unneeded 
further investigation, unnecessary and prolonged hospital stay, and increased costs. 
Unfortunately, clinical evaluation alone seems inadequate and several studies have shown 
that the clinical diagnosis diverticulitis appears to be wrong in 34% to 68% of cases.
3-5
 
Because of the frequent misdiagnosis, routine imaging such as computed tomography (CT) 
and ultrasound (US) has been recommended for patients with a clinical suspicion of 
diverticulitis with the hope of yielding a rapid and accurate diagnosis.
2
 Routine use of 
imaging techniques, however, has its drawbacks; the ionizing radiation of CT is potentially 
harmful
6
 and US is examiner-dependent. 
 
Decision-making in patients with diverticulitis is a subjective synthesis of clinical 
information and basic laboratory tests and merely relies on the surgeon’s clinical 
expertise. Similar to acute appendicitis, the diagnostic process in diverticulitis might be 
improved by using a clinical scoring system. These scoring systems are based on history, 
physical examination, and routine laboratory tests and are a suitable instrument for 
identifying patients with a low, intermediate or high chance of having the disease and 
provide a structured algorithm for further investigation and treatment.
7, 8
 The diagnostic 
value of particular elements of disease history, physical examination and laboratory tests 
are not well studied for ALCD. A few studies reported on diagnostic features and found the 
low sensitivity to be the major problem in clinically diagnosing diverticulitis.
9, 10
 Up till now 
there is no report of a scoring system in use for patients suspected of ALCD. The objective 
of the present study was to assess and compare the diagnostic value of elements of the 
disease history, physical examination and routine laboratory tests in patients suspected of 
ALCD and to provide a clinical scoring system that can simply and accurately predict ALCD 
in clinical practice. 
 
 
Methods 
 
Between January 2002 and March 2006, routine abdominal CT was done in consecutive 
adult patients who were hospitalized with acute abdominal pain and who did not require 
immediate surgery. All patients were seen at the emergency department by junior and 
senior surgical residents with direct supervision of a surgeon who decided about 
hospitalization. Patient selection for this study was based on the abdominal CT request 
forms written in the earlier-mentioned time period. Request forms were reviewed for the 
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probability of ALCD based on the following specific text: ‘suspected diverticulitis’ or ‘lower 
left abdominal pain’. Selected forms were crosschecked with the writings of ‘clinical 
suspicion of diverticulitis’ in the medical records. Most patients were referred to the 
emergency department by general practitioners and patients discharged from the 
emergency department with suspected ALCD but without abdominal CT were not 
included. 
 
The following data were extracted from the records: gender, age, previous episodes of 
diverticulitis, duration of symptoms (days), localization of symptoms, aggravation of pain 
on movement, anorexia, vomiting, signs of illness, localization of abdominal tenderness, 
rebound tenderness and muscular guarding, body temperature, white blood cell count, C-
reactive protein (CRP), and type of treatment. 
 
Computed tomography was used as gold standard for diagnosing ALCD, in case of non-
operative management, based on the high sensitivity (94%) and specificity (99%) reported 
in literature.
11
 Pathology and operative reports were used as gold standard in case of 
operative management. Diverticulitis based on CT was defined if signs of thickening of the 
colonic wall of 4mm or more was present, with signs of inflammation of the pericolonic fat 
(hyper vascularisation or pericolic oedema) with or without abscess formation or con-
tained or free perforation.
12
 The final diagnosis ALCD was established based on the CT 
result or the pathology and operative report if applicable. Other diagnoses in case of no 
diverticulitis on CT, at surgery or in the pathology report, were also noted. In all patients 
with an alternative diagnosis, the medical record was reviewed for the final diagnosis 
during follow-up.  
 
Statistical analysis 
Analysis was done on complete datasets. Univariate logistic regression was used to study 
the differences in patients’ characteristics and symptoms, findings at physical examination 
and inflammatory markers between patients with and without documented ALCD. To this 
purpose, categories of a specific variable were grouped in case of small numbers. The 
disease prevalences (n) and the crude odds ratios (OR) with 95% confidence intervals (CI) 
are presented. Multivariate logistic regression with selection procedures was used to 
identify variables that contributed independently to the risk of ALCD. The selection 
procedures were partitioned into three steps related to the three categories of variables: 
1) patients characteristics and symptoms 2) signs at physical examination, and 3) 
laboratory tests. In each step the selection procedure was performed using variables from 
that category, while the variables already found were included in the model. The 
reasoning for this procedure was to find those variables that in addition to those already 
found in the previous step, significantly contributed to the ability to discriminate patients 
with ALCD from those without. The adjusted OR with 95% CI of the final model were 
calculated. The pseudo-R
2
 is presented to indicate the information gained by addition of 
the covariate(s) in the logistic regression model versus a model without any covariates. 
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The area under the curve (AUC) of the receiver operating characteristic (ROC) curve is 
used as a measure of predictive discrimination. In general, these measures are too high 
because the model is developed solely using the study sample and this model will perform 
less on a different random sample. Therefore, to evaluate the reliability of the created 
prediction model, an internal validation was performed using bootstrap methods and the 
corrected R
2
 and the corrected AUC are presented.
13
 Using the multivariate prognostic 
model, a boundary value (i.e., the optimal cut-off point) of the risk of ALCD, given the 
values of the prognostic variables only, was constructed under the condition of equal 
‘costs’ of misclassification of cases and non-cases. Finally, a nomogram was constructed 
using the multivariable prognostic model. Such a nomogram can be used by filling in the 
values of each of the independent risk factors separately. The corresponding number of 
points is then read from the scale mentioned earlier. These are then summed to give a 
total point score, which is translated into a probability of having ALCD by using the two 
scales at the bottom of the nomogram. All statistical analyses were performed using SAS 
version 8.2, and the nomogram was constructed using standard procedures in R version 
2.6.1. 
 
Results 
 
One thousand two hundred ninety consecutive admitted patients with acute abdominal 
pain had an abdominal CT scan. Three hundred seven patients (24%) fulfilled the inclusion 
criteria of suspected ALCD based on the CT request forms and the crosscheck with the 
medical records. The records of twenty patients (7%) were incomplete and excluded for 
analysis. A total of 287 patients (110 men and 177 women) remained for further analysis 
of which 124 patients (43%) were diagnosed with ALCD as the final diagnosis (Figure 1).  
 
Table 1 summarizes the final diagnoses based on CT findings and the clinical picture. Main 
diagnoses in the remaining 163 patients included no abnormalities, gynaecologic 
disorders, and diverticulosis without inflammation. All patients were followed for at least 
six months after the initial diagnosis and none of these patients developed ALCD; that is, 
there were no false negatives. Thirty-one patients (25%) required surgery, with the 
majority of them (77%) having a first episode of ALCD. Perioperative findings and 
pathology reports confirmed the diagnosis ALCD in all patients and no additional disorders 
were found during surgery or in the pathology reports. 
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1,290 patients with acute abdominal 
pain and abdominal CT scan 
983 patients excluded based on 
abdominal CT scan request forms 
307 patients with suspected acute 
left-sided colonic diverticulitis based 
on abdominal CT request forms and 
crosscheck with medical records 
20 patients excluded based on 
incomplete hospital records 
287 patients with suspected acute 
left-sided colonic diverticulitis 
124 patients with diagnosis acute 
left-sided colonic diverticulitis 
163 patients with other diagnosis 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flowchart of the selection process for the study group 
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Table 1: Alternative diagnoses in patients suspected of having acute left-sided colonic diverticulitis 
(ALCD) based on initial CT scan findings and subsequent clinical diagnosis 
 
Diagnosis  N patients 
No abnormalities found  57 
Gynecologic abnormalities  15 
Other  15 
Diverticulosis coli without infection  13 
Colorectal malignancy  11 
Renal abnormalities  10 
Ischemic colitis  9 
Enteritis  9 
Intestinal obstruction  7 
Appendicitis acuta  4 
Mesenteric lymphadenitis  3 
Psoas hematoma  2 
Sigmoid volvulus  2 
Cholecystitis  2 
Iliacal aneurysm  2 
Femoral hernia  1 
Epiploic appendagitis  1 
Total  163 
 
Baseline patient characteristics and symptoms expressed by crude odds ratios for the 
probability of ALCD using univariate analysis are given in Table 2. Statistically significant 
predictors of ALCD were age (>50 years, OR 3.99, CI: 1.99-8.03), one or more previous 
episodes of diverticulitis (OR 7.60, CI: 3.72-15.52), localization of symptoms in the lower 
left abdomen (OR 3.43, CI: 1.98-5.92) and aggravation of pain on movement (OR 2.97, CI: 
1.83-4.83). Vomiting was a negative predictor of ALCD (OR 0.49, CI: 0.59-0.86). The 
discriminating power of the patients’ characteristics and symptoms expressed as AUC of 
the ROC curve was low (0.52-0.64), except for the variable localization of pain (AUC = 
0.73). 
 
The diagnostic value of physical examination expressed by crude odds ratios for the 
probability of ALCD is given in Table 3. Localization of abdominal tenderness in the lower 
left abdomen (OR 5.36, CI: 3.18-9.04), rebound tenderness (OR 2.92, CI: 1.80-4.74) and 
body temperature ≥38.5 (OR 2.00, CI: 1.06-3.78) were statistical significant predictors of 
ALCD. Discriminating power of these variables was comparable to the discriminating 
power of the patient characteristics and symptoms with an AUC of 0.51-0.63 and thus 
generally low. Abdominal tenderness on physical examination was the only variable with a 
relatively high discriminating power (AUC = 0.70).   
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Table 2: The number of patients with baseline characteristics and symptoms and the odds ratios 
with 95% confidence interval for the probability of acute left-sided colonic diverticulitis, using 
univariate logistic regression 
 
  Number of patients   
Characteristic  ALCD +  
(n=124) 
ALCD – 
(n=163) 
OR  
(95% CI) 
AUC (%) 
(95% CI) 
Gender Male 50 60 1.16 (0.72; 1.87) 52 
 Female 74 103 1.00 (reference) (46-58) 
Age (years) <40 12 45 1.00 (reference) 62 
 41-70 87 88 2.08 (0.85; 5.11)  (57-67) 
 ≥71 25 30 3.99 (1.99; 8.03)  
Previous episodes No 80 153 1.00 (reference) 64 
 One or more 44 10 7.60 (3.72; 15.52) (59-69) 
Duration of symptoms (days) 0-1 48 60 1.00 (reference) 57 
 2-3 47 80 0.73 (0.44; 1.24) (51-64) 
 ≥4 29 23 1.58 (0.81; 3.07)  
Localization of symptoms 
(abdomen) 
Lower left 81 44 3.43 (1.98; 5.92) 73 
Lower right 7 52 0.25 (0.11; 0.61) (67-78) 
Diffuse 36 67 1.00 (reference)  
Aggravation of pain on  
movement 
No 51 110 1.00 (reference) 63 
Yes 73 53 2.97 (1.83; 4.83) (57-69) 
Anorexia No 62 68 1.00 (reference) 54 
 Yes 62 95 0.71 (0.44; 1.13)  (48-60) 
Vomiting No 99 108 1.00 (reference) 57 
 Yes 25 55 0.49 (0.59; 0.86) (51-62) 
Diarrhea No 95 133 1.00 (reference) 52 
 Yes 29 30 1.35 (0.76-2.40) (48-57) 
ALCD + indicates patients with acute left-sided colonic diverticulitis; ALCD – indicates patients without acute left-sided 
colonic diverticulitis; OR: Odds Ratio; CI: Confidence Interval; AUC: Area Under the ROC Curve 
 
Table 3: Number of patients with a diagnostic value of physical examination and the odds ratios with 
95% confidence interval for the probability of acute left-sided colonic diverticulitis, using univariate 
logistic regression 
 
  Number of patients   
Characteristic  ALCD +  
(n=124) 
ALCD – 
(n=163) 
OR  
(95% CI) 
AUC (%) 
(95% CI) 
Signs of illness No 55 79 1.00 (reference) 52 
 Yes 69 84 1.18 (0.74; 1.89) (46-58) 
Localization of abdominal  
tenderness 
Lower left 94 57 5.36 (3.18; 9.04) 70 
Other
† 
 30 106 1.00 (reference) (64-75) 
Rebound tenderness No 49 107 1.00 (reference) 63 
 Yes 75 56 2.92 (1.80; 4.74) (57-69) 
Body temperature 
(degrees Celsius) 
≤37.5 49 79 1.00 (reference) 57 
37.6-37.9 22 32 1.11 (0.58; 2.12) (50-63) 
38.0-38.4 22 27 1.31 (0.68; 2.56)  
≥38.5 31 25 2.00 (1.06; 3.78)  
†
 Group contains patients with right-sided and diffuse abdominal tenderness 
ALCD + indicates patients with acute left-sided colonic diverticulitis; ALCD – indicates patients without acute left-sided 
colonic diverticulitis; OR: Odds Ratio; CI: Confidence Interval; AUC: Area Under the ROC Curve 
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Diagnostic value of laboratory tests expressed by crude OR for the probability of ALCD is 
given in Table 4. An elevated white blood cell count and a CRP level 50mg/l or more (OR 
3.78, CI: 1.92-7.43) were statistically significant predictors of ALCD. The discriminating 
power of each laboratory test was low (AUC = 0.61-0.63). 
 
Table 4: Number of patients with a diagnostic value of laboratory tests and the odds ratios with 95% 
confidence interval for the probability of acute left-sided colonic diverticulitis, using univariate 
logistic regression 
 
  Number of patients   
Characteristic  ALCD +  
(n=124) 
ALCD – 
(n=163) 
OR  
(95% CI) 
AUC (%) 
(95% CI) 
WBCC <10 35 77 1.00 (reference) 61 
(x10
9
/l) 10-12 31 27 2.53 (1.32; 4.85)  
 13-15 29 26 2.45 (1.26; 4.76)  
 >15 29 33 1.93 (1.02; 3.66)  
CRP ≤10 14 46 1.00 (reference) 63 
(<10mg/l) 11-49 26 44 1.94 (0.90; 4.19)  
 ≥50 84 73 3.78 (1.92; 7.43)  
ALCD + indicates patients with acute left-sided colonic diverticulitis; ALCD – indicates patients without acute left-sided 
colonic diverticulitis; OR: Odds Ratio; CI: Confidence Interval; AUC: Area Under the ROC Curve; WBCC: White Blood Cell 
Count (4.3-10.0 x10
9
/l); CRP: C-reactive protein (<10mg/l) 
 
Table 5 shows the adjusted OR using a multivariate logistic regression model with 
selection procedures. Age more than 50 years, one or more previous episodes, localization 
of symptoms in the lower left abdomen, aggravation of pain on movement, the absence of 
vomiting, localization of abdominal tenderness in the lower left abdomen and CRP 50 or 
more were found to be independent predictors of ALCD. The area under the ROC curve as 
a measure of predictive discrimination for this model was 86% (95% CI: 82%-91%) and the 
pseudo-R
2
 was 50%. After bootstrapping the corrected AUC and the corrected R
2
 were, 
84% and 44%, respectively. 
 
A nomogram (Figure 2) was constructed to calculate the probability of ALCD in patients 
with suspicion of ALCD. Figure 3 shows the accompanying confidence intervals of the 
estimated probability of ALCD calculated from the nomogram. A probability of ALCD 
greater than 50% had a corresponding sensitivity and specificity of 75% and 84%, 
respectively. For example, a patient 55 years of age (= 40 points) with one previous 
episode of diverticulitis (= 88 points), with lower left abdominal tenderness (= 57 points), 
with a CRP of 66 (= 85 points), with localization of symptoms in the lower left abdomen 
(= 100 points), without aggravation of pain on movement (= 0 points) and without 
vomiting (= 50 points) will receive a total of 420 points. The probability for having ACLD is 
then 93%, or 2.7 on the linear prediction scale, with a CI of 84%-98% (Figure 3). 
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Table 5: The adjusted odds ratios with 95% confidence interval for the probability of acute left-sided 
colonic diverticulitis, using multivariate logistic regression analysis with selection procedures.* 
 
Variable  Adjusted OR (95% CI) 
Age (years) <50 1.00 (reference) 
 ≥50 2.15 (1.05; 4.37) 
Previous episodes No 1.00 (reference) 
 One or more 5.67 (2.36; 13.62) 
Localization of symptoms Lower left 1.73 (0.80; 3.74) 
 Lower right 0.26 (0.09; 0.73) 
 Diffuse 1.00 (reference) 
Aggravation of pain on movement No 1.00 (reference) 
 Yes 3.28 (1.71; 6.63) 
Vomiting No 1.00 (reference) 
 Yes 0.38 (0.17; 0.79) 
Localization of abdominal tenderness Lower left 2.96 (1.35; 6.49) 
 Other
†
 1.00 (reference) 
CRP (<10mg/l) ≤10 1.00 (reference) 
 11-49 1.96 (0.73; 5.24) 
 ≥50 5.18 (2.11; 12.76) 
*
 The area under the ROC curve was 86% (95% CI: 82%-91%) 
†
 Group contains patients with right-sided and diffuse abdominal tenderness 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Nomogram to calculate the risk of acute left-sided diverticulitis (ALCD) in patients 
suspected of ALCD. Draw a vertical line for all the variables to the ‘Points’ axis on the top of the 
page. Sum the points for each variable and locate this on the ‘Total Points’ axis at the bottom of the 
page. Draw a vertical line from this spot on the ‘Total Points’ axis straight down to calculate the risk 
of ALCD. Age in years; Episodes: one or more previous episodes of diverticulitis; Tenderness: 
localization of pain by disease history, Left: pain lower left abdomen. Other: pain lower right 
abdomen and diffuse abdominal pain; CRP in mg/l; Symptoms: localization of pain by physical 
examination; Left: pain lower left abdomen; Diffuse: diffuse abdominal pain and Right: right-sided 
abdominal pain; Movement: aggravation of pain on movement.  
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Figure 3: The estimated probability of acute left-sided colonic diverticulitis (solid line) and the 95% 
confidence bands (broken lines) against the linear predictor. The 95% confidence interval is found by 
means of the vertical intersection with the broken lines at the point where the estimated probability 
intersects the solid line. For example the 95% CI of an estimated probability of 0.5 is (0.3-0.7). 
 
 
Discussion  
 
In this study, the majority of patients were misdiagnosed based on clinical evaluation 
alone. To improve clinical decision making, we studied the diagnostic value of 15 elements 
of the disease history, physical examination and laboratory tests in patients suspected of 
ALCD. The discriminating power of the different variables was generally low. Age, a 
previous episode of diverticulitis, tenderness in the lower left abdomen both as complaint 
and at physical examination, aggravation of pain on movement, CRP 50 or more and the 
absence of vomiting were found to be independent predictors of ALCD. A nomogram was 
built based on these variables with good diagnostic accuracy. Using this nomogram the 
probability of ALCD can be simply and reliably predicted in clinical practice. 
 
We selected patients with suspected ALCD in a large group of patients seen at the 
emergency department and admitted with acute abdominal pain. All patients underwent 
abdominal CT scan, which allowed us to differentiate between patients with and without 
suspected ALCD. The approach to match clinical findings in a large consecutive group of 
patients with CT outcome as gold standard has strengthened our results. Patient selection 
based on CT request forms, on the contrary, harbors a few limitations which should be 
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taken into account before generalizing our results. Most of our patients were referred to 
the emergency department by a general practitioner. Referral patterns differ between 
countries, resulting in differences in disease prevalence and patient population. A number 
of patients with suspected ALCD will be treated by the general practitioner and not 
referred to the emergency department, hence missed in our analysis. Also patients with 
minimal abdominal pain and no general signs of illness that are discharged from the 
emergency department without imaging and patients with acute abdominal pain in need 
for urgent surgery were not included in our analysis. There is a great variation in the 
intensity of symptoms at presentation of patients with suspected diverticulitis. Some 
patients can be treated on an outpatient basis where as others require hospitalization and 
medical treatment or surgery. The results of this study reflect a patient population with 
abdominal pain seen on the emergency department in a large University Hospital and 
apply to patients with suspected diverticulitis needing hospital admission. 
 
In our study clinical suspicion proved to be correct in only 43% of patients, demonstrating 
that the majority of patients were misdiagnosed on the basis of clinical decision making 
alone. Only two prospective studies report on diagnostic accuracy in colonic diverticulitis 
and correctly identified 64% and 68% of patients with diverticulitis based on clinical 
parameters alone.
9, 10
 Our misdiagnosis rate was higher compared to these two studies 
but is in accordance with previously published data of reported misdiagnosis rates varying 
between 34% and 68%.
3, 5, 14
 
 
In our study, overestimation of the number of patients with suspected ALCD might have 
occurred because doctors tend to write down a differential diagnosis on the CT request 
forms including ALCD. To minimize this problem, we crosschecked the medical records and 
found that all 287 patients were hospitalized with the entrance diagnosis ALCD. Diagnostic 
accuracy depends on the surgeon’s previous experience and should always be taken into 
account when interpreting clinical findings. In our study all patients were seen by junior- 
and senior residents but always supervised by an experienced surgeon. This approach 
minimizes the risk of lack of experience being the cause of a high misdiagnosis rate. Based 
on our findings, it seems to be a safe assumption that misdiagnosis rates in patients with 
suspected diverticulitis truly are high. 
 
Because of the high clinical misdiagnosis rates and the possibility that other diseases 
mimicking ALCD are missed, the view nowadays is that imaging is mandatory in the initial 
assessment of patients suspected of ALCD.
2, 15
 Ultrasound and CT are used in daily practice 
to complement clinical assessment and physical examination in diagnosing ALCD. The 
main disadvantages in case of US are operator-dependent factors and the emergence of 
inconclusive results that lead to further uncertainty in clinical decision making. 
Furthermore, US performs less in patients with high amounts of body fat.
16
 The main 
disadvantages of CT are that it requires ionizing radiation with a potential cancer risk and 
the use of intravenous contrast material.
6
 Although the disadvantages of additional 
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imaging are well known, little has been done to improve clinical decision making without 
the use of additional imaging techniques. 
 
This is the first study in which the diagnostic value of the different elements of disease 
history, physical examination and laboratory tests is analyzed for their contribution to the 
prediction of ALCD. Seven independent predictors for ALCD were found, by which 
variables of disease history and patient characteristics were the most contributing. Age, a 
previous episode of diverticulitis, tenderness in the lower left abdomen as complaint and 
at physical examination, aggravation of pain on movement, CRP 50 or more and the 
absence of vomiting were the most important clinical parameters to consider when 
differentiating ALCD from other acute abdominal conditions. Most of the individual 
variables alone did not have high discriminating power, but when combined, the 
discriminating power of the independent risk factors was improved to 86%. To use this 
finding in clinical practice the individual risk factors were translated into a nomogram. This 
nomogram can be used as a clinical scoring system that estimates the probability of ALCD 
in patients who are seen at the emergency department with acute abdominal pain and a 
clinical suspicion of ALCD. Accuracy of such a nomogram represents the most important 
consideration. To assess our model’s predictive accuracy we used the area under the ROC 
curve. Generally accepted accuracy ranges of a model are 70% to 80%.
17
 Even though our 
model can be considered a good prediction model (accuracy of 86% and 84% after internal 
validation), validation of the model and the proposed diagnostic algorithm in a different 
patient population is an important next research step. 
 
The optimal sensitivity and specificity of the ROC curve in our study were 77% and 85%, 
respectively. The specificity of our model can compete with that of US (90%), as found in a 
recent meta-analysis.
11
 Specificity of CT in this study was higher (99%), but did not 
significantly differ from US. Sensitivity of US and CT reached 92% and 94%, respectively, in 
the meta-analysis as compared with 77% of the nomogram. It should be realized that 
these sensitivities and specificities come from meta-analyses having included the best 
available evidence. Sensitivity of our model is expectedly lower than that of additional 
imaging, but still far better than based on clinical assessment alone. The big advantage of 
CT, over US or the nomogram, is the better identification of alternative diagnoses and CT 
better demonstrates the extent of the disease in case of complicated diverticulitis. Our 
model provides an accurate prediction of the chance of having ALCD but in case of a low 
chance of ALCD the model cannot predict which other disease is present. On the contrary, 
in case of a high chance of ALCD based on the nomogram, additional imaging may not be 
needed. The nomogram can be of help in determining the risk of ALCD and the decision 
for further investigation and treatment. 
 
This study showed that the clinical diagnosis diverticulitis is difficult to make but can be 
improved by the use of a clinical scoring system. Elements of disease history, physical 
examination and laboratory tests provide important diagnostic information and when put 
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into a nomogram a reliable prediction can be made of the chance of having ALCD. These 
variables should therefore be included in the diagnostics workup and integrated into the 
clinical assessment of patients suspected of having acute colonic diverticulitis. In case of a 
high chance of ALCD based on the nomogram, additional imaging may not be needed. 
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Letter to the Editor: 
  
The role of abdominal imaging in cases with a high probability of acute 
left-sided colonic diverticulitis based on a clinical scoring system 
 
Andeweg, et al.
1
 have proposed a clinical scoring system for the diagnosis of acute left-
sided colonic diverticulitis (ALCD), which was shown to improve clinical diagnosis rates 
with the help of a nomogram. This is undoubtedly a useful clinical tool expected to reduce 
misdiagnosis rates for diverticulitis after further validation in prospective studies. We 
would like, however, to point out two significant limitations of this study. 
 
First, the authors have expectedly identified the history of previous episodes of 
diverticulitis as an independent predictor of the risk of ALCD, with the highest odds ratio in 
multivariate logistic regression analysis. However, a positive or negative history of left-
sided diverticular disease without signs of diverticulitis has not been included in their 
analysis. With the increasing use of colonoscopy as a screening tool for colorectal cancer 
above the age of 50 years and given that diverticulosis and diverticulitis are associated 
with advanced age, more patients are expected to be aware of the presence or absence of 
asymptomatic diverticular disease. A positive history of left-sided diverticulosis may 
facilitate clinical differentiation in cases of suspect clinical presentation, whereas a 
negative history in a recent lower endoscopy may strongly influence clinical diagnosis 
against diverticulitis. In our opinion, history of asymptomatic left-sided diverticular disease 
should have been included in multivariate analysis and probably in the construction of this 
useful nomogram in case of an associated high diagnostic value. 
 
Second, the authors have stressed the use of their clinical scoring system as a clinical 
adjunct to diagnose ALCD, but also as an approach to restrict the use of additional 
imaging, i.e. ultrasound and abdominal computed tomography (CT), in selected cases with 
high probability of ALCD as calculated by linear prediction. Although their clinical scoring 
system bears relatively high sensitivity and specificity rates, a more thorough assessment 
of its utility in clinical decision-making might, interestingly, reveal an enhanced role for CT 
imaging. Imaging with abdominal CT upon admission for ALCD has been so far strongly 
recommended
2
 to demonstrate the severity, the local extent of the disease and the 
presence of possible complications with the exception of patients presenting with diffuse 
peritonitis. The authors suggest that additional imaging may not be needed in cases with a 
high chance of ALCD based on the nomogram. However, abdominal imaging provides 
significant information for the management of these patients through classification in 
appropriate treatment groups, i.e. conservative therapy vs. percutaneous drainage of a 
pericolic abscess vs. surgery,
3
 and affects the duration and cost of hospitalization. 
Moreover, the severity of ALCD on CT imaging has been previously shown to be predictive 
of the risk of nonoperative treatment failure and secondary long-term complications after 
the initial episode.
4, 5
 In fact, patients with a high probability of ALCD constitute a group 
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which will mostly benefit from abdominal CT from a clinical aspect, ensuring that they will 
receive the most appropriate treatment. Therefore, we believe that the nomogram 
presented in this study could be really useful for the selection of patients who actually 
need additional imaging between those that present with acute abdominal pain and 
suspect ALCD in the emergency department. In other words, the diagnosis of ALCD in a 
case with high probability based on the nomogram should be documented and further 
investigated with abdominal CT. However, a valuable clinical tool has emerged from this 
study and we would like to compliment the authors for their contribution in a clinical 
condition with high misdiagnosis rates. 
 
Nikolaos P. Karidis, MD  
Dimitrios Dimitroulis, PhD 
Gregory Kouraklis, PhD 
Second Department of Propedeutic Surgery, Medical School, University of Athens, Greece 
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Reply 
 
We are pleased to have the opportunity to respond to the letter to the editor and would 
like to thank Dr. Karidis and his colleagues for the interest in our work. The nomogram was 
developed based on the scientific question whether or not the clinical diagnosis acute 
colonic left-sided diverticulitis (ALCD) could be improved by the use of a scoring system, 
similar to the way clinical scoring systems have been developed to diagnose acute 
appendicitis. Based on the nomogram we aim to develop a structured algorithm for 
further investigation and treatment of patients with ALCD, and therefore we highly 
appreciate to exchange views with other experts in the field on how we could improve the 
nomogram and thereby the work-up of patients with ALCD. 
 
The authors suggest including the presence or absence of asymptomatic diverticular 
disease in the multivariate analysis and in case of an associated high diagnostic value to 
use this in the nomogram. This suggestion has merit because a patient needs to have 
diverticulosis to develop diverticulitis and in literature, an estimated 10-25% risk of 
diverticulitis in patients with asymptomatic diverticulosis has been reported. However, the 
suggestion of the authors raises the question how to establish asymptomatic diverticular 
disease, e.g., when a patient has no complaints. Routine screening colonoscopy for this 
diagnosis is not done and screening for (pre)malignancies has only recently started in The 
Netherlands and many other countries. Including absence or presence of asymptomatic 
diverticulosis in the nomogram will imply blank spots in a considerable amount of 
patients. We also believe that the presence or absence of asymptomatic diverticulosis is 
already partly reflected in the variable age, being an independent predictor of ALCD in our 
study. Asymptomatic diverticulosis increases with age and is estimated less than 10% in 
young patients (<40 years) and increases to 65-70% in patients above 65 years of age.
1
 As 
a result, the risk of developing ALCD will increase with advancing age, as confirmed in our 
study; a four times higher risk of developing ALCD in the group of patients older than 50 
years of age. We could safely assume that with advancing age the risk of asymptomatic 
diverticulosis and the risk of developing ALCD will increase.  
 
The authors also advocate a more prominent role of CT imaging in case of a high likelihood 
of ALCD based on the clinical scoring system. Although CT imaging plays a major role in 
staging the severity of the disease and may even be predictive of the risk of nonoperative 
treatment failure and secondary long-term complications after the initial episode, in most 
patients with first or recurrent episodes of ALCD the disease will run a benign course. 
These patients, if diagnosed with a high degree of probability based on the nomogram are 
not expected to gain from additional imaging and can be withheld, in our opinion, from 
additional imaging from a diagnostic point of view. Moreover, the latest insight on the 
natural history of diverticulitis has shown that most perforations do not occur after 
recurrences, but at the first attack of diverticulitis. In case of suspected complicated ALCD, 
a CT scan is indicated to adequately stage the severity of the disease and to initiate proper 
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treatment and to classify patients in appropriate treatment groups, i.e., conservative 
therapy versus percutaneous drainage of abscesses or surgery.  
 
Finally, we would like to mention the external validation study in which the nomogram 
was validated in another Dutch database provided by Laméris et al. They prospectively 
enrolled 1021 consecutive patients presenting at the Emergency Department with acute 
abdominal pain and found similar variables that have the best predictive value in 
diagnosing ALCD. Based on the variables with the highest discriminating power they 
developed a clinical decision rule.
4
 Both predictive tools were used crosswise for external 
validation and in addition were validated in a third independent cohort provided by Laurell 
et al.
5
 Despite the fact that the two recent predictive tools have been developed 
independently, both analyses ended up with the same variables that have the best 
predictive value in diagnosing acute ALCD. Preliminary results of this unpublished study 
showed that isolated left tenderness in the lower left abdomen, CRP >50 and the absence 
of vomiting have significant predictive value in patients with suspected ALCD. With 
additional variables present (older age, pain on movement, previous episodes of 
diverticulitis) the certainty of the diagnosis can be increased. Hopefully, the combination 
of these variables will proof to be useful in limiting the use of CT imaging to diagnose 
ALCD. A future study prospectively evaluating patients with acute abdominal pain 
subjected to the externally validated nomogram, will give more insight in the use of these 
variables in reducing the use of abdominal CT imaging to diagnose diverticulitis. It might 
be worthwhile to introduce asymptomatic diverticulitis as a covariate in this study. 
 
Caroline S. Andeweg, MD 
Robert P. Bleichrodt, MD 
Harry van Goor, MD 
Department of Surgery, Radboud University Nijmegen Medical Centre, The Netherlands  
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Abstract 
 
Aim 
The aim of this study was external of the validation and comparison diagnostic accuracy of 
two predictive tools, the emergency department triad and the clinical scoring tool in 
diagnosing acute diverticulitis. 
 
Methods 
The two derivation datasets were used crosswise for external validation. In addition, both 
tools were validated in a third independent cohort. Predictive values were reassessed and 
the Area Under the Curve expressed discriminatory capacity. Performance was compared 
by calculating positive predictive values of the emergency department triad in the 
validation cohorts and with a cut-off analysis for the clinical scoring tool at a positive 
predictive value of 90%.  
 
Results 
Predictive value of the emergency department triad was comparable to the clinical scoring 
tool. The positive predictive value of the emergency department triad (97%) decreased in 
the clinical scoring tool cohort (81%) and was excellent in the independent cohort (100%), 
identifying 24%, 20% and 14% of the patients. A smaller proportion of patients with 
diverticulitis could be identified with the clinical scoring tool (6%, 19% and 9%). 
 
Conclusion 
The emergency department triad as well as the clinical scoring tool has significant 
predictive value in external cohorts of patients suspected of diverticulitis. These tools can 
be used to select patients in whom additional imaging to diagnose acute diverticulitis may 
be omitted. 
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Introduction 
 
Acute colonic diverticulitis is a frequently encountered diagnosis in patients presenting at 
the Emergency Department (ED) with acute abdominal pain.
1, 2
 Early distinction from 
other diagnoses is of great value since treatment of acute diverticulitis is conservative in 
the majority of cases. Hence, adequate and timely diagnosis could prevent needless 
additional imaging or hospitalization and therefore costs, but most of all reduce the 
burden on the patient. Although stated in guidelines that the diagnosis often can be made 
by clinical evaluation
2
, additional diagnostic imaging is widely used in patients with 
suspected acute diverticulitis.
3, 4
 Several studies endorse the feeling of clinicians that the 
current clinical evaluation is not adequate, expressed in wrongful diagnosis of diverticulitis 
of up to 40%.
5, 6
  
 
Two recent studies, published almost simultaneously, developed a predictive tool that can 
increase the diagnostic accuracy and reliability of the clinical diagnosis of acute colonic 
diverticulitis. Both predictive tools increase the diagnostic accuracy of the clinical 
evaluation. Laméris et al. constructed a decisional rule consisting of three questions.
1
 
These questions address elements of disease history, physical examination and laboratory 
tests. The aim of this decisional triad is to have a high diagnostic accuracy for patients 
suspected of diverticulitis and rule out those with other causes of acute abdominal pain. 
Andeweg et al. used a slightly different approach and looked at the diagnostic value of a 
variety of elements of disease history, physical examination and laboratory tests.
7
 
Herewith, a scoring system has been constructed that attributes points to the separate 
elements of clinical evaluation that are independent predictors resulting in a probability of 
having acute diverticulitis. Before any predictive tool, be it a scoring system or a decisional 
rule, can be propagated for widespread use it should be tested in other data sets than it 
was developed in, also known as external validation.
8-12
 External validation enhances the 
general applicability and can address historical, geographic and methodological 
differences.
10
 External validation of these two recently developed predictive tools may 
further increase the diagnostic accuracy of the clinical diagnosis of acute diverticulitis and 
minimizes unnecessary imaging.  
 
Therefore, the aim of this study was external validation and comparison of the diagnostic 
accuracy of the decisional rule and the scoring system. If one of these tools or both 
perform well in external validation it becomes possible to minimize unnecessary imaging 
to diagnose diverticulitis and thereby reduce patient burden and healthcare utilization. 
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Material and methods 
 
Data 
Laméris et al. prospectively enrolled consecutive patients with acute abdominal pain 
presenting at the Emergency Department (ED) in a multicenter diagnostic accuracy study 
between March 2005 and November 2006.
1, 13
 With this dataset the ‘ED triad’ was 
constructed to diagnose patients with acute diverticulitis. Only patients in whom 
additional imaging was deemed necessary after clinical evaluation were included and 
these patients received a full diagnostic protocol (plain X-ray, ultrasound and CT). For the 
development of the ED triad, patients were selected from the study cohort when patients 
were suspected of having acute diverticulitis. 
 
Andeweg et al. retrospectively enrolled consecutive patients admitted to the hospital with 
a clinical suspicion of acute diverticulitis to develop their clinical scoring system (‘CS 
tool’).
7
 The patients were admitted between January 2002 and March 2006 and in every 
patient abdominal computed tomography (CT) was performed to diagnose acute 
diverticulitis.  
 
Laurell et al. enrolled consecutive patients with acute abdominal pain presenting at a 
single hospital between February 1997 and June 2000.
14
 In this independent cohort (‘IND 
cohort’) the clinical presentation of acute diverticulitis was described and the natural 
history characterized in the short perspective.
14
 The aim of this study was not to evaluate 
the predictive value of variables from the disease history, physical examination and 
laboratory tests. Therefore, in the current study only those patients were used with 
complete data sets to allow validation of the two tools.  
 
The two derivation datasets of each tool (ED triad and CS tool) were used to perform a 
crosswise external validation. Crosswise validation indicates the use of the data of the ED 
triad cohort to externally validate the CS tool and vice versa. In addition, the two tools 
were externally validated on a third, independent dataset (IND cohort). All statistical 
analyses were performed using SPSS® version 18 and SAS® version 9.1.  
 
Study characteristics 
Thorough assessment of differences in the included population, definition of outcome and 
data acquisition in the three cohorts was essential to evaluate the diagnostic performance 
of the ED triad and the CS tool. Prevalence of diverticulitis, severity of diverticulitis 
(Hinchey classification), gender, admission rate and the performance of acute/subacute 
surgery were compared between the different cohorts with chi
2
 tests. Median age and 
hospital stay were compared with Kruskall-Wallis tests. To gain further insight in the 
differences between the study populations, the frequencies of the variables of both 
predictive tools were compared. 
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ED triad 
The ED triad comprehends three variables; tenderness exclusively in the lower left 
quadrant (LLQ) on physical examination, absence of vomiting and elevated serum C-
reactive protein (CRP) >50mg/l. The rule is positive when these variables are present 
simultaneously and indicative for diverticulitis. The predictive value of the variables 
expressed in odds ratios (OR’s), was calculated in the derivation dataset (ED triad cohort) 
and recalculated in the validation datasets (CS tool cohort and the IND cohort) with a 
multivariable regression analysis to provide insight in the relative weight of each variable 
in the triad. The discriminatory capacity of the ED triad was expressed by calculating the 
Area Under the Curve (AUC) with the 95% confidence interval (CI). The AUC indicates how 
well a model distinguishes patients with a high probability of having diverticulitis from 
patients with a low probability of having diverticulitis. The value of the AUC varies 
between 0.5 (no extra information above chance), and 1 (indicating perfect discrimin-
ation).  
 
The ED triad was developed to have a high positive predictive value to select patients with 
uncomplicated diverticulitis rendering additional imaging unnecessary. Performance of 
the triad was therefore evaluated in the validation cohorts by calculating the positive 
predictive value, the negative predictive value, sensitivity and specificity. If present, 
patients rendered false positive were described in detail. These patients are of special 
interest since they might be wrongfully withheld from additional diagnostic tests delaying 
adequate treatment. Primary analyses were done in patients with complete datasets. 
Since the ED triad has three variables and the CS tool has seven, the ED triad can be 
evaluated in more patients of the IND cohort because there are fewer patients with 
missing data. To evaluate consistency of results separate analysis of the ED triad was 
performed with these additional patients from the IND cohort.  
 
CS tool  
The CS tool includes seven variables; age (two categories), previous episodes of 
diverticulitis, localization of symptoms, aggravation of pain on movement, localization of 
tenderness on physical examination, vomiting or not and serum CRP (divided into three 
categories). Similar to the ED triad the predictive value of each variable in the derivation 
dataset (CS tool cohort) was compared to the value in the validation datasets (ED triad 
cohort and IND cohort) to gain insight in the most consistent and strongest contributing 
variables. Discriminatory capacity was quantified with the AUC and the 95% CI. 
 
Diagnostic accuracy of the CS tool was evaluated by calculating individual probabilities in 
the derivation cohort. To allow comparison of the diagnostic accuracy of the CS tool with 
the ED triad, a cut-off was chosen to resemble the aim of the ED triad, namely to have a 
high positive predictive value (PPV). The value of the cut-off analysis was set at a 
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calculated probability of 90% to correspond with a PPV of around 90%. The individual 
probabilities in the validation datasets were calculated using the original values obtained 
with the regression analysis of the derivation dataset. However, the CS tool was adjusted 
based on the background prevalence of diverticulitis which is likely to differ between the 
cohorts. To express discriminatory capacity of the CS tool, AUC’s with 95% CI’s were 
calculated with univariable logistic regression analyses of the individual probabilities. 
Furthermore, the probabilities were used to calibrate the CS tool. Calibration refers to the 
agreement between predicted presence of acute diverticulitis and the observed rates. The 
predicted prevalence of diverticulitis per decile of patients was plotted against the ob-
served prevalence in the validation cohorts. 
 
 
Results 
 
Study characteristics 
Patient and study characteristics of the three cohorts are displayed in Table 1. There was a 
substantial difference in selection of patients between the studies. In the ED triad cohort 
patients were included only whenever additional imaging was deemed necessary based on 
the clinical judgment of the attending physician, whereas in the IND cohort all patients 
with acute abdominal pain were included. Patients included in the ED triad derivation 
cohort and the IND cohort, where patients presented at the ED with acute abdominal pain 
and data were prospectively assessed. Thereby, also false-negatives had been included in 
these study cohorts. As a result of the retrospective identification of patients in the CS tool 
derivation cohort, patients not suspected of having diverticulitis, but with a final diagnosis 
of diverticulitis were not included (i.e., the false negatives of the clinical diagnosis 
‘diverticulitis’ had not been included in the cohort). Furthermore, in the CS tool cohort, 
patients were only included whenever hospital admission was deemed necessary.  
  
The final diagnosis in all patients of the ED triad cohort was established in consensus by an 
expert panel after six months of follow-up, based on all available clinical information. In 
the CS tool cohort CT was considered the gold standard for diagnosing acute diverticulitis 
in case of non-operative management. Pathology- and operative reports were used as 
gold standard in case of operative treatment. In case of another diagnosis than 
diverticulitis, CT findings and medical records were used to determine the final diagnosis 
during follow-up. The final diagnosis in the IND cohort had been established by its study 
coordinator with all clinical information available in a follow-up period of at least one year 
(up to three years). One-hundred and three patients of the 145 patients suspected of 
having diverticulitis in the IND cohort were included in the current study due to missing 
data in the remaining 42 patients. An additional separate analysis of the ED triad was 
performed in 126 patients of the IND cohort to examine consistency of results. Twenty-
three additional patients could be included since they had complete data for the 
evaluation of the ED triad but missing data to evaluate the CS tool. The prevalence of the 
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final diagnosis of diverticulitis was significantly different between the ED triad cohort 
(63%), the CS tool cohort 43% and the IND cohort (56%) (p=0.01). Diverticulitis was more 
severe in the CS tool cohort where 33% of patients had complicated diverticulitis (Hinchey 
classification ≥2) compared to 8% of patients in the ED triad cohort and 5% in the IND 
cohort (p<0.01). Median age did not differ between patients with a final diagnosis of 
diverticulitis and those that had another final diagnosis in the ED triad and CS tool cohort. 
However, patients were slightly older in the IND cohort compared to the two derivation 
cohorts (p<0.01). 
 
Table 1: Comparison of study and patient characteristics between the emergency department triad 
derivation cohort, the clinical scoring tool derivation cohort and the independent cohort 
 
 ED
a
 triad cohort CS
b
 tool cohort IND
c
 cohort 
Study characteristics    
Patient selection Prospective inclusion of 
patients with acute 
abdominal pain for >2 hours 
and less than 5 days, 
warranting additional 
radiological examination 
Retrospective inclusion of 
patients admitted to the 
hospital with acute 
abdominal pain and clinical 
suspicion of acute 
diverticulitis based on the CT 
application form 
Prospective inclusion of 
patients with acute abdominal 
pain for <7 days 
Reference standard Expert panel consensus 
based on all available clinical 
information obtained in a 
follow-up of 3 months 
In case of non-operative 
treatment CT was reference 
standard, whenever the final 
diagnosis was not 
diverticulitis, CT findings  
were complemented with  
the medical chart to execute 
as reference standard 
All available clinical 
information obtained in a 
follow-up period of at least 1 
year up to 3 years was used to 
establish the final diagnosis by 
the first author 
Patient characteristics       
 
 
No  
diverticulitis 
Diverticulitis No 
diverticulitis 
Diverticulitis No 
diverticulitis 
Diverticulitis 
N patients 46 80 163 124 45 58 
Age
d
 54 (43-66) 58 (50-70) 53 (40-67) 59 (51-68) 67 (54-76) 62 (52-75) 
Gender (% female) 67% 56% 63% 60% 78% 67% 
Admission rate 59% 55% 100% 100% 87% 95% 
Hospital stay
d
 4 (3-8) 5 (4-7) not recorded 6 (4-12) 3 (2-5) 3 (2-4) 
Hinchey class ≥2 (%) na
e
 6 (8%) na
e
 41 (33%) na
e
 3 (5%) 
Acute/subacute 
colonic surgery for 
diverticulitis 
na
e
 13 (16%) na
e
 31 (25%) na
e
 1 (2%) 
a
 Emergency department 
b
 Clinical scoring 
c
 Independent 
d
 Median an interquartile range 
e
 Not applicable 
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Table 2 displays the frequencies of all the variables included in both tools. All three 
variables in the ED triad are part of the CS tool be it with minor adjustments. A history of 
one or more previous episodes of diverticulitis is part of the CS tool. However, it was not 
recorded in the ED triad derivation cohort prohibiting the display of the frequencies. 
Moreover, the lack of this information compels to perform the external validation without 
this variable. Apart from some variance, patterns of frequencies were consistent between 
the ED triad, CS tool and IND cohort for age, tenderness in the lower left quadrant on 
physical examination, anamnestic localization of pain, CRP and absence of vomiting. Pain 
on movement was the only variable that showed an opposite distribution between the ED 
triad cohort and the CS tool and IND cohorts in patients with and without diverticulitis. 
   
Table 2: Frequencies of variables included in both predictive tools 
 
 ED
a
 triad cohort CS
b
 tool cohort IND
c
 cohort 
Variables in ED
a
 triad and CS
b
 tool   
 
 
No  
diverticulitis 
Diverticulitis No 
diverticulitis 
Diverticulitis No 
diverticulitis 
Diverticulitis 
N patients 46 80 163 124 45 58 
Age >50 years 59% (27) 74% (59) 57% (93) 78% (97) 78% (35) 85% (49) 
Previous episode(s) not reported not reported 7% (11) 35% (44) 44% (18)
d
 61% (35)
d
 
Tenderness LLQ
e
  13% (6) 49% (39) 33% (53) 73% (90) 22% (10) 52% (30) 
CRP
f
       
 - ≤10 (reference) 28% (13) 1% (1) 28% (46) 11% (14) 51% (23) 14% (8) 
 - 11-49 39% (18) 18% (14) 27% (44) 21% (26) 16% (7) 19% (11) 
 - ≥50 33% (15) 81% (65) 45% (73) 68% (84) 33% (15) 67% (39) 
Pain localization history      
 - RLQ
g
 (reference) 11% (5) 5% (4) 27% (44) 5% (6) 20% (9) 28% (16) 
 - LLQ
e
 20% (9) 50% (40) 27% (44) 65% (81) 29% (13) 57% (33) 
 - Diffuse/Other 70% (32) 45% (36) 46% (75) 30% (37) 51% (23) 16% (9) 
Pain on movement 46% (21) 43% (34) 33% (53) 59% (73) 44% (20) 53% (31) 
Absence of vomiting 61% (28) 95% (76) 66% (108) 80% (99) 73% (33) 91% (53) 
a
 Emergency department 
b
 Clinical scoring 
c
 Independent 
d
 Unknown for four patients in the no diverticulitis group and one in the diverticulitis group, percentages were calculated 
without these patients 
e
 Left lower quadrant  
f
 C-reactive protein  
g
 Right lower quadrant 
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ED triad 
Table 3 displays the relative weight and predictive value of the three variables of the ED 
triad in the derivation cohort as well as in its validation cohorts (CS tool cohort and IND 
cohort). In the derivation cohort the absence of vomiting was the most important 
predictive variable with an odds ratio (OR) of 16.32 (95% CI: 3.70-72.07) while it was the 
least important variable in the CS tool cohort where the OR was 2.12 (95% CI: 1.14-3.93). 
For all three variables the predictive value in the validation cohorts was less than in the 
derivation cohort. This is illustrated by the difference in discriminatory capacity expressed 
in the AUC that was good in the ED triad derivation cohort (0.86, 95% CI: 0.80-0.93) versus 
fair in the CS tool cohort (0.77, 95%CI: 0.72-0.83) and the IND cohort (0.73, 95%CI: 0.63-
0.82).  
 
Out of the 30 patients in the derivation cohort (24% of the cohort) of which the ED triad 
was positive, 29 had a final diagnosis of diverticulitis. This makes the performance of the 
ED triad highly adequate with a PPV of 97% (Table 4). However, two of the patients who 
would not have received imaging based on a positive outcome of the rule, had 
complicated diverticulitis warranting operative intervention. In the CS tool cohort all three 
variables were present simultaneously in 57 patients making up 20% of the total cohort 
(Table 4). Of these, 11 patients did not have a final diagnosis of diverticulitis, resulting in a 
PPV of 81%. In at least five of them, delay of treatment as a result of refrained imaging 
could have had serious consequences (acute appendicitis, adnexitis, anastomotic leakage, 
two tumors of the sigmoid). Of the remaining 46 patients who did have diverticulitis 7 had 
complicated diverticulitis warranting an intervention. The ED triad was positive in 14 out 
of 103 patients in the IND cohort (14% of the cohort). The PPV of the ED triad was 100% so 
no patients with a positive triad had an alternative final diagnosis other than diverticulitis 
(Table 4). The separate analysis including the additional patients with complete data 
(N=126) from the IND cohort show similar results. The AUC of the ED triad is the same as 
in the primary analysis with slightly different confidence intervals (0.73, 95% CI: 0.64-
0.81). The ED triad was positive in 17 out of 126 patients identifying 13% of the cohort. 
The NPV (51%, 95% CI: 42%-61%), sensitivity (22%, 95% CI: 14%-33%) and specificity (97%, 
95% CI: 88%-99%) were comparable as well. The PPV was lower (88%, 95% CI: 66%-97%) 
than in analysis of the IND cohort with 103 patients. In the separate analysis two patients 
were classified false positive having nonspecific abdominal pain as final diagnosis.  
 
CS tool 
The predictive value of the six available variables of the CS tool was recalculated in the 
derivation cohort with a multivariable regression analysis since the variable ‘previous 
episodes’ was not recorded in the ED triad cohort. Table 3 displays the regression 
coefficients and OR’s of the CS tool in the derivation cohort as well as in its validation 
cohorts (ED triad cohort and IND cohort). In the derivation cohort and in the IND cohort 
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pain on movement is predictive for diverticulitis (OR; 4.00, 95% CI; 2.15-7.42 and 1.98, 
95% CI; 0.70-5.60), whereas in the ED triad cohort it is predictive for not having 
diverticulitis (OR; 0.60, 95% CI; 0.21-1.77). The predictive value of age, CRP and absence of 
vomiting was higher in the validation cohorts. Only the reported localization of the pain 
had less predictive value than in the derivation cohort. Furthermore, localization of pain in 
the LLQ on examination had a higher predictive value in the ED triad cohort but less 
predictive value in the IND cohort. The multivariable discriminatory capacity without fixed 
regression coefficients was good in the CS tool derivation cohort (AUC; 0.84, 95% CI; 0.80-
0.89), and even somewhat higher in the ED triad and IND cohorts (AUC; 0.89, 95% CI; 0.82-
0.95 and 0.85, 95% CI; 0.78-0.92). 
 
Table 3: Odds ratios with 95% confidence intervals of the variables of the emergency department 
triad and the clinical scoring tool in the derivation cohorts and the independent cohort 
 
 ED
a
 triad cohort CS
b
 tool cohort IND
c
 cohort 
 OR
d
 95% CI
e
 OR
d
 95% CI
e
 OR
d
 95% CI
e
 
ED
a
 triad       
Intercept 0.03 na
f
 0.08 na
f
 0.18 na
f
 
CRP
g
 >50  8.98 3.43-24.13 3.84 2.18-6.79 2.98 1.22-7.30 
Tenderness LLQ
h 
 6.21 1.96-19.73 6.41 3.66-11.22 3.86 1.54-9.69 
Absence of vomiting 16.32 3.70-72.07 2.12 1.14-3.93 3.58 1.03-12.49 
AUC
i
 (95% CI
e
) 0.86 (0.80-0.93) 0.77 (0.72-0.83) 0.73 (0.63-0.82) 
       
CS
b
 tool       
Intercept 0.00 na
f
 .006 na
f
 .049 na
f
 
Age >50 years 2.43 0.79-7.52 2.28 1.17-4.45 2.58 0.70-9.50 
Tenderness LLQ
h
 3.44 0.60-19.63 3.42 1.69-6.92 2.02 0.53-7.70 
CRP
g
       
 - ≤10 (reference) 1.0 na
f
 1.0 na
f
 1.0 na
f
 
 - 11-49 19.14 1.57-232.78 1.80 0.72-4.52 2.62 0.60-11.34 
 - ≥50 116.06 9.52-1415.49 4.71 2.04-10.84 7.50 2.34-24.07 
Pain localization history      
 - RLQ
j
 (reference) 1.0 na
f
 1.0 na
f
 1.0 na
f
 
 - LLQ
h
 2.34 0.22-24.98 7.94 2.50-25.18 0.87 0.20-3.87 
 - Diffuse 1.03 0.15-7.09 3.50 1.20-10.25 0.15 0.04-0.61 
Pain on movement 0.60 0.21-1.77 3.99 2.15-7.42 1.98 0.70-5.60 
Absence of vomiting 20.26 4.20-97.77 2.10 1.06-4.13 4.79 1.16-19.88 
AUC
i
 (95% CI
e
) 0.89 (0.82-0.95) 0.84 (0.80-0.89) 0.85 (0.78-0.92) 
a
 Emergency department 
b
 Clinical scoring 
c
 Independent 
d
 Odds ratio 
e
 Confidence interval 
 
f
 Not applicable 
g
 C-reactive protein  
h
 Left lower quadrant 
I
 Area Under the Curve in the Receiver Operating Characteristics curve 
j
 Right lower quadrant 
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Only 18 (6%) patients in the CS tool cohort had a probability above 90%. Two of these did 
not have diverticulitis. As a consequence the 90% probability cut-off value corresponded 
with a PPV of 89% (Table 4). With fixed values for the variables of the CS tool and 
adjustment to differences in prevalence of diverticulitis the AUC was good in the ED triad 
cohort (0.81, 95% CI; 0.73-0.89) and fair in the IND cohort (0.71, 95% CI; 0.61-0.81). 
Without adjustment of the CS tool to differences in prevalence it systematically 
underestimated the probability of diverticulitis. Figure 1 depicts this calibration and shows 
improved calibration after adjustment of the model especially in the ED triad cohort. After 
adjustment of the intercept the CS tool assigned a probability of >90% to 24 (19%) of the 
patients in the ED triad cohort and 9 (9%) in the IND cohort. The PPV was 92% in the ED 
triad cohort and 89% in the IND cohort (Table 4). 
 
Table 4: Performance parameters with 95% confidence intervals of the emergency department triad 
and the clinical scoring tool at a cut-off predicted probability of 90% in the three cohorts 
 
 ED
a
 triad cohort CS
b
 tool cohort IND
c
 cohort 
 % (95% CI
d
) % (95% CI
d
) % (95% CI
d
) 
ED
a
 triad    
PPV
e
 97 (83-99) 81 (69-89) 100 (78-100) 
NPV
f
 47 (37-57) 66 (60-72) 51 (40-61) 
Sensitivity 36 (27-47) 37 (29-46) 24 (1-37) 
Specificity 98 (89-100) 93 (88-96) 100 (92-100) 
Patients identified 24 20 14 
CS
b
 tool    
PPV
e
 92 (74-98) 89 (67-97) 89 (57-98) 
NPV
f
 76 (67-84) 67 (60-72) 47 (37-57) 
Sensitivity 48 (34-62) 17 (11-26) 14 (7-25) 
Specificity 98 (91-99) 99 (95-100) 98 (88-100) 
Patients identified 19 6 9 
a
 Emergency department 
b
 Clinical scoring 
c
 Independent 
d
 Confidence interval 
e
 Positive predictive value 
f
 Negative predictive value 
 
 
Discussion  
 
The performance of a predictive tool is prone to be overestimated in the derivation 
cohort. That is why external validation is of crucial importance prior to widespread use in 
daily clinical practice. Validation of tools in as many different settings as possible creates 
insight in the applicability and reliability. Therefore, we included not only the crosswise 
external validation, but also an independent cohort (IND cohort) for external validation. 
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This cohort especially provides more information about where the differences found in 
predictive capacity originate. For instance, the diagnostic performance of both tools was 
better in the ED triad and IND cohort then in the CS tool cohort. This finding suggests that 
there is a systematic difference between the three cohorts influencing the predictive 
capacity. We propose that the described study characteristics and more specifically 
patient selection plays a major role. In the CS tool cohort patients are all hospitalized, 
whereas in the ED triad and the IND cohort this is not a selection criterion. Logically, 
patients needing admittance to the hospital are in worse condition than those who are 
treated on an outpatient basis. This is illustrated in the comparison of the Hinchey 
classification of the cohorts; a third (33%) of the patients in the CS tool cohort has 
complicated diverticulitis compared to only 8% in the ED triad cohort and 5% in the IND 
cohort. Patients with a higher Hinchey classification are more frequently in need of acute 
interventions. The disadvantage of predictive tools is that they do not only have to 
distinguish between the presence of illness and no illness, but also have to distinguish 
between diverticulitis and other abdominal conditions, for instance appendicitis. Not only 
were the patients in the CS tool cohort with a final diagnosis of diverticulitis more severely 
ill, but it is plausible that the patients with a different final diagnosis in this cohort were 
also more severely ill and that they had more acute underlying abdominal conditions 
needing intervention. The increasing difficulty to distinguish between the more severely ill 
patients is illustrated in Table 1 where the differences between patients with and without 
diverticulitis are smaller in the CS tool cohort then in its validation cohorts (ED triad cohort 
and IND cohort). There is substantial variance in the OR’s of the variables included in both 
tools across the different cohorts. Most striking is the high predictive value of CRP levels 
>50mg/l and absence of vomiting in the ED triad cohort compared to the other two 
cohorts who have more similar OR’s. Disease severity of the cohorts might play a role, 
however it cannot fully account for the differences found since the ED triad cohort and the 
IND cohort are more alike in terms of disease severity compared to the CS tool cohort. 
Differences in the way clinicians identify patients to be suspected of having acute 
diverticulitis could have led to selection bias. For example, the way primary care is 
organized differs between countries (ED triad cohort and CS tool cohort versus IND 
cohort), which might have influenced patient selection. Unfortunately a large part of this 
selection process is not well described, so most factors remain elusive. The separate 
analysis of the ED triad with additional patients in the IND cohort illustrates that the 
performance of the model is consistent with the same AUC and comparable NPV, 
sensitivity and specificity. Only the PPV was lower in than in the primary analysis (88% 
versus 100%) because of two false positive classifications. However, as these two patients 
had nonspecific abdominal pain as their final diagnosis they did not warrant direct 
imaging. The aim of both predictive tools was to aid the clinical diagnosis and primarily 
prevent unnecessary additional imaging. However, to be useful in clinical practice the tool 
must be applicable to a substantial proportion of patients suspected of diverticulitis. The 
ED triad identified a more substantial part of patients (24% in the ED triad cohort, 20% in 
the CS tool cohort and 14% in the IND cohort) with high positive predictive values in the 
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ED triad cohort (97%) and the IND cohort (100%). However, in the CS tool cohort the PPV 
was only 81% which is substantially lower than the PPV of the CS tool in all three cohorts 
(CS tool cohort 89%, ED triad cohort 92%, IND cohort 89%). The CS tool fell short in 
identifying a substantial proportion of patients with diverticulitis; only 6% in the derivation 
cohort, 19% in the ED triad cohort and 9% in the IND cohort. Two surveys revealed that 
surgeons would use imaging in 8 out of 10 (87% and 72%, respectively) patients suspected 
of diverticulitis.
3, 4
 On average the ED triad identifies 19% of patients which would result in 
a 15% decrease of imaging, while the CS tool identifies 11% and thus would reduce 
imaging by 9%. A shortcoming of this study is that the occurrence of previous episodes of 
diverticulitis was not recorded in the ED triad cohort prohibiting the external validation of 
the original CS tool that included this variable, especially since this was the variable with 
the best predictive value in the CS tool. (OR 5.67, 95% CI 2.36-13.62). In the IND cohort 
more patients with a final diagnosis of diverticulitis had a previous episode (61%) 
compared to patients with another diagnosis (44%), indicating that it could have 
predictive value. There is, however, some limitation to the use of this variable in a clinical 
decision rule. In the CS tool cohort 35% of patients with a final diagnosis of diverticulitis 
had one or more previous episodes of diverticulitis. As a consequence, the rule would only 
identify a third of the patients on forehand and will turn out even lower when we account 
for the fact that there are more variables in the rule. 
 
Identification of variables with predictive value for the diagnosis of diverticulitis is feasible. 
Despite the fact that the two recent predictive tools have been developed independently, 
both analyses ended up with the same variables that have the best predictive value in 
diagnosing acute colonic diverticulitis. All three variables that constitute the ED triad are 
included in the CS tool, be it with minor adaptations.  
 
Isolated tenderness in the LLQ on examination, CRP >50mg/l and absence of vomiting 
have significant predictive value in patients with suspected acute diverticulitis. With 
additional variables present (older age, pain on movement, previous episode) the 
certainty of the diagnosis could be increased. By using these variables the need of 
additional imaging to diagnose acute diverticulitis may be reduced. 
 
External validation of two tools for the clinical diagnosis of acute diverticulitis without imaging 
58 
Reference list 
 
1  Lameris W, van Randen A, van Gulik TM et al. 
A clinical decision rule to establish the 
diagnosis of acute diverticulitis at the 
emergency department. Dis Colon Rectum 
2010;53:896-904. 
2  Rafferty J, Shellito P, Hyman NH et al. 
Practice parameters for sigmoid 
diverticulitis. Dis Colon Rectum 2006;49:939-
944. 
3  Munikrishnan V, Helmy A, Elkhider H et al. 
Management of acute diverticulitis in the 
East Anglian region: results of a United 
Kingdom regional survey. Dis Colon Rectum 
2006;49:1332-1340. 
4  Schechter S, Mulvey J, Eisenstat TE. 
Management of uncomplicated acute 
diverticulitis: results of a survey. Dis Colon 
Rectum 1999;42:470-475. 
5  Cho KC, Morehouse HT, Alterman DD et al. 
Sigmoid diverticulitis: diagnostic role of CT--
comparison with barium enema studies. 
Radiology 1990;176:111-115. 
6  Wexner SD, Dailey TH. The initial 
management of left lower quadrant 
peritonitis. Dis Colon Rectum 1986;29:635-
638. 
7  Andeweg CS, Knobben L, Hendriks JC et al. 
How to Diagnose Acute Left-sided Colonic 
Diverticulitis: Proposal for a Clinical Scoring 
System. Ann Surg 2011;253:940-946. 
8  Altman DG, Royston P. What do we mean by 
validating a prognostic model? Stat Med 
2000;19:453-473. 
9  Harrell FE, Jr., Lee KL, Mark DB. Multivariable 
prognostic models: issues in developing 
models, evaluating assumptions and 
adequacy, and measuring and reducing 
errors. Stat Med 1996;15:361-387. 
10  Justice AC, Covinsky KE, Berlin JA. Assessing 
the generalizability of prognostic 
information. Ann Intern Med 1999;130:515-
524. 
11  Reilly BM, Evans AT. Translating clinical 
research into clinical practice: impact of 
using prediction rules to make decisions. Ann 
Intern Med 2006;144:201-209. 
12  Steyerberg EW. Clinical Prediction Models. 
Springer-Verlag New York, 2008.  
13  Lameris W, van Randen A, van Es HW et al. 
Imaging strategies for detection of urgent 
conditions in patients with acute abdominal 
pain: diagnostic accuracy study. BMJ 
2009;338:b2431- 
14  Laurell H, Hansson LE, Gunnarsson U. Acute 
diverticulitis--clinical presentation and 
differential diagnostics. Colorectal Dis 
2007;9:496-501. 
 
Chapter 4 
59 
 
 
 
 
Chapter 4 
 
Toward an evidence based step-up approach  
in diagnosing diverticulitis 
 
 
 
 
Caroline S. Andeweg 
 
Johannes A. Wegdam 
 
Gert Jan van der Wilt 
 
Johannes Groenewoud 
 
Robert P. Bleichrodt 
 
Harry van Goor 
 
 
 
 
 
Scandinavian Journal of Gastroenterology 2014 Jul;49(7):775-84  
  
Toward an evidence based step-up approach in diagnosing diverticulitis 
60 
Abstract 
 
Background 
The lack of pathognomonic findings and the chance of complicated disease have resulted 
in the widespread use of additional imaging to diagnose acute colonic diverticulitis (ACD). 
The added value of additional imaging in the diagnostic work-up of patients suspected of 
ACD is not well defined. 
 
Aims 
The aim of this study was to systematically review the literature of the accuracy of the 
clinical evaluation and diagnostic modalities for patients with suspected ACD, to come to 
an evidence-based approach to diagnose ACD. 
 
Methods 
A systematic review and meta-analysis of studies that reported diagnostic accuracy of the 
clinical diagnosis and diagnostic modalities in patients with suspected diverticulitis were 
performed. Study quality was assessed with the STARD checklist. TP, TN, FP and FN 
findings were extracted and pooled estimates of sensitivity and specificity per diagnostic 
test were calculated, if applicable.  
 
Results 
The overall quality of the studies reporting the diagnostic accuracy of the clinical 
diagnosis, contrast enema and MRI were moderate to poor and not suitable for meta-
analysis. Sensitivity of the clinical diagnosis varied between 64% and 68%. US and CT 
studies were eligible for meta-analysis. Summary sensitivity estimates for US were 90% 
(95% CI: 76%-98%) versus 95% (95% CI: 91%-97%) for CT (p=0.86). Summary specificity 
estimates for US were 90% (95% CI: 86%-94%) versus 96% (95% CI: 90%-100%) for CT 
(p=0.04). Sensitivity for MRI was 98% and specificity varied between 70% and 78%. 
Sensitivity of contrast enema studies varied between 80% and 83%. 
 
Conclusions 
In two-thirds of the patients the diagnosis of ACD can be made based on clinical 
evaluation alone. In one-third of the patients, additional imaging is a necessity to establish 
the diagnosis. US and CT are comparable in diagnosing diverticulitis and superior to other 
modalities. CT has the advantage of higher specificity and the ability to identify alternative 
diagnoses. The role of MRI is not yet clear in diagnosing ACD. Contrast enema is 
considered an obsolete imaging technique to diagnose ACD based on lower sensitivity and 
specificity than US and CT. A step-up approach with CT performed after an inconclusive or 
negative US, seems a logical and safe approach for patients suspected of ACD. 
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Introduction 
 
Diverticulosis is a common disorder affecting approximately 65% of the population over 65 
years. Twenty-five percent of these patients will suffer one or more episodes.
1
 Patients 
with acute colonic diverticulitis (ACD) impose a large burden to national healthcare. 
Recent evidence suggests that rates of treatment for ACD have increased over the last 
decade.
2
  
 
The lack of pathognomonic findings and the chance of complicated disease have resulted 
in the widespread use of additional imaging to diagnose ACD. With only about 10% of 
patients presenting with complicated disease, additional imaging is not beneficiary in the 
majority of patients.
3, 4
 Although important, the added value of additional imaging to 
clinical in the diagnostic work-up of patients suspected of ACD is not well defined. This 
prompted us to systematically review the literature to establish an evidence-based 
approach to diagnose ACD, taking into consideration patient’s burden and safety and 
efficient use of diagnostic resources. 
 
 
Methods 
 
Search strategy 
The following databases were searched to identify studies reporting on diagnostic 
accuracy of the clinical diagnosis and imaging modalities in patients with suspected ACD: 
Pubmed, Medline and Embase and the Cochrane Library of Systematic Reviews. The 
search strategies were adapted to the different databases to maximize yield. All keywords 
suited for the different databases were used in different order to expose the maximum 
amount of hits relevant to the subject. All terms used are shown in Table S1. Only 
publications in the English, German and Dutch language were used and publications 
before 1980 were excluded. Only full text studies were included for the purpose of 
retrieving data since abstracts alone do not contain all information necessary to score the 
quality of a study. All selected studies were reviewed for cross-references. After 
completion of the review, the search was repeated to detect the latest reported studies, 
the most recent being December 2013.  
 
Selection criteria 
All studies designed to evaluate the diagnostic performance of any diagnostic test in 
patients with suspected ACD were considered. Two reviewers independently reviewed all 
abstracts (CA and JW) and selected relevant studies according to the following criteria: 
Prospective studies that reported the number of true positives (TP), true negatives (TN), 
false positives (FP) and false negatives (FN) or provided enough information to extract 
them from the study report. Only those studies were selected for review that defined a 
reliable reference for the presence or absence of ACD and that adequately defined and 
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reported patient recruitment criteria. Articles that met the above criteria were again 
subjected to inclusion criteria, but this time to judge the eligibility for meta-analysis. Only 
studies that evaluated a consecutive series of patients with suspected ACD were included 
for meta-analysis. 
Assessment of methodological quality 
All selected papers were evaluated for methodological quality according to the Standards 
for Reporting of Diagnostic Accuracy (STARD) initiative.
5
 The STARD initiative is a 25-item 
checklist to improve the quality of the reporting of diagnostic accuracy studies. The results 
of the quality appraisal can be summarized to offer a general impression of the validity of 
the available evidence. Three authors (CSA, JAW and RPB) independently completed the 
STARD checklist of each paper and in case of different outcomes the definitive answer was 
reached by consensus. The STARD checklist was completed based on the information 
clearly enunciated in the published article without attempting to make contact with its 
authors to seek clarification. (Table S2)  
 
Data extraction and meta-analysis 
Data were extracted only from full articles and summarized using the data extraction 
sheet as provided by the STARD initiative group. Meta-analysis, if applicable, was 
conducted and heterogeneity between selected studies was assessed on patient 
characteristics (age and percentage women), presence of diverticulitis (presences of both 
diverticula and bowel wall thickening on US or CT) or complicated diverticulitis (ACD with 
pericolic abscesses or signs of perforation or fistula) and reference testing (percentage of 
patients with a high validity reference test, i.e., histopathological confirmation after 
surgery or colonoscopy with biopsy). 
 
For each variable, a weighted average with corresponding 95% confidence interval (CI) 
was calculated. Homogeneity between the studies was defined if the standard deviation of 
a variable was less than 20% of the weighted average. Standard test characteristics (TP, 
TN, FP, FN findings) were extracted and positive and negative likelihood ratios (LR+ and 
LR-, respectively) were calculated. Pooled estimates of sensitivity and specificity per 
diagnostic test, including 95% CI’s were calculated using StatsDirect, using the random 
effects model. Differences in sensitivity and specificity per diagnostic modality were tested 
for statistical significance using logistic regression analysis, with sensitivity or specificity as 
dependent variable and diagnostic test as independent variable. Heterogeneity within 
subgroups was estimated by calculating Cochran’s Q statistic. Logistic regression analysis 
was conducted in SAS 8.2, using proc-logistic. A p-value <0.05 was considered statistically 
significant. 
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Reports identified through database 
searching and other sources 
(n=2,338) 
Records excluded by title review 
(n=1,973) 
Records screened on the basis of 
title and abstract (n=365) 
Records excluded on the basis of 
title and abstract (n=325) 
Full-text articles assessed for 
eligibility (n=40) 
Full-text articles excluded (n=25) 
Studies included for systematic 
review (n=15) of which n=8 were 
eligible for meta-analysis 
Results 
 
Search results 
Fifteen studies evaluating diagnostic accuracy of the clinical evaluation and imaging 
modalities in patients with suspected ACD were retrieved from the databases, of which 
eight were eligible for meta-analysis. Search results are displayed in Figure 1. Most studies 
were of moderate quality according to the STARD checklist and are discussed separately. A 
summary of the diagnostic accuracy of the clinical evaluation and diagnostic modalities in 
patients suspected of ACD is given in Table 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow chart of search results and study selection 
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Clinical evaluation 
Two studies reporting on diagnostic accuracy of clinical evaluation in patients suspected of 
ACD were eligible for inclusion. Both studies were of moderate quality and did not report 
a consecutive series of patients, hence were not included for meta-analysis.
6, 7
 Sensitivities 
and specificities of the clinical evaluation in patients suspected of ACD varied between 
64%-68% and 97%-98%, respectively. Laurell
7
 discussed the role of clinical findings and 
basic laboratory tests separately. They reported that isolated left abdominal tenderness, 
signs of constipation and a higher level of C-reactive protein (CRP) (73 (95% CI: 63-84) vs 
20 (95% CI: 17-22) were more frequent findings in patients with ACD. Vomiting and right-
sided abdominal pain were more frequent in patients with non-specific abdominal pain.  
 
 
Imaging modalities 
 
Ultrasound (US) 
Six studies reported on diagnostic accuracy of graded compression US. Three studies were 
of moderate quality and did not report a consecutive series of patients.
8-10
 The remaining 
three studies were of moderate
11, 12
 to good quality [13] and were included for meta-
analysis. These studies encompassed a total of 382 patients with clinical suspicion of ACD, 
who underwent graded compression US. Sensitivities and specificities with corresponding 
confidence intervals of graded compression US and with the results of the Q- and I
2
-test 
are presented in Figure 2. Summary estimates for US were 90% (95% CI: 76%-98%) for 
sensitivity and 90% (95% CI: 86%-94%) for specificity.  
 
Computed Tomography (CT)  
Eight studies reported on diagnostic accuracy of CT in diagnosing ACD, were included. Two 
were of moderate quality and did not report a consecutive series of patients.
10, 14
 The 
remaining six studies were of moderate
15-19
 to good quality
13
 and were included for meta-
analysis. These studies encompassed a total of 588 patients with clinical suspicion of ACD, 
who underwent CT. Sensitivities and specificities with corresponding confidence intervals 
of CT and with the results of the Q- and I
2
-test are presented in Figure 2. Summary 
estimates for CT were 95% (95% CI: 91%-97%) for sensitivity and 96% (95% CI: 90%-100%) 
for specificity. 
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Figure 2: Proportion meta
model in prospective studies evaluating graded compression ultrasound and CT in consecutive 
patients with the clinical diagnosis 
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Comparison of US and CT  
Pooled sensitivity of US 90% (95% CI: 76%-98%) and CT 95% (95% CI: 91%-97%) were 
comparable (p=0.86; OR 1.12; 95% CI: 0.32-3.94). The pooled specificity of CT 96% (95% CI: 
90%-100%) was significantly higher compared to US 90% (95% CI: 86%-94%) (p=0.04; OR 
2.46; 95% CI: 1.01-5.96). Age, gender and type of reference test did not explain the 
differences in sensitivity and specificity between the two imaging modalities. 
 
The evaluated studies showed homogeneity regarding age, gender and incidence of 
complicated ACD. Heterogeneity existed in the incidence of ACD and the percentage of 
patients that underwent high validity reference testing. (Table 2) Definitions criteria of 
ACD and complicated ACD varied between studies. (Table S2)  
 
Fifty-five percent of the patients in the US group had ACD as a final diagnosis as compared 
to 49% in the CT group (p=0.04). To determine whether US or CT is better to detect 
alternative diagnoses, the percentages of patients in whom the diagnosis was truly based 
on the initial US or CT findings were compared. An accurate diagnosis was made in 68% of 
patients with a CT scan and in 48% with US (p=0.002; OR 2.6; CI: 1.41-4.93). (Table 3) 
False-positive (US 3%; CT 2%) and false-negative (US 6%; CT 5%) results were similar for US 
and CT. 
 
Magnetic resonance imaging (MRI) 
For MRI only one moderate quality study was included.
20
 Two investigators, blinded to all 
clinical, laboratory and radiologic results independently evaluated MRI images of 55 
patients suspected of having ACD. Reference standard for the diagnosis of diverticulitis 
was a combination of surgery and histopathology findings (29%) and clinical follow-up 
including US of at least three months (71%). Thirty-one patients (57%) additionally 
underwent abdominal CT in follow-up. Sensitivities of MRI to diagnose ACD in this study 
were 94% and 96% for both investigators. Specificity was 88%, and the same for both 
investigators.  
 
 
 
 
 
 
 
 
 
 
  
Toward an evidence based step-up approach in diagnosing diverticulitis 
70 
T
a
b
le
 2
: 
In
d
e
p
e
n
d
e
n
t 
v
a
ri
a
b
le
s 
e
xt
ra
ct
e
d
 f
ro
m
 p
ro
sp
e
ct
iv
e
 s
tu
d
ie
s 
n
o
t 
in
cl
u
d
e
d
 i
n
 m
e
ta
-a
n
a
ly
si
s 
d
e
a
li
n
g
 w
it
h
 d
ia
g
n
o
st
ic
 a
cc
u
ra
cy
 t
o
 d
ia
g
n
o
se
 a
cu
te
 c
o
lo
n
ic
 d
iv
e
rt
ic
u
li
ti
s 
(A
C
D
) 
P
a
ti
e
n
ts
 w
it
h
 h
ig
h
 v
a
li
d
it
y
 
re
fe
re
n
ce
 t
e
st
 (
%
) 
 
1
2
 (
1
) 
4
1
 (
5
) 
1
0
 (
8
) 
2
4
 (
1
8
) 
3
4
 (
5
4
) 
9
 (
2
7
) 
1
6
 (
2
9
) 
 
2
2
 (
3
9
) 
3
0
 (
3
4
) 
3
2
 (
2
3
) 
1
8
 (
3
3
) 
3
9
 (
2
3
) 
4
1
 (
2
8
) 
4
9
 (
4
1
) 
7
4
 (
6
7
) 
 
3
5
 (
2
5
-4
6
) 
4
0
 (
2
7
-5
2
) 
2
3
 (
1
9
-2
8
) 
p
<
0
.0
0
0
1
 
P
a
rt
ic
ip
a
n
ts
 w
it
h
 
co
m
p
li
ca
te
d
 A
C
D
 (
%
) 
 
1
1
 (
8
) 
6
 (
1
4
) 
8
 (
1
6
) 
1
3
 (
2
5
) 
2
0
 (
4
7
) 
2
 (
1
0
) 
N
R
 
 
1
6
 (
6
0
) 
N
R
 
1
1
 (
1
5
) 
9
 (
2
7
) 
2
4
 (
2
4
) 
1
3
 (
2
0
) 
1
1
 (
1
6
) 
1
4
 (
3
6
) 
 
2
6
 (
1
8
-3
6
) 
3
0
 (
1
8
-4
4
) 
2
1
 (
1
5
-2
9
) 
p
=
0
.1
2
 
P
a
rt
ic
ip
a
n
ts
 
w
it
h
 A
C
D
 (
%
) 
 
1
4
5
 (
1
1
) 
4
4
 (
5
) 
5
2
 (
4
3
) 
5
2
 (
4
0
) 
4
3
 (
6
8
) 
2
1
 (
6
4
) 
4
7
 (
8
5
) 
 
2
7
 (
4
8
) 
5
2
 (
6
0
) 
7
4
 (
5
2
) 
3
3
 (
5
2
) 
1
0
2
 (
5
8
) 
6
4
 (
4
3
) 
6
7
 (
5
6
) 
3
9
 (
3
5
) 
 
5
0
 (
4
4
-5
6
) 
4
9
 (
4
1
-5
6
) 
5
5
 (
5
0
-6
0
) 
p
=
0
.0
4
 
W
o
m
e
n
, 
 
n
 (
%
) 
 
N
R
 
N
R
 
N
R
 
6
6
 (
5
1
) 
N
R
 
2
0
 (
6
1
) 
2
6
 (
4
7
) 
 
3
7
 (
6
6
) 
6
4
 (
7
3
) 
7
9
 (
5
5
) 
N
R
 
1
0
9
 (
6
2
) 
9
1
 (
6
1
) 
6
5
 (
5
4
) 
7
0
 (
6
4
) 
 
6
1
 (
5
7
-6
6
) 
6
3
 (
5
7
-6
9
) 
5
9
 (
5
2
-6
6
) 
p
=
0
.3
4
 
M
e
a
n
 a
g
e
  
(r
a
n
g
e
) 
 
N
R
 
N
R
 
N
R
 
5
8
 (
2
3
-8
8
) 
6
2
 (
m
e
d
ia
n
) 
7
1
 (
4
0
-8
4
) 
5
9
 (
2
9
-7
6
) 
 
6
3
 (
2
8
-9
8
) 
6
3
 (
2
9
-9
1
) 
(m
e
d
ia
n
) 
5
6
 (
2
0
-8
9
) 
6
4
 (
3
8
-8
7
) 
6
1
 (
1
5
-8
9
) 
5
9
 (
1
9
-9
2
) 
6
2
 (
2
1
-8
8
) 
5
7
 (
3
0
-8
2
) 
 
6
0
.5
 (
5
8
.4
-6
2
.6
) 
6
1
.2
 (
5
8
.7
-6
3
.6
) 
6
0
.3
 (
5
5
.8
-6
4
.8
) 
p
=
0
.7
2
 
n
  
1
,2
8
7
 
 8
0
2
 
 1
2
3
 
 1
3
0
 
 
6
3
 
 
3
3
 
 
5
5
 
  
5
6
 
 
8
8
 
 1
4
3
 
 
6
4
 
 1
7
5
 
 1
5
0
 
 1
2
0
 
 1
1
0
 
 9
0
6
 
  5
8
8
 
 3
8
2
  
D
ia
g
n
o
st
ic
 m
o
d
a
li
ty
 
 
 
C
li
n
ic
a
l 
e
v
a
lu
a
ti
o
n
 
C
li
n
ic
a
l 
e
v
a
lu
a
ti
o
n
 
U
S
 
U
S
 
U
S
 /
 C
T
 
C
T
 
M
R
I 
 B
a
ri
u
m
 e
n
e
m
a
 /
 C
T
 
B
a
ri
u
m
 e
n
e
m
a
 /
 C
T
 /
 
la
p
a
ro
sc
o
p
y
 
U
S
 
U
S
 /
 C
T
 
U
S
 
C
T
 
C
T
 
C
T
 
     
S
tu
d
y
/y
e
a
r  
 A
rt
ic
le
s 
n
o
t 
in
cl
u
d
e
d
 i
n
 m
e
ta
-a
n
a
ly
si
s 
La
u
re
ll
, 
2
0
0
6
 
T
o
o
re
n
v
li
e
t,
 2
0
0
8
 
V
e
rb
a
n
ck
 ,
 1
9
8
9
 
S
ch
w
e
rk
, 
1
9
9
3
 
F
a
ra
g
 S
o
li
m
a
n
, 
2
0
0
4
 
D
o
ri
n
g
e
r,
 1
9
9
0
 
H
e
v
e
rh
a
g
e
n
, 
2
0
0
8
 
A
rt
ic
le
s 
in
cl
u
d
e
d
 i
n
 m
e
ta
-a
n
a
ly
si
s 
C
h
o
, 
1
9
9
0
 
S
te
fá
n
ss
o
n
, 
1
9
9
7
 
Z
ie
lk
e
, 
1
9
9
7
 
P
ra
d
e
l,
 1
9
9
7
 
H
o
ll
e
rw
e
g
e
r,
2
0
0
0
 
R
a
o
, 
1
9
9
8
 
W
e
rn
e
r,
 2
0
0
3
 
T
a
ck
, 
2
0
0
5
 
A
b
so
lu
te
 n
u
m
b
e
r 
∏
 
W
e
ig
h
te
d
 a
v
e
ra
g
e
 w
it
h
 C
I  
P
a
ti
e
n
ts
 p
o
o
le
d
 b
y
 C
T
 
P
a
ti
e
n
ts
 p
o
o
le
d
 b
y
 U
S
 
P
o
o
le
d
 U
S
 v
s 
p
o
o
le
d
 C
T
 
 
Chapter 4 
71 
T
a
b
le
 2
 (
co
n
ti
n
u
e
d
):
 I
n
d
e
p
e
n
d
e
n
t 
v
a
ri
a
b
le
s 
e
xt
ra
ct
e
d
 f
ro
m
 p
ro
sp
e
ct
iv
e
 s
tu
d
ie
s 
n
o
t 
in
cl
u
d
e
d
 i
n
 m
e
ta
-a
n
a
ly
si
s 
d
e
a
li
n
g
 w
it
h
 d
ia
g
n
o
st
ic
 a
cc
u
ra
cy
 t
o
 d
ia
g
n
o
se
 a
cu
te
 c
o
lo
n
ic
 
d
iv
e
rt
ic
u
li
ti
s 
(A
C
D
)  
P
a
ti
e
n
ts
 w
it
h
 h
ig
h
 v
a
li
d
it
y
 
re
fe
re
n
ce
 t
e
st
 (
%
) 
3
5
 (
2
5
-4
6
) 
4
0
 (
2
7
-5
2
) 
2
3
 (
1
9
-2
8
) 
p
<
0
.0
0
0
1
 
 A
C
D
: 
a
cu
te
 c
o
lo
n
ic
 d
iv
e
rt
ic
u
li
ti
s,
 d
e
fi
n
e
d
 a
s 
p
re
se
n
ce
 o
f 
b
o
th
 d
iv
e
rt
ic
u
la
 a
n
d
 b
o
w
e
l 
w
a
ll
 t
h
ic
k
e
n
in
g
 
co
m
p
li
ca
te
d
 A
C
D
: 
co
m
p
li
ca
te
d
 a
cu
te
 c
o
lo
n
ic
 d
iv
e
rt
ic
u
li
ti
s,
 d
e
fi
n
e
d
 a
s 
p
re
se
n
ce
 o
f 
p
e
ri
co
li
c 
a
b
sc
e
ss
e
s 
o
r 
si
g
n
s 
o
f 
p
e
rf
o
ra
ti
o
n
 o
r 
fi
st
u
la
 
h
ig
h
 v
a
li
d
it
y
 r
e
fe
re
n
ce
 t
e
st
: 
a
 r
e
fe
re
n
ce
 t
e
st
 i
n
 w
h
ic
h
 t
h
e
 d
ia
g
n
o
si
s 
A
C
D
 i
s 
co
n
fi
rm
e
d
 b
y
 h
is
to
p
a
th
o
lo
g
ic
a
l 
co
n
fi
rm
a
ti
o
n
 a
ft
e
r 
su
rg
e
ry
 o
r 
co
lo
n
o
sc
o
p
y
 w
it
h
 b
io
p
sy
 
N
R
: 
n
o
t 
re
p
o
rt
e
d
 
∏
 A
s 
P
ra
d
e
l 
st
u
d
ie
d
 b
o
th
 U
S
 a
n
d
 C
T
 i
n
 a
 h
e
a
d
-t
o
-h
e
a
d
 c
o
m
p
a
ra
ti
v
e
 s
tu
d
y
, 
th
e
 s
u
m
 o
f 
th
e
 t
w
o
 p
o
o
le
d
 r
e
su
lt
s 
d
o
e
s 
n
o
t 
m
a
tc
h
 t
h
e
 t
o
ta
l 
su
m
 o
f 
a
b
so
lu
te
 p
a
ti
e
n
ts
; 
th
e
 p
-v
a
lu
e
 
b
e
tw
e
e
n
 U
S
 a
n
d
 C
T
 g
ro
u
p
 i
s 
ca
lc
u
la
te
d
 b
y
 l
o
g
is
ti
c 
re
g
re
ss
io
n
 e
s t
im
a
ti
n
g
 t
h
e
 p
ro
p
o
rt
io
n
 
P
a
rt
ic
ip
a
n
ts
 w
it
h
 
co
m
p
li
ca
te
d
 A
C
D
 (
%
) 
2
6
 (
1
8
-3
6
) 
3
0
 (
1
8
-4
4
) 
2
1
 (
1
5
-2
9
) 
p
=
0
.1
2
 
P
a
rt
ic
ip
a
n
ts
 
w
it
h
 A
C
D
 (
%
) 
5
0
 (
4
4
-5
6
) 
4
9
 (
4
1
-5
6
) 
5
5
 (
5
0
-6
0
) 
p
=
0
.0
4
 
W
o
m
e
n
, 
 
n
 (
%
) 
6
1
 (
5
7
-6
6
) 
6
3
 (
5
7
-6
9
) 
5
9
 (
5
2
-6
6
) 
p
=
0
.3
4
 
M
e
a
n
 a
g
e
  
(r
a
n
g
e
) 
6
0
.5
 (
5
8
.4
-6
2
.6
) 
6
1
.2
 (
5
8
.7
-3
.6
) 
6
0
.3
 (
5
5
.8
-6
4
.8
) 
p
=
0
.7
2
 
n
 
  5
8
8
 
 3
8
2
  
D
ia
g
n
o
st
ic
 m
o
d
a
li
ty
 
    
S
tu
d
y
/y
e
a
r  
 W
e
ig
h
te
d
 a
v
e
ra
g
e
 w
it
h
 C
I  
P
a
ti
e
n
ts
 p
o
o
le
d
 b
y
 C
T
 
P
a
ti
e
n
ts
 p
o
o
le
d
 b
y
 U
S
 
P
o
o
le
d
 U
S
 v
s 
p
o
o
le
d
 C
T
 
Toward an evidence based step-up approach in diagnosing diverticulitis 
72 
Table 3: Alternative diagnoses in consecutive patients with clinically suspected acute colonic 
diverticulitis included in the meta-analysis 
 
Study/year 
 
Diagnostic 
modality 
n Participants with 
alternative diagnoses 
(%) 
Participants with a 
specific alternative 
diagnosis (%) 
Specific alternative 
diagnosis as first 
diagnosed by either  
US of CT (%) 
Zielke, 1997 US 143 69 (48) 35 (24) 16 (46) 
Hollerweger, 2000 US 175 73 (42) 47 (27) NR 
Cho, 1990 CT 56 29 (52) 23 (41) 20 (87) 
Stefánsson, 1997 CT 88 36 (41) 24 (27) NR 
Pradel, 1997 US 
CT 
64 31 (48) 24 (38) 12 (50) 
8 (33) 
Rao, 1998 CT 150 86 (57) 64 (43) 50 (78) 
Werner, 2003 CT 120 53 (44) 31 (26) 22 (71) 
Tack, 2005 CT 110 71 (65) 22 (20) NR 
Absolute number  906    
Weighted average (CI)   50 (44-56) 30 (25-36) 73 (59-85) 
Patients pooled by CT  588 51 (44-59) 32 (24-40) 68 (47-86) 
Patients pooled by US  382 45 (40-50) 28 (22-35) 48 (35-60) 
Pooled US vs pooled CT
 ∏
   p=0.04 
(OR 1.31; CI: 1.012-1.697) 
p=0.16 p=0.002 
(OR 2.6; CI: 1.41-4.93) 
NR: not reported 
Alternative diagnoses are divided in specific alternative diagnosis clearly stated in the article and specific alternative 
diagnosis as first diagnosed by either US or CT  
∏
 the p-value between US and CT group is calculated by logistic regression estimating the proportion 
 
 
Contrast Enema  
Two studies reported on diagnostic accuracy of contrast enema in patients with suspected 
ACD that were eligible for inclusion. Both studies were of moderate quality and the 
number of patients was too small to permit a sensible meta-analysis.
15, 16
 Reported 
sensitivities of contrast enema in these studies were 80%-83%, with a specificity of 81%-
100%.  
This systematic review has demonstrated that HRQoL and HS reach levels comparable to 
the general population after IPAA. It also illustrated that a systematic and uniform 
approach to QoL and its measurement is needed. Often in studies HS or HRQoL 
instruments were used while titles incorrectly referred to QoL.
12
 QoL, HRQoL, and HS are 
different entities and are not interchangeable. Considering the HRQoL results in the high 
quality studies and the consistent results observed in the other studies, one might expect 
that QoL results in patients after IPAA for UC will be comparable to the general population 
as well. However, studies will have to be performed examining all the domains of QoL to 
answer this question.  
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To be able to improve future patient care, QoL evaluation is of importance. QoL is 
evaluated by assessing many more domains than HRQoL. This makes QoL questionnaires 
the most sensitive tool to detect subtle changes and flaws in today’s patient care with 
regard to (HR)QoL. During the last decades, great advances have been made reducing 
mortality and decreasing morbidity which resulted in levels of HRQoL and HS comparable 
to the general population. Evaluating QoL and the separate domains can make further 
improvements possible for patients entrusted to us. 
 
 
Discussion  
 
Summary of results 
The aim of this study was to systematically review the literature of the accuracy of the 
clinical evaluation and diagnostic modalities for patients with suspected ACD. In two-thirds 
of the patients the diagnosis of ACD can be made based on clinical evaluation without 
additional imaging.
6, 7
 In one-third of the patients, additional imaging is a necessity to 
establish the diagnosis. US and CT are comparable in diagnosing diverticulitis and superior 
to other modalities. CT has the advantage of higher specificity and the ability to identify 
alternative diagnoses. The role of MRI is not yet clear in diagnosing ACD. Contrast enema 
should be considered an obsolete imaging technique to diagnose ACD based on lower 
sensitivity and specificity than US and CT.  
 
Strengths and limitations of the study  
Major strength of this study is the detailed evaluation of the literature and the study 
quality by applying the validated STARD model. This enabled us to give a clear and 
comprehensive overview of the quality and the possible risk of bias of the included 
studies. We could only pool the data of US and CT studies for meta-analysis. All studies 
included in the US and CT meta-analysis displayed acceptable homogeneity and were not 
affected by confounding. Although the studies reporting on diagnostic accuracy of US and 
CT were of acceptable overall quality, the lack of adequate reference testing to establish 
the final diagnosis was an important restriction in interpreting these studies. 
Histopathology is the gold standard for diagnostic studies of ACD. However, obtaining 
histological confirmation in the acute phase of uncomplicated ACD is seldom a real option 
because of the risk at colonoscopy and patient’s discomfort. Selection of studies by 
stringent in- and exclusion criteria has introduced bias, for example by excluding studies 
that did not report a consecutive series of patients. However, including studies of 
methodological poor quality would have negatively affected the generalizability of meta-
analysis results  
 
Comparison with other studies 
Based on results of this study, clinical evaluation should be considered the mainstay of the 
diagnostic process in ACD. This finding is in accordance with two recent reports in which 
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the use of a clinical (and laboratory) scoring system was analyzed to improve the clinical 
evaluation in patients suspected of having ACD.
21, 22
 Such scoring systems are able to 
identify patients with ACD with a high degree of diagnostic accuracy without additional 
imaging, however only in a small subset of patients with pain solely in the lower left 
abdomen, the absence of vomiting and a CRP >50mg/l and only if there is no indication of 
complicated disease. These studies were not included in our systematic review since 
diagnostic accuracy was not calculated for each individual variable in terms of sensitivity 
or specificity.  
 
An earlier meta-analysis by Laméris et al. regarding test accuracy of graded compression 
US and CT in diagnosing ACD showed comparable results to our study. Main difference is 
the finding of a significant difference in specificity favoring CT in our study. Differences in 
outcome results between the Laméris study and our meta-analysis are mainly attributed 
to a difference in quality assessment and more stringent inclusion criteria in our meta-
analysis.
23
 Based on results of these two meta-analyses, graded compression US seems 
safe and accurate in diagnosing ACD, with comparable sensitivity to CT.  
 
A recent large prospective study of diagnostic accuracy in patients with acute abdominal 
pain supports this assumption. This study was designed to identify an optimal imaging 
strategy for the accurate detection of urgent conditions in patients with acute abdominal 
pain with ACD as second most common diagnosis (12% of the study population). A 
conditional strategy, with CT performed after inconclusive or negative US, resulted in the 
highest overall sensitivity and the lowest overall exposure to radiation in this study.
23
 
 
This step-up approach seems a logical and safe approach for patients with suspected ACD 
and is supported by several findings in our study. The first step of the diagnostic process is 
an estimation of the probability of ACD based on clinical evaluation and laboratory 
findings. In case of questionable disease, an ultrasound examination is the following step. 
In case of an inconclusive or negative US, a CT scan is made. 
 
Adoption of such a step-up approach is hampered by geographic differences and personal 
preferences in diagnosing ACD. In two surveys, conducted among colon- and rectal 
surgeons in the UK and USA, differences in the use of initial imaging techniques to 
diagnose ACD were clearly demonstrated. UK surgeons who deemed additional imaging 
necessary, chose US as the initial imaging technique in a third of patients as compared to 
only 7% of the colon- and rectal surgeons in the USA.
24, 25
 Obesity might have been a 
reason why physicians favored initial CT over US. With approximately two-thirds of the 
population in various western parts of the world estimated as being overweight or obese 
the use of CT as initial screening for abdominal conditions is expected to increase further. 
Besides the well-known disadvantages of CT (i.e., exposure to radiation and contrast 
nephropathy), the reproducibility of CT images, and the ability to adequately define an 
alternative diagnosis, further aid in the widespread use of CT in diagnosing ACD. 
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Furthermore, CT has the advantage of delineating the extent of the extra luminal disease 
process and may also direct therapeutic intervention in case of complicated disease, e.g., 
percutaneous drainage of intra-abdominal abscesses.
26, 27
 
 
Liberal use of CT in patients suspected of uncomplicated diverticulitis, however, is not 
recommended because in 90% of the patients with ACD the disease follows a rather 
indolent course.
28
 Furthermore, it has been shown that cross-sectional imaging in patients 
with suspected ACD only leads to alterations in management in 7% of the patients, with 
the majority being minor changes.
6
  
 
The step-up approach does not apply for critically ill patients with acute abdominal pain 
and signs of sepsis, possibly caused by complicated diverticulitis. These patients need to 
be subjected to immediate CT scanning without further delay to initiate proper treat-
ment.
29, 30
 
 
Implications for clinical practice 
Although imaging is widely applied in patients suspected of ACD, not every patient needs 
the complete diagnostic work-up. Despite the fact that we are able to diagnose two-thirds 
of the patients with suspected ACD based on clinical evaluation alone, we fail to define 
this group of patients. The CRP may be an important factor in identifying patients with 
complicated ACD. In a recently published report a CRP level over 90mg/l was 88% sensitive 
and 75% specific for complicated disease in patients not on corticosteroids. A CRP level 
below 50mg/l at hospital admission correlated with non-complicated diverticulitis, sug-
gesting that CT may be avoided in patients presenting with this level of CRP.
31
 The 
contribution of a single variable or a combination of variables to diagnose ACD should be 
further researched in a prospective trial to identify patients who may be safely withheld 
from further diagnostics in the acute phase to diagnose diverticulitis. It remains of key 
importance to recognize those patients with signs of complicated disease, who are in need 
of early intervention.  
 
The step-up approach of diagnosing ACD presented in this review might be a first step in 
reducing patient’s burden and risks, while controlling costs through a more efficient use of 
resources.
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Table S1: Search strategy for electronic databases 
 
[Diverticulitis (MeSH) OR Colonic diverticulitis (MeSH)] AND clinical diagnosis OR diagnostic accuracy 
OR Contrast Enema OR Barium Enema OR contrast barium enema OR double contrast barium enema 
OR “Ultrasonography” (MeSH) OR ultrasound OR ultrasound diagnosis OR “Tomography, Spiral 
Computed” (MeSH) OR “Tomography, X-Ray Computed” (MeSH) OR “Tomography Scanners, X-Ray 
Computed” (Mesh) OR “Magnetic Resonance Imaging” (Mesh) OR “Colonography, Computed 
Tomographic” (Mesh) AND prospective studies [mh] or control * [tw] OR prospectiv* 
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e
d
 s
tu
d
ie
s 
b
a
se
d
 o
n
 t
h
e
 S
T
A
R
D
 i
n
it
ia
ti
v
e
 c
h
e
ck
li
st
 
T
e
ch
n
ic
a
l 
sp
e
ci
fi
ca
ti
o
n
s 
 
(8
) 
H
e
li
ca
l,
 m
u
lt
is
li
ce
 C
T
 f
ro
m
 t
h
e
 p
e
lv
ic
 
fl
o
o
r 
to
 t
h
e
 l
o
w
e
r 
e
d
g
e
 o
f 
th
e
 l
iv
e
r 
w
a
s 
p
e
rf
o
rm
e
d
 
4
x2
.5
m
m
 
Iv
 c
o
n
tr
a
st
 1
0
0
%
 (
1
.3
 m
l/
k
g
)  
If
 i
n
it
ia
l 
sc
a
n
 d
id
n
’t
 s
h
o
w
 A
C
D
 t
h
e
 
u
p
p
e
r 
a
b
d
o
m
e
n
 w
a
s 
sc
a
n
n
e
d
 a
s 
w
e
ll
 
H
e
li
ca
l,
 m
u
lt
is
li
ce
 C
T
 
A
b
d
o
m
e
n
 4
x2
.5
m
m
 
T
w
o
 d
if
f e
re
n
t 
C
T
 r
e
g
im
e
s 
to
 c
o
m
p
a
re
 
co
n
tr
a
st
 e
n
h
a
n
ce
d
 a
n
d
 s
ta
n
d
a
rd
 
d
o
se
 C
T
 (
1
2
0
 m
A
s)
 v
e
rs
u
s 
n
o
 c
o
n
tr
a
st
 
lo
w
 d
o
se
 C
T
 (
3
0
m
A
s)
 
 1
.0
 T
 M
R
 s
ca
n
n
e
r 
u
si
n
g
 a
 b
o
d
y
 
p
h
a
se
d
-a
rr
a
y
 c
o
il
 
 im
m
e
d
ia
te
ly
 b
e
fo
re
 M
R
I 
sc
o
p
o
la
m
in
e
  
w
a
s 
a
d
m
in
is
te
re
d
 t
o
 r
e
d
u
ce
 b
o
w
e
l 
p
e
ri
st
a
ls
is
 
R
e
fe
re
n
ce
 s
ta
n
d
a
rd
  
(7
) 
H
ig
h
 v
a
li
d
it
y
 r
e
fe
re
n
ce
 t
e
st
 i
s 
a
 t
e
st
 
b
y
 h
is
to
-p
a
th
o
lo
g
ic
a
l 
co
n
fi
rm
a
ti
o
n
 
(a
ft
e
r 
su
rg
e
ry
 o
r 
co
lo
n
o
sc
o
p
y
 w
it
h
 
b
io
p
sy
)  
Lo
w
 v
a
li
d
it
y
 r
e
fe
re
n
ce
 t
e
st
 i
s 
a
 t
e
st
 
b
y
 c
li
n
ic
a
l 
o
u
tc
o
m
e
 p
o
ss
ib
ly
 
su
p
p
o
rt
e
d
 b
y
 e
xa
m
in
a
ti
o
n
s 
o
th
e
r 
th
a
n
 t
h
e
 i
n
d
e
x 
te
st
 
H
ig
h
 v
a
li
d
it
y
 r
e
fe
re
n
ce
 t
e
st
 i
s 
a
 t
e
st
 
b
y
 h
is
to
p
a
th
o
lo
g
ic
a
l 
co
n
fi
rm
a
ti
o
n
 
(a
ft
e
r 
su
rg
e
ry
 o
r 
co
lo
n
o
sc
o
p
y
 w
it
h
 
b
io
p
sy
)  
Lo
w
 v
a
li
d
it
y
 r
e
fe
re
n
ce
 t
e
st
 i
s 
a
 t
e
st
 
b
y
 c
li
n
ic
a
l 
o
u
tc
o
m
e
 p
o
ss
ib
ly
 
su
p
p
o
rt
e
d
 b
y
 e
xa
m
in
a
ti
o
n
s 
o
th
e
r 
th
a
n
 t
h
e
 i
n
d
e
x 
te
st
 
 H
ig
h
 v
a
li
d
it
y
 r
e
fe
re
n
ce
 t
e
st
 i
s 
a
 t
e
st
 
b
y
 h
is
to
p
a
th
o
lo
g
ic
a
l 
co
n
fi
rm
a
ti
o
n
 
(a
ft
e
r 
su
rg
e
ry
 o
r 
co
lo
n
o
sc
o
p
y
 w
it
h
 
b
io
p
sy
)  
Lo
w
 v
a
li
d
it
y
 r
e
fe
re
n
ce
 t
e
st
 i
s 
a
 t
e
st
 
b
y
 c
li
n
ic
a
l 
o
u
tc
o
m
e
 p
o
ss
ib
ly
 
su
p
p
o
rt
e
d
 b
y
 e
xa
m
in
a
ti
o
n
s 
o
th
e
r 
th
a
n
 t
h
e
 i
n
d
e
x 
te
st
 
D
a
ta
  
co
ll
e
ct
io
n
  
(6
) 
P
ro
sp
e
ct
iv
e
 
P
ro
sp
e
ct
iv
e
 
 P
ro
sp
e
ct
iv
e
 
P
a
rt
ic
ip
a
n
t 
sa
m
p
li
n
g
  
(5
) 
C
o
n
se
cu
ti
v
e
 
se
ri
e
s 
o
f 
p
a
rt
ic
ip
a
n
ts
 
C
o
n
se
cu
ti
v
e
 
se
ri
e
s 
o
f 
p
a
rt
ic
ip
a
n
ts
 
 C
o
n
se
cu
ti
v
e
 
se
ri
e
s 
o
f 
p
a
rt
ic
ip
a
n
ts
 
P
a
rt
ic
ip
a
n
t 
re
cr
u
it
m
e
n
t 
 
(4
) 
P
a
rt
ic
ip
a
n
ts
 w
e
re
 
re
cr
u
it
e
d
 b
e
ca
u
se
 
o
f 
th
e
ir
 p
re
se
n
ti
n
g
 
sy
m
p
to
m
s  
P
a
rt
ic
ip
a
n
ts
 w
e
re
 
re
cr
u
it
e
d
 b
e
ca
u
se
 
o
f 
th
e
ir
 p
re
se
n
ti
n
g
 
sy
m
p
to
m
s  
 P
a
rt
ic
ip
a
n
ts
 w
e
re
 
re
cr
u
it
e
d
 b
e
ca
u
se
 
o
f 
th
e
ir
 p
re
se
n
ti
n
g
 
sy
m
p
to
m
s  
S
tu
d
y
 p
o
p
u
la
ti
o
n
  
(3
) 
In
cl
u
si
o
n
 o
f 
p
a
ti
e
n
ts
  
w
it
h
 t
h
e
 p
re
su
m
p
ti
v
e
 d
ia
g
n
o
si
s 
 
o
f 
A
C
D
 b
a
se
d
 o
n
 p
a
ti
e
n
t 
h
is
to
ry
; 
p
h
y
si
ca
l 
e
xa
m
in
a
ti
o
n
  
a
n
d
 l
a
b
o
ra
to
ry
 f
in
d
in
g
s  
Le
ft
 l
o
w
e
r 
a
b
d
o
m
in
a
l 
p
a
in
 a
n
d
 
C
R
P
 >
5
m
g
/l
 
n
=
1
2
0
 
si
n
g
le
 i
n
st
it
u
ti
o
n
 
G
e
rm
a
n
y
, 
2
0
0
3
 
In
cl
u
si
o
n
 o
f 
p
a
ti
e
n
ts
 w
it
h
 t
h
e
 
p
re
su
m
p
ti
v
e
 d
ia
g
n
o
si
s 
o
f 
A
C
D
 
(p
a
in
 i
n
 t
h
e
 l
e
ft
 i
li
a
c 
fo
ss
a
 f
o
r 
le
ss
 
th
a
n
 2
 w
e
e
k
s)
 
n
=
1
1
0
 
si
n
g
le
 i
n
st
it
u
ti
o
n
 
B
e
lg
iu
m
, 
2
0
0
5
 
 In
cl
u
si
o
n
 o
f 
p
a
ti
e
n
ts
 w
it
h
 t
h
e
 
p
re
su
m
p
ti
v
e
 d
ia
g
n
o
si
s 
o
f 
A
C
D
 
(l
o
w
e
r 
le
ft
 q
u
a
d
ra
n
t 
p
a
in
 a
n
d
 
lo
ca
li
ze
d
 p
e
ri
to
n
it
is
)  
S
p
e
ci
fi
e
d
 i
n
 s
y
m
p
to
m
s 
p
e
r 
p
a
ti
e
n
t 
(p
a
in
, 
W
B
C
C
, 
fe
v
e
r,
 v
o
m
it
in
g
, 
re
b
o
u
n
d
 t
e
n
d
e
rn
e
ss
)  
n
=
5
5
 
si
n
g
le
 i
n
st
it
u
ti
o
n
 
G
e
rm
a
n
y
, 
2
0
0
8
 
A
im
 o
f 
th
e
 s
tu
d
y
  
(2
) 
T
h
e
 a
ss
e
ss
m
e
n
t 
 
o
f 
d
ia
g
n
o
st
ic
  
a
cc
u
ra
cy
 o
f 
C
T
 
T
h
e
 s
tu
d
y
 c
o
m
p
a
re
d
 
a
cc
u
ra
cy
 o
f 
tw
o
 
d
if
fe
re
n
t 
C
T
 r
e
g
im
e
s,
 
co
n
tr
a
st
 e
n
h
a
n
ce
d
 
a
n
d
 s
ta
n
d
a
rd
 d
o
se
 C
T
 
(1
2
0
m
A
s)
 v
e
rs
u
s 
n
o
 
co
n
tr
a
st
 l
o
w
 d
o
se
 C
T
 
(3
0
m
A
s)
 
 T
h
e
 a
ss
e
ss
m
e
n
t 
o
f 
d
ia
g
n
o
st
ic
 a
cc
u
ra
cy
 o
f 
M
R
I  
D
ia
g
n
o
st
ic
 
a
cc
u
ra
cy
  
(1
) 
S
tu
d
y
 p
re
se
n
ts
 
se
n
si
ti
v
it
y
 a
n
d
 
sp
e
ci
fi
ci
ty
 
S
tu
d
y
 p
re
se
n
ts
 
se
n
si
ti
v
it
y
 a
n
d
 
sp
e
ci
fi
ci
ty
 
 S
tu
d
y
 p
re
se
n
ts
 
se
n
si
ti
v
it
y
 a
n
d
 
sp
e
ci
fi
ci
ty
 
S
tu
d
y
 /
 y
e
a
r 
W
e
rn
e
r,
 2
0
0
3
 
T
a
ck
, 
2
0
0
5
 
M
R
I  
H
e
v
e
rh
a
g
e
n
, 
2
0
0
8
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T
a
b
le
 S
2
: 
Q
u
a
li
ty
 a
ss
e
ss
m
e
n
t 
o
f 
in
cl
u
d
e
d
 s
tu
d
ie
s 
b
a
se
d
 o
n
 t
h
e
 S
T
A
R
D
 i
n
it
ia
ti
v
e
 c
h
e
ck
li
st
 
T
e
ch
n
ic
a
l 
sp
e
ci
fi
ca
ti
o
n
s 
 
(8
) 
 T
h
e
 a
tt
e
n
d
in
g
 p
h
y
si
ci
a
n
 h
a
d
 t
o
 
su
g
g
e
st
 a
 f
ir
st
 a
n
d
 s
e
co
n
d
 m
o
st
 l
ik
e
ly
 
d
ia
g
n
o
si
s  
C
li
n
ic
a
l 
d
ia
g
n
o
si
s 
b
a
se
d
 o
n
 h
is
to
ry
, 
p
h
y
si
ca
l 
e
xa
m
in
a
ti
o
n
 a
n
d
 b
lo
o
d
 a
n
d
 
u
ri
n
e
 a
n
a
ly
si
s 
w
it
h
 a
 s
u
b
se
q
u
e
n
t 
m
a
n
a
g
e
m
e
n
t 
p
ro
p
o
sa
l,
 a
ft
e
r 
th
a
t 
a
 
d
e
ci
si
o
n
 w
a
s 
m
a
d
e
 w
h
e
th
e
r 
o
r 
n
o
t 
to
 
p
e
rf
o
rm
 a
d
d
it
io
n
a
l 
im
a
g
in
g
, 
U
S
 o
r 
C
T
 
a
t 
th
e
 r
a
d
io
lo
g
is
t 
d
is
cr
e
ti
o
n
 
S
T
A
R
D
 i
n
it
ia
ti
v
e
 c
h
e
ck
li
st
  
(1
) 
Id
e
n
ti
fy
 t
h
e
 a
rt
ic
le
 a
s 
a
 s
tu
d
y
 o
f 
d
ia
g
n
o
st
ic
 a
cc
u
ra
cy
 (
re
co
m
m
e
n
d
 M
e
S
H
 h
e
a
d
in
g
 ‘
se
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
fi
ci
ty
’)
. 
(2
) 
S
ta
te
 t
h
e
 r
e
se
a
rc
h
 q
u
e
st
io
n
s 
o
r 
st
u
d
y
 a
im
s,
 s
u
ch
 a
s 
e
st
im
a
ti
n
g
 d
ia
g
n
o
st
ic
 a
cc
u
ra
cy
 o
r 
co
m
p
a
ri
n
g
 a
cc
u
ra
cy
 b
e
tw
e
e
n
 t
e
st
s 
o
r  
a
cr
o
ss
 p
a
rt
ic
ip
a
n
t 
g
ro
u
p
s.
 
(3
) 
T
h
e
 s
tu
d
y
 p
o
p
u
la
ti
o
n
: 
T
h
e
 i
n
cl
u
si
o
n
 a
n
d
 e
xc
lu
si
o
n
 c
ri
te
ri
a
, 
se
tt
in
g
 a
n
d
 l
o
ca
ti
o
n
s 
w
h
e
re
 d
a
ta
 w
e
re
 c
o
ll
e
ct
e
d
. 
(4
) 
P
a
rt
ic
ip
a
n
t 
re
cr
u
it
m
e
n
t:
 W
a
s 
re
cr
u
it
m
e
n
t 
b
a
se
d
 o
n
 p
re
se
n
ti
n
g
 s
y
m
p
to
m
s,
 r
e
su
lt
s 
fr
o
m
 p
re
v
io
u
s 
te
st
s,
 o
r 
th
e
 f
a
ct
 t
h
a
t 
p
a
rt
ic
ip
a
n
ts
 h
a
d
 r
e
ce
iv
e
d
 t
h
e
 i
n
d
e
x 
te
st
s 
o
r 
th
e
 r
e
fe
re
n
ce
 s
ta
n
d
a
rd
?
 
(5
) 
P
a
rt
ic
ip
a
n
t 
sa
m
p
li
n
g
: 
W
a
s 
th
e
 s
tu
d
y
 p
o
p
u
la
ti
o
n
 a
 c
o
n
se
cu
ti
v
e
 s
e
ri
e
s 
o
f 
p
a
rt
ic
ip
a
n
ts
 d
e
fi
n
e
d
 b
y
 t
h
e
 s
e
le
ct
io
n
 c
ri
te
ri
a
 i
n
 i
te
m
 3
 a
n
d
 4
?
 I
f 
n
o
t,
 s
p
e
ci
fy
 h
o
w
 p
a
rt
ic
ip
a
n
ts
 w
e
re
 f
u
rt
h
e
r 
se
le
ct
e
d
. 
(6
) 
D
a
ta
 c
o
ll
e
ct
io
n
: 
W
a
s 
d
a
ta
 c
o
ll
e
ct
io
n
 p
la
n
n
e
d
 b
e
fo
re
 t
h
e
 i
n
d
e
x 
te
st
 a
n
d
 r
e
fe
re
n
ce
 s
ta
n
d
a
rd
 w
e
re
 p
e
rf
o
rm
e
d
 (
p
ro
sp
e
ct
iv
e
 s
tu
d
y
) 
o
r 
a
ft
e
r 
(r
e
tr
o
sp
e
ct
iv
e
 s
tu
d
y
)?
 
(7
) 
T
h
e
 r
e
fe
re
n
ce
 s
ta
n
d
a
rd
 a
n
d
 i
ts
 r
a
ti
o
n
a
le
.  
(8
) 
T
e
ch
n
ic
a
l 
sp
e
ci
fi
ca
ti
o
n
s 
o
f 
m
a
te
ri
a
l 
a
n
d
 m
e
th
o
d
s 
in
v
o
lv
e
d
 i
n
cl
u
d
in
g
 h
o
w
 a
n
d
 w
h
e
n
 m
e
a
su
re
m
e
n
ts
 w
e
re
 t
a
k
e
n
, 
a
n
d
/o
r 
ci
te
 r
e
f e
re
n
ce
s 
fo
r 
in
d
e
x 
te
st
s 
a
n
d
 r
e
fe
re
n
ce
 s
ta
n
d
a
rd
. 
 
  
 
R
e
fe
re
n
ce
 s
ta
n
d
a
rd
  
(7
) 
 A
b
d
o
m
in
a
l 
p
a
in
, 
fe
v
e
r 
a
n
d
/o
r 
e
le
v
a
ti
o
n
 o
f 
C
R
P
 a
n
d
 a
 f
in
d
in
g
 o
f 
d
iv
e
rt
ic
u
la
 a
t 
X
-r
a
y
 o
r 
e
n
d
o
sc
o
p
ic
 
e
xa
m
in
a
ti
o
n
 p
ri
o
r 
to
 a
d
m
is
si
o
n
 o
r 
d
u
ri
n
g
 f
o
ll
o
w
-u
p
. 
F
o
r 
st
a
ti
st
ic
a
l 
a
n
a
ly
si
s 
d
ia
g
n
o
si
s 
a
t 
o
n
e
 y
e
a
r 
fo
ll
o
w
-
u
p
 w
e
re
 u
se
d
 a
n
d
 d
e
sc
ri
b
e
s 
th
o
se
 
p
a
ti
e
n
ts
 w
h
o
 a
ct
u
a
ll
y
 h
a
d
 
d
iv
e
rt
ic
u
li
ti
s  
P
a
th
o
lo
g
ic
a
l 
e
xa
m
in
a
ti
o
n
 f
o
r 
p
a
ti
e
n
ts
 w
h
o
 w
e
re
 o
p
e
ra
te
d
 a
n
d
 
cl
in
ic
a
l 
re
sp
o
n
se
 t
o
 m
e
d
ic
a
l 
th
e
ra
p
y
 
w
it
h
 a
n
 a
d
e
q
u
a
te
 f
o
ll
o
w
-u
p
 f
o
r 
 
th
o
se
 t
h
a
t 
w
e
re
 m
a
n
a
g
e
d
 
co
n
se
rv
a
ti
ve
ly
 
D
a
ta
  
co
ll
e
ct
io
n
  
(6
) 
 P
ro
sp
e
ct
iv
e
 
P
ro
sp
e
ct
iv
e
 
P
a
rt
ic
ip
a
n
t 
sa
m
p
li
n
g
  
(5
) 
 N
o
 c
o
n
se
cu
ti
v
e
 
p
a
ti
e
n
t 
re
cr
u
it
m
e
n
t 
m
e
n
ti
o
n
e
d
 
 C
o
m
p
le
te
 
fo
ll
o
w
-u
p
 9
2
%
 
C
o
n
se
cu
ti
v
e
 
se
ri
e
s 
o
f 
p
a
rt
ic
ip
a
n
ts
 
P
a
rt
ic
ip
a
n
t 
re
cr
u
it
m
e
n
t 
 
(4
) 
 P
a
rt
ic
ip
a
n
ts
 w
e
re
 
re
cr
u
it
e
d
 b
a
se
d
 o
n
 
p
re
se
n
ti
n
g
 
sy
m
p
to
m
s 
a
n
d
 
la
b
o
ra
to
ry
 f
in
d
in
g
s 
P
a
rt
ic
ip
a
n
ts
 w
e
re
 
re
cr
u
it
e
d
 b
a
se
d
 o
n
 
p
re
se
n
ti
n
g
 
sy
m
p
to
m
s 
a
n
d
 
la
b
o
ra
to
ry
 f
in
d
in
g
s 
S
tu
d
y
 p
o
p
u
la
ti
o
n
  
(3
) 
 P
a
ti
e
n
ts
 w
it
h
 a
cu
te
 a
b
d
o
m
in
a
l 
p
a
in
 o
f 
u
p
 t
o
 7
 d
a
y
s 
o
ld
e
r 
th
a
n
 1
 
y
e
a
r 
o
f 
a
g
e
 
n
=
3
0
7
3
 
si
n
g
le
 i
n
st
it
u
ti
o
n
 S
w
e
d
e
n
, 
2
0
0
6
 
P
a
ti
e
n
ts
 w
it
h
 a
cu
te
 a
b
d
o
m
in
a
l 
p
a
in
 e
v
a
lu
a
te
d
 a
t 
th
e
 E
D
 b
y
 a
 
su
rg
e
o
n
 
n
=
8
0
2
 
si
n
g
le
 i
n
st
it
u
ti
o
n
 
T
h
e
 N
e
th
e
rl
a
n
d
s,
 2
0
0
8
 
A
im
 o
f 
th
e
 s
tu
d
y
  
(2
) 
 D
e
sc
ri
b
e
 c
li
n
ic
a
l 
p
re
se
n
ta
ti
o
n
 o
f 
a
cu
te
 
d
iv
e
rt
ic
u
li
ti
s 
in
 a
n
 
e
m
e
rg
e
n
c y
 
d
e
p
a
rt
m
e
n
t 
a
n
d
 
co
m
p
a
re
 t
o
 n
o
n
-
sp
e
ci
fi
c 
a
b
d
o
m
in
a
l 
p
a
in
 (
N
S
A
P
)  
E
v
a
lu
a
te
 t
h
e
 
d
ia
g
n
o
st
ic
 a
cc
u
ra
cy
 o
f 
cl
in
ic
a
l 
e
v
a
lu
a
ti
o
n
 a
n
d
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a
g
in
g
 m
o
d
a
li
ti
e
s 
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s 
U
S
 a
n
d
 C
T
 a
n
d
 
d
e
te
rm
in
e
 t
h
e
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a
lu
e
 
o
f 
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e
se
 e
xa
m
in
a
ti
o
n
s 
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 c
li
n
ic
a
l 
d
e
ci
si
o
n
 
m
a
k
in
g
 
D
ia
g
n
o
st
ic
 
a
cc
u
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(1
) 
 S
tu
d
y
 p
re
se
n
ts
 
se
n
si
ti
v
it
y
 a
n
d
 
sp
e
ci
fi
ci
ty
 o
f 
cl
in
ic
a
l 
d
ia
g
n
o
si
s 
d
iv
e
rt
ic
u
li
ti
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S
tu
d
y
 p
re
se
n
ts
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n
si
ti
v
it
y
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n
d
 
sp
e
ci
fi
ci
ty
 o
f 
cl
in
ic
a
l 
d
ia
g
n
o
si
s 
d
iv
e
rt
ic
u
li
ti
s  
S
tu
d
y
 /
 y
e
a
r 
C
li
n
ic
a
l 
d
ia
g
n
o
si
s  
La
u
re
ll
 ,
 2
0
0
6
 
T
o
o
re
n
v
li
e
t,
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0
0
8
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e
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m
e
n
t 
o
f 
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u
d
e
d
 s
tu
d
ie
s 
b
a
se
d
 o
n
 t
h
e
 S
T
A
R
D
 i
n
it
ia
ti
v
e
 c
h
e
ck
li
st
 (
co
n
ti
n
u
e
d
) 
D
e
m
o
g
ra
p
h
ic
s 
st
u
d
y
 
p
o
p
u
la
ti
o
n
  
(1
5
) 
 F
in
a
l 
d
ia
g
n
o
si
s 
A
C
D
 n
=
2
7
 
m
e
a
n
 a
g
e
 6
3
, 
p
ro
p
o
rt
io
n
 
fe
m
a
le
s 
6
6
%
, 
a
b
sc
e
ss
e
s 
2
9
%
, 
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u
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s 
0
%
, 
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e
ry
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0
%
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-
m
o
rb
id
it
y
 a
n
d
 c
u
rr
e
n
t 
tr
e
a
tm
e
n
ts
 w
e
re
 n
o
t 
sp
e
ci
fi
e
d
 
p
a
ti
e
n
ts
 w
e
re
 r
e
cr
u
it
e
d
 a
t 
th
e
 
E
R
 
F
in
a
l 
d
ia
g
n
o
si
s 
A
C
D
 n
=
5
2
 
m
e
a
n
 a
g
e
 6
3
, 
p
ro
p
o
rt
io
n
 
fe
m
a
le
s 
7
3
%
, 
co
-m
o
rb
id
it
y
 a
n
d
 
cu
rr
e
n
t 
tr
e
a
tm
e
n
ts
 w
e
re
 n
o
t 
sp
e
ci
fi
e
d
 
p
a
ti
e
n
t 
re
cr
u
it
m
e
n
t 
n
o
t 
cl
e
a
rl
y
 
sp
e
ci
fi
e
d
 
 F
in
a
l 
d
ia
g
n
o
si
s 
A
C
D
 n
=
5
2
 
m
e
a
n
 a
g
e
 n
o
t 
re
p
o
rt
e
d
, 
p
ro
p
o
rt
io
n
 f
e
m
a
le
s 
n
o
t 
re
p
o
rt
e
d
, 
a
b
s c
e
ss
e
s 
1
6
%
, 
fi
st
u
la
s 
4
%
, 
co
-m
o
rb
id
it
y
 a
n
d
 
cu
rr
e
n
t 
tr
e
a
tm
e
n
ts
 w
e
re
 n
o
t 
sp
e
ci
fi
e
d
 
p
a
ti
e
n
t 
re
cr
u
it
m
e
n
t 
n
o
t 
cl
e
a
rl
y
 
sp
e
ci
fi
e
d
 
S
tu
d
y
 d
a
te
  
a
n
d
 d
u
ra
ti
o
n
  
(1
4
) 
 1
9
8
6
-1
9
8
9
 
S
tu
d
y
 p
e
ri
o
d
 3
6
 
m
o
n
th
s  
N
o
v
e
m
b
e
r 
1
9
9
1
 –
 
A
p
ri
l 
1
9
9
4
 
S
tu
d
y
 p
e
ri
o
d
 4
0
 
m
o
n
th
s  
 S
tu
d
y
 p
e
ri
o
d
 2
4
 
m
o
n
th
s  
E
xa
ct
 d
a
te
 n
o
t 
g
iv
e
n
 
T
e
st
  
R
e
p
ro
d
u
ci
b
il
it
y
  
(1
3
) 
 N
o
 m
e
th
o
d
s 
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r 
ca
lc
u
la
ti
n
g
 t
e
st
 
re
p
ro
d
u
ci
b
il
it
y
 
N
o
 m
e
th
o
d
s 
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r 
ca
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u
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ti
n
g
 t
e
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p
ro
d
u
ci
b
il
it
y
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o
 m
e
th
o
d
s 
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r 
ca
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u
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ti
n
g
 t
e
st
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p
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d
u
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b
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it
y
 
M
e
a
su
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s 
o
f 
d
ia
g
n
o
st
ic
 
a
cc
u
ra
cy
  
(1
2
) 
 S
e
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
fi
ci
ty
 
w
e
re
 e
n
u
cl
e
a
te
d
 i
n
 t
h
e
 
st
u
d
y
 a
n
d
 P
P
V
, 
N
P
V
, 
p
o
si
ti
v
e
 L
R
, 
n
e
g
a
ti
v
e
 L
R
 
a
n
d
 t
h
e
ir
 9
5
%
 C
I 
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n
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e
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b
se
q
u
e
n
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y
 c
a
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u
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te
d
 
S
e
n
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v
it
y
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n
d
 s
p
e
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n
u
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e
a
te
d
 i
n
 t
h
e
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u
d
y
 a
n
d
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P
V
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N
P
V
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p
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ti
v
e
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R
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n
e
g
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ti
v
e
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R
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d
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h
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5
%
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I 
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n
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e
 
su
b
se
q
u
e
n
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y
 c
a
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u
la
te
d
 
 S
e
n
si
ti
v
it
y
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n
d
 s
p
e
ci
fi
ci
ty
 
w
e
re
 e
n
u
cl
e
a
te
d
 i
n
 t
h
e
 
st
u
d
y
 a
n
d
 P
P
V
, 
N
P
V
, 
p
o
si
ti
v
e
 L
R
, 
n
e
g
a
ti
v
e
 L
R
 
a
n
d
 t
h
e
ir
 9
5
%
 C
I 
ca
n
 b
e
 
su
b
se
q
u
e
n
tl
y
 c
a
lc
u
la
te
d
 
B
li
n
d
in
g
  
(1
1
) 
 N
o
 b
li
n
d
 e
v
a
lu
a
ti
o
n
 b
e
tw
e
e
n
 
re
fe
re
n
ce
 a
n
d
 i
n
d
e
x 
te
st
 
 N
o
 i
n
d
e
p
e
n
d
e
n
t 
e
v
a
lu
a
ti
o
n
 o
f 
in
d
e
xt
e
st
 s
in
ce
 p
a
ti
e
n
ts
 w
e
re
 
re
fe
rr
e
d
 t
o
 t
h
e
 r
a
d
io
lo
g
ic
a
l 
d
e
p
a
rt
m
e
n
t 
a
n
d
 t
h
e
 r
a
d
io
lo
g
is
t 
k
n
e
w
 t
h
e
 p
re
su
m
p
ti
v
e
 
d
ia
g
n
o
si
s 
o
f 
A
C
D
 
C
T
 i
n
te
rp
re
ta
ti
o
n
 w
a
s 
d
o
n
e
 
se
p
a
ra
te
ly
 b
e
tw
e
e
n
 t
w
o
 
ra
d
io
lo
g
is
ts
 b
li
n
d
e
d
 t
o
 t
h
e
 
re
su
lt
s 
o
f 
cl
in
ic
a
l 
a
ss
e
ss
m
e
n
t,
 
la
b
o
ra
t o
ry
 t
e
st
s,
 C
E
 a
n
d
 
la
p
a
ro
sc
o
p
y
 
 C
E
 a
n
d
 l
a
p
a
ro
sc
o
p
y
 b
li
n
d
in
g
 
n
o
t 
m
e
n
ti
o
n
e
d
 
 S
o
n
o
g
ra
p
h
ic
 i
n
v
e
st
ig
a
to
r 
w
a
s 
n
o
t 
g
iv
e
n
 i
n
fo
rm
a
ti
o
n
 
re
g
a
rd
in
g
 c
li
n
ic
a
l 
d
ia
g
n
o
si
s 
o
r 
p
re
v
io
u
s 
h
is
to
ry
, 
b
u
t 
w
a
s 
in
fo
rm
e
d
 o
n
ly
 a
b
o
u
t 
th
e
 
p
re
se
n
ti
n
g
 s
y
m
p
to
m
s  
P
e
rs
o
n
s 
a
n
d
  
E
x
p
e
rt
is
e
  
(1
0
) 
 O
n
e
 o
f 
fo
u
r 
ra
d
io
lo
g
is
ts
 
(C
T
) 
o
r 
G
I -
ra
d
io
lo
g
is
ts
 (
B
E
) 
C
E
: 
p
e
rs
o
n
s 
a
n
d
 e
xp
e
rt
is
e
 
n
o
t 
g
iv
e
n
 
 C
T
: 
se
p
a
ra
te
ly
 i
n
te
rp
re
te
d
 
b
y
 t
w
o
 e
xp
e
ri
e
n
ce
d
 
ra
d
io
lo
g
is
t,
 d
ia
g
n
o
si
s 
w
a
s 
co
n
se
n
su
s 
b
e
tw
e
e
n
 t
h
e
 
ra
d
io
lo
g
is
ts
 
 La
p
a
ro
sc
o
p
y
: 
sa
m
e
 
co
lo
re
ct
a
l 
su
rg
e
o
n
, 
e
xp
e
ri
e
n
ce
 n
o
t 
m
e
n
ti
o
n
e
d
 
 P
e
rs
o
n
s 
a
n
d
 e
xp
e
rt
is
e
 
in
te
rp
re
ti
n
g
 U
S
 f
in
d
in
g
s 
n
o
t 
sp
e
ci
fi
e
d
 
D
e
fi
n
it
io
n
 i
n
d
e
x
te
st
  
(9
) 
 B
E
: 
 
(a
) 
e
xt
ra
v
a
sa
ti
o
n
 o
f 
b
a
ri
u
m
 o
r 
a
ir
, 
(b
) 
se
g
m
e
n
ta
l 
n
a
rr
o
w
in
g
 w
it
h
 t
h
ic
k
e
n
e
d
 a
n
d
 
te
th
e
re
d
 m
u
co
sa
 o
r 
(c
) 
e
xt
ra
lu
m
in
a
l 
m
a
ss
 
e
ff
e
ct
 
 C
T
:  
P
e
ri
co
li
c 
fa
t 
in
fl
a
m
m
a
ti
o
n
 w
it
h
 b
o
w
e
l 
w
a
ll
 
th
ic
k
e
n
in
g
 >
4
-5
 m
m
 
B
E
: 
 
n
a
rr
o
w
in
g
 i
n
 t
h
e
 b
o
w
e
l 
lu
m
e
n
 w
it
h
 a
n
 
ir
re
g
u
la
ri
ty
 o
f 
th
e
 m
u
co
sa
 o
r 
a
 l
e
a
k
a
g
e
 o
f 
co
n
tr
a
st
 m
a
te
ri
a
l 
o
u
ts
id
e
 t
h
e
 l
u
m
e
n
 o
f 
th
e
 
b
o
w
e
l 
co
m
b
in
e
d
 w
it
h
 d
iv
e
rt
ic
u
lo
si
s  
 C
T
:  
P
e
ri
co
li
c 
fa
t 
in
fl
a
m
m
a
ti
o
n
 w
it
h
 b
o
w
e
l 
w
a
ll
 
t h
ic
k
e
n
in
g
 <
4
-5
m
m
 a
n
d
 d
iv
e
rt
ic
u
la
 
 La
p
a
ro
sc
o
p
y
:  
R
e
d
d
e
n
e
d
, 
in
fl
a
m
e
d
 a
n
d
 e
d
e
m
a
to
u
s 
se
ro
sa
 t
h
ro
u
g
h
 t
h
e
 l
a
p
a
ro
sc
o
p
e
, 
a
n
d
 
th
ic
k
e
n
e
n
d
 b
o
w
e
l 
w
a
ll
 i
d
e
n
ti
fi
e
d
 t
h
ro
u
g
h
 
p
a
lp
a
ti
n
g
 w
it
h
 a
n
 i
n
st
ru
m
e
n
t,
 i
n
fl
a
m
e
d
 
a
d
h
e
si
o
n
s 
to
 a
d
ja
ce
n
t 
o
rg
a
n
s 
o
r 
a
b
d
o
m
in
a
l 
w
a
ll
 
 D
if
fu
se
, 
h
y
p
o
e
ch
o
ic
 b
o
w
e
l 
w
a
ll
 t
h
ic
k
e
n
in
g
 
o
f 
m
o
re
 t
h
a
n
 4
m
m
 o
v
e
r 
a
t 
le
a
st
 a
 5
cm
 
lo
n
g
 b
o
w
e
l 
lo
o
p
 i
n
 t
h
e
 l
e
ft
 h
e
m
i 
a
b
d
o
m
e
n
 
S
tu
d
y
 /
 y
e
a
r  
C
o
n
tr
a
st
 E
n
e
m
a
 
C
h
o
, 
1
9
9
0
 
S
te
fá
n
ss
o
n
, 
1
9
9
7
 
U
lt
ra
so
u
n
d
 
V
e
rb
a
n
ck
 ,
 1
9
8
9
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d
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h
e
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T
A
R
D
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n
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v
e
 c
h
e
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st
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co
n
ti
n
u
e
d
) 
D
e
m
o
g
ra
p
h
ic
s 
st
u
d
y
 
p
o
p
u
la
ti
o
n
  
(1
5
) 
F
in
a
l 
d
ia
g
n
o
si
s 
A
C
D
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=
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2
 
m
e
a
n
 a
g
e
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8
, 
p
ro
p
o
rt
io
n
 
fe
m
a
le
s  
5
1
%
, 
a
b
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e
ss
e
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1
6
%
, 
fi
st
u
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s 
4
%
, 
co
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o
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id
it
y
 a
n
d
 
cu
rr
e
n
t 
tr
e
a
tm
e
n
ts
 w
e
re
 n
o
t 
sp
e
ci
fi
e
d
 
p
a
ti
e
n
t 
re
cr
u
it
m
e
n
t 
n
o
t 
cl
e
a
rl
y
 
sp
e
ci
fi
e
d
 
n
=
2
 p
a
ti
e
n
ts
 w
it
h
 d
iv
e
rt
ic
u
li
ti
s 
o
f 
th
e
 c
o
e
cu
m
 a
n
d
 t
ra
n
v
e
rs
u
m
 
F
in
a
l 
d
ia
g
n
o
si
s 
A
C
D
 n
=
7
4
, 
m
e
a
n
 
a
g
e
 5
6
, 
p
ro
p
o
rt
io
n
 f
e
m
a
le
s 
5
5
%
, 
a
b
sc
e
ss
e
s 
8
%
, 
fi
st
u
la
s 
2
%
, 
su
rg
e
ry
 2
2
%
 c
o
-m
o
rb
id
it
y
 a
n
d
 
cu
rr
e
n
t 
tr
e
a
tm
e
n
ts
 w
e
re
 n
o
t 
sp
e
ci
fi
e
d
 
p
a
ti
e
n
ts
 w
e
re
 r
e
cr
u
it
e
d
 a
t 
th
e
 
E
R
 
F
in
a
l 
d
ia
g
n
o
si
s 
A
C
D
 n
=
1
0
2
 
m
e
a
n
 a
g
e
 6
1
, 
p
ro
p
o
rt
io
n
 
fe
m
a
le
s 
6
2
%
, 
a
b
sc
e
ss
e
s 
1
1
%
, 
fi
st
u
la
s 
6
%
, 
p
e
rf
o
ra
ti
o
n
s 
7
%
, 
su
rg
e
ry
 %
  
co
-m
o
rb
id
it
y
 a
n
d
 c
u
rr
e
n
t 
tr
e
a
tm
e
n
ts
 w
e
re
 n
o
t 
sp
e
ci
fi
e
d
; 
p
a
ti
e
n
t 
re
cr
u
it
m
e
n
t 
u
n
cl
e
a
r  
S
tu
d
y
 d
a
te
  
a
n
d
 d
u
ra
ti
o
n
  
(1
4
) 
S
tu
d
y
 p
e
ri
o
d
 2
4
 
m
o
n
th
s  
E
xa
ct
 d
a
te
 n
o
t 
g
iv
e
n
 
N
o
 e
xa
ct
 d
a
te
 g
iv
e
n
 
b
u
t 
p
ri
o
r 
to
 1
9
9
7
 
S
tu
d
y
 p
e
ri
o
d
 4
8
 
m
o
n
th
s  
Ja
n
u
a
ry
 1
9
9
8
 t
o
 
M
a
y
 2
0
0
0
 
S
tu
d
y
 p
e
ri
o
d
 2
7
 
T
e
st
  
R
e
p
ro
d
u
ci
b
il
it
y
  
(1
3
) 
N
o
 m
e
th
o
d
s 
fo
r 
ca
lc
u
la
ti
n
g
 t
e
st
 
re
p
ro
d
u
ci
b
il
it
y
 
N
o
 m
e
th
o
d
s 
fo
r 
ca
lc
u
la
ti
n
g
 t
e
st
 
re
p
ro
d
u
ci
b
il
it
y
 
C
o
n
tr
o
l 
g
ro
u
p
 o
f 
4
0
 
p
a
ti
e
n
ts
 w
it
h
o
u
t 
cl
in
ic
a
l 
su
sp
ic
io
n
 o
f 
A
C
D
 u
n
d
e
rw
e
n
t 
U
S
 
to
 e
v
a
lu
a
te
 t
h
e
 
a
p
p
e
a
ra
n
ce
 o
f 
n
o
n
- 
in
fl
a
m
e
d
 d
iv
e
rt
ic
u
la
 
M
e
a
su
re
s 
o
f 
d
ia
g
n
o
st
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a
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u
ra
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(1
2
) 
S
e
n
si
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v
it
y
 a
n
d
 s
p
e
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ty
 
w
e
re
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n
u
cl
e
a
te
d
 i
n
 t
h
e
 
st
u
d
y
 a
n
d
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P
V
, 
N
P
V
, 
p
o
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v
e
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R
,  
n
e
g
a
ti
v
e
 L
R
 
a
n
d
 t
h
e
ir
 9
5
%
 C
I 
ca
n
 b
e
 
su
b
se
q
u
e
n
tl
y
 c
a
lc
u
la
te
d
, 
cl
e
a
rl
y
 s
ta
te
d
 i
n
 e
v
a
lu
a
ti
o
n
 
a
n
d
 c
a
lc
u
la
ti
o
n
s  
T
P
/T
N
/F
P
/F
N
 a
re
 g
iv
e
n
, 
se
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
fi
ci
ty
, 
N
P
V
, 
P
P
V
, 
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+
 a
n
d
 L
R
- 
w
it
h
 
9
5
%
 C
I 
a
re
 c
a
lc
u
la
te
d
 
S
e
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
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ci
ty
 
w
e
re
 e
n
u
cl
e
a
te
d
 i
n
 t
h
e
 
st
u
d
y
 a
n
d
 P
P
V
, 
N
P
V
, 
p
o
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ti
v
e
 L
R
, 
n
e
g
a
ti
v
e
 L
R
 
a
n
d
 t
h
e
ir
 9
5
%
 C
I 
ca
n
 b
e
 
su
b
se
q
u
e
n
tl
y
 c
a
lc
u
la
te
d
 
B
li
n
d
in
g
  
(1
1
) 
S
o
n
o
g
ra
p
h
ic
 i
n
v
e
st
ig
a
to
r 
h
a
d
 
k
n
o
w
le
d
g
e
 o
f 
th
e
 p
a
ti
e
n
t 
b
e
in
g
 
a
 d
iv
e
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u
li
ti
s 
st
u
d
y
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a
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e
n
t,
 
b
u
t 
w
a
s 
b
li
n
d
e
d
 t
o
 d
e
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il
s 
o
f 
th
e
 c
li
n
ic
a
l 
e
xa
m
in
a
ti
o
n
 
N
o
 b
li
n
d
 e
v
a
lu
a
ti
o
n
 b
e
tw
e
e
n
 
in
d
e
x 
te
st
 a
n
d
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e
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n
ce
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 p
a
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e
fe
rr
e
d
 t
o
 
th
e
 r
a
d
io
lo
g
ic
a
l 
d
e
p
a
rt
m
e
n
t 
a
n
d
 t
h
e
 r
a
d
io
lo
g
is
t 
k
n
e
w
 t
h
e
 
p
re
su
m
p
ti
v
e
 d
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 d
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 d
if
fe
re
n
t 
su
rg
e
o
n
s 
in
 
tr
a
in
in
g
 w
h
o
 p
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ra
d
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p
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 c
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 c
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d
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 b
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b
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 m
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 m
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i c
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 m
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b
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P
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 d
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d
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 f
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p
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 p
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ra
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 d
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 c
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d
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 c
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ra
d
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d
io
lo
g
is
ts
 
F
o
u
r 
e
xp
e
ri
e
n
ce
d
 
re
se
a
rc
h
e
rs
 w
it
h
 a
 f
o
cu
s 
o
n
 g
a
st
ro
in
te
st
in
a
l 
d
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 C
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 f
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 b
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 m
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 p
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P
e
ri
co
li
c 
fa
t 
in
fl
a
m
m
a
ti
o
n
 w
it
h
 b
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 b
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p
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p
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io
n
 
fe
m
a
le
s 
6
4
%
, 
co
m
p
li
ca
te
d
 
d
iv
e
rt
ic
u
li
ti
s 
n
=
1
4
 (
3
6
%
) 
 
co
-m
o
rb
id
it
y
 a
n
d
 c
u
rr
e
n
t 
tr
e
a
tm
e
n
ts
 w
e
re
 n
o
t 
sp
e
ci
fi
e
d
 
p
a
ti
e
n
t 
re
cr
u
it
m
e
n
t 
u
n
cl
e
a
r  
S
tu
d
y
 d
a
te
  
a
n
d
 d
u
ra
ti
o
n
  
(1
4
) 
Ju
n
e
 1
9
9
6
 t
o
 
S
e
p
te
m
b
e
r 
1
9
9
7
 
S
tu
d
y
 p
e
ri
o
d
 1
5
 
m
o
n
th
s  
S
tu
d
y
 p
e
ri
o
d
 1
5
 
m
o
n
th
s  
E
xa
ct
 d
a
te
 n
o
t 
g
iv
e
n
, 
b
u
t 
b
e
fo
re
 
2
0
0
2
 
F
e
b
ru
a
ry
 t
o
 A
u
g
u
st
 
2
0
0
2
 
S
tu
d
y
 p
e
ri
o
d
 6
 
m
o
n
th
s  
T
e
st
  
R
e
p
ro
d
u
ci
b
il
it
y
  
(1
3
) 
N
o
 m
e
th
o
d
s 
fo
r 
ca
lc
u
la
ti
n
g
 t
e
st
 
re
p
ro
d
u
ci
b
il
it
y
 
N
o
 m
e
th
o
d
s 
fo
r 
ca
lc
u
la
ti
n
g
 t
e
st
 
re
p
ro
d
u
ci
b
il
it
y
 
D
e
fi
n
it
iv
e
 d
ia
g
n
o
si
s 
o
f 
A
C
D
 w
a
s 
e
st
a
b
li
sh
e
d
 b
y
 t
w
o
 
ra
d
io
lo
g
is
ts
 a
n
d
 
o
n
e
 
g
a
st
ro
e
n
te
ro
lo
g
is
t,
 
in
tr
a
re
a
d
e
r 
a
n
d
 
in
te
rr
e
a
d
e
r 
a
g
re
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n
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re
 g
iv
e
n
, 
se
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
fi
ci
ty
, 
N
P
V
, 
P
P
V
, 
LR
+
 a
n
d
 L
R
- 
w
it
h
 
9
5
%
 C
I 
a
re
 c
a
lc
u
la
te
d
 
T
P
/T
N
/F
P
/F
N
 a
re
 g
iv
e
n
, 
se
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
fi
ci
ty
, 
N
P
V
, 
P
P
V
, 
LR
+
 a
n
d
 L
R
- 
w
it
h
 
9
5
%
 C
I 
a
re
 c
a
lc
u
la
te
d
 
B
li
n
d
in
g
  
(1
1
) 
N
o
 b
li
n
d
 e
v
a
lu
a
ti
o
n
 b
e
tw
e
e
n
 
re
fe
re
n
ce
 t
e
st
 a
n
d
 i
n
d
e
x 
te
st
 
N
o
 b
li
n
d
 e
v
a
lu
a
ti
o
n
 b
e
tw
e
e
n
 
re
fe
re
n
ce
 t
e
st
 a
n
d
 i
n
d
e
x 
te
st
 
T
h
e
 r
a
d
io
lo
g
is
ts
 w
e
re
 b
li
n
d
e
d
 
to
 t
h
e
 r
e
su
lt
 o
f 
th
e
 o
th
e
r 
e
xa
m
in
a
ti
o
n
 (
tw
o
 d
if
fe
re
n
t 
C
T
 
re
g
im
e
s)
. 
T
h
e
se
 t
e
st
s 
w
e
re
 
b
o
th
 i
n
d
e
xt
e
st
s,
 t
h
u
s 
n
o
 f
o
rm
a
l 
b
li
n
d
 e
v
a
lu
a
ti
o
n
 b
e
tw
e
e
n
 
re
fe
re
n
ce
 a
n
d
 i
n
d
e
x 
te
st
 w
a
s 
a
p
p
li
e
s  
P
e
rs
o
n
s 
a
n
d
  
E
x
p
e
rt
is
e
  
(1
0
) 
T
w
o
 e
xp
e
ri
e
n
ce
d
 
ra
d
io
lo
g
is
ts
 
Im
m
e
d
ia
te
ly
 i
n
te
rp
re
ta
ti
o
n
 
b
y
 r
a
d
io
lo
g
is
t 
o
n
 c
a
ll
 
F
in
a
l 
d
ia
g
n
o
si
s 
m
a
d
e
 b
y
 
tw
o
 e
xp
e
ri
e
n
ce
d
 
ra
d
io
lo
g
is
ts
 i
n
 c
o
n
se
n
su
s 
w
it
h
in
 8
 h
 
F
o
u
r 
re
a
d
e
rs
; 
1
 g
e
n
e
ra
l 
ra
d
io
lo
g
is
t 
w
it
h
 >
2
0
 y
rs
 
e
xp
e
ri
e
n
ce
; 
1
 G
E
 
ra
d
io
lo
g
is
t 
>
1
0
 y
rs
 
e
xp
e
ri
e
n
ce
; 
1
 r
a
d
io
lo
g
is
t 
 
in
 t
ra
in
in
g
; 
1
 
g
a
st
ro
e
n
te
ro
lo
g
is
t  
D
e
fi
n
it
io
n
 i
n
d
e
x
te
st
  
(9
) 
P
e
ri
co
li
c 
fa
t 
in
fl
a
m
m
a
ti
o
n
 w
it
h
 b
o
w
e
l 
w
a
ll
 
th
ic
k
e
n
in
g
 >
5
m
m
 a
n
d
 t
h
e
 p
re
s e
n
ce
 o
f 
d
iv
e
rt
ic
u
la
 
P
e
ri
co
li
c 
a
b
sc
e
ss
, 
a
ir
 b
u
b
b
le
s,
 f
re
e
 f
lu
id
 
a
n
d
 f
is
tu
la
 i
n
 c
a
se
 o
f 
co
m
p
li
ca
te
d
 
d
iv
e
rt
ic
u
li
ti
s  
P
e
ri
co
li
c 
fa
t 
in
fl
a
m
m
a
ti
o
n
 w
it
h
 b
o
w
e
l 
w
a
ll
 
th
ic
k
e
n
in
g
 >
4
m
m
 a
n
d
 t
h
e
 p
re
se
n
ce
 o
f 
d
iv
e
rt
ic
u
la
 
C
o
n
ta
in
e
d
 o
r 
fr
e
e
 p
e
rf
o
ra
ti
o
n
 o
r 
a
b
sc
e
ss
, 
in
 c
a
se
 o
f  
co
m
p
li
ca
te
d
 d
iv
e
rt
ic
u
li
ti
s 
P
e
ri
co
li
c 
fa
t 
in
fl
a
m
m
a
ti
o
n
 w
it
h
 b
o
w
e
l 
w
a
ll
 
th
ic
k
e
n
in
g
 n
o
t 
fu
rt
h
e
r 
sp
e
ci
fi
e
d
 (
th
e
 
ra
d
io
lo
g
is
t 
h
a
d
 t
o
 g
iv
e
 t
h
e
 w
a
ll
 t
h
ic
k
n
e
ss
 i
n
 
m
m
) 
a
n
d
 t
h
e
 l
o
w
 g
ra
d
e
 d
iv
e
rt
ic
u
li
ti
s 
o
r 
h
ig
h
 g
ra
d
e
 d
iv
e
rt
ic
u
li
ti
s  
a
cc
o
rd
in
g
 t
o
 t
h
e
 A
m
b
ro
se
tt
i 
cr
it
e
ri
a
 
(a
b
sc
e
ss
 f
o
rm
a
ti
o
n
, 
g
a
se
o
u
s 
co
ll
e
ct
io
n
 a
n
d
 
o
r 
fi
st
u
la
 i
n
 c
a
se
 o
f 
co
m
p
li
ca
te
d
 A
C
D
)  
S
tu
d
y
 /
 y
e
a
r  
R
a
o
, 
1
9
9
8
 
W
e
rn
e
r,
 2
0
0
3
 
T
a
ck
, 
2
0
0
5
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T
a
b
le
 S
2
: 
Q
u
a
li
ty
 a
ss
e
ss
m
e
n
t 
o
f 
in
cl
u
d
e
d
 s
tu
d
ie
s 
b
a
se
d
 o
n
 t
h
e
 S
T
A
R
D
 i
n
it
ia
ti
v
e
 c
h
e
ck
li
st
 (
co
n
ti
n
u
e
d
) 
D
e
m
o
g
ra
p
h
ic
s 
st
u
d
y
 p
o
p
u
la
ti
o
n
 
(1
5
) 
 F
in
a
l 
d
ia
g
n
o
si
s 
A
C
D
 n
=
4
7
 (
8
5
%
) 
M
e
d
ia
n
 a
g
e
 5
9
, 
p
ro
p
o
rt
io
n
 f
e
m
a
le
s 
4
7
%
, 
co
m
p
li
ca
te
d
 d
iv
e
rt
ic
u
li
ti
s 
o
n
ly
 
m
e
n
ti
o
n
e
d
 b
a
se
d
 o
n
 M
R
I 
fi
n
d
in
g
s 
a
n
d
 
d
if
fe
rs
 s
ig
n
if
ic
a
n
tl
y
 b
e
tw
e
e
n
 t
w
o
 
a
ss
e
ss
o
rs
 (
9
%
 v
s 
3
4
%
)  
co
-m
o
rb
id
it
y
 a
n
d
 c
u
rr
e
n
t 
tr
e
a
tm
e
n
ts
 
w
e
re
 n
o
t 
s p
e
ci
fi
e
d
 
p
a
ti
e
n
t 
re
cr
u
it
m
e
n
t 
o
n
 e
m
e
rg
e
n
cy
 
d
e
p
a
rt
m
e
n
t 
b
y
 a
n
 e
xp
e
ri
e
n
ce
d
 
su
rg
e
o
n
 
 F
in
a
l 
d
ia
g
n
o
si
s 
A
C
D
 n
=
1
4
5
 
m
e
a
n
 a
g
e
 6
2
, 
p
ro
p
o
rt
io
n
 f
e
m
a
le
s 
6
5
%
 
3
7
%
 l
e
ft
 a
b
d
o
m
in
a
l 
te
n
d
e
rn
e
ss
 o
n
ly
, 
1
4
%
 v
o
m
it
in
g
 a
s 
co
m
p
a
re
d
 t
o
 2
7
%
 
N
S
A
P
 (
p
<
0
.0
0
1
) 
5
4
%
 p
re
v
io
u
s 
e
p
is
o
d
e
s 
a
s 
co
m
p
a
re
d
 t
o
 
4
0
%
 N
S
A
P
 (
p
<
0
.0
0
1
) 
C
R
P
 7
3
 a
s 
co
m
p
a
re
d
 t
o
 2
0
 N
S
A
P
 
( p
<
0
.0
0
1
) 
F
ir
st
 c
li
n
ic
a
l 
d
ia
g
n
o
si
s 
A
C
D
 n
=
6
0
, 
fi
n
a
l 
d
ia
g
n
o
si
s 
n
=
5
7
 
 1
4
 o
f 
th
e
 5
7
 p
a
ti
e
n
ts
 w
it
h
 A
C
D
 a
s 
fi
n
a
l 
d
ia
g
n
o
si
s 
w
e
re
 n
o
t 
su
sp
e
ct
e
d
 o
f 
h
a
v
in
g
 A
C
D
 a
s 
th
e
 i
n
it
ia
l 
d
ia
g
n
o
si
s  
S
T
A
R
D
 i
n
it
ia
ti
v
e
 c
h
e
ck
li
st
 
(9
) 
D
e
fi
n
it
io
n
 o
f 
a
n
d
 r
a
ti
o
n
a
le
 f
o
r 
th
e
 u
n
it
s,
 c
u
t -
o
ff
s 
a
n
d
/o
r 
ca
te
g
o
ri
e
s 
o
f 
th
e
 r
e
su
lt
s 
o
f 
th
e
 i
n
d
e
x 
te
st
s 
a
n
d
 t
h
e
 r
e
fe
re
n
ce
 s
ta
n
d
a
rd
. 
(1
0
) 
T
h
e
 n
u
m
b
e
r,
 t
ra
in
in
g
 a
n
d
 e
xp
e
rt
is
e
 o
f 
th
e
 p
e
rs
o
n
s 
e
xe
cu
ti
n
g
 a
n
d
 r
e
a
d
in
g
 t
h
e
 i
n
d
e
x 
te
st
s 
a
n
d
 t
h
e
 r
e
fe
re
n
ce
 s
ta
n
d
a
rd
. 
(1
1
) 
W
h
e
th
e
r 
o
r 
n
o
t 
th
e
 r
e
a
d
e
rs
 o
f 
th
e
 i
n
d
e
x 
te
st
s 
a
n
d
 r
e
fe
re
n
ce
 s
ta
n
d
a
rd
 w
e
re
 b
li
n
d
 (
m
a
sk
e
d
) 
to
 t
h
e
 r
e
su
lt
s 
o
f 
th
e
 o
th
e
r 
te
s t
 a
n
d
 d
e
sc
ri
b
e
 a
n
y
 o
th
e
r 
cl
in
ic
a
l 
in
fo
rm
a
ti
o
n
 a
v
a
il
a
b
le
 t
o
 t
h
e
 r
e
a
d
e
rs
. 
(1
2
) 
M
e
th
o
d
s 
fo
r 
ca
lc
u
la
ti
n
g
 o
r 
co
m
p
a
ri
n
g
 m
e
a
su
re
s 
o
f 
d
ia
g
n
o
st
ic
 a
cc
u
ra
cy
, 
a
n
d
 t
h
e
 s
ta
ti
st
ic
a
l 
m
e
th
o
d
s 
u
se
d
 t
o
 q
u
a
n
ti
fy
 u
n
ce
rt
a
in
ty
 (
e
.g
. 
9
5
%
 c
o
n
fi
d
e
n
ce
 i
n
te
rv
a
ls
).
 
(1
3
) 
M
e
th
o
d
s 
fo
r 
ca
lc
u
la
ti
n
g
 t
e
st
 r
e
p
ro
d
u
ci
b
il
it
y
, 
if
 d
o
n
e
.  
(1
4
) 
W
h
e
n
 s
tu
d
y
 w
a
s 
p
e
rf
o
rm
e
d
, 
in
cl
u
d
in
g
 b
e
g
in
n
in
g
 a
n
d
 e
n
d
 d
a
te
s 
o
f 
re
cr
u
it
m
e
n
t.
 
(1
5
) 
C
l i
n
ic
a
l 
a
n
d
 d
e
m
o
g
ra
p
h
ic
 c
h
a
ra
ct
e
ri
st
ic
s 
o
f 
th
e
 s
tu
d
y
 p
o
p
u
la
ti
o
n
 (
a
t 
le
a
st
 i
n
fo
rm
a
ti
o
n
 o
n
 a
g
e
, 
g
e
n
d
e
r,
 s
p
e
ct
ru
m
 o
f 
p
re
se
n
ti
n
g
 s
y
m
p
to
m
s,
 c
o
m
o
rb
id
it
y
, 
cu
rr
e
n
t 
tr
e
a
tm
e
n
ts
, 
re
cr
u
it
m
e
n
t 
ce
n
te
rs
).
 
S
tu
d
y
 d
a
te
  
a
n
d
 d
u
ra
ti
o
n
 
(1
4
) 
 S
tu
d
y
 p
e
ri
o
d
 i
s 
n
o
t 
g
iv
e
n
 
 F
e
b
ru
a
r y
 1
st
 
1
9
9
7
 t
o
 1
st
 o
f 
Ju
n
e
 2
0
0
0
 
S
tu
d
y
 p
e
ri
o
d
 4
1
 
m
o
n
th
s  
Ju
n
e
 2
0
0
5
 a
n
d
 
Ju
ly
 2
0
0
6
 
S
tu
d
y
 p
e
ri
o
d
 1
2
 
m
o
n
th
s  
T
e
st
  
R
e
p
ro
d
u
ci
b
il
it
y
  
(1
3
) 
 N
o
 m
e
th
o
d
s 
fo
r 
ca
lc
u
la
ti
n
g
 t
e
st
 
re
p
ro
d
u
ci
b
il
it
y
 
 N
o
t 
d
o
n
e
 
N
o
t 
d
o
n
e
 
M
e
a
su
re
s 
o
f 
d
ia
g
n
o
st
ic
 
a
cc
u
ra
cy
  
(1
2
) 
 T
P
/T
N
/F
P
/F
N
 a
r e
 g
iv
e
n
, 
se
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
fi
ci
ty
, 
N
P
V
, 
P
P
V
, 
LR
+
 a
n
d
 L
R
- 
w
it
h
 
9
5
%
 C
I 
a
re
 c
a
lc
u
la
te
d
 
 S
e
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
fi
ci
ty
 
a
re
 g
iv
e
n
 o
f 
p
re
li
m
in
a
ry
 
d
ia
g
n
o
si
s 
a
t 
th
e
 e
m
e
rg
e
n
cy
 
d
e
p
a
rt
m
e
n
t 
a
n
d
 d
is
ch
a
rg
e
 
d
ia
g
n
o
si
s 
w
h
e
n
 p
a
ti
e
n
ts
 
w
e
re
 h
o
sp
it
a
li
ze
d
 
T
P
/T
N
/F
P
/F
N
 a
re
 g
iv
e
n
, 
se
n
si
ti
v
it
y
 a
n
d
 s
p
e
ci
fi
ci
ty
, 
N
P
V
, 
P
P
V
, 
LR
+
 a
n
d
 L
R
- 
B
li
n
d
in
g
  
(1
1
) 
 T
h
e
 r
a
d
io
lo
g
is
ts
 w
e
re
 b
li
n
d
e
d
 t
o
  
a
ll
 c
li
n
ic
a
l,
 l
a
b
o
ra
to
ry
 a
n
d
 
ra
d
io
lo
g
ic
 r
e
su
lt
s,
 a
s 
w
e
ll
 a
s 
th
e
 
re
su
lt
s 
o
f 
e
a
ch
 o
th
e
r,
 b
u
t 
a
w
a
re
  
o
f 
th
e
 s
tu
d
y
 d
e
si
g
n
 
 N
o
 b
li
n
d
 e
v
a
lu
a
ti
o
n
 b
e
tw
e
e
n
  
in
d
e
x 
te
st
 a
n
d
 r
e
fe
re
n
ce
 t
e
st
 
 O
n
e
 y
e
a
r 
a
ft
e
r 
cl
in
ic
a
l 
d
ia
g
n
o
si
s 
fi
n
a
l 
d
ia
g
n
o
si
s 
w
a
s 
e
st
a
b
li
sh
e
d
, 
fi
n
a
l 
d
ia
g
n
o
si
s 
b
a
se
d
 o
n
 c
li
n
ic
a
l 
p
a
ra
m
e
te
rs
 a
n
d
 X
-r
a
y
 o
r 
e
n
d
o
sc
o
p
ic
 e
xa
m
in
a
ti
o
n
, 
n
o
t 
m
e
n
ti
o
n
e
d
 w
h
o
 d
e
ci
d
e
s 
a
b
o
u
t 
fi
n
a
l 
d
ia
g
n
o
si
s  
N
o
 b
li
n
d
 e
v
a
lu
a
ti
o
n
 b
e
tw
e
e
n
  
i n
d
e
x 
te
st
 a
n
d
 r
e
fe
re
n
ce
 t
e
st
 
P
e
rs
o
n
s 
a
n
d
  
E
x
p
e
rt
is
e
  
(1
0
) 
 E
v
a
lu
a
ti
o
n
 b
y
 t
w
o
 
a
ss
e
ss
o
rs
, 
e
xp
e
ri
e
n
ce
 n
o
t 
fu
rt
h
e
r 
sp
e
ci
fi
e
d
 
 A
tt
e
n
d
in
g
 p
h
y
si
ci
a
n
, 
n
o
t 
fu
rt
h
e
r 
sp
e
ci
fi
e
d
 
8
4
%
 o
f 
p
a
ti
e
n
ts
 w
e
re
 
e
v
a
lu
a
te
d
 a
t 
th
e
 E
D
 b
y
 
su
rg
ic
a
l 
re
si
d
e
n
ts
 i
n
 t
h
e
ir
 
fi
rs
t 
3
 y
e
a
rs
 o
f  
tr
a
in
in
g
, 
o
th
e
r 
b
y
 s
e
n
io
r 
re
si
d
e
n
ts
 
o
f 
su
rg
e
o
n
s  
D
e
fi
n
it
io
n
 i
n
d
e
x
te
st
  
(9
) 
 P
re
se
n
ce
 o
f 
a
t 
le
a
st
 o
n
e
 
d
iv
e
rt
ic
u
lu
m
, 
co
lo
n
ic
 w
a
ll
 
th
ic
k
e
n
in
g
 (
>
5
m
m
) 
a
n
d
 p
e
ri
co
li
c 
fa
tt
y
 i
n
fi
lt
ra
ti
o
n
. 
 
 S
u
p
p
o
rt
iv
e
 o
f 
th
e
 d
ia
g
n
o
si
s 
w
e
re
 
se
g
m
e
n
ta
l 
n
a
rr
o
w
in
g
, 
a
sc
it
e
s 
a
n
d
 
a
b
sc
e
ss
e
s 
 D
e
ta
il
e
d
 s
ch
e
d
u
le
 f
o
r 
h
is
to
ry
, 
cl
in
ic
a
l 
si
g
n
s 
a
n
d
 r
e
su
lt
s 
o
f 
la
b
o
ra
to
ry
 i
n
v
e
st
ig
a
ti
o
n
s.
 
S
u
g
g
e
st
io
n
 o
f 
a
tt
e
n
d
in
g
 p
h
y
si
ci
a
n
 
fi
rs
t 
a
n
d
 s
e
co
n
d
 m
o
st
 l
ik
e
ly
 
d
ia
g
n
o
si
s  
C
li
n
ic
a
l 
d
ia
g
n
o
si
s 
w
it
h
 a
d
d
it
io
n
a
l 
im
a
g
in
g
 i
f 
d
e
e
m
e
d
 n
e
ce
ss
a
ry
 
S
tu
d
y
 /
 y
e
a
r  
M
R
I  
H
e
v
e
rh
a
g
e
n
, 
2
0
0
8
 
C
li
n
ic
a
l 
d
ia
g
n
o
si
s  
La
u
re
ll
, 
2
0
0
6
 
T
o
o
re
n
v
li
e
t,
 2
0
0
8
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Q
u
a
li
ty
 a
ss
e
ss
m
e
n
t 
o
f 
in
cl
u
d
e
d
 s
tu
d
ie
s 
b
a
se
d
 o
n
 t
h
e
 S
T
A
R
D
 i
n
it
ia
ti
v
e
 c
h
e
ck
li
st
 (
co
n
ti
n
u
e
d
 I
I)
 
C
li
n
ic
a
l 
a
p
p
li
ca
b
il
it
y
 
(2
5
) 
 A
cc
u
ra
cy
 o
f 
cl
in
ic
a
l 
d
ia
g
n
o
si
s 
4
8
%
 
A
d
e
q
u
a
te
 c
li
n
ic
a
l 
a
p
p
li
ca
b
il
it
y
 
La
p
a
ro
sc
o
p
y
 
n
o
w
a
d
a
y
s 
n
o
t 
d
o
n
e
 t
o
 
co
n
fi
rm
 o
r 
ru
le
 o
u
t 
d
ia
g
n
o
si
s,
 n
o
t 
cl
e
a
r 
w
h
y
 u
se
d
 i
n
 t
h
is
 
a
rt
ic
le
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Abstract 
 
Background 
Right-sided colonic diverticulitis is a rare disorder in Western patients and is considered to 
behave more aggressively than left-sided diverticulitis. 
 
Objective 
This study evaluates the differences in the disease course between right- and left-sided 
diverticulitis in a Western population. 
 
Patients 
Adult patients hospitalized between 2004 and 2008 with an episode of acute diverticulitis 
confirmed by imaging were divided in two groups of patients with a right- or a left-sided 
diverticulitis. 
 
Main outcome measures 
Differences in incidence, patient characteristics, clinical presentation and disease course 
between the two groups.  
 
Results 
The hospital coding system yielded 425 patients with a diverticulitis discharge code. A 
total of 183 patients was admitted with confirmed acute diverticulitis by imaging. The 
incidence of right-sided diverticulitis was 8%. Patients with right-sided diverticulitis were 
predominantly female, 86% compared to 47% in left sided diverticulitis (p=0.05). Median 
CRP at presentation was lower in right sided diverticulitis, 30 compared to 71mg/l 
(p=0.001). No other significant differences in clinical presentation and disease course were 
found between right and left-sided diverticulitis. 
 
Conclusions 
Acute right-sided diverticulitis in Western patients has a low incidence, affects predomin-
antly females and presents with a lower CRP than patients with left-sided diverticulitis. 
Clinical presentation and disease course are comparable. 
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Introduction 
 
The type and location of diverticula in the colon differ between populations living in the 
Eastern and Western hemisphere resulting in different patterns of diverticulitis.
1-5 
Right-
sided colonic diverticulitis (RCD) is common in Asia, but is rare in Europe and the USA. RCD 
in Asians originates mainly from congenital, solitary true diverticula in the cecum.
5
 It is not 
clear if RCD in Western patients also originates from true diverticula or is a consequence 
of acquired pseudo-diverticula with a left to right sequence.
6
 The difference in etiology 
has led to the assumption that RCD and left-sided diverticulitis (LCD) in Western patients 
have different disease courses. 
 
The clinical picture of RCD resembles that of acute appendicitis. In the era before 
widespread use of imaging, an inflamed cecum was encountered as unexpected finding 
during intended appendectomy. Emergency resection of the inflamed colonic segment 
usually was performed to eradicate the origin of the inflammation, possibly a malign-
ancy.
1-3, 6-9
 Aggressive treatment of RCD by removing all apparent disease at the time of 
initial presentation was also justified because of studies reporting severe complications 
after conservative treatment of RCD.
1, 6, 10
 The high operative rate of RCD precluded the 
knowledge on the natural disease course of RCD in Western patients and the effect of 
conservative treatment, and led to the opinion that RCD is a more aggressive disease than 
LCD and needs a different, less conservative approach.
9, 11-14
  
 
The routine use of radiological imaging in the diagnostic work-up of patients with acute 
abdominal pain caused a pivotal shift from a surgical diagnosis for RCD and a clinical 
diagnosis for LCD to both radiological diagnoses. This change has contributed to a better 
evaluation of the natural course of both diseases and their treatment managements. 
Current guidelines recommend a more conservative approach in patients with LCD.
15
 
Asian groups advocate an identical approach in the RCD patients, but treatment guidelines 
for Western patients with RCD are lacking.
11-14
  
 
We hypothesize that the disease course and treatment of RCD is similar to LCD in Western 
patients, when RCD is established by imaging instead of by surgery. To this purpose we 
retrospectively analyzed a consecutive series of patients who were admitted to the 
hospital with right or left-sided diverticulitis with an adequate radiological diagnostic work 
up. 
 
 
Material and methods 
 
Patients 
This retrospective study was performed in a non-teaching hospital in the Netherlands with 
an adherence of 175,000 persons and encompasses a 5-year period, from January 2004 to 
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December 2008. We searched the electronic hospital information system for the Diagnosis 
Treatment Combination (DTC) code for diverticular disease/diverticulitis (code 327) to 
identify all consecutive emergency patients admitted with left or right-sided diverticulitis, 
who were potentially eligible for inclusion in the study.  
 
Inclusion criteria 
All consecutive patients admitted for conservative or operative management of clinically 
and radiologically confirmed acute LCD or RCD were included. Diverticulitis was 
considered to be clinically suspect if the patient presented a history of pain at the left 
and/or right lower abdomen combined with at least one of the following elevated 
inflammatory parameters: temperature (T) >37.5° Celsius, erythrocyte sedimentation rate 
(ESR) >10mm/hr, or white blood cell count (WBC) >10.000/m
3
 or C-reactive protein (CRP) 
>5mg/l. Radiological diagnosis of diverticulitis was established if at least one imaging 
modality, ultrasonography (US) or computed tomography (CT), performed within one 
week after admission, demonstrated signs of acute LCD or RCD: colonic wall thickness 
greater than 4mm, pericolic fat displaying straining and/or signs of complicated diverticu-
litis like pericolic abscess, pelvic abscess, extraluminar fluid, air or contrast.
16
 Acute 
diverticulitis located in the cecum, ascending colon or proximal transverse colon was 
classified as RCD. Diverticulitis in the rest of the colon was defined as LCD.  
The Hinchey-Wasvary classification (stage 0-IV) was used to stage acute diverticulitis. 
(Table 1) Hinchey-Wasvary stages 0 and I were considered mild and stages II-IV severe 
diverticulitis.
16
 
Data extraction 
The following data were extracted from the electronic and hardcopy medical records: 
Patient characteristics: age, gender, previous appendectomy, previous episode(s) of di-
verticulitis; Clinical presentation: location of abdominal pain, presence of vomiting, body 
temperature in degrees Celsius; Laboratory findings: (erytrocyte sedimentation rate (ESR) 
in mm/h, white blood cell count (WBC) in 103/l and C-reactive protein (CRP) in mg/l); 
Radiological findings: type of imaging modality (US and/or CT) for the final diagnosis. 
Clinical course: conservative or operative management, early operative management 
(within 30 days after initial hospital admission) and length of hospital stay (days). In case 
of RCD, follow-up investigations, i.e., colonoscopy (CS) and colonic enema (CE) were 
documented and patients were interviewed by telephone regarding the number of 
recurrences and surgery for RCD. The duration of follow up was defined by the number of 
years between the first admission for RCD and last months of data accrual (September 
2013). 
 
Statistical analysis 
The t-test for two independent groups was used to test differences between patients with 
RCD and LCD in case of normally distributed continuous variables; for not-normally 
distributed data the Mann-Whitney U test was used. The Chi-square test was used in case 
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of nominal data, and the Fisher exact test in case of small groups of patients (n <10). A 
value of p less than 0.05 was considered statistically significant. SPSS software (PASW 
statistics 20.0) was used to analyze data. 
 
 
Results 
 
The hospital information system revealed 425 patients with the DTC-code diverticular 
disease/diverticulitis during the 5-year study period of whom 183 were eligible for analysis 
(Figure 1). 
 
A total of fourteen patients (8%) were diagnosed with RCD. Table 2 summarizes the 
annual incidence of RCD compared to LCD. 
 
Table 3 summarizes the patient characteristics and clinical outcome of patients with acute 
LCD and RCD. In the RCD group females were significantly overrepresented (p=0.05) and 
CRP at admission was significantly lower (p=0.001). No significant differences were found 
in other patient characteristics, clinical presentation or disease course data between 
patients with RCD and with LCD. More specifically the percentage of severe diverticulitis 
cases and of operative treatment was comparable.  
 
Table 4 describes patient characteristics and clinical outcome of all patients with acute 
RCD in detail. Two out of 14 RCD patients underwent immediate surgery after initial 
radiological imaging. Both patients had inconclusive radiological findings of an atypical 
appendicitis or cecal diverticulitis. A gridiron incision was performed in both patients and 
an inflamed cecum with a normal appendix was seen. Uncertainty concerning the 
diagnosis led to ileocecal resection in both patients. Both recovered uneventful. 
Histopathological examination demonstrated a non-inflamed appendix and a solitary 
inflamed diverticulum in the cecum in both cases. The 12 remaining RCD patients were 
successfully managed by conservative means with a median hospital stay of six days. One 
patient had a prolonged hospital stay for non-RCD related reasons. All RCD patients had a 
follow up with a median time of seven (range 5-10) years. Follow-up colonoscopy was not 
performed in one patient due to significant co-morbidities and refused by another patient. 
Only one patient, a 31-year old female, experienced a second episode of RCD (recurrence 
rate 7%), which was again successfully treated without operation. None of the RCD 
patients had late elective or acute surgery for RCD during the follow-up period. Combining 
the radiological findings with the postoperative pathology reports or follow-up 
colonoscopy reports, it was concluded that ten patients had a solitary diverticulum and 
four patients had multiple diverticula present in the cecum and ascending colon. 
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425 patients with code 
diverticular disease/diverticulitis 
Excluded for analysis: 
- 33 duplicate patients with recurrent 
diverticulitis 
- 23 patients underwent elective surgery for 
diverticular complications 
- 8 patients with wrong DTC code 
- 6 patients referred from other hospitals 
with diverticulitis 
- 4 patients without clinical signs of 
diverticulitis 
- 2 patients with diverticular perforation after 
colonoscopy 
 
349 patients with first episode of 
clinical suspected diverticulitis 
279 patients with clinical 
suspected diverticulitis and 
radiological evaluation 
Excluded for analysis 
- 70 patients without radiological evaluation 
Excluded for analysis 
- 79 patients with negative ultrasound or 
computed tomography for diverticulitis 
- 17 patients not admitted 
 
14 patients with right-sided 
diverticulitis 
183 patients admitted with 
radiologically proven acute 
diverticulitis 
163 patients with left-sided 
diverticulitis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow-chart for patient selection with right-sided or left-sided diverticulitis based on 
diagnosis treatment combination-code (DTC-code) diverticular disease/diverticulitis in 5-year study 
period 
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Table 1: Hinchey-Wasvary classification for acute diverticulitis 
 
0 Direct visualization of the diverticulum with symptoms 
Ia Confined pericolic inflammation (phlegmon) 
Ib Confined pericolic abscess 
II  Distant intra-abdominal or retroperitoneal abscess 
III Generalized purulent peritonitis 
IV Fecal peritonitis 
 
Table 2: Annual incidence of patients with confirmed right- and left-sided diverticulitis 
 
 2004 2005 2006 2007 2008 Total 
RCD patients  2  6  1  2  3  14 
LCD patients  37  31  35  39  27  169 
Total  39  37  36  41  30  183 
Incidence of RCD  5%  16%  3%  5%  10%  8% 
LCD: left-sided colonic diverticulitis; RCD: right-sided colonic diverticulitis 
 
Table 3: Patient characteristics and clinical outcome of patients with confirmed acute right- and left-
sided diverticulitis 
 
 RCD (14) LCD (169) p value 
Patient characteristics    
 mean age (years) 53 (SD 15,3) 56 (SD 12,8) 0,84 
 gender (M/F) 2/12 (14%) 90/79 (53%) 0,05 
 appendicitis in medical history 4 (29%) 23 (14%) 0,13 
 diverticulitis in medical history 2 (14%) 41 (24%) 0,53 
Clinical presentation    
 pain left lower abdomen 0 159 (94%)  
 pain right lower abdomen 14 (100%) 51 (30%)  
 pain left and right lower abdomen 0 41 (24%)  
 vomitus 2 (14%) 24 (14%) 0,73 
 mean body temperature 37.0 (SD 0,6) 37.4 (SD 0.8) 0,09 
 median CRP 30 (5-228) 71 (1-413) <0,01 
 median WBC 13.2 (6.5-27.7) 13.2 (1.5-27.4) 0,79 
 median ESR 32 (2-78) 33 (0-149) 0,54 
 US performed 14 (100%) 162 (96%) 0,44 
 CT performed 6 (43%) 46 (27%) 0,23 
 mild diverticulitis 14 (100%) 154 (91%) 0,61 
Clinical course    
 median days of hospital stay 5.5 (3-8) 6.0 (1-49) 0,46 
 operative treatment <30 days 2 (14%) 18 (11%) 0,65 
RCD: right-sided colonic diverticulitis; LCD: left-sided colonic diverticulitis; M: male; F: female; CRP: C-reactive protein 
(mg/l); WBC: white blood cell count (x10
3
/l); ESR: erythrocyte sedimentation rate (mm/h); US: Ultrasound; CT: 
Computed Tomography 
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Discussion  
 
The primary aim of this study was to evaluate the differences in the disease course of 
right- and left-sided diverticulitis in Western patients. Results of this study demonstrated 
that RCD is about twelve times less common than LCD in a cohort of Western patients and 
has a predominance for females. The disease course and treatment approach of RCD 
resemble that of LCD.  
 
The clinical presentation of LCD or RCD is known to mimic that of other diseases. Based on 
clinical findings alone the diagnosis of diverticulitis is often inaccurate and therefore 
imaging is recommended in the diagnostic process of diverticulitis.
17
 Major strength of this 
study is the use of radiologically proven diverticulitis. This excludes the erroneous 
inclusion of patients with an assumed but later unconfirmed diagnosis of diverticulitis.  
 
Interpretation of the results is limited by the retrospective nature of this study, the single 
center design and the relatively small number of RCD patients compared to LCD patients. 
The use of a diagnostic code to identify eligible diverticulitis patients may have resulted in 
a relative underestimation of the true incidence of RCD. RCD may have been unrecognized 
because not every patient presenting with acute indeterminate right lower abdominal 
pain has routine radiological evaluation. In general, the interpretation of many study 
results on diverticulitis is hampered by the lack of a classifying diagnosis based on 
radiological imaging. Comparing RCD with LCD is even more difficult because most studies 
on RCD in Caucasians lack pre-operative radiological evaluation and are based on intra-
operative findings. The 8% prevalence of RCD is in accordance with that reported in 
literature.
7, 10, 18
 This percentage varies between 60-90% in Asians with acute 
diverticulitis.
4, 19
 Our study shows a predominant prevalence of RCD in elderly females in 
contrast to young males in Asian studies.
20
 RCD in elderly female patients suggests an 
acquired origin of diverticula at the right side similar to that at the left side. However, in 
more than 70% of our patients RCD originated from solitary diverticula, indicative of true 
diverticula. Whether a right-sided diverticulum is a true congenital or an acquired pseudo-
diverticulum, this study demonstrates that the clinical outcome is not different from LCD 
in Caucasian patients.  
 
Arguments exist to believe that RCD had a milder clinical course than LCD in our patients 
based on a lower level of the inflammatory parameter CRP and the lower rate of severe 
diverticulitis at presentation. Perforated RCD with distant abdominal abscesses or fecal 
peritonitis has rarely been described in Western patients. In addition, recurrence rate of 
RCD (7% in 7 years in our study) seems lower than that of LCD (up to 20% in 10 years).
14-
16, 19, 21-25
  
 
Successful results of non-operative management of uncomplicated RCD in both Western 
and Asian patients have been published before.
4, 10-12, 14, 26-30
 All but one of the RCD 
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patients received antibiotics as part of the conservative treatment, which is questionable 
for patients with mild RCD similar to patients with LCD.
31, 32
 Oudenhoven and Lee 
demonstrated excellent results from non-antibiotic treatment for RCD.
4, 26
 No need for 
antibiotics and successful conservative treatment in the majority of patients supports the 
theory that RCD in Western patients is a self-limiting disease. The mild clinical 
presentation of RCD may also explain the relative low incidence of RCD in the Western 
world whereby most patients are not referred to a hospital and remain undiagnosed. 
 
Conclusion 
Radiologically proven RCD in Western patients has a low incidence, develops predomin-
antly in females, is a self-limiting disease in most cases and seems to have a milder disease 
course compared with LCD. 
 
The concept that RCD in Western patients is a more aggressive disease than LCD is merely 
a reflection of the unfamiliarity with this disease in the Western world, and inadequate 
diagnostic workup and decision making in the operating room. 
 
An adult Caucasian patient over 50 years with pain in the lower right abdomen suspected 
of an acute inflammatory process benefits from radiological imaging to avoid unnecessary 
surgery for RCD. Imaging allows clinicians to determine the optimal management 
according to the severity of the diverticulitis.
27
 Taking into account the similar mild or even 
milder disease course found in this study current guidelines for the treatment of LCD also 
can apply for the treatment of RCD.
33
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Abstract 
 
Background 
Although colonic diverticulitis is a common disorder, the optimal treatment strategy for 
patients with recurrent episodes of diverticulitis remains unclear. We aimed to determine 
whether colonic resection, conservative or medical treatment, would be preferred 
treatment in terms of quality-adjusted life years (QALYs). 
 
Method 
A Markov model simulating patients with two episodes of non-surgically treated 
diverticulitis was used to simulate all relevant outcomes of each treatment strategy. A 
one-year cycle length with 10-year follow-up was used to allow for chance of recurrent 
diverticulitis. Primary outcome was QALYs gained from each strategy. Factors considered 
were morbidity, mortality, chance of colostomy formation, risk of recurrence and 
persisting abdominal pain. The probabilities of clinical events were determined using the 
best available data from the literature. 
 
Results 
The strategy in which colonic resection was performed after two episodes of diverticulitis 
was associated with the lowest quality-adjusted survival of 8.66 QALY, the highest chance 
of stoma formation (1.1%) but the lowest chance of a mild (3.5%) or severe (1.1%) 
recurrence. The strategies of colonic resection, conservative or medical treatment after 
the third episode of diverticulitis were comparable in terms of quality–adjusted survival, 
with 8.78, 8.76 and 8.74 QALYs, respectively. Probabilistic sensitivity analysis did not 
change these results. Persistent abdominal complaints were lowest in the medical 
treatment strategy.  
 
Conclusion 
Elective surgery after two episodes of diverticulitis should be questioned in terms of 
QALYs. After the third episode of diverticulitis surgical, conservative or medical treatment 
provide similar QALYs but rates of abdominal symptoms are lower in the medical 
treatment strategy. This Markov decision model has limitations when the individual 
patient and physician face a complex decision weighing early and long-term risks and 
benefits of elective surgery or conservative management. 
 
Keywords 
Diverticulitis; Quality of Life; recurrent disease; treatment options 
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Introduction 
 
The main indication for elective colonic resection in patients with recurrent colonic 
diverticulitis is to prevent an emergency operation. Studies also suggest that elective 
resection reduces the burden of recurrent disease, lowers persistent abdominal 
complaints and treats symptomatic uncomplicated diverticular disease (SUDD).
1, 2
 SUDD is 
a chronic illness characterized by persistent abdominal pain in between the overt flares of 
diverticulitis.
3
 
 
To properly advise the individual patient with recurrent episodes of diverticulitis, it seems 
crucial to differentiate between patients who are likely to benefit from prophylactic 
resection to prevent complicated disease, and those who will have a benign course. The 
decision to recommend surgery seems affected by the age and medical condition of the 
patient, frequency and severity of the attack(s), and whether there are persistent 
symptoms after the acute episode.
4
 Despite these new insights, evidence supporting the 
withheld of elective colectomy is still limited.
5
 
 
Similarities between diverticulitis and inflammatory bowel disease have been 
demonstrated and potential beneficial results with medical therapy are being reported in 
small series.
6, 7
 Results of medical treatment options have not been incorporated in recent 
guidelines, but might play a role in the decision whether or not to operate. 
 
To determine the best strategy for patients with recurrent episodes of diverticulitis we 
designed a state-transition Markov model in which surgical and conservative treatment 
strategies in patients with recurrent episodes of diverticulitis were compared, with quality 
of life (QoL) as primary outcome measure. Quality of life was used because it 
encompasses best the different outcomes reported for treatment modalities of recurrent 
diverticulitis. 
 
 
Material and methods 
 
We constructed a Markov-based decision model to simulate the course of events for 
patients after two episodes of non-surgically treated acute colonic diverticulitis (ACD). 
TreeAge Pro 2009, release 1.0.2 was used to construct and analyze the Markov model.  
 
Markov model  
A simplified version of the Markov model is given in Figure 1. The model was designed 
from a patient perspective, using quality-adjusted life years (QALYs) as the overall 
outcome measure. The Markov model used a cycle time of one year and we ran the model 
for ten years to allow time for a diverticulitis recurrence. The base-case patient was a 58-
year-old patient after two episodes of diverticulitis. The age-specific mortality rates for the 
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general population were taken from the Dutch mortality registry, which are comparable to 
other Western countries. We chose not to include patients of different age groups in the 
model to avoid major complexity and because high quality data to properly assign age 
related risks are lacking in literature. 
 
Model strategies 
After recovery from the second episode of diverticulitis patients undergo either colonic 
resection or a watch and wait ‘treatment’. If colonic resection is performed (strategy 1), 
patients risk the chance of colostomy formation, major morbidity and mortality with the 
benefit of reducing the risk of recurrence with its accompanying chance of complicated 
disease, morbidity and mortality. Elective resection might also reduce persistent 
abdominal pain and IBS-like symptoms associated with recurrent episodes of diverticulitis. 
In case of a watch and wait policy, patients might completely recover and never 
experience a recurrent episode of ACD again. In case of recurrent disease there are four 
possibilities. The recurrence can be complicated necessitating emergency surgery with its 
own chance of colostomy formation, morbidity and mortality. In case of a mild recurrence, 
patients can either undergo colonic resection (strategy 2) or medical treatment can be 
initiated. Medical treatment can consist of conservative treatment with antibiotics for 
flares of diverticulitis only (strategy 3) or treatment with intermittent suppressive medical 
therapy (strategy 4). Both groups can re-enter the model again with the chance of having 
a next recurrent episode of diverticulitis. Patients with a Hartmann’s procedure were 
considered candidates for a stoma reversal operation in the same model. Diverting 
ileostomy or colostomy after primary anastomosis and treatment with percutaneous 
drainage of abscesses were not considered in the model to avoid major complexity. During 
the simulation there were five possible health states in which patients could be: well with 
or without a colostomy, persisting abdominal pain with or without a colostomy, or dead.  
 
Probabilities of clinical events 
A Pubmed, Medline and Embase database search was conducted of articles published 
from January 1970 till June 2014 relevant to the subject of diverticulitis and natural history 
of the disease, conservative and/or operative treatment and/or reporting on chronic 
abdominal pain or abdominal symptoms (full search strategy available as supplemental 
material). A weighted mean was obtained for each variable and used as the baseline 
estimate, taking into account the number of patients that contributed to each outcome by 
each data source. Data extracted from the literature was used to obtain ranges for 
sensitivity analysis. (Table 1)  
 
Recurrent ACD and medical treatment 
The chance of recurrent diverticulitis was estimated at approximately 25% (range 9-29%) 
in a ten-year cycle length.
8-11
 Each episode of diverticulitis predicts a higher risk of 
recurrence up to four recurrences.
8
 The chance of having a recurrence that required 
emergency surgical intervention was estimated at 5.5%.
9, 11-14
 Conservative measures in 
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case of recurrent episodes of diverticulitis are dietary changes, fiber supplementation and 
the use of antibiotic treatment for flares of diverticulitis only.
15
 Medical treatment in the 
Markov model consisted of a non-absorbable antibiotic (rifaximin) combined with 5-
aminosalicylic acid (mesalazine), which has been shown to reduce the severity of 
abdominal symptoms.
6, 16, 17
 The role of medical treatment in preventing diverticulitis 
recurrence remains under debate, and a potential benefit in a decrement in recurrences 
was therefore not incorporated in the model.
6, 17, 18
 Morbidity of medical treatment is 
defined as patients with persistent abdominal symptoms
14, 15, 19
 and differs from surgical 
morbidity in the model. Calculated morbidity in the medical treatment strategy in the 
Markov model is corrected for by using the different utilities assigned to symptomatic and 
asymptomatic patients after recurrent episodes of ACD.  
 
Elective surgery 
Weighted averages of morbidity, mortality and chance of stoma formation after elective 
surgery are given in Table 1.
20-22
 Both open- and laparoscopic surgical techniques were 
considered standard of care, having no difference in long-term outcomes.
21, 22
 Surgical 
morbidity was defined as all major complications within 30 days that required radiological 
or surgical intervention. Surgical mortality was defined as the 30-day in hospital mortality. 
Recurrence rates following surgery are estimated at 2%.
20, 23
 The risk of a complicated 
recurrence requiring emergency surgery after previous elective surgery was estimated 
0.5%.
23
 Persisting abdominal symptoms after elective surgery was considered to be 
associated with a four times higher risk of recurrence.
14, 23
 
 
Emergency surgery 
Weighted averages of morbidity, mortality and chance of stoma formation after 
emergency surgery are given in Table 1.
12, 24, 25
 Primary resection with anastomosis and 
protecting ileostomy is favored over a Hartmann’s procedure in patients with Hinchey 
III/IV perforated diverticulitis.
26, 27
 Only acute complications of ACD requiring surgical 
intervention (e.g., Hartmann’s procedure, resection with primary anastomosis with or 
without defunctioning ileostomy) were considered in the model. Definitions for major 
morbidity and mortality in elective surgery were also used for emergency surgery. The 
chance of stoma formation included both patients with Hartmann’s procedure and 
patients with primary anastomosis and defunctioning ileostomies.
27
 
 
Reversal operation 
It was estimated that approximately 60% of the patients with a Hartmann’s procedure 
would be candidates for a reversal operation.
28
 Since data on loop ileostomy or colostomy 
take down in diverticulitis is limited, only Hartmann’s reversal was considered in the 
model, with its own chance of morbidity and mortality.
25, 28
 (Table 1) 
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Figure 1: Simplified version of the Markov model 
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Table 1: Weighted estimates of probabilities and threshold values from one-way sensitivity analysis 
used in the Markov model 
 
Variable Baseline 
value  
(%) 
Range from 
references  
(%) 
References Threshold 
value  
(%)
***
 
Sensitive ß-Distribution 
parameters 
(α;ß)
***
 
Elective surgery       
- morbidity 16 1.5-36 20-22 NT N 3.84; 19.89 
- mortality 1.5 0-3 20-22 0.1 Y 15.16; 985.24 
- stoma formation 5 0-9 20-22 NT N  5.32; 102.58 
- recurrence mild 4 0-8 20, 23 NT N NA 
- recurrence complicated 0.5 0-1 20, 23 NT N NA 
- persistent pain 20 10-30 14, 23 NT N 20.89; 83.94 
Emergency surgery       
- morbidity 40 11-51 12, 24, 25 NT N 20.54; 31.22 
- mortality 14 18-21 12, 24, 25 NT N 14.61; 90.75 
- stoma formation 47 45-61 26, 27 NT N 44.97; 50.37 
- recurrence mild 4 0-8 20, 23 NT N NA 
- recurrence complicated 0.5 0-1 20, 23 NT N NA 
- persistent pain 20 10-30 20, 23 NT N 20.89; 83.94 
Conservative treatment 
(flares of diverticulitis only) 
      
- morbidity
*
 - - - NA NA NA 
- mortality 0.5 0-1 8-11, 15 NT N NA 
- recurrence mild 20 9-29 8-11, 15 NT N NA 
- recurrence complicated 5.5 3-8 9-11, 15 NT N NA 
- persistent pain 30 10-40 14, 15, 19 NT N 24.90; 58.10 
Medical treatment 
(intermittent 5-ASA and  
non-absorbable antibiotic) 
      
- morbidity
*
 - - - NA NA NA 
- mortality 0.5 0-1 6, 17, 18 NT N NA 
- recurrence mild 20 9-29 6, 8, 9, 17-19 NT N NA 
- recurrence complicated 5.5 3-8 6, 9, 11-15, 17, 18 NT N NA 
- persistent pain 10 5-20 6, 16, 17 73.1
**
 Y 9.90; 89.10 
Hartmann reversal       
- morbidity 47 44-50 25, 28, 31 NA NA 195.89; 221.45 
- mortality 11 2-13 25, 28, 31 NA NA 10.78; 86.07 
Duration of simulation (years) 10 years 5-25 years - NT N NA 
*
 Morbidity of medical treatment is defined as patients with persistent abdominal complaints after medical treatment and not 
directly compared in the Markov to surgical morbidity that can only arise in the medical treatment strategy from patients with 
recurrences requiring emergency surgery. Medical morbidity is corrected for in the Markov model with the different utilities for 
symptomatic and asymptomatic patients. 
**
 Reduction (%) in probability of persistent pain  
***
 A number of probabilities in the model were dependent of a specific parameter or event. In a situation in which the 
probability of a recurrence dependent on the number of recurrences that already occurred for that specific patient, the 
probability used in the model was extracted from a table. In such a table, a number of different probabilities is available that 
belong to different numbers of already occurred recurrences. Tables make the model more realistic, but using tables also has 
some disadvantages. Variables for which the values are extracted from a table can’t be used in a sensitivity analysis; neither in a 
one-way sensitivity analysis, nor in a probabilistic sensitivity analysis. 
N = No 
Y = Yes 
NT = No threshold 
NA = Not applicable 
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Utilities 
The utilities assigned to the different health states are summarized in Table 2. A utility of 1 
was used for a patient who was well without a colostomy after recurrent episodes of 
diverticulitis. A utility of 0 was assigned to all health states with the outcome death. 
Patients who remain well but with a colostomy were given a utility of 0.8. This was based 
on a previously published assessment done in colostomy patients combined with a report 
on patients with non-cancer colostomies.
29, 30
 Patients with persisting abdominal pain but 
without a colostomy had a utility of 0.95, and patients with persisting abdominal pain and 
a colostomy a utility of 0.75.
31
 To model the decrease in quality of life associated with 
chronic medication use, we considered a disutility of 0.005 in patients taking maintenance 
therapy with a non-absorbable antibiotic and 5-ASA.
32
 To model the decrease in quality of 
life associated with an episode of diverticulitis, we considered a loss of 0.042 QALYs (two 
weeks) for each recurrence.  
 
Sensitivity analysis 
One-way deterministic sensitivity analyses were performed for each variable in the model 
and for utility states, discount rate, and disutility associated with chronic medication use 
and the duration of simulation if applicable, over their plausible range. The purpose of the 
one-way sensitivity analysis was to determine which variables, according to the ranges in 
literature, would affect outcome. If the outcome of the model did not change considerably 
when the variable was changed, the model was not sensitive to that variable and no 
threshold was identified. If changing the variable would lead to a different outcome of the 
model, the model was considered sensitive to that variable and the value to which the 
optimal strategy changed was considered to be the threshold value for that variable. In 
order to check the influence of the uncertainty in all variables in the model together, we 
also performed a probabilistic sensitivity analysis (Monte Carlo simulation). Beta 
distributions were assumed for proportions and disutilities. Future health is often 
considered to be less valuable than immediate health. This was handled in the model by 
discounting future utility with 0.015. 
 
Results 
 
Table 3 summarizes the measured QALYs for all four competing strategies. Over a ten-year 
period, the strategy colonic resection after two episodes of diverticulitis was associated 
with the lowest quality-adjusted survival of 8.66 QALY. The strategies colonic resection or 
conservative treatment or medical treatment after the third episode of diverticulitis were 
comparable in terms of quality-adjusted survival, 8.78 QALYs, 8.76 QALYs and 8.74 QALYs, 
respectively. Over a twenty-year period, no change in the optimal treatment strategy was 
found based on one-way sensitivity analysis. (Table 1) 
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Table 2: State utilities and threshold values from one-way sensitivity analysis used in the Markov 
model 
 
 
Health state 
Utility 
estimate 
Range  
 
References Threshold 
value 
*
 
Sensitive ß-Distribution 
parameters
*
 
(α;ß) 
Well without stoma 1.00 - - NA NA NA 
Well with stoma 0.80 0.20-1.00 29,30 NT N 156.75; 39.17 
Persisting abdominal pain without stoma 0.95 0.50-1.00 29 0.82 Y 192.67; 10.21 
Persisting abdominal pain with stoma 0.75 0.40-1.00 30,31 NT N 158.07; 52.46 
Death 0 - - NA NA NA 
Disutilities Disutility      
Chronic medication use 0.005 0-0.04 32 NT N 0.057; 11.38 
Discount rate 0.05 0-0.1 - NT N 3.75; 71.25 
* A number of probabilities in the model were dependent of a specific parameter or event. In a situation in which the probability 
of a recurrence dependent on the number of recurrences that already occurred for that specific patient, the probability used in 
the model was extracted from a table. In such a table, a number of different probabilities is available that belong to different 
numbers of already occurred recurrences. Tables make the model more realistic, but using tables also has some disadvantages. 
Variables for which the values are extracted from a table can’t be used in a sensitivity analysis. 
Y = Yes 
NT = No threshold 
NA = Not applicable 
 
Mortality 
Overall mortality for each strategy is summarized in Table 3. Overall mortality, e.g., 30-day 
in hospital surgical mortality and mortality based on age-specific mortality rates, was 
comparable between the strategies colonic resection, conservative treatment and medical 
treatment after the third episode of diverticulitis, 7.8%, 7.6% and 7.6%, respectively. The 
30-day in hospital surgical mortality in the strategy colonic resection after two episodes of 
diverticulitis was 1.4% with 8.4% overall mortality. The lower QALYs generated by the 
elective surgery strategy after two episodes is mainly caused by this early mortality risk. 
This effect was also notable through one-way sensitivity analysis. At a probability of 
mortality for elective surgery less than 0.1%, elective surgery became the dominant 
strategy. (Figure 2) 
 
Table 3: Results of base case analysis for patients who suffered from two episodes of diverticulitis 
 
 STRATEGY 
 I 
Colonic resection 
after two episodes  
of diverticulitis 
II 
Colonic resection 
after three episodes 
of diverticulitis 
III 
Conservative treatment 
after three episodes of 
diverticulitis 
(flares of diverticulitis only) 
IV 
Medical treatment 
after three episodes of 
diverticulitis (5-ASA 
and rifaximin) 
QALYs
*
 8.66 8.78 8.76 8.74 
Overall mortality 8.4% 7.8% 7.6% 7.6% 
Stoma formation 1.1% 0.7% 0.9% 0.9% 
Mild recurrence 3.5% 5.3% 8.9% 8.7% 
Severe recurrence 1.1% 2.4% 5.2% 5.2% 
Persistent complaints 18.2% 18.5% 18.4% 14.7% 
*
 QALYs: Quality Adjusted Life Years 
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Stoma formation and recurrences 
The chance of stoma formation and chance of a mild or severe recurrence for each 
strategy are summarized in Table 3. The strategy colonic resection after two episodes of 
diverticulitis had the highest chance of stoma formation (1.1%); most enterostomies are 
made due to complications after surgical resection. The conservative and medical 
treatment strategies had a 0.9% chance of stoma formation, all caused by patients with a 
severe recurrence necessitating emergency surgery. The strategy colectomy after the third 
episode of diverticulitis, had the lowest overall chance of stoma formation (0.7%). 
 
The chance of a mild recurrence was the highest for the conservative (8.9%) and medical 
(8.7%) treatment strategies, and the lowest for the strategy colectomy after two episodes 
of diverticulitis (3.5%). The number of severe recurrences necessitating emergency 
surgery was the lowest for the strategy colectomy after two episodes of diverticulitis 
(1.1%) and the highest for the conservative and medical treatment strategies (5.2%).  
 
Persistent symptoms 
The chance of persistent symptoms after each strategy is summarized in Table 3. The 
lowest rate of persistent abdominal symptoms was observed in the medical treatment 
strategy (14.7%). The other three strategies were comparable in terms of persistent 
abdominal symptoms, varying between 18.2% and 18.5%. Sensitivity analysis revealed a 
change in strategy in favor of medical treatment, in case a reduction of 73% of abdominal 
symptoms would be achieved by medical treatment (Figure 2) or if the utility of persistent 
abdominal symptoms in patients with a stoma was less than 0.82.  
 
Sensitivity analysis 
Probabilistic sensitivity analysis demonstrated that the strategies colonic resection, 
conservative or medical treatment after the third episode of diverticulitis were 
comparable across the full range of variables in the model with a mean QALY of 8.78 (sd = 
0.052), 8.77 (sd = 0.053) and 8.74 (sd = 0.049), respectively. The range of QALYs for these 
three strategies overlaps completely. (Figure 3, Table S1) Elective surgery consistently 
generated a lower mean QALY of 8.66 (sd = 0.071) across the full range of variables in the 
model. Considering the results found by the one-way sensitivity analysis this is caused by 
an early mortality risk of surgery. 
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Figure 2: One-way sensitivity analysis on surgical mortality and reduction of persistent abdominal 
complaints with medical treatment 
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Figure 3: Boxplot with the results of generated QALYs in ten years for all the four treatment 
strategies with Monte Carlo simulation (probabilistic sensitivity analysis) 
 
 
Discussion  
 
Although persistent abdominal symptoms are increasingly recognized as a paramount 
problem in post-diverticulitis patients, we could not adequately define these patients 
because of large heterogeneity in persistent abdominal symptoms. Abdominal symptoms 
in conservatively treated diverticulitis may reflect visceral hypersensitivity.
19
 After surgery 
these may be related to a shorter bowel (increased bowel movements), to a stenosis of 
the anastomosis (obstructive signs) or a stoma presence (leakage). 
 
Timing of elective colectomy has been previously studied in two Markov models.
38, 39
 Both 
studies differed in modeling approach but showed comparable results regarding (early) 
colectomy. Our imputed data in the Markov model was based on the most recent 
literature, embedding pivotal changes in both surgical and medical treatment of recurrent 
disease from the last ten years. In addition, persistent abdominal symptoms were 
incorporated, which occur in one of six patients and are indispensable for accurate 
determining of quality-adjusted survival. 
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Recurrent episodes of diverticulitis mostly run a benign course; only 5.5% of patients with 
recurrent hospitalizations for diverticulitis have emergency surgery.
10, 11
 Most patients 
presenting with complicated diverticulitis do so at the time of their first attack.
12
 Based on 
these findings a shift towards a conservative treatment in patients with recurrent 
diverticulitis was proposed albeit that elective surgery still is routine practice in many 
countries.
4, 8, 12
 Notably, an increase of elective resection for diverticulitis is reported 
especially in young patients.
40
  
 
Although a Markov model is a helpful tool, it has a few limitations. The probability of each 
outcome is based on results from previous studies. A recent systematic review of surgery 
for diverticulitis revealed that the overall quality of studies is low.
33
 Utilities could not be 
derived directly from individuals with diverticulitis but from limited comparable studies of 
patients with other benign colonic diseases. This was believed to be acceptable for utilities 
including an enterostomy because stomas significantly impair QoL scores.
41
 Altering the 
range of utilities over their plausible range, only affected the results of the decision 
analysis in patients with persistent abdominal complaints without a stoma. Best would be 
to have utilities based on patient reported outcomes (PROs), but studies are scarce that 
report on PROs in patients with diverticulitis. 
 
Elective surgery after two episodes of diverticulitis should be questioned as primary 
treatment option for recurrent diverticulitis. Surgeons should not operate at quite the rate 
they have been trained to think. The model has limitations when the individual patient 
and physician face a complex decision, particularly a young patient with large disease 
burden. A patient-oriented decision aid using data from this analysis would be a valuable 
tool to facilitate shared decision making for treatment of recurrent diverticulitis. 
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Full search description to obtain the probabilities of clinical events 
(supplemental material) 
 
A Pubmed, Medline and Embase database search was conducted of articles published 
from January 1970 till June 2014 relevant to the subject of diverticulitis, using the 
following keywords and MeSH terms: [“Diverticulitis”[MeSH] OR “Diverticulitis, 
Colonic”[MeSH] OR (“Diverticulum AND “Inflammation”) OR (“Diverticulosis, Colonic” AND 
“Inflammation”[MesH] OR “natural history“, OR “Recurrence”[MesH] OR “abdominal 
complaint” OR “abdominal symptoms” OR “Chronic Pain[Mesh]” OR “SUDD” OR 
“Surgery”[Subheading] OR “medical treatment” OR “Therapy”[Subheading] OR 
“Treatment outcome”[MesH]” OR “antibiotics” OR “probiotics” OR “Anti-bacterial 
agents”[MesH] or “5-ASA”[MesH] OR “Mesalamine”[MesH]. The search strategies were 
adapted to the different databases to maximize yield. Additionally, all selected studies 
were reviewed for cross-references. Data were extracted from systematic reviews and 
meta-analysis, Randomised Controlled Trials (RCTs) and cohort studies with a minimal 
follow-up of three months and more than 50 patients. The following inclusion criteria 
were applied: adults with every stage diverticulitis; conservative and/or operative 
treatment and/or reporting on chronic abdominal pain or abdominal symptoms. A 
weighted mean was obtained for each variable and used as the baseline estimate, taking 
into account the number of patients that contributed to each outcome by each data 
source. Furthermore, the data extracted from the literature was used to obtain ranges for 
sensitivity analysis. (Table 1) 
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Table S1: Results of generated QALYs for each strategy after probabilistic sensitivity analysis (Monte 
Carlo simulation) 
 
 Descriptive statistics 
 
Strategy 
 
N  
 
Minimum 
 
Maximum 
 
Mean 
Standard 
deviation 
I Generated QALYs: Colonic resection after two 
episodes of diverticulitis 
1000 8.35 8.87 8.66 0.071 
II Generated QALYs: Colonic resection after 
three episodes of diverticulitis 
1000 8.59 8.95 8.78 0.052 
III Generated QALYs: Conservative treatment 
after three episodes of diverticulitis 
1000 8.57 8.93 8.77 0.053 
IV Generated QALYs: Medical treatment after 
three episodes of diverticulitis 
1000 8.57 8.89 8.74 0.047 
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Abstract 
 
Background and aims 
Patients with diverticulitis may develop multiple recurrences and chronic abdominal 
complaints. Recurrent diverticulitis is seldom complicated, which has led to a shift towards 
conservative treatment. However, some studies suggest that surgical intervention reduces 
the burden of recurrent disease and persistent abdominal complaints. We conducted a 
systematic review and meta-analysis of Quality of Life (QoL) and other Patient-Reported 
Outcomes (PROs) following conservative and surgical treatments for diverticulitis. 
 
Methods 
CENTRAL, MEDLINE, EMBASE, and Psycinfo were searched for randomized trials and 
cohort studies reporting on QoL or other PROs after conservative or operative treatment 
for any stage of diverticulitis from January 1990 to May 2014. Eight PROs were defined 
and graded according to their clinical relevance. Risk of bias was assessed using the 
Cochrane Collaboration tool. Subgroup and sensitivity analyses were performed to test 
the robustness of the results. The review protocol was registered through PROSPERO 
(CRD42013005854).  
 
Results 
Thirty-four studies (3,670 patients) were selected; each had a high risk of bias. Patients 
reported better general QoL after elective laparoscopic colonic resection short form (SF) 
36 score (78.3, 95% confidence interval [CI]: 70.5-86.2) than after conservative treatment 
(58.1, 95% CI: 47.2-69.1), but the difference was not reproduced in studies with head-to-
head comparisons. Gastrointestinal QoL was comparable between the treatments. One 
third of the patients reported chronic abdominal pain following both treatment types. 
Gastrointestinal symptoms were less frequent following laparoscopic surgery when 
compared with conservative treatment, among all cohorts (9% [95% CI: 4-14%] vs. 36% 
[95% CI: 27-45%]), and in one trial directly comparing both treatments (odds ratio: 0.35, 
95% CI: 0.16-0.7). 
 
Conclusions 
Elective laparoscopy for recurrent diverticulitis results in better general QoL and 
gastrointestinal symptoms compared with conservative treatment. Almost one third of 
patients have gastro-intestinal complaints after undergoing treatment for diverticulitis. 
There is a further need for high-quality trials regarding PROs in diverticulitis. 
 
Keywords 
Diverticulitis; Quality of Life; Patient Reported Outcomes; treatment; systematic review; 
meta-analysis
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Introduction 
 
Diverticular disease of the sigmoid and descending colon is a common condition in 
Western countries. It is present in more than 50% of individuals at the age of 65 years. The 
prevalence steadily increases with advancing age to around 65% at the age of 85.
1, 2
 An 
estimated 10-25% of patients with diverticulosis develop one or more episode of 
diverticulitis during their lifetime.
3, 4
 Uncomplicated diverticulitis occurs when in-
flammation of one or more diverticulum leads to an inflammatory process without 
perforation or abscess formation.
5
 Episodes of uncomplicated diverticulitis often involve 
abdominal pain, mild fever, flatulence, and constipation. An episode of complicated acute 
diverticulitis is associated with abscess formation or perforation. Complicated diverticulitis 
is relatively rare and occurs in approximately 10% of patients with diverticulitis.
6, 7
 
Complicated diverticulitis is associated with high rates of morbidity and mortality and 
often requires percutaneous drainage of abscesses or emergent surgery in the event of 
purulent or faecal peritonitis secondary to perforation of the colon. 
 
Uncomplicated recurrent diverticulitis can be treated by conservative means or by 
surgery. Recent epidemiological data show that recurrent episodes of diverticulitis are 
seldom complicated, which has led to a marked shift from surgical treatment towards 
conservative treatment.
8-11
 Although conservative treatment is often satisfactory and 
avoids the risks of complications and mortality associated with elective surgery, 
approximately 25% of patients suffer from additional episodes of diverticulitis.
12-14 
Surgery 
for diverticulitis has become less invasive and safer.
15
 Some evidence suggests that 
surgical intervention reduces the burden of recurrent disease and chronic abdominal 
complaints.
16-18
 
 
Early symptom relief and complications associated with the treatment are the primary 
outcomes reported in most studies of the treatment of diverticulitis. The patients’ 
perspectives on recurrences and persistent bowel symptoms associated with the 
treatment are seldom reported, which is surprising considering the large health burden, 
the recurrent and chronic character, and the controversies associated with the treatment 
of diverticulitis.
11, 19
 
 
Quality of Life (QoL) and other Patient Reported Outcomes (PROs) are increasingly 
recognized as relevant clinical outcomes after medical interventions, especially in chronic 
disease.
20, 21
 The effects of conservative or operative treatment for (recurrent) 
diverticulitis on QoL and PROs are not clear, which prompted us to undertake a systematic 
review and meta-analysis of studies addressing QoL and other PROs after conservative or 
operative treatment for diverticulitis. The results of this study will help doctors and 
patients to make informed decisions when choosing between conservative and operative 
treatments in cases of recurrent diverticulitis. 
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Materials and methods 
 
Search strategy and selection criteria 
Two researchers (CSA and RB) searched entries in the Cochrane Central Register of 
Controlled Trials, MEDLINE, EMBASE, and Psycinfo made from January 1990 to May 25, 
2014. Searches included the following MeSH descriptors: “Diverticulitis”, “Diverticulitis, 
Colonic”, (“Diverticulum” AND “Inflammation”), (“Diverticulosis, Colonic” AND 
"Inflammation”[Mesh]), “Quality of Life”, “Health Status”, “Questionnaires”, “Symptom 
Assessment”, “Defecation”, “Chronic Pain”, “Pain Measurement”, “Faecal Incontinence”, 
“Disability Evaluation”, “Activities of Daily Living”, “Return to Work”, and “Satisfaction”. 
For a full description of the search strategy, see Appendix A. Additionally, we searched the 
reference lists of relevant studies and previous reviews. Grey literature was searched 
using Open SIGLE, Scientific Web Plus, and ‘Grey literature available in the Netherlands’. 
Trial registers were searched (International Clinical Trials Registry Platform and the UK 
Clinical Trials Gateway) for relevant records of unpublished trials. No language restrictions 
were applied. We carried out the review in accordance with a protocol that was registered 
in PROSPERO (CRD42013005854). 
 
Studies were retrieved and selected by two independent reviewers (CSA and RB) in two 
rounds, first based on the title and abstract and then based on the full text measured 
against pre-specified criteria. Randomized Controlled Trials (RCTs) and cohort studies with 
a minimal follow-up of three months were considered eligible for inclusion. Studies that 
included adults with any stage of diverticulitis, conservative and/or operative treatment of 
diverticulitis, and reports of QoL or other PROs were selected (Table S1). Studies reporting 
on colorectal surgery for a variety of indications were excluded if we could not extract 
separate results for the cohort of patients with diverticulitis.  
 
Data extraction 
Two reviewers (RB and RPGtB) extracted and checked the data. We extracted information 
on the study design, patient characteristics, the number of participants, and the outcomes 
reported. Any discrepancies were resolved by discussion or by a third reviewer (CSA). If 
the dataset was incomplete, the authors were contacted by e-mail for the missing data. 
 
Outcome measures were extracted from the literature. Eight PROs were defined and 
graded by clinical relevance (critical for decision-making, important for decision-making, 
or of limited importance), as suggested by the GRADE working group.
22
 PROs critical for 
decision-making included gastrointestinal QoL, based on answers to the Gastrointestinal 
Quality of Life Index (GIQLI), and general QoL, based on the Short Form (36) Health Survey 
(SF-36), the European Organisation for Research and the Treatment of Cancer quality of 
life survey (EORTC), and the Cleveland Global Quality of Life instrument (CGQL). Disability 
(defined as an inability to perform the activities of daily living, physical activities, and the 
activities necessary to return to work) was also graded as critical for decision-making. 
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Chronic abdominal pain, faecal incontinence, and patient satisfaction were graded as PROs 
important for decision-making. Chronic abdominal pain was defined as the persistence of 
abdominal pain after three months of follow-up. Studies that used a visual analogue scale 
to score pain were included. Faecal incontinence was assessed either on a faecal 
incontinence scale or by the percentage of patients who complained of incontinence. 
Patient satisfaction was assessed either by a satisfaction score or as the percentage of 
patients expressing good to excellent satisfaction with the treatment. 
 
The PROs of limited clinical relevance were persistent bowel symptoms (i.e., hypogastric 
pain or bloating, diarrhea, constipation, flatulence, painful defecation, and rectal bleeding) 
and urogenital symptoms (i.e., erectile dysfunction, ejaculation difficulties, diminished 
libido, and urinary and sexual dysfunction; Table 1). 
 
Table 1: Patient-reported outcomes ranked according to Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) by relevance according to the patients’ perspective 
 
Grading  Outcomes 
Critical for decision-making ⊕⊕⊕ Gastro-intestinal quality of life ∏ 
 ⊕⊕⊕ General quality of life ∑ 
 ⊕⊕⊕ Disability 
Important for decision-making ⊕⊕ Chronic abdominal pain 
 ⊕⊕ Faecal incontinence 
 ⊕⊕ Patient satisfaction 
Limited importance ⊕ Persistent bowel symptoms 
 ⊕ Urinary/sexual function 
∏
 Gastro-intestinal quality of life, measured by the Gastro Intestinal Quality of Life Index (GIQLI) questionnaire 
∑
 General quality of life assessed by the Short Form 36 Health Survey questionnaire (SF-36), The European 
Organization for Research and Treatment of Cancer, Quality of Life Questionnaire-C 30 (EORTC QLQ-C30), and/or 
the Cleveland Global Quality of Life instrument (CGQL) 
 
Risk-of-bias assessment 
Two reviewers (CSA and RB) independently assessed the methodological quality of the 
retrieved articles. Any discrepancies were resolved by discussion or by a third reviewer 
(RPGtB). The Cochrane Collaboration’s tool for the assessment of bias risk was used to 
assess the risk of systematic error.
23
 Seven components associated with the risk of bias 
were assessed: the generation of the allocation sequence, the allocation concealment, the 
blinding of participants, the masking of outcome assessors, selective outcome reporting, 
incomplete follow-up, and other potential sources of bias. The incomplete follow-up 
component was considered adequate if fewer than 10% of the patients were lost to 
follow-up and a description of the loss was provided. Trials in which one or more of the 
seven components had a high score or was unclear were defined as having a high risk of 
bias. Heterogeneity among baseline characteristics, clinically suspected diverticulitis 
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without radiological confirmation, and premature trial stoppage were considered as other 
biases.  
 
Data analysis and presentation 
The inverse variance method for the pooling of prevalence and continuous data was used. 
The Mantel-Haenszel method was applied for the pooling of dichotomous data, and the 
results were presented as the Relative Risk (RR) with 95% Confidence Interval (CI). A p-
value <0.05 was considered statistically significant. Heterogeneity was explored using I
2
 
tests, as recommended by the Cochrane Handbook for Systematic Reviews of 
Intervention. An I
2
 value between 50% and 75% was defined as substantial heterogeneity, 
and an I
2
 value = 75% was defined as considerable heterogeneity. A fixed-effect model was 
applied for the meta-analysis. In the presence of significant statistical heterogeneity, a 
random-effects model was used. Data were analyzed using Review Manager 5.0. (Review 
Manager (RevMan) [Computer program] Version 5.1. Copenhagen: The Nordic Cochrane 
Centre, The Cochrane Collaboration, 2011) and R version 2.12.0. 
 
In the primary analyses, only available data were analyzed. The impact of incomplete data 
was explored through sensitivity analyses using the standard deviation imputed from p-
values according to the algorithms in the Cochrane Handbook for Systematic Reviews of 
Intervention. The median was used when the mean was not available. If it was not 
possible to calculate the standard deviation from the p-value or the CI, the standard 
deviation was imputed as the highest standard deviation noted for the group and 
outcome in question. 
 
Subgroup analyses were performed for the study type (trials with low risk of bias vs. trials 
with high risk of bias), the treatment type (conservative, elective laparoscopic surgery, 
elective open surgery, emergency surgery, and studies with mixed or unspecified types of 
surgery), and the diverticulitis type (complicated vs. uncomplicated and first episode vs. 
recurrent disease). 
 
We followed both the Meta-analysis of Observational Studies in Epidemiology (MOOSE) 
and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines in reporting the results. 
 
 
Results 
 
Search results 
The search identified 2,075 published articles, 1,306 of which were unique studies. The 
manual review of the references, grey literature, and trial registers identified an additional 
275 studies for abstract evaluation. We excluded 1,491 studies after title and abstract 
screening and 50 more after full-text review. We extensively reviewed the remaining 40 
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769 duplicates removed 
 2,075 search results 
  689 Medline 
  1,165 Embase 
  199 Cochrane 
  22 Psycinfo  
275 additional records identified by manual search 
 17 reference lists 
 156 grey literature 
 102 trial registers 
 
1,306 original records screened 
1,581 records screened 1,491 records excluded after title-abstract screen 
90 full-text articles assessed for eligibility 
 50 full/text articles excluded 
  1 unretrievable 
  2 no intervention reported 
  6 no patient-reported outcome data 
  9 lack of follow-up 
  26 insufficient data 
  5 published protocols of ongoing trials 
  1 double publication of same cohort 
 
40 articles included in systematic review 
 6 excluded 
  2 unvalidated symptom scores 
  2 incomplete data outcome 
  2 other outcome 
 
34 articles included in meta-analysis 
studies, which included a total of 4,228 patients. Six studies either used unvalidated 
symptom scores
24, 25
 or had incomplete outcome data.
26-28
 Consequently, 34 studies 
comprising 3,670 patients were included in our meta-analyses (Figure 1). 
14, 16-18, 29-59
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Study selection 
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Characteristics and quality assessment of the selected studies  
Table S1 shows descriptive data for the 40 qualifying studies, and Figure 2 shows the 
quality assessment of the selected studies. The inclusion criteria were well documented in 
most of the studies, but they varied widely. Complicated (symptomatic) diverticular 
disease and diverticulitis were used interchangeably as terms for the same disorder. The 
disease severity was staged according to the Hinchey classification in one third of the 
studies and according to Hansen Stock classification in two studies. Elective surgery was 
generally performed at least 3 months after the last episode of diverticulitis. Emergency 
surgery consisted of a single staged or staged resection. All the studies had a high risk of 
bias in the assessment-of-outcome domain, because the outcome assessors were not 
blinded or may have been involved in the treatment. Most of the studies failed to describe 
how the allocation sequence was generated (80% of the studies), adequately conceal the 
allocation (80% of the studies), or blind the participants or personnel (85% of the studies). 
More than half of the studies had inadequate follow-up methods and inadequate 
descriptions of the reasons for loss to follow-up. The risk of outcome bias through 
selective reporting was high in 80% of the studies. Overall, none of the selected studies 
had a low risk of bias (Figure 2). The eight predefined PROs were distributed unevenly 
among the studies. Table 2 summarizes the main findings for each outcome measure, 
sorted by treatment modality.  
 
Outcomes critical for decision-making 
Gastrointestinal QoL was reported in three studies evaluating 237 patients. The mean 
gastrointestinal QoL, as measured by the GIQLI (range: 0-144), was good, with a mean of 
113 (95% CI: 111-116). The type of treatment did not influence the gastrointestinal QoL. 
General QoL was reported in six studies evaluating 591 patients. The mean SF-36 score 
(range: 0-100) for patients with diverticulitis was 70.3 (95% CI: 60.5-80.0). The SF-36 score 
was significantly higher for patients who underwent laparoscopic surgery (mean=78.3; 
95% CI: 70.5-86.2) compared with those who underwent conservative treatment 
(mean=58.1; 95% CI: 47.2-69.1), but the difference was only apparent when comparing 
cohorts among studies and not in a head-to-head analysis (Table 3 and Figure 3). There 
was considerable heterogeneity among the results of the different studies (I
2
=92%). There 
was no significant difference in the mean SF-36 score between laparoscopic and open 
surgery. The type of treatment did not affect the EORTC or CGQL scores (EORTC 
mean=82.7, 95% CI: 77.2-88.2; CGQL mean=73, 95% CI: 66.6-79.4; Figure 3). The 
prevalence of disability (6%, 95% CI: 2-10%) was reported in one study evaluating 120 
patients who had undergone laparoscopic surgery.  
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Figure 2: Methodological quality of the studies included in the systematic review 
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Table 3: Head-to-head comparison of patient-reported outcomes of elective surgical treatment and 
conservative treatment 
 
Outcome GRADE Elective Surgery P 
Gastrointestinal related QoL ⊕⊕⊕   
- GICLI score (mean difference ± 95% CI)  +1.0 (-10.6-12.6) 0.87 
General QoL ⊕⊕⊕   
- SF-36 (mean difference ± 95% CI)  NA  
- CGQL (mean difference ± 95% CI)
*
  0.0 (-0.5-0.5) >0.99 
Disability ⊕⊕⊕   
- Prevalence  NA  
Chronic abdominal pain ⊕⊕   
- Prevalence RR (95% CI)  0.96 (0.29-3.17) 0.95 
Faecal incontinence ⊕⊕   
- Prevalence  NA  
Satisfaction ⊕⊕   
- Prevalence  NA  
Gastrointestinal symptoms ⊕   
- Overall RR (95% CI)  0.35 (0.16-0.79) 0.01 
- Constipation RR (95% CI)  0.35 (0.16-0.79) 0.01 
- Diarrhea RR (95% CI)  0.28 (0.08-1.00) 0.05 
- Flatulence RR (95% CI)  0.35 (0.16-0.79) 0.01 
- Painful defecation RR (95% CI)  0.39 (0.17-0.90) 0.03 
Urogenital symptoms ⊕   
- Prevalence RR (95% CI)  NA  
*
 as percentage of maximum score (10) 
NA: not available 
RR: relative risk 
 
 
Outcomes important for decision-making 
The prevalence of chronic abdominal pain (31%, 95% CI: 29-34%) was reported in eight 
studies evaluating, patients and was not affected by the type of treatment. The 
prevalence of faecal incontinence (9%, 95% CI: 5-12%) was reported in four studies 
evaluating 543 patients, and the prevalence of patient satisfaction (96%, 95% CI: 95-98%) 
was reported in five studies evaluating 344 patients; the type of surgery affected neither 
outcome. Scores for faecal incontinence and patient satisfaction were not available for the 
conservative treatments. 
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Figure 3: General quality of life (QoL) sorted by type of treatment in patients with diverticulitis 
 
 
Outcomes of limited importance 
The prevalence of persistent gastrointestinal symptoms (28%, 95% CI: 24-31%) was 
reported in 13 studies evaluating 1,853 patients. Both among cohorts and in a head-to-
head analysis, gastrointestinal symptoms were less frequent among patients treated by 
laparoscopic surgery (prevalence = 9%, 95% CI: 4-14%) than among those who underwent 
conservative treatment (prevalence = 36%, 95% CI: 27-45%; Table 3), although the head-
to-head comparison was made in only one study.
16
 Heterogeneity among the studies 
describing persistent symptoms was considerable (I
2
 = 91%). Overall gastrointestinal 
symptoms, flatulence, and painful defecation were all significantly improved among the 
patients who had undergone surgery (Figure 4). Taking into account the head-to-head 
comparison of elective laparoscopic surgery and conservative treatment, the overall 
gastrointestinal symptoms, constipation, diarrhea, flatulence, and painful defecation were 
improved in the laparoscopic group (Table 3). 
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Figure 4: Gastrointestinal symptoms compared between surgical and conservative treatment of 
diverticulitis 
 
Urogenital symptoms; as measured by prevalence of impotency (1%, 95% CI: 0-3%), 
ejaculation difficulties (3%, 95% CI: 0-7%), diminished libido (28%, 95% CI: 15-40%), and 
urinary and sexual dysfunction (9%, 95% CI: 4-14%); were reported in four studies 
analyzing a total of 247 patients treated with laparoscopic surgery. Scores for urogenital 
symptoms were not available for the other treatment modalities. 
 
Sensitivity analyses 
The sensitivity analyses included the results of the studies that were not eligible for the 
meta-analysis. None of the sensitivity analyses changed the results for any outcome. 
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Discussion  
 
Summary of results 
We analyzed patient-reported outcomes for surgical and conservative treatments of 
diverticulitis. None of the included studies had a low risk of bias. The patients reported 
better general QoL after elective laparoscopic colonic resection compared with 
conservative treatment, but the difference could not be reproduced in a head-to-head 
analysis of both treatment options. Gastrointestinal QoL was comparable between the 
two treatment strategies. Almost one third of the patients reported chronic abdominal 
pain after surgical or conservative treatment, and the type of treatment did not affect the 
outcome. Laparoscopic colonic resection resulted in fewer gastrointestinal symptoms 
compared with conservative treatment, both among cohorts and within one trial directly 
comparing both treatments. Gastrointestinal symptoms were considered to be of limited 
importance in clinical decision-making, however.  
 
Strengths and limitations of the study 
This is the first systematic review assessing the effects of different treatment modalities 
on QoL and PROs among patients with diverticulitis. The major strengths of this review are 
the systematic approach and the use of the GRADE system for ranking outcomes. A large 
number of studies were included based on an extensive literature search of different 
databases. The analysis of grey literature and trial registers did not reveal a publication 
bias. Because of the introduction of minimally invasive surgical techniques, we focused the 
review on studies published after 1989. The results of the analysis were shown to be 
robust by extensive sensitivity and subgroup analyses. 
 
All of the selected studies had a high risk of bias, and many of the studies lacked complete 
follow-up or did not report dropouts correctly. Most of the studies were not randomized, 
and the staging of primary or recurrent diverticulitis was often poorly described, with 
considerable heterogeneity among the studies. Many of the surgical cohorts did not 
differentiate between the results of elective or emergency therapy. Therefore, selection 
bias within the studies could not be excluded. The exclusion of studies conducted before 
1990 may have introduced a bias, although we believe that older studies would not have 
provided data reflecting the current practice of laparoscopic surgery. Open surgery for 
complicated diverticulitis was often a three-staged resection prior to 1990, whereas now it 
is usually a one-staged or two-staged surgery. In addition, conservative treatment with 
anti-inflammatory agents and intermittent antibiotics has been introduced in recent years.  
 
Comparison with other studies 
The optimal treatment strategy for patients with an acute episode of diverticulitis 
depends on the severity of the disease. In patients with recurrent diverticulitis or 
persistent abdominal complaints, the need to operate and the timing of the surgery are 
subjects of debate. Previously, the standard was to perform elective colectomy following 
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two episodes of diverticulitis to prevent future complicated diverticulitis. Recent data 
show that recurrent cases are seldom complicated, however, making prophylactic surgery 
less indicated, especially in light of the risk of morbidity and mortality associated with 
surgery.
9, 10, 16, 60
 Decisions between surgery and conservative treatment need to account 
for early morbidity and long-term QoL and PROs for the individual patient. Patients may 
improve QoL and gastrointestinal symptoms by undergoing laparoscopic resection. 
 
For patients presenting with acute diverticulitis, urgent surgery is performed when there 
are signs of sepsis or diffuse peritonitis or when the condition fails to improve despite 
medical therapy and/or percutaneous drainage.
8
 QoL and PROs are difficult to account for 
when urgent surgery is needed. Surgical approaches for acute diverticulitis have changed, 
however, with the intention of causing less morbidity and better QoL with comparable 
survival. Survivors of perforated diverticulitis have poorer QoL than patients with other 
forms of diverticulitis, mainly due to the presence of an end colostomy.
28
 
 
The avoidance of Hartmann’s procedure by resectional therapy of the affected colonic 
segment with primary anastomosis and defunctioning loop ileostomy has gained in 
popularity among patients with Hinchey III/IV diverticulitis.
28, 30, 61
 Treatment with 
laparoscopic lavage and drainage of the abdominal cavity in which the colon is not 
resected is a promising new approach for patients with purulent peritonitis and may result 
in better QoL by avoiding an end colostomy, although the results of properly conducted 
trials are not yet available.
28, 26
 
 
We found a high overall prevalence (almost one in three patients) of chronic abdominal 
pain after treatment for diverticulitis. A confounding factor might be the co-prevalence of 
Irritable Bowel Syndrome (IBS) among patients with diverticular disease. A few studies 
showed an association between IBS and diverticulitis, with overlapping symptoms and 
pathophysiology.
63-65
 Furthermore, an episode of acute diverticulitis can result in post-
diverticulitis IBS causing chronic bowel symptoms, possibly due to changes in the colon 
wall.
65
 Because the symptoms of diverticulitis can mimic those of inflammatory bowel 
disease, patients (especially those who are elderly) are often misdiagnosed as having 
diverticulitis. The treatments for diverticulitis and inflammatory bowel disease are not 
similar, and bowel symptoms in misdiagnosed patients may persist despite intervention.
66
 
 
Implications for clinical practice 
We have shown that elective laparoscopic colonic resection may be better than 
conservative treatment in terms of improving the QoL and gastrointestinal symptoms of 
patients with diverticulitis. The quality and power of the studies supporting this finding are 
low, however. Therefore, a re-evaluation of the most important determinants of 
treatment success following laparoscopic surgery and conservative treatment reported by 
patients with recurrent episodes of diverticulitis is justified. Especially for young patients 
with low comorbidity for whom bowel symptoms might have strong social implications, 
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elective surgery could be a valuable treatment option. Our findings also indicate that 
clinical practice should move away from one-size-fits-all guidelines on when to operate 
towards a more individualized approach, assessing the operative risk and the potential 
gain in QoL for the individual patient.  
 
Conclusions 
The available evidence on QoL among patients treated for diverticulitis is limited, and 
heterogeneity among the existing studies is substantial. There is a benefit favoring elective 
laparoscopy, however, for recurrent diverticulitis in terms of general QoL and gastro-
intestinal symptoms. Further high-quality trials focusing on patient-reported outcomes 
and QoL are needed. 
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Abstract 
 
Background 
Diverticular disease is a common problem in Western countries. Rationale for elective 
surgery is to prevent recurrent complicated diverticulitis and to reduce emergency 
procedures. Recurrent diverticulitis occurs in about 10% after resection. The pathogenesis 
for recurrence is not completely understood. We studied the incidence and risk factors for 
recurrence and the overall morbidity and mortality of surgical therapy for diverticular 
disease. 
 
Methods 
Medical records of 183 consecutive patients with pathology-proven diverticulitis were 
eligible for evaluation. Mean duration of follow-up was 7.2 years. Number of preoperative 
episodes, emergency or elective surgeries, type of operation, level of anastomosis, 
postoperative complications, persistent postoperative pain, complications associated with 
colostomy reversal, and recurrent diverticulitis were noted. The Kaplan-Meier method was 
used to calculate the cumulative probability of recurrence. Cox regression was used to 
identify possible risk factors for recurrence. 
 
Results 
The incidence of recurrence was 8.7% with an estimated risk of recurrence over a 15-year 
period of 16%. Risk factors associated with recurrence were (younger) age (p<0.02) and 
the persistence of postoperative pain (p<0.005). Persistent abdominal pain after surgery 
was present in 22% of patients. Eighty percent of patients who needed emergency surgery 
for acute diverticulitis had no manifestation of diverticular disease prior to surgery. In 
addition, recurrent diverticulitis was not associated with a higher percentage of 
emergency procedures. 
 
Conclusions 
Estimated risk of recurrence is high and abdominal complaints after surgical therapy for 
diverticulitis are frequent. Younger age and persistence of postoperative symptoms 
predict recurrent diverticulitis after resection. The clinical implication of these findings 
needs further investigation. Results of this study support the careful selection of patients 
for surgery for diverticulitis. 
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Introduction 
 
Diverticulosis is considered to be mainly a problem of old age, with a prevalence of 35-
50%.
1, 2
 About 10 to 25% of patients with diverticulosis will develop diverticular disease in 
their lifetime.
3, 4
  
 
The clinical presentation of diverticular disease depends on the severity of the 
inflammatory process and whether complications are present. Complicated diverticulitis 
refers to the presence of perforation, obstruction and abscess or fistula formation. 
Between 25 and 55% of the patients with complicated diverticulitis will require surgery 
during their initial hospitalization.
5
  
 
The current recommendation for patients with diverticular disease is elective surgery after 
the second documented episode of diverticulitis to prevent recurrent disease, because 
recurrence may lead to more complications and greater morbidity.
5-7
 Recently however, 
the necessity and timing of elective surgery has been debated with respect to recurrent 
disease and prevention of major complications.
8, 9
 Elective surgery for diverticular disease 
has failed when there is a recurrence that adversely affects the patients’ well-being. In the 
literature recurrence rates after appropriate resection of the sigmoid vary between five 
and 11% and a substantial number of these patients even needs urgent reoperation.
10-14
 
Identifying patients at risk for failure of resectional therapy would help to better select 
patients for elective surgery. Thus far, the level of anastomosis and age have been 
associated with recurrence, but data confirming this are scarce.
11, 12
  
 
The aim of this study was to assess the incidence and to identify possible risk factors for 
recurrence of diverticulitis in a large well-defined group of patients who underwent 
surgery for uncomplicated and complicated diverticulitis. Moreover, overall morbidity and 
mortality of surgical therapy for diverticular disease was evaluated. 
 
 
Patients and methods 
 
A consecutive series of patients operated for diverticulitis in our department between 
1985 and 2003 were identified from the Dutch pathology computer database, using search 
terms “diverticular disease”, “diverticulitis” and “diverticulosis”. Medical records were 
reviewed and the following data were collected: number of preoperative episodes 
(number of episodes of diverticulitis requiring hospital admission before operation), 
emergency or elective surgery, type of operation (sigmoid resection, sigmoid resection 
with colostomy (Hartmann), left sided hemicolectomy, anterior resection (AR), AR with 
colostomy, miscellaneous), level of anastomosis (colorectal or colosigmoidal), post-
operative complications, complications associated with colostomy reversal, and recurrent 
diverticulitis. Only major complications related to the surgical procedure and reoperations 
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were noted. Anastomotic leak had to be confirmed by either radiographic enema, CT-scan 
or by reoperation. Colostomies, time until reversal of the colostomy, and complications 
thereof were also recorded. Signs of active inflammation and the length of the resected 
specimen were noted from the pathology report. To complete follow-up, a questionnaire 
was sent to the patients’ general practitioner (GP) and patients were interviewed by 
phone about recurrent diverticulitis, persistent complaints of left abdominal pain and, 
discomfort after initial surgery. Recurrent diverticulitis was defined as tenderness in the 
left lower abdomen, in combination with fever (temperature ≥38°C), or, alternatively, a 
sedimentation rate, C-reactive protein, or white blood cell count above normal values 
resulting into hospital admission. These findings had to be consistent with barium enema, 
colonoscopy, or CT findings. This study was conducted with the approval of the ethics 
board of our hospital and written informed consent was obtained from all patients in the 
study who received a questionnaire. 
 
Statistical analysis 
The t-test for two independent groups was used to test differences between patients with 
and without recurrence for statistical significance in case of quantitative variables. The 
Chi-square test was used in case of qualitative variables, and the Fisher exact test in case 
of 2 x 2 tables. To deal with the variable length of follow-up, the Kaplan-Meier product-
limit method was used to calculate the cumulative time-related incidence of recurrent 
diverticulitis after resection. The endpoint used was the recurrence of diverticulitis after 
resection. For those patients with no recurrence, the date was considered to be right-
censored at the date of death or the end of the observational period. This method 
calculates incidence curves over time by using follow-up data from all individuals in the 
cohort, regardless of duration of follow-up. A univariate Cox regression was used to study 
differences in the incidence curve for the following risk factors: age, gender, number of 
preoperative episodes, type of operation, emergency or elective surgery, level of 
anastomosis, length of resected specimen and persistent complaints after surgery. The 
hazard ratios with 95% confidence interval are presented. A value of p less than 0.05 was 
considered statistically significant. 
 
 
Results 
 
Demographics 
Two hundred and twenty-two patients were identified by the computer database. Thirty-
nine patients were excluded because of coexisting colonic malignancy or an alternative 
diagnosis (Crohn’s disease or ulcerative colitis) in the definite pathologic examination 
report. Follow-up was complete in the remaining 183 patients. Patients’ demographics are 
listed in Table 1. Mean duration of follow-up was 7.2 years (range = 0-18 years). Mean age 
at time of operation was 63 (range = 26-93 years). Seventy-three patients (40%) had 
emergency surgery including sigmoid resection with colostomy in 47 patients (64%) and 
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sigmoid resection with primary anastomosis in 26 patients (36%). Patients underwent 
elective surgery (60%) after completing diagnostic procedures, including barium enema (n 
= 101) and/or coloscopy (n = 48) and/or CT scanning (n = 4). All patients undergoing 
elective surgery had previous complaints suggesting diverticular disease with one to more 
than four documented episodes. The median documented number of episodes in the total 
group was 2 (range = 0-10). Signs of active inflammation were present in 166 patients 
(91%) at pathology. 
 
Table 1: Patient demographics by recurrence of diverticulitis 
 
Variable N 
Recurrence No recurrence 
p value 
N % N % 
Gender Female 99 9 9 90 91 1.00
*
 
 Male 84 7 8.3 77 91.7  
Operation Elective 110 10 9 100 91 1.00
*
 
 Emergency 73 6 8.2 67 91.8  
Number of preoperative 0 63 3 4.8 60 95.2 0.07
**
 
episodes 1 16 3 18.8 13 71.2  
 2 88 7 8 81 82  
 3 11 3 27 8 73  
 ≥ 4 5 0 0 5 100  
Type of operation Sigmoid resection 88 10 11.4 78 88.6 0.53
**
 
Hartmann 62 4
†
 6.5 58 93.5  
AR and primary anastomosis 12 2 11.1 10 88.9  
 AR and colostomy 6 0 0 6 100  
Miscellaneous 10 0 0 10 100  
 Left-sided hemicolectomy 5 0 0 5 100  
Signs of active  Yes 166 13 7.8 153 92.2 0.17
*
 
inflammation at pathology No 17 3 17.6 14 82.4  
Persistent complaints Yes 36 8 22.2 28 77.8 <0.01
*
 
 No 147 8 5.4 139 94.6  
Level of anastomosis Colorectal 21 3 14.3 18 85.7 0.04
**
 
 Colosigmoidal 90 12 13.3 78 86.7  
 Colostomy 68 1 1.5 67 98.5  
 Other 4 0 0 4 100  
  Mean  
Age Recurrence 54 years (range 33-75) <0.02
***
 
 No recurrence 64 years (range 27-93)  
Length of resected  Recurrence 19.6 cm (range 12-34) 0.16 (3) 
specimen No recurrence 17.1 cm (range 7-35)  
AR = Anterior Resection 
   
*  
p value by Fisher exact test 
  
**
 p value by Chi-square 
***
 p value by t-test 
†
 Recurrence occurred in three patients after reversal of the colostomy and in one patient with a colostomy who later 
underwent a subtotal colectomy because of multiple diverticula in the entire colon 
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Postoperative morbidity and mortality 
Early postoperative complications (within 30 days after primary surgery) requiring 
reoperation occurred in nine patients (4.9%). Indications for reoperation was anastomotic 
leak (n = 3), abscess formation with abdominal sepsis (n = 3), gauze left behind at initial 
laparotomy (n = 1), iatrogenic bowel perforation (n = 1), and fascial dehiscence (n = 1). The 
30-day mortality rate for patients with emergency surgery was 9.5% (n = 7). No patients 
died within 30 days after elective surgery. Sixty-eight patients (37.2%) received a 
colostomy, which was reversed in 36 patients (53%) after a mean of 10 (range = 1-63) 
months. One patient died after colostomy reversal due to cardiogenic shock. Mean age of 
the group with colostomy reversal was significantly lower than the group who did not 
have colostomy reversal (60 vs. 69 years; t-test; p = 0.01). Three patients (8.3%) had 
anastomotic leak resulting in reoperation. 
 
Persistent abdominal pain 
Thirty-four patients died before the end of the observational period, leaving 149 patients 
available for long-term follow up. Of this group, 33 patients (22.1%) complained of 
persistent abdominal pain after primary resection. Signs of active inflammation were 
present at pathology in 29 of them (88%). One hundred and sixteen patients did not have 
persistent postoperative pain but signs of inflammation were present in a similar 
percentage (103 patients; 89%). The mean length of resected sigmoid in the group with 
persistent postoperative pain was 17cm compared to 17.5cm in patients without 
complaints. (t-test; p=0.15) 
 
Recurrences 
Recurrence rate was 8.7% (n = 16) and recurrences occurred after a mean of 3.2 (range = 
0.5-12) years. Mean age at operation was significantly lower in the recurrence group than 
in the non-recurrence group (54 vs. 64 years; t-test; p<0.01). The type of previous 
operation performed in the recurrence group was resection of the sigmoid in ten cases; 
Hartmann’s procedure in four cases and a low anterior resection in two cases. Six out of 
16 (37.5%) were emergency procedures. Eight patients (50%) with recurrent disease were 
treated conservatively, because the complaints were mild in seven patients and the 
remaining patient was in poor general condition not favoring surgery. The other eight 
patients underwent a left-sided hemicolectomy because of multiple diverticula in three, a 
partial resection of the transverse colon after inflammation induced stenosis in two, and 
active inflammation in one patient. It was necessary to conduct a subtotal colectomy in 
two cases because of multiple diverticula in the entire colon. Only two patients (12.5%) 
with recurrent diverticulitis were operated on in an emergency setting. Figure 1 shows 
Kaplan-Meier estimator of the cumulative time-related incidence of recurrence. The 
estimated risk of recurrent diverticulitis one year after operation was 3% (standard error 
(se) = 1.3), increasing to 8.2 % (se = 2.3) at 5 years, 12% (se = 3.0) at 10 years and 16% (se 
= 3.7) at 15 years.  
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Figure 1: Cumulative incidence of recurrent diverticulitis after resection using the Kaplan-Meier 
method for time-related incidence. This method adjusts the incidence ratio to account for various 
lengths of follow-up and losses to follow-up. 
 
Table 2 shows the hazard ratios (with 95% confidence interval) of risk factors for recurrent 
diverticulitis adjusted for length of follow-up using a univariate Cox regression. Age, level 
of anastomosis, and the persistence of postoperative symptoms appeared to be significant 
risk factors for recurrent diverticulitis. Younger age and persistent postoperative 
symptoms were significantly related to an increased risk for recurrence. This also held for 
either colorectal of colosigmoidal anastomosis compared to colostomy. A multivariate Cox 
regression showed that these were independent risk factors for recurrent diverticulitis. 
 
Gender, elective or emergency surgery, type of operation and number of episodes were 
not significantly associated with a higher risk of recurrence. 
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Table 2: The hazard ratio with 95% confidence interval for recurrence of diverticulitis 
 
Variable Hazard ratio (95% CI) p value 
Gender  0.86 
 - Female 1.09 (0.41-2.94)  
 - Male 1.00 (reference)  
Operation  0.60 
 - Elective 1.00 (reference)  
 - Emergency 1.31 (0.47-3.61)  
Episodes (number) 1.20 (0.71-2.4) 0.49 
Type of operation  0.34 
 - Sigmoid resection 1.00 (reference)  
 - Hartmann 0.72 (0.23-2.30)  
 - Anterior resection
†
 1.33 (0.29-6.09)  
 - Miscellaneous
‡
 NE  
Signs of active inflammation at pathology  0.30 
 - Yes 0.48 (0.14-1.69)  
 - No 1.00 (reference)  
Persistent complaints  <0.01 
 - Yes 4.76 (1.79-12.5)  
 - No 1.00 (reference)  
Level of anastomosis  0.02 
 - Colorectal 11.35 (1.18-109.50)  
 - Colosigmoidal 7.49 (0.97-57.63)  
 - Other 1.00 (reference)  
Age (years) 0.96 (0.93-0.99) 0.02 
CI: confidence interval 
NE: not estimable 
†
 Anterior resection with primary anastomosis and colostomy pooled 
‡
 Left-sided hemicolectomy and miscellaneous pooled 
 
 
Discussion  
 
Primary aim of this large and well-documented study was to calculate the cumulative 
incidence of recurrent diverticulitis in patients who underwent emergency or elective 
surgery for diverticulitis and to identify possible risk factors associated with recurrence in 
a large group of patients with histology-confirmed diverticulitis. Diverticulitis recurred in 
about 9% of the cases and in two thirds within five years after initial surgery. Young 
patients and those with abdominal complaints were significantly at risk for recurrent 
diverticulitis. 
 
Data from the 1960s and 80s showed rates of clinically suspected recurrent diverticulitis 
after resection varying between 7% and 11%.
10, 11, 14
 Slightly lower recurrence rates 
between 5% and 8% were found more recently, explained by the fact that recurrences had 
to be consistent with barium enema or CT-findings.
12, 13
 Our overall recurrence rate agrees 
with that of others, but the advantage of our long-term data lies in the estimated risk of 
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recurrence adjusted for length of follow-up. The estimated risk of recurrence is 16% over 
15 years, meaning that of every six patients risks a recurrence after resection. 
 
Younger age was a risk factor for recurrence independent of the greater life time exposure 
to diverticulosis in the present study. The pathogenic mechanism in young patients with 
diverticular disease presumably differs from that in older patients, in whom age-related 
weakening of the colonic wall seems to play an important role. Recent findings of 
histological similarity between the colonic wall surrounding diverticula and biopsies of 
patients with inflammatory bowel disease are interesting in that they give a deeper 
understanding of potential pathogenic mechanisms of diverticula formation and diverticu-
litis in young patients.
15-17
  
 
Abdominal symptoms persist after resection in up to 33% of the cases and are attributed 
by most authors to coexisting irritable bowel syndrome (IBS) based on considerable 
overlap between symptoms of both diseases.
3, 18
 It cannot be ruled out that IBS accounted 
for a certain failure rate after surgery; however, this would be expected in patient groups 
lacking inflammatory changes in the resected specimens. Over 90% of resected bowel 
parts had histological signs of inflammation in our series, making IBS an unlikely cause for 
persistent complaints, which is further supported by the finding that postoperative 
abdominal complaints are an independent risk factor for recurrent diverticulitis. This 
implies that persistence of symptoms after resection for complicated diverticulitis should 
be taken seriously and properly be investigated by physicians. 
  
It has been found that recurrence rates are lower if the total sigmoid had been removed 
and a rectal anastomosis had been made.
11, 12
 We could not confirm this finding in the 
present study, wherein data on the level of anastomosis and type of operation were 
carefully extracted from the operative reports. Mean specimen length of 19.6cm and 
17.1cm, respectively, did not significantly differ between the recurrence and non-recur-
rence groups, further suggesting that the extent of resection and type of anastomosis are 
not important factors for recurrence. 
 
Elective surgical resection is advised after two episodes of uncomplicated diverticulitis, 
although recent reports suggest a more conservative and individualized approach.
19
 The 
rationale for surgery is to prevent recurrent complicated diverticulitis and to reduce 
emergency procedures. We challenge this advice based on the findings that one of every 
six operated patient is at risk of recurrence, 22% of patients have persistent abdominal 
complaints, and 80% of patients, needing emergency surgery for acute diverticulitis had 
no manifestation of diverticular disease prior to surgery. Moreover, recurrent diverticulitis 
was not associated with a higher percentage of emergency procedures. Long-term mor-
bidity related to colostomy reversal further emphasizes that patient selection for elective 
surgery should be done with caution. 
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Conclusion 
 
After surgical therapy for diverticulitis the estimated risk of recurrence is high and 
abdominal complaints are frequent. Younger age and the persistence of postoperative 
symptoms predict a recurrence of diverticulitis after resection. The clinical implication of 
these findings needs further investigation. Results of this study support the practice of 
careful selection of patients who will undergo surgery for diverticulitis. 
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Abstract 
 
Background 
Incidence of acute left-sided diverticulitis (ACD) is increasing in the Western world. To 
improve the quality of patient care, a guideline for diagnosis and treatment of diverticu-
litis is needed. 
 
Methods 
A multidisciplinary working group, representing experts of relevant specialties, was 
involved in the guideline development. A systematic literature search was conducted to 
collect scientific evidence on epidemiology, classification, diagnostics and treatment of 
diverticulitis. Literature was assessed using the classification system according to an 
evidence-based guideline development method, and levels of evidence of the conclusions 
were assigned to each topic. Final recommendations were given, taken into account the 
level of evidence of the conclusions and relevant other considerations such as patient 
preferences, costs and availability of facilities. 
 
Results 
The natural history of diverticulitis is usually mild and treatment is mostly conservative. 
Although younger patients have a higher risk of recurrent disease, a higher risk of 
complications compared to older patients was not found. In general, the clinical diagnosis 
of ACD is not accurate enough and therefore imaging is indicated. The triad of pain in the 
lower left abdomen on physical examination, the absence of vomiting and a CRP>50mg/l 
has a high predictive value to diagnose ACD. If this triad is present and there are no signs 
of complicated disease, patients may be withheld from further imaging. If imaging is 
indicated, conditional computed tomography, only after a negative or inconclusive 
ultrasound gives the best results. There is no indication for routine endoscopic 
examination after an episode of diverticulitis. There is no evidence for the routine 
administration of antibiotics in patients with a clinically mild uncomplicated diverticulitis. 
Treatment of pericolic or pelvic abscesses can initially be treated with antibiotic therapy or 
combined with percutaneous drainage. If this treatment fails, surgical drainage is required. 
Patients with a perforated ACD resulting in peritonitis should undergo an emergency 
operation. There is an ongoing debate about the optimal surgical strategy. 
 
Conclusions 
Scientific evidence is scarce for some aspects of ACD treatment (e.g., natural history of 
ACD, ACD in special patient groups, prevention of ACD, treatment of uncomplicated ACD, 
and medical treatment of recurrent ACD), leading to treatment being guided by the 
surgeons’ personal preference. Other aspects of the management of patients with ACD 
have been more thoroughly researched (e.g., imaging techniques, treatment of 
complicated ACD, elective surgery of ACD). This guideline of the diagnostics and treatment 
of ACD can be used as a reference for clinicians who treat patients with ACD. 
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Introduction 
 
Left-sided diverticulosis of the colon is a common condition in Western society. The 
prevalence of diverticulosis coli depends on age and increases from about 5% around 40 
years of age to 65% at the age of 85 years or older.
1, 2
 It is estimated that approximately 
25% of the patients with diverticulosis will develop an episode of acute colonic 
diverticulitis (ACD).
3
 Patients with acute abdominal pain due to ACD impose an impressive 
burden to healthcare.
4
 In the past years, a dramatic rise in the number of hospitalizations 
for ACD has been noted in the Netherlands. In 2009, 18,355 patients were hospitalized 
with ACD as compared to 13,655 patients in 2006. Meanwhile, expenditures for these 
hospital admissions in the Netherlands exceed 80 million euro per year.
5, 6
 This rise in 
hospital admissions is also notable in other countries. A recent study from the United 
States showed an increase in hospital admissions during the period 1998-2005 of 26%, 
with the greatest rise in patients between 18 and 44 years of age.
4
 In the Netherlands, 
women make up 60% of hospital admissions for ACD.
6
 This difference in incidence of ACD 
between men and women has been noticed in other countries as well. Patients younger 
than 50 years of age with ACD are predominantly men, whereas in the age group of 50-70 
years there seems to be a preference for women.
7-11
 Patients with mild (recurrent) 
diverticulitis are usually treated by a general practitioner or on an outpatient basis, which 
makes it difficult to accurately determine the true incidence and recurrence rates of 
diverticulitis. 
  
Although ACD is a very common disease, the clinical diagnosis remains a challenge for 
clinicians and health care researchers. Diagnostics and treatment of diverticulitis are 
mostly characterized by doctors’ personal preferences rather than standardized evidence-
based protocols. This is mainly due to the fact that there is a large amount of conflicting 
and low quality evidence in publications regarding diverticulitis. To provide doctors and 
other health care providers support in clinical decision-making, practice guidelines can be 
developed. Guidelines are applicable nationwide, but if based on international literature 
can be applicable to developed countries. Therefore, a multidisciplinary working group 
developed national guidelines including the epidemiology, classification, diagnostics and 
treatment of ACD in all its aspects based on an evidence-based review of the international 
literature. 
 
 
Methods 
 
The guideline was written under the auspices of the Netherlands Society of Surgery, in 
collaboration with the Netherlands Societies of Internal Medicine, Gastroenterologists, 
Radiology, Health Technology Assessment and Dieticians. The working group consisted of 
four surgeons, a gastroenterologist, a radiologist, an internist specialized in infectious 
diseases, a dietician and an epidemiologist and statistician. Participation of a patients’ 
Guidelines of diagnostics and treatment of acute left-sided diverticulitis 
172 
representative in the working group was not possible because a patient association for 
patients with ACD does not exist in the Netherlands. The working group defined the 
following sections of relevance: terminology and classification, epidemiology, special 
patient groups with ACD, prevention of recurrent ACD, clinical diagnosis and radiological 
imaging, colonoscopy, treatment of uncomplicated and complicated ACD, elective surgery 
and medical treatment in patients with ACD. 
 
Search strategy  
Systematic searches of the Medline and Embase database were performed using the 
keywords relevant to each section. Terms relevant to each section of the guideline were 
mapped to Medline Subjects Headings (MeSH) terms, as well as being searched for as text 
items. Relevant keywords and search strategies can be found in Appendix 1. Articles 
describing randomized controlled trials and systematic reviews were searched for using 
the methodological filters of the Scottish Intercollegiate Guidelines Network 
(https://www.sign.ac.uk/methodology/filters.html). Different date censoring and limita-
tions were applied according to the relevance of each keyword. Only publications in 
English, France, German and Dutch were retrieved and read in full. The bibliographies of 
included articles were subsequently hand-searched for other relevant references and 
experts in the field were asked if they found any relevant reports missing. 
 
Critical appraisal  
Articles selected to support recommendations were assessed using the national 
classification system for evidence-based guideline development (http://www.cbo.nl), 
which is equivalent to the levels of evidence as published by the Centre of Evidence Based 
Medicine of the University of Oxford (http://www.cbem.net). (Table 1) Articles were 
classified according to the type of article and individually assessed for methodological 
quality using the GRADE method as proposed by the GRADE working group. That working 
group has developed a common, sensible and transparent approach to grading quality of 
evidence and strength of recommendations (http://www.gradeworkinggroup.org).  
 
The main literature on which the conclusion for each relevant topic is based, is stated with 
the conclusion, accompanied by the level of evidence (Table 2). The final recom-
mendations are based on the available evidence from literature, also taking into account 
‘soft’ factors such as patient preferences, costs and availability of facilities. 
Recommendations can be strong (we can be confident about the recommendation, level I) 
to weak (we cannot be confident, level IV). A concept guideline was sent to all involved 
societies for comment and approval after which internal consensus was reached between 
the members of the working group. Amendments were made based upon these 
comments, leading to the final version of the guideline ‘Diagnostics and treatment of 
Acute Colonic Diverticulitis’, as approved by all societies. 
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Table 1: Classification of evidence 
 
Level of 
evidence 
Interventional research Studies concerning diagnostic 
accuracy 
Studies on complications or side-
effects, etiology, prognosis 
A1 Systematic review/ meta-analysis of at least 2 independently performed level A2 studies 
A2 Double blind controlled 
randomized comparative clinical 
trial of good study quality with 
adequate number of study 
participants 
Diagnostic test compared to 
reference test; criteria and 
outcomes defined in advance; 
assessment of test results by 
independent observers; 
independent interpretation of test 
results; adequate number of 
consecutive patients enrolled; all 
patients subjected to both tests 
Prospective cohort with sufficient 
amount of study participants and 
follow-up, adequately controlled 
for confounders. Selection in 
follow-up has been successfully 
excluded 
B Comparative studies, but without 
all the features mentioned for 
level A2 (including patient-control 
studies, cohort studies) 
Diagnostic test compared to 
reference test, but without all the 
features mentioned in A2 
Prospective cohort study, but 
without all the features 
mentioned for level A2 or 
retrospective cohort study or 
case-control study 
C Non-comparative studies 
D Expert opinion 
 
 
Table 2: Grading of the conclusions according to the level of evidence 
 
Level Conclusion based on 
1 Systematic review (A1) or at least 2 independent studies with evidence level A2 
(There is evidence that…) 
2 One study with evidence level A2 or at least 2 independent studies with evidence level B 
(It is likely that … ) 
3 One study with evidence level B or level C 
(There are indications that…) 
4 Expert opinion 
(The working group recommends….) 
 
 
Results 
 
Terminology and classification 
The term “diverticular disease” used in Anglo-Saxon literature is made up of a spectrum of 
conditions all related to diverticulosis of the colon. Some use the term “diverticular 
disease” for patients having symptoms associated with diverticulosis and distinguish 
diverticulitis as a different entity, whereas others include diverticulitis and diverticular 
bleeding in the term “diverticular disease”. The lack of uniformity in terminology results in 
difficulties interpreting and comparing findings between studies. It seems best to use the 
term “diverticulosis coli” and to distinguish between uncomplicated (asymptomatic) and 
complicated (symptomatic) diverticulosis. Patients with uncomplicated diverticulosis have 
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no symptoms, and therefore the term asymptomatic diverticulosis is also used. 
Complicated diverticulosis coli, or symptomatic diverticulosis coli, is the complete 
spectrum of symptoms that can arise in patients with diverticulosis coli. This includes 
patients with (chronic) persistent abdominal pain, acute colonic diverticulitis and 
diverticular bleeding. ACD refers to inflammation of diverticula. Uncomplicated ACD is 
referred to when inflammation of one or more diverticula leads to an inflammatory 
process without perforation or abscess formation. Complicated diverticulitis is associated 
with abscess formation, perforation or fistula formation. Recurrent episodes of ACD may 
result in stenosis and obstruction or fistula to nearby organs (mostly bladder) or the skin; 
these late complications are also referred to as complicated diverticulitis. 
 
To classify acute diverticulitis, Hinchey et al.
12
 proposed a classification system, which is 
currently used in clinical practice in a modified version (Table 3).
13
 The Hinchey 
classification has traditionally been used to distinguish four stages of complicated 
diverticulitis. Wasvary et al.
13
 introduced stage 0, clinically mild diverticulitis, and 
differentiation in stage I between limited pericolic inflammation (stage Ia) and abscess 
formation smaller than 5cm in the proximity of the primary inflammatory process (stage 
Ib). This broadened the original Hinchey classification by not only addressing perforated 
disease, but also including mild clinical disease. 
13, 14
 After the introduction of computed 
tomography (CT) for diagnosing acute diverticulitis, several radiologic classification 
systems were proposed additionally.
15, 16
 CT findings were correlated with the modified 
Hinchey scores to come to uniform reporting of CT findings (Table 3).  
 
Table 3: CT findings according to Kaiser et al 2005
52
 
 
Modified Hinchey classification Accompanying CT findings 
Stage 0 Clinically mild diverticulitis Diverticula with or without wall thickening of the 
colon 
Stage Ia Confined pericolic inflammation and 
phlegmonous inflammation 
Colonic wall thickening with inflammatory 
reaction in pericolic fatty tissue 
Stage Ib Abscess formation (<5cm) in the proximity of 
the primary inflammatory process 
Alterations as stage Ia + pericolic or mesocolic 
abscess formation 
Stage II Intra-abdominal abscess, pelvic or 
retroperitoneal abscess, abscess distant from 
the primary inflammatory process 
Alteration as stage Ia + distant abscess 
formation (mostly pelvic or interloop abscesses) 
Stage III Generalized purulent peritonitis Free air with local or generalized free fluid and 
possible thickening of the peritoneum 
Stage IV Faecal peritonitis Similar findings to stage III 
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Conclusion and recommendations 
Uniform terminology is needed in patients with diverticulosis coli. A distinction is made 
between uncomplicated (asymptomatic) diverticulosis and complicated (symptomatic) 
diverticulosis. The latter term is used for the complete spectrum of symptoms that can 
arise in patients with diverticulosis coli (level 4). 
 
Epidemiology 
Researching the natural history of ACD is hampered by a number of factors. There is no 
registry of patients regarding the natural course of the disease. Most patients with 
recurrent episodes of ACD have had elective surgery after two episodes of ACD, which 
makes it difficult to determine true recurrence rates in patients with ACD.
17
 Recurrence 
rates of ACD, in which a recurrence is based on the clinical diagnosis without imaging, 
varies between 9%-29% (level C
9, 18-23
). The accuracy of the diagnosis in these studies is 
questionable, because of the lack of a good reference test. There are two studies with 
adequate reference testing that give information on the natural disease history, which 
report an estimated chance of recurrence of 9% (level C
24
) and 23% (level C
25
). The highest 
risk of recurrence seems to be in the first year (10%) and drops to approximately 3% in the 
years thereafter (level C
21
). The real risk of recurrence is underestimated in these studies; 
recurrence rates apply invariably to a selected group of patients, namely patients with 
symptoms severe enough for hospital admittance. The majority of recurrences tend to be 
mild recurrences that can be managed by conservative treatment (level C
9, 18, 19, 21-25
). 
Based on recent studies, most perforations do not occur after recurrences, but after the 
first attack of ACD (level C
26-33
). Multiple recurrences were not associated with a higher 
chance of mortality, nor did they lead to a higher chance of complicated disease (level C
26-
33
). 
 
Conclusions and recommendations 
The natural history of diverticulitis is usually mild and most patients are treated 
successfully by conservative means (level 3). Multiple recurrences do not lead to a higher 
risk of complicated diverticulitis (level 3). Patients should be informed of an approximately 
25% risk of recurrence after an initial episode of ACD (level 3).  
 
Special patient groups 
 
Young patients 
The definition of young age in patients with ACD is either below 40 or 50 years. Of all 
patients hospitalized for ACD, 18-34% are younger than 50 years.
34, 35
 Some authors have 
reported that young patients have an increased risk of complications and recommend 
early resection.
8, 36-38
 This assumption is based on outdated studies, in which 48-88% of 
the patients who had surgery for suspected diverticulitis appeared to have another 
diagnosis at surgery. Recent studies, using CT to diagnose ACD, did not find a higher risk of 
complications in young patients (level C
7, 18-20, 25, 34, 35, 39, 40
). In young patients the reported 
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high risk of recurrent disease is caused by a higher accumulated risk due to higher life 
expectancy rather than absolute risk (level C
18-20, 40
). There is no evidence that younger 
patients should be treated different than older patients (level C
20, 25, 34, 35, 39, 40
). 
 
Immunocompromised patients 
In patients with a compromised immune system an increased incidence of ACD has been 
reported compared to healthy individuals, especially in patients with kidney failure, organ 
transplant patients and patients using corticosteroids (level C
41, 42
). These patients were 
significantly more often diagnosed with complicated diverticulitis (level C
28, 42-45
). 
Screening and prophylactic sigmoid resection is not routine for patients waiting for organ 
transplantation (level C
42, 46
). Patients with immune deficiency caused by HIV infection, 
diabetes, malignancy or chemotherapy do not have an increased risk of complicated 
diverticulitis (level C
47, 48
). Some reports indicate an increased risk of ACD in obese 
patients, but evidence is inconsistent (level B
49
 and level C
50, 51
). 
 
Conclusions and recommendations 
Young patients do not have a more aggressive course of ACD than older patients (level 3). 
Young patients have a higher risk of recurrent disease, but the absolute risk difference is 
relatively small (level 3). Screening for diverticulosis in immunocompromised patients or 
patients awaiting organ transplantation in order to perform a profylactic colonic resection 
is not effective (level 3). 
 
Prevention of diverticulitis 
There are indications that people with a healthy lifestyle, characterized by physical 
exercise, fiber rich diet, limited intake of red meat, low alcohol consumption and non-
smoking, have a decreased risk of diverticulitis (level B
52
 and level C
53
). 
 
Conclusions and recommendations 
Counselling patients on risk factors for developing diverticulosis should be included in 
treatment protocols (level 3). 
 
Clinical diagnosis and radiological imaging 
 
Clinical diagnosis 
The clinical diagnosis of ACD, based on reported complaints, physical examination and 
laboratory results, is correct in 43%-68% of patients (level B
54, 55
 and level C
56, 57
). To 
improve diagnostic reliability a clinical decision rule and a clinical scoring system for 
diagnosing ACD, using logistic regression have been published.
54, 55
 Reliable independent 
individual risk factors for ACD in both studies were pain only in the left lower abdominal 
quadrant, the absence of vomiting and a CRP level >50mg/l. If all three criteria were met, 
97% of the patients had ACD (level B 
54, 55
). 
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Radiological imaging 
Radiological imaging techniques that are used for the diagnosis of ACD are soluble 
contrast enemas, ultrasound (US), CT and magnetic resonance imaging (MRI). Soluble 
contrast enemas are obsolete for diagnosing ACD due to low accuracy and the inability to 
determine the extent and complications of the disease (level A2
58
 and level B
59
). The most 
used US technique to examine patients with suspected ACD is the graded compression 
procedure. With this technique, interposing fat and bowel can be displaced or compressed 
by means of gradual compression to show underlying structures.
60
 US is a real-time 
dynamic examination with wide availability and easy accessibility. The use of CT in 
evaluation of patients with ACD has increased to a large extent. CT has the advantage of 
delineating the extent of the extra luminal disease process, has an unlimited view and may 
also direct therapeutic intervention in case of complicated disease, e.g., US-guided 
percutaneous drainage of intra-abdominal abscesses. CT criteria are also used as a 
prognostic tool to determine the risk of complications during conservative treatment.
16, 61
 
The most used diagnostic criteria to diagnose ACD with US and CT are increased thickness 
of the colonic wall, pericolic fat stranding and presence of inflamed diverticula. To 
optimally depict diverticulitis the use of intravenous, oral and/or rectal contrast agents are 
advised.
62
 Studies report high diagnostic sensitivity and specificity for both US (92% and 
90%, respectively) and CT after negative or inconclusive US (94% and 99%, respectively; 
level A1
63, 64
). More recently, in a large prospective series of unselected patients with 
acute abdominal pain at the emergency department, for which imaging was indicated by 
the treating physician, a much lower sensitivity of 61% (52-70%) was found for US, 
whereas the sensitivity of CT for the diagnosis of ACD was 81% (74-88%). Sensitivity can be 
increased up to 94% by performing US first, and CT only in case of a negative or 
inconclusive US. This step-up approach lowered the exposure to ionizing radiation for the 
study population (level A2
65, 66
). Besides the known differences between the techniques 
(availability, costs, reproducibility and inter observer differences) exposure to radiation 
during CT and contrast induced nephropathy are a concern.
60
 MRI has the advantage that 
no ionizing radiation and intravenous contrast medium are needed to reach a higher soft 
tissue contrast than CT. MRI is increasingly used in the acute setting for patients with 
acute abdominal pain, but accuracy data are still limited. Based on studies with small 
numbers of patients, sensitivity and specificity of MRI for diagnosing ACD vary between 
86% and 100% and 88% and 100% (level B
67, 68
 and level C
69, 70
). 
 
Conclusions and recommendations 
In general, the clinical diagnosis of ACD is not sufficiently accurate and therefore 
radiological imaging is indicated in these patients (level 2). Patients with mild symptoms 
and no signs of complicated ACD, and the combination of pain in the lower left abdomen 
on physical examination, the absence of vomiting and a CRP >50mg/l may be withheld 
from initial imaging for diagnosing ACD (level 2). If imaging is indicated, a conditional CT 
after negative or inconclusive ultrasound is the most appropriate approach in diagnosing 
ACD (level 2).  
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Colonoscopy  
Colonoscopy is not recommended in the acute phase to diagnose ACD (level B
71
 and level 
C
72
). Although proven feasible in one prospective study, it is rarely needed in the acute 
phase (level C
73
). Possible difficulties of colonoscopy in the acute phase are incomplete 
examination due to pain, stenosis and incomplete bowel preparation. Discouragements to 
perform colonoscopy in the acute phase are based on the hypothesis that insufflation of 
air is associated with the risk of converting a sealed perforation to a free perforation.
73-75
 
 
Colonoscopy is usually done 6 weeks after an episode of ACD, to exclude a colonic 
malignancy. The lifetime risk of developing colonic cancer is approximately 5%. It is 
unlikely that patients after an episode of ACD have an increased risk of the development 
of colonic cancer (level B
76, 77
 and level C
78
) Although safe, routine performance of a 
colonoscopy in asymptomatic patients after an episode of ACD, to exclude other 
diagnoses was found not to be helpful (level B
71, 79, 80
). 
 
Conclusions and recommendations 
Colonoscopy in the acute phase of diverticulitis is not recommended for diagnostic 
purposes (level 3). There is no place for routine endoscopic examination after an episode 
of ACD (level 2).  
 
Treatment of uncomplicated diverticulitis 
Most patients with uncomplicated diverticulitis (Hinchey 0 or Ia) can be treated 
conservatively with a success rate of 93%-100% (level C
15, 81-86
). Conservative treatment 
includes antibiotics, starvation and bed rest in almost all studies. There is no evidence that 
bed rest, dietary restrictions or laxatives, positively influence the treatment outcome of 
ACD. In patients who do not tolerate oral feeding it is recommended to start parenteral 
feeding when oral feeding is not to be expected within three days (level D
87
). Almost all 
international guidelines advise the use of antibiotics for the treatment of diverticulitis. 
17, 88-91
 However, there is no evidence that routine administration of antibiotics influences 
the course of uncomplicated diverticulitis (level A2
92
 and level B
79
). Oral administration of 
antibiotics seems equally effective to intravenous administration (level B
93
). Intravenous 
administration over 4 days is equally effective as 7 days (level B
84
). A recent prospective 
randomized clinical trial did not find a reduction of abscess formation, perforation and 
recurrence rates with the use of antibiotics.
92
 The use of antibiotics seems appropriate in 
patients presenting with signs of generalized infection (temperature >38.5°C), affected 
general condition or signs of bacteraemia or septicaemia and in immunocompromised 
patients. 
 
Analgesia is part of the treatment of patients with ACD. There is no evidence that 
acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs) or morphinomimetics 
have a negative effect on the course of an episode of ACD. Multiple studies found that 
patients on home NSAID medication present more often with complicated diverticulitis, 
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i.e. perforation (level C
48, 94-97
). The (adverse) effect of NSAIDs started as an analgesic in 
patients with uncomplicated ACD has not been studied. Morphinomimetics can be safely 
administered to patients with acute abdominal pain without negatively affecting the 
diagnostic accuracy of clinical evaluation (level A2
98, 99
). 
 
Conclusions and recommendations 
There is no evidence that bed rest, dietary restrictions or laxatives influence the treatment 
of ACD (no evidence). There is no evidence that antibiotics should be routinely 
administered to patients with uncomplicated diverticulitis (level 2). Antibiotic treatment is 
recommended when signs of generalized infection (temperature >38.5°C) and affected 
general condition or signs of bacteraemia or septicaemia are present (level 4). Antibiotic 
treatment is recommended in immunocompromised patients (level 4). 
 
Treatment of complicated diverticulitis  
 
Hinchey Ib and II 
There are no high-quality reports on the management of patients with ACD and abscess 
formation (Hinchey Ib and II); therefore no consensus has been reached about the most 
optimal treatment strategy. Since the introduction of broad-spectrum antibiotics and 
improvement in US- and CT-guided percutaneous drainage techniques, alternatives to 
surgery have become available. Conservative treatment with antibiotics is successful in up 
to 73% (95% CI: 66.3-78.9) of patients presenting with an abscess of less than 4 to 5cm in 
diameter (level C
16, 18, 100-104
). When conservative treatment fails, percutaneous drainage 
should be performed, which is successful in up to 81% (95% CI: 73.7-89.1) of patients 
(level C
15, 16, 100-104
). The risk of failure of conservative treatment is higher in patients with 
abscesses larger than 4-5cm than in patients with smaller abscesses (level C
15, 16, 100-104
). 
 
Hinchey III and IV 
Peritonitis is the most life-threatening complication of ACD, with a mortality of 14%.
105, 106
 
Perforation of the colon to the intra-abdominal cavity results in a purulent or faecal 
peritonitis. Perforation is a relative rare complication with an incidence of 3.5 per 100,000 
individuals per year.
107
 In a large population based study from the United States, only 1.5% 
of patients with ACD were found to have a perforation, and 9.6% were found to have an 
abscess.
108
 Peritonitis is a progressive disease leading to general signs of illness, expressed 
in organ dysfunction or organ failure caused by bacteraemia and septicaemia. Prevention 
of these events by early intervention, i.e., aggressive resuscitation preventing inadequate 
tissue perfusion and oxygenation, the administration of broad spectrum antibiotics and 
elimination of the source of infection is the keystone of sepsis treatment.
109
 Early 
treatment in patients with peritonitis significantly improves outcome.
109-111
 No evidence-
based advice can be provided for the indications for surgery in patients with perforated 
diverticulitis, but the indication seems self-evident. 
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Operative therapy 
There are different surgical options for patients with Hinchey III and IV peritonitis: 
diverting colostomy, Hartmann’s procedure or primary resection with anastomosis, and 
laparoscopic lavage with drainage of the abdominal cavity. Hartmann’s procedure is the 
most performed, which is a two stage procedure involving resection of the diseased colon, 
closure of the distal rectal stump and construction of an end colostomy. In the second 
stage the colostomy is reversed, however restoration of the bowel continuity is not 
performed in up to 55% of patients due to operative risks.
112
 Alternatively, resection with 
primary anastomosis, with or without a protective ileostomy or colostomy, can be 
performed. A diverting ileostomy or colostomy combined with intra-operative irrigation of 
the afferent colon can be performed to reduce the rate of symptomatic complications in 
case anastomotic leakage (level B
113, 114
) Studies comparing mortality, morbidity, wound 
complications, operation time and antibiotic treatment of Hartmann’s procedure and 
primary anastomosis did not show any significant differences. However, most studies 
were prone to selection bias: patients were not randomized for Hartmann’s procedure or 
primary anastomosis and patient groups were not comparable on patient characteristics 
and disease severity. It is likely that the choice of operation is influenced by patient 
conditions and peroperative findings. Nevertheless, there are indications that Hartmann’s 
procedure and primary anastomosis have comparable outcomes (level B
113, 115, 116
). 
However, in critically ill patients, hemodynamic instability is a relative contraindication for 
a primary anastomosis. Due to administration of inotropes to maintain sufficient blood 
pressure, splanchnic perfusion can be reduced leading to increased risk of anastomotic 
leakage. This hypothesis has been confirmed (mainly in animal experiments) in studies on 
anastomotic healing in general surgery, although not after resection for diverticulitis. 
Faecal contamination of the abdominal cavity is thought not to be a contraindication for 
construction of a primary anastomosis.
117
 Another treatment option in patients with 
purulent peritonitis is laparoscopic lavage and drainage of the abdominal cavity in which 
the colon is not resected. In nonrandomized series, hampered by patient selection, 
laparoscopic treatment accompanied by intravenous antibiotics seems to be an effective 
and safe treatment in Hinchey III patients (level C
57, 118
). However, the results of the first 
randomized trial need to be reviewed for a definite conclusion.
119
 
 
Conclusions and recommendations 
Smaller abscesses (<4-5cm) can be treated with antibiotics alone, whereas larger 
abscesses can best be treated with percutaneous drainage combined with antibiotic 
treatment (level 3). Operative treatment is considered standard therapy for patients with 
Hinchey III and IV diverticulitis (no evidence). In hemodynamically stable patients with 
acute diverticulitis and an indication for operative treatment, primary anastomosis with or 
without a diverting ileostomy or colostomy is preferred over Hartmann’s procedure 
(level 2). In patients with Hinchey III diverticulitis, the safety and efficacy of treatment with 
laparoscopic peritoneal lavage is uncertain and remain so until the results of the first 
randomized trial on the subject become available (level 3). 
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Elective surgery 
The American Society of Colon and Rectal Surgeons (ASCRS) state in their most recent 
guideline that elective sigmoid resection after recovery from ACD should be made on a 
case-by-case basis.
90
 This advice differs significantly from the previous advice, given 6 
years earlier, in which a plea for elective surgery after two episodes of diverticulitis was 
proposed.
120
 Recent data on the natural history of diverticulitis has shown that recurrent 
episodes of diverticulitis mostly run a benign course and only 5.5% of the patients with 
recurrent hospitalizations for diverticulitis are subjected to emergency surgery.
20
 
Moreover, most patients who present with complicated diverticulitis do so at the time of 
their first attack (level C
26, 121, 122
) Recurrent diverticulitis even seems to reduce the risk of 
perforation, possibly due to adhesion formation caused by inflammation. Therefore, a 
policy of elective sigmoid resection after recovery from uncomplicated ACD does not 
decrease the likelihood of later emergency surgery and the number of previous episodes 
itself is no longer an indication for elective sigmoid resection (level C
18, 26, 33, 113, 121-123
) 
Persistent colonic symptoms, particularly abdominal pain, have been reported in patients 
after episodes of diverticulitis. It has been suggested that this pain represents increased 
visceral sensitivity.
124
 These patients might benefit from early colonic resection. 
 
After elective sigmoid resection there is a risk of anastomotic leakage, stoma formation, 
morbidity and mortality. Despite resection, even recurrent diverticulitis and continuing 
complaints have been described. Patients with immune deficiencies might benefit from 
early resection since they have a greater risk of perforations and a complicated course of 
recurrent episodes of diverticulitis (level C
18, 33, 121, 122
). 
 
Elective sigmoid resection for complicated diverticulosis can be performed either with an 
open or laparoscopic approach. Two randomized trials favor laparoscopic surgery over 
open surgery. In the ‘Sigma trial’, significantly more complications, higher pain scores and 
longer hospital stay were found among patients with open surgery. Operating time was 
significantly longer in the laparoscopic group, with a conversion rate of 19%. Quality of life 
was significantly better after six weeks, but did not differ after 6 months (level A2
125
). The 
study by Gervaz et al.
126
 also had equal long-term results, except for the cosmetic 
outcome, which was better in the laparoscopic group. No difference was found con-
sidering ventral hernia, patient satisfaction, quality of life or total costs (level A2). 
Laparoscopic surgery provides a faster functional recovery than open sigmoid resection 
and possible less chance of complications, but the long-term advantages of laparoscopic 
sigmoid resection are not evident yet (level A2
125, 126
 and level B
127-131
). Both the Sigma trial 
and the Gervaz study did not use the Enhanced Recovery after Surgery (ERAS) principles, 
which are now widely adopted in the perioperative care of patients with abdominal 
surgery. The ERAS program reduced the risk of complications and hospital stay of open 
surgery to a large extent.
130
 In addition, laparoscopic surgery is often done by dedicated 
surgeons, while open surgery is usually performed by a much larger group of surgeons, 
possibly influencing the results. 
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To reduce the risk of recurrent diverticulitis, the sigmoid should be resected up to the 
proximal rectum (level C
131, 132
). There is no evidence for the optimal proximal resection 
margin; however a resection as limited as possible in soft compliant bowel is recom-
mended.
90 
 
Conclusions and recommendations 
Patient-related factors, not so much the number of previous episodes of diverticulitis, 
should play the most important role in selecting patients who might benefit from elective 
sigmoid resection (level 3). If appropriate laparoscopic expertise is present, laparoscopic 
surgery for recurrent episodes of diverticulitis might be favored over open sigmoid 
resection in terms of short-term outcome, but no long-term benefits have been reported 
(level 1). During elective sigmoid resection, the part of the colon resected proximally to 
the inflammatory process should be as limited as possible with the proximal rectum as 
distal margin (level 3). 
 
Medical treatment of recurrent diverticulitis 
Traditionally, fiber-enriched diets in patients with diverticulitis have been considered to 
prevent recurrent episodes of ACD. However, randomized clinical trials on fiber-enriched 
diets in patients with ACD have inconsistent results.
133
 A recently published systematic 
review of high-fiber dietary therapy could not include any studies concerning prevention 
of diverticulitis with a high-fiber diet.
134
 Despite the lack of evidence, high daily fiber 
intake is recommended as treatment in various guidelines.
17, 88, 91, 135
 Since obesity and 
smoking are associated with an increased risk of complications of diverticulitis, weight 
reduction and cessation of smoking can have a favorable influence on prevention of 
recurrent diverticulitis (level B
51, 136
). Although evidence on lifestyle advices to prevent 
recurrent episodes of ACD is missing, it is likely that the same measures to prevent ACD 
also apply to patients after an episode of ACD. Hence, a healthy lifestyle, characterized by 
physical exercise, fiber-rich diet, little intake of red meat, low alcohol consumption and 
non-smoking are advised in patients after an episode of ACD (level B
52
 and level C
53
). 
 
Recently, new theories about similarities between ACD and inflammatory bowel disease 
have been proposed, leading to new treatment possibilities, such as probiotics, antibiotics 
and anti-inflammatory agents.
137
 Regarding drug treatment, intermittent administration of 
a non-absorbable antibiotic (rifaximin) after an episode of acute diverticulitis decreased 
the chance of readmission by 50% and of recurrent diverticulitis by 73% (level B
138
). 
Prevention of recurrent disease is more effective when 5-aminosalicylic acid (mesalazine) 
is combined with rifaximin, compared to rifaximin alone (level A2
139
 and level B
140
). 
Furthermore, a combination of probiotics and anti-inflammatory medication is preferred 
over treatment with probiotics alone (level A2
141
). 
 
Residual complaints after an episode of diverticulitis occur often and medical treatment 
can reduce symptoms. In these patients a trial period of intermittent administration of a 
Chapter 9 
183 
nonabsorbable antibiotic with mesalazine or probiotics should be considered. Especially 
since there is little risk from treatment by nonresorbable antibiotics or mesalazine 
combined with probiotics, while mortality and morbidity of operative treatment are 
substantial.  
 
Conclusions and recommendations 
The working group advises to give lifestyle advice to patients following an attack of 
diverticulitis, focusing on increasing daily fiber intake, weight reduction, cessation of 
smoking and increasing physical activity (level 4). Nonabsorbable antibiotics seem to 
reduce the risk of recurrent episodes of diverticulitis (level 3). The combination of 5-
aminosalicylic acid and rifaximin is more effective than rifaximin alone in the prevention of 
recurrent episodes of diverticulitis (level 2). The working group opinion is that in patients 
with recurrent diverticulitis or patients with residual complaints following an episode of 
diverticulitis, in which other pathology has been excluded, a trial period of intermittent 
mesalazine, with or without a combination of an oral nonresorbable antibiotic or 
probiotic, should be considered (level 4). 
 
 
Conclusion  
 
This review of guidelines for diverticulitis summarizes the extensive literature available on 
epidemiology, prevention, diagnosing and treatment of patients with acute diverticulitis in 
all its aspects. The guideline was developed in order to standardize the treatment of 
patients with acute diverticulitis and to provide clinicians who deal with patients with 
diverticulitis on a daily basis, with an evidence-based medicine approach in treating and 
counseling patients. Despite a large amount of literature, not all topics were equally well 
addressed. Nevertheless, this review is the best evidence based approach currently 
available. The results of well-designed randomized studies will become available in the 
near future and give more insight in the optimal treatment of patients with acute 
diverticulitis of the colon. 
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Appendix 1 
 
Search strategies for the relevant key words 
 
 
Last search update February 2012 
 
Subject: natural course of ACD  
Date censoring: none 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “Natural history” 
[MesH] OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND 
“Natural history” OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” 
AND “uncomplicated” 
 
Subject: natural course in young and immunocompromised patients 
Date censoring: from 1960 
Restrictions: none 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “Young” OR 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “Recurrence” 
[MesH] OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND 
“diabetes mellitus” [MesH] OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All 
Fields]” AND “transplantation” [MesH] OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR 
“diverticulitis” [All Fields]” AND “immunosuppression” [MesH] OR “Diverticulitis” [MesH] OR “Diverticulitis, 
Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “AIDS or HIV” [MesH] OR “Diverticulitis” [MesH] OR 
“Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “neoplasms” [MesH] 
 
Subject: colonoscopy 
Date censoring: from 1970 
Restrictions: none 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “colonoscopy” OR 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” (“Diverticulitis” OR 
“Diverticular disease”) AND (“Colon carcinoma” OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR 
“diverticulitis” [All Fields]” AND “colon cancer” OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR 
“diverticulitis” [All Fields]” AND “IBD”  
 
Subject: clinical diagnosis 
Date censoring: from 1980 
Restrictions: none 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND clinical parameters 
OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “sensitivity” OR 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “Diverticulitis” 
[MesH] OR “Diverticulitis, Colonic” [MeSH] AND “diagnosis” 
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Subject: radiological imaging 
Date censoring: from 1980 
Restrictions: none 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “contrast enema” 
OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND 
“Ultrasonography” [MeSH] OR “ultrasonography”[subheading] OR “Diverticulitis” [MesH] OR “Diverticulitis, 
Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “Tomography, Spiral Computed” [MeSH] OR “Tomography, 
X-Ray Computed” [MeSH] OR “Tomography Scanners, X-Ray Computed” [Mesh] OR Computed Tomographic” 
[Mesh] OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND 
“Magnetic Resonance Imaging” [Mesh] OR “Colonography, 
 
Subject: uncomplicated diverticulitis 
Date censoring: from 1975 
Restrictions: none 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “uncomplicated 
diverticulitis” OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND 
“Anti-Bacterial Agents”[Mesh] OR “Anti-Bacterial Agents”[Pharmacological Action])) OR “Diverticulitis” [MesH] 
OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” 
((“diverticulitis” [MeSH Terms] OR “diverticulitis” [AllFields]) AND (“intestines” [MeSH Terms] OR “intestines” [All 
Fields] OR “bowel” [All Fields]) AND (“rest” [MeSH Terms] OR “rest” [All Fields])) OR ((“diverticulitis” [MeSH 
Terms] OR “diverticulitis” [All Fields]) AND (“bed rest” [MeSH Terms] OR (“bed” [All Fields] AND “rest” [All Fields]) 
OR “bed rest” [All Fields] OR “bedrest” [All Fields])) OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] 
OR “diverticulitis” [All Fields]” AND ((“diverticulitis” [MeSH Terms] OR “diverticulitis” [All Fields]) AND 
(“overweight” [MeSH Terms] OR “overweight” [All Fields])) OR ((“diverticulitis” [MeSHTerms] OR “diverticulitis” 
[All Fields]) AND BMI [All Fields]) OR ((“diverticulitis” [MeSH Terms] OR “diverticulitis” [All Fields]) AND adipositas 
[All Fields]) OR ((“diverticulum” [MeSH Terms] OR “diverticulum” [All Fields] OR (“diverticular” [All Fields] AND 
“disease” [All Fields]) OR “diverticular disease” [All Fields]) AND adipositas [All Fields]) OR ((“diverticulum” [MeSH 
Terms] OR “diverticulum” [All Fields] OR (“diverticular” [All Fields] AND “disease” [All Fields]) OR “diverticular 
disease” [All Fields]) AND BMI [All Fields]) OR ((“diverticulum” [MeSH Terms] OR “diverticulum” [All Fields] OR 
(“diverticular” [All Fields] AND “disease” [All Fields]) OR “diverticular disease” [All Fields]) AND (“overweight” 
[MeSH Terms] OR “overweight” [All Fields])) 
 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND [Diet Therapy] OR 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND Vegetables OR 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND Fruit OR 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND Starvation OR 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND Laxatives 
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Subject: complicated diverticulitis 
Date censoring: from 1990 
Restrictions: Adults 19+, Series > 50 patients 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND “Abscess” 
[Mesh:NoExp] OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND 
Hinchey III OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND 
“Hinchey IV” OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND 
“Diverticulitis, Colonic/mortality”[Mesh] OR “Diverticulitis, Colonic” [Mesh] AND “Intestinal Perforation” [Mesh] 
OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]” AND laparoscopy  
 
‘diverticulitis’/exp OR diverticulitis:ab,ti OR ‘diverticular disease’:ab,ti) AND (‘laparoscopy’/exp OR ‘laparoscopic 
surgery’/exp OR ‘laparoscope’/exp OR ‘minimally invasive surgery’/exp OR laparoscop*:ab,ti OR 
laparascop*:ab,ti OR (minimal*:ab,ti AND adj:ab,ti AND invasive:ab,ti)) AND (‘acute disease’/exp OR 
‘emergency’/exp OR acute:ab,ti OR emergenc*:ab,ti OR ‘colon perforation’/exp OR (perforat*:ab,ti AND [1970-
2011]/py)) “Diverticulitis, Colonic”[Mesh] AND “Recurrence” [Mesh] AND “Therapeutics” [Mesh] 
database 
 
Subject: prevention of recurrence and antibiotics 
Dare censoring: from 1966 
Restricitons: none 
(“Diverticulitis” AND “Recurrence” AND “Therapy”) OR (“Diverticulum, Colon” [Mesh]) AND ((“Diet Therapy” 
[Mesh]) OR (“Dietary Fiber” [Mesh])). 
 
((“diverticulitis” [MeSH Terms] OR “diverticulitis” [All Fields]) AND (“overweight” [MeSH Terms] OR “overweight” 
[All Fields])) OR ((“diverticulitis” [MeSH Terms] OR “diverticulitis” [All Fields]) AND BMI [All Fields]) OR 
((“diverticulitis” [MeSH Terms] OR “diverticulitis” [All Fields]) AND adipositas [All Fields]) OR ((“diverticulum” 
[MeSH Terms] OR “diverticulum” [All Fields] OR (“diverticular” [All Fields] AND “disease” [All Fields]) OR 
“diverticular disease” [All Fields]) AND adipositas [All Fields]) OR ((“diverticulum” [MeSH Terms] OR 
“diverticulum” [All Fields] OR (“diverticular” [All Fields] AND “disease” [All Fields]) OR “diverticular disease” [All 
Fields]) AND BMI [All Fields]) OR ((“diverticulum” [MeSH Terms] OR “diverticulum” [All Fields] OR (“diverticular” 
[All Fields] AND “disease” [All Fields]) OR “diverticular disease” [All Fields]) AND (“overweight” [MeSH Terms] OR 
“overweight” [All Fields])) 
 
((“diverticulitis” [MeSH Terms] OR “diverticulitis” [All Fields]) AND (“smoking” [MeSH Terms] OR “smoking” [All 
Fields]) ( (“diverticular disease” [MeSH Terms] OR “diverticular disease” [All Fields]) AND (“smoking” [MeSH 
Terms] OR “smoking” [All Fields]) 
 
((“diverticulitis” [MeSH Terms] OR “diverticulitis” [All Fields]) AND (“exercise” [MeSH Terms] OR “exercise” [All 
Fields] OR (“physical” [All Fields] AND “exercise” [All Fields]) OR “physical exercise” [All Fields])) OR 
((“diverticulum” [MeSH Terms] OR “diverticulum” [All Fields] OR (“diverticular” [All Fields] AND “disease” [All 
Fields]) OR “diverticular disease” [All Fields]) AND (“exercise” [MeSH Terms] OR “exercise” [All Fields] OR 
(“physical” [All Fields] AND “exercise” [All Fields]) OR “physical exercise” [All Fields])) OR ((“diverticulitis” [MeSH 
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Terms] OR “diverticulitis” [All Fields]) AND (“physical therapy modalities” [MeSH Terms] OR (“physical” [All 
Fields] AND “therapy” [All Fields] AND “modalities” [All Fields]) OR “physical therapy modalities” [All Fields] OR 
“physiotherapy” [All Fields])) OR ((“diverticulum” [MeSH Terms] OR “diverticulum” [All Fields] OR (“diverticular” 
[All Fields] AND “disease” [All Fields]) OR “diverticular disease” [All Fields]) AND (“physical therapy modalities” 
[MeSH Terms] OR (“physical” [All Fields] AND “therapy” [All Fields] AND “modalities” [All Fields]) OR “physical 
therapy modalities” [All Fields] OR “physiotherapy” [All Fields])) 
 
Subject: Elective surgery  
Date censoring: 1970 
Restrictions: none 
“Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” [All Fields]”  
AND Elective sigmoid resection OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR “diverticulitis” 
[All Fields]” AND “Elective colectomy” OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR 
“diverticulitis” [All Fields]” OR “Surgery” AND “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” [MeSH] OR 
“diverticulitis” [All Fields]” AND “laparoscopic colectomy” OR “Diverticulitis” [MesH] OR “Diverticulitis, Colonic” 
[MeSH] OR “diverticulitis” [All Fields]” AND “laparosc*”. 
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Summary and future perspectives 
 
The studies presented in this thesis focus on a systematic approach diagnosing acute 
colonic diverticulitis (ACD), treatment dilemmas particularly in recurrent diverticulitis, and 
patient reported outcomes and Quality of Life (QoL) after surgical or medical treatment. 
Evidence based guidelines of diagnostics and treatment of diverticulitis have been 
established. 
 
Chapter 1 is the introductory chapter in which a description is given of the aetiology and 
epidemiology of diverticula and diverticulitis. The current diagnosis and treatment of 
diverticulitis is outlined. The chapter also includes the content and objectives of this 
thesis. 
 
PART ONE - Clinical decision making in ACD (Chapter 2-5) 
In the first part of the thesis difficulties in diagnosing acute colonic diverticulitis (ACD) are 
discussed. ACD is a frequent suspected diagnosis in patients presenting with acute 
abdominal pain.
1
 It is a challenge to correctly identify patients with ACD, because 
numerous other acute abdominal conditions mimic its clinical picture. Clinical assessment 
alone for the diagnosis of diverticulitis has been reported as insufficiently precise.
2-5
 A 
decision model and external validation of the model to improve diagnostic accuracy of the 
clinical diagnosis ACD is presented, along with a systematic review of the clinical 
evaluation and diagnostic modalities to develop an evidence-based approach in 
diagnosing ACD. In the last chapter of Part 1 the potential pitfalls in diagnosing right-sided 
diverticulitis are discussed. 
 
In Chapter 2 relevant data of patients who entered the emergency department with acute 
abdominal pain and suspected ACD were retrospectively retrieved from medical charts 
and analyzed for factors predicting ACD. Independent predictors for having ACD after 
multivariable logistic regression model were age older than 50 years, one or more 
previous episodes of ACD, localization of pain in the lower left abdomen both on history 
taking and physical examination, pain on movement, and a C-reactive protein level higher 
than 50mg/l. Vomiting was a negative independent predictor for having ACD. Based on 
these variables, a decision model was made that can predict the probability of ACD. The 
optimal sensitivity and specificity of the model was 75% and 84%, respectively. Important 
clinical consequence of using the model is that additional imaging can be omitted when 
the chance of having ACD is high based on the model. Patients with mild symptoms 
without imaging and treated in an outpatient setting and patients with an acute abdomen 
in whom immediate operation was performed, were not included in the study. Hence, the 
decision model cannot be used in general practice, or in patients with suspected 
complicated diverticulitis. 
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An external validation of our decision model was done and described in Chapter 3. The 
diagnostic value of the decision model was compared with the decision rule for the 
diagnosis of patients with diverticulitis, developed by the Department of Surgery of the 
Academic Medical Centre Amsterdam (AMC).
6
 In a subanalysis of patients suspected of 
ACD in the OPTIMA study, independent variables were selected that could be of value in 
predicting ACD. In this study, the triad pain in the lower left abdomen on physical 
examination, the absence of vomiting and a CRP >50mg/l had a very high predictive value 
(positive predictive value 97%) for patients having ACD. Approximately 25% of the patients 
with diverticulitis were positive for the triad. In a quarter of patients with suspected ACD, 
the diagnosis could be solely based on this triad. The clinical applicability of both models 
was tested with external validation using a third independent cohort of patients with 
acute abdominal pain.
7
 The predictive value of each variable in the decision model was 
compared with the predictive value of each variable in the two validation cohorts to gain 
insight in the variables with the best discriminatory power. Results of the external 
validation study showed that the positive predictive value of our decision model remained 
intact (range 89%-92%), but the diagnosis ACD could only be made in 1 out of every 5 
patients with a greater than 90% certainty. A disadvantage of our model was that it could 
only differentiate between patients with ACD and another diagnosis but lacked the ability 
to determine the alternative diagnosis. Also, the model could not distinguish between 
moderately ill and critically ill patients. Taking these limitations into account the diagnosis 
ACD can still be made with a probability reaching certainty in 1 out of 5 patients with 
suspected uncomplicated diverticulitis in our model, similar to 1 out of 4 patients with the 
triad of the AMC group. 
 
In Chapter 4 the added value of imaging in the diagnostic work-up of patients suspected of 
ACD was described. To this purpose the medical literature regarding accuracy of the 
clinical evaluation and diagnostic modalities for patients with suspected ACD was 
systematically reviewed to develop an evidence-based approach diagnosing ACD. Taking 
into account that the overall quality of the studies that reported the diagnostic accuracy of 
the clinical diagnosis, a contrast enema and a MRI was moderate to poor, we concluded 
that two-thirds of the diagnosis of ACD could be made without imaging and based on 
clinical evaluation alone. The role of MRI was not clear in diagnosing ACD. Contrast enema 
was inferior to US and CT in terms of sensitivity and specificity and was considered an 
obsolete imaging technique to diagnose ACD. Studies describing diagnostic accuracy of US 
and CT were of good quality and could be included in a meta-analysis. US and CT were 
comparable in diagnosing diverticulitis and superior to other modalities. CT had the 
advantage of higher specificity and the ability to better identify alternative diagnoses. We 
concluded that the first step of the diagnostic process should be an estimation of the 
probability of ACD based on clinical evaluation. In case of questionable disease, an 
ultrasound examination should be performed. In case of an inconclusive or negative US, a 
CT scan is the next diagnostic step to reveal the diagnosis. This process was named the 
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step-up approach to diagnose ACD, similar to the approach in diagnosing acute 
appendicitis. 
 
In Chapter 5 differences were evaluated in the clinical course between right- and left-
sided ACD in a Western population. Right-sided colonic diverticulitis (RCD) is common in 
Asia but rare in the Western world.
8
 Critical analysis of our data led to the conclusion that 
RCD has a low incidence, behaves as a self-limiting disease and acts more benign than left-
sided ACD in Western patients. The historical concept that RCD in Western patients is an 
aggressive disease seemed merely a reflection of the unfamiliarity with this disease in the 
Western world, inadequate diagnostic workup and decisions made in the operating room. 
Outcome of RCD seemed more determined by the aggressive management of the disease 
than the nature of the disease itself.  
 
PART TWO – Treatment strategies, Risk factors and Quality of Life (QoL) in recurrent 
diverticulitis (Chapter 6-8) 
The second part of the thesis describes various treatment strategies for patients with 
recurrent episodes of ACD and the effect of conservative or operative treatment on 
quality of life (QoL) and other patient reported outcomes (PROs). In this part also risk 
factors were determined for recurrence of diverticulitis after surgery for uncomplicated or 
complicated diverticulitis. 
 
Generally accepted indications for elective sigmoid resection after diverticulitis are 
obstruction, fistula formation, or the suspicion of colonic cancer. Recurrent episodes of 
ACD are generally considered an indication of a partial colonic resection. A frequently 
used argument to justify elective colonic resection after recurrent episodes of ACD is an 
increased risk of serious complications with each recurrent episode. Elective resection 
may reduce the risk of (complicated) recurrent ACD and may be a solution for patients 
with persistent pain after an episode of ACD. Elective resection, however, is not without 
risks. Patients risk major morbidity, mortality and the chance of stoma formation while the 
risk of recurrent ACD still may exist. Furthermore, persistent abdominal complaints seem 
common after surgery. Whether or not to perform an elective sigmoid resection in 
patients with recurrent episodes of ACD is a therapeutic dilemma. In order to properly 
advise the individual patient with recurrent episodes of diverticulitis it seems crucial to 
differentiate between patients who are likely to benefit from prophylactic resection 
preventing complicated disease and chronic abdominal complaints and patients with 
recurrent episodes who have a benign course. The decision to recommend surgery 
probably is influenced by the age and medical condition of the patient, the frequency and 
severity of the attack(s), and whether there are persistent symptoms after the acute 
episode.
1
 
 
Recently, new theories about similarities between diverticulitis and inflammatory bowel 
disease have been proposed and good results with medication are reported. The use of 5-
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aminosalicylic acid in combination with a non-absorbable antibiotic reduced persistent 
abdominal symptoms in between recurrences, but has not proved yet to diminish the risk 
of recurrent diverticulitis.
9-12
 The results of these new treatment options have not been 
incorporated in recent guidelines, but might play an important role in the decision 
whether or not to operate. In terms of the best strategy for patients with recurrent 
episodes of diverticulitis, we designed a state-transition Markov model in which different 
treatment strategies in patients with recurrent episodes of diverticulitis were compared 
with Quality of Life (QoL) as primary outcome measure in Chapter 6. Four competing 
strategies were formulated based on the current uncertainty of the optimal treatment 
strategy in patients with recurrent episodes of diverticulitis, i.e., colonic resection after 
two episodes of diverticulitis and colonic resection or medical or conservative treatment 
after the third episode of diverticulitis. The course of events of 1,000 patients after two 
episodes of ACD was simulated in the model and sensitivity analyses were performed to 
determine which variables, according to the ranges in literature, would affect outcome. 
We found that colonic resection after two episodes of diverticulitis resulted in the lowest 
QALYs. The low QALYs associated with colonic resection after two episodes of diverticulitis 
were mainly caused by an early mortality risk related to the surgical procedure. Based on 
these results surgical treatment after two episodes of diverticulitis should no longer be 
advised. In patients suffering from a third episode of diverticulitis, the surgical, medical 
and conservative treatment strategies are similar in terms of quality-adjusted survival. 
Sensitivity analyses further revealed that surgical resection and conservative or medical 
treatment after the third episode of diverticulitis are superior to surgical resection after 
two episodes of diverticulitis. In the Markov model, patients with recurrent episodes of 
diverticulitis who received medical treatment generated the lowest QALYs compared to 
surgical and conservative treatment strategies because of the disutility associated with the 
use of chronic medication. An important finding was the relatively low incidence of 
persistent abdominal complaints compared to the other treatment strategies. Sensitivity 
analysis showed that if it is possible to reduce abdominal symptoms with 73%, medical 
treatment would become the treatment strategy of choice for patients with chronic 
abdominal pain in between recurrences, which percentage of reduction in symptoms has 
been described in previous studies.
13, 14
 Results of the Markov analyses seriously questions 
surgery after two episodes of diverticulitis. Surgeons should not operate at quite the rate 
they have been trained to think. Patients may be counseled in choosing elective surgery if 
the frequency and severity of their episodes or abdominal complaints is sufficient to 
justify the burden of surgery and after treatment for abdominal complaints with medical 
treatment has been offered. 
 
Clinical trials evaluating medical treatments or health interventions increasingly 
incorporate self-reported measures from patients often referred to as patient reported 
outcomes (PROs). A PRO is “any report of the status of a patient’s health condition that 
comes directly from the patient without interpretation of the patient’s response by a 
clinician or anyone else”. Several recent initiatives have emphasized the need to use PROs 
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in the assessment of quality of care, reflecting the need to include PROs in the choice of 
treatment modality.
15
 The impact of conservative and operative treatment in case of 
recurrent diverticulitis complaints on QoL and PROs was evaluated in Chapter 7. A 
systematic review and meta-analysis were conducted and outcome measures were 
extracted from the literature and analyzed. Eight PROs were defined and graded according 
to clinical relevance, as proposed by the GRADE working group in outcomes critical for 
decision-making, important for decision-making, and outcomes of limited importance. 
16, 17
 
Gastrointestinal QoL (GIQLI) and general Qol (SF-36, EORTC, CGQL), measured by validated 
questionnaires, were graded as PROs critical for decision-making. Disability, defined as the 
lack of being able to perform activities of daily living, physical activities and return to 
work, was also graded as critical for decision-making. Chronic abdominal pain, faecal 
incontinence and patient satisfaction were graded as PROs important for decision-making. 
Chronic abdominal pain was defined as persistence of abdominal pain after three months 
follow-up. Outcomes of limited clinical relevance were: persistent bowel symptoms, (i.e., 
hypogastric pain or bloating, diarrhea, constipation, flatulence, fever, painful defecation, 
dyschesia, pain or intestinal dysfunction, rectal bleeding, loose or hard stools), and 
urogenital symptoms (i.e., impotency, ejaculation difficulties, diminished libido and 
urinary dysfunction). Patients treated with laparoscopic colonic resection reported better 
general quality of life in the SF-36 questionnaire compared to conservatively treated 
patients, but this difference could not be reproduced in head to head analysis of both 
treatment options. Patients treated by laparoscopic colonic resection reported less 
gastrointestinal symptoms compared to conservative treated patients, also in a head to 
head analysis. In this study we showed that elective laparoscopic colonic resection, more 
than conservative treatment, might benefit the quality of life and gastrointestinal 
symptoms of patients with diverticulitis. However, the quality and power of studies to 
support this finding is low. Therefore a re-evaluation of laparoscopic surgery and 
conservative treatment is justified in patients with recurrent episodes of diverticulitis 
regarding what patients report as most important denominator of treatment success. 
Especially for the young patient with low co-morbidity for whom bowel symptoms might 
have large social implications, elective surgery could be a valuable treatment option. 
Results of this study also indicate that clinical decision-making should move from one-size 
fits all guidelines on when to operate to a more individual approach assessing the 
operative risk and the potential gain in quality of life for the individual patient.  
 
In Chapter 8, we studied the incidence and risk factors of recurrence, and overall 
morbidity and mortality in patients who underwent surgery for uncomplicated and 
complicated diverticulitis. Recurrent diverticulitis was seen in 9% of the patients and two 
thirds of the recurrences occurred within five years after the index operation. Young 
patients and patients with persisting abdominal complaints had a significantly higher risk 
of recurrent diverticulitis. No association between an index emergency procedure and 
subsequent recurrent disease could be found. Furthermore, no relation was found 
between type of anastomosis and length of specimen and recurrent diverticulitis. One of 
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five operated patients reported chronic abdominal pain that persisted after the operation. 
Results of our study and novel data at that time of publication on the natural history of 
diverticulitis showed that most perforations do not occur at recurrences, but at the first 
attack of diverticulitis.
18
 This study adds further proof that surgical resection after two 
episodes of diverticulitis is not beneficiary in terms of preventing complicated disease and 
reducing the risk of emergency procedures. 
 
PART THREE – Summary of the Dutch Guideline (Chapter 9) and future perspectives 
(Chapter 10) 
The third part of the thesis consists of a summary of the Dutch Guideline “Diagnostics and 
treatment of acute diverticulitis of the colon” and future perspectives are described. 
Chapter 9 is a review article based on the Dutch guideline. The guideline was inspired by 
the fact that ACD is a very common condition but is characterized by reports having 
generated low evidence data and by diagnosis and treatment primarily based on the 
doctors’ personal preferences rather than evidence. The guideline is based on the most 
recent international literature and therefore generalizable to any other Western country. 
This review article summarizes all relevant topics concerning epidemiology, classification, 
diagnosis and treatment of diverticulitis and reports levels of evidence for the conclusions 
from the literature leading to final recommendations. In summary, the guideline states 
that the natural history of diverticulitis is mild and can be largely treated by conservative 
means. Younger patients do not have a more aggressive course of disease than older 
patients but do have a higher risk of recurrent disease, however, the absolute risk 
difference is relatively small. The combination of pain in the lower left abdomen on 
physical examination, the absence of vomiting and a CRP >50mg/l has a high positive 
predictive value for diverticulitis, with good arguments to omit additional imaging. A 
conditional CT, only after a negative or inconclusive ultrasound provides the best results in 
imaging for diagnosing ACD. There is no evidence for the routine administration of 
antibiotics in patients with a clinically mild and uncomplicated diverticulitis. Pericolic or 
pelvic abscesses can initially be treated with antibiotics, possibly in combination with 
percutaneous drainage. If this treatment fails surgical drainage is required. Patients with a 
perforated diverticulitis resulting in peritonitis should undergo an emergency operation. 
Patient related factors and not so much the number of previous episodes of diverticulitis 
should play the most important role in selecting patients who might benefit from elective 
sigmoid resection, as also discussed in Part two of this thesis. 
  
Future perspectives (Chapter 10) 
Diverticulitis is a common, morbid and costly condition with remaining diagnostic and 
therapeutic challenges. The results of the studies in this thesis provide data for a better 
understanding of “diverticular disease” and diverticulitis in particular, but also raise 
questions. 
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The first question regards the usability of a clinical scoring system avoiding potentially 
harmful diagnostics. Will we be able to rightfully withhold patients suspected of ACD from 
additional imaging to come to the correct diagnosis? 
 
Based on results of the clinical decision model we can only withhold one out of five 
patients from additional imaging to diagnose ACD. This would mean that the majority of 
patients still need imaging. The challenge in minimizing imaging is to achieve a better 
understanding of the individual variables that contribute to the diagnosis of ACD, and to 
distinguish between uncomplicated and complicated diverticulitis based on clinical and/or 
laboratory parameters without compromising quality of care. Increase in knowledge of 
predictive clinical and laboratory variables would benefit both the individual patient and 
society avoiding unnecessary hospital admissions and reducing costs. To illustrate there is 
a dramatic rise in the number of hospitalizations for ACD in the Netherlands in the past 
years. Expenditures for the hospital admissions in the Netherlands already exceed EUR 80 
million per year.
19
 This rise in hospital admissions is also notable in other countries. A 
study from the United States also showed an increase in hospital admissions, with the 
greatest rise in young patients.
20
 Since diverticulitis is a recurrent disease in approximately 
a quarter of the patients, and recurrences can be multiple, patients run the risk of having 
multiple CT scans for suspicion of diverticulitis. This will impose an impressive burden on 
costs associated with imaging and not to forget patients’ risk of exposure to radiation and 
contrast nephropathy. Further validation of prediction models in different subsets of 
patients with diverticulitis (first, recurrent, uncomplicated, complicated, primary 
healthcare population, hospital population) is the next step to individualize the diagnostic 
process in diverticulitis and to delineate the role of additional imaging and necessity for 
institutional care. The exponential growth of possibilities in health monitoring, home 
biotechnology and information technology in the near future will probably contribute to 
patient’s self-management of (recurrent) diverticulitis, reduction of avoidable hospital-
izations and associated costs.
21
 
 
One of the first steps at this moment in reducing patient’s burden and risks and controlling 
the costs through a more efficient use of resources is the step-up approach to diagnose 
diverticulitis as discussed in this thesis. The step-up approach is a conditional strategy in 
which a CT scan is only made after inconclusive or negative ultrasound. The first step of 
the diagnostic process is an estimation of the probability of ACD based on clinical 
evaluation, and ideally of the chance of complicated disease. In case of questionable 
disease, an ultrasound examination is carried out. When the US is inconclusive or is 
negative for diverticulitis, a CT scan is performed to reveal the diagnosis. This step-up 
approach is appealing from a patient and cost standpoint, however, geographic 
differences in use of imaging modalities may hamper widespread use. In a review amongst 
colon-and rectal surgeons from the UK and USA, differences in the use of initial imaging 
techniques were clearly demonstrated.
22, 23
 Less than 10% of the colon- and rectal 
surgeons in the USA chose ultrasound as the initial imaging technique. This is probably due 
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to the imminent risk of legal claims and the high prevalence of obesity in the USA. Obesity 
renders ultrasound less valuable as initial screening tool for ACD. In many parts of Europe, 
abdominal ultrasound is performed by radiologists or other hospital based specialists. 
With advancing technology and increased experience of primary care physicians and 
physician assistants with out of hospital ultrasound, patient’s comfort may increase and 
costs even decrease further.
24
 
 
Second important question is what role surgery has in recurrent diverticulitis or patients 
with chronic abdominal pain in between recurrences? The main indication for elective 
colonic resection in patients with recurrent colonic diverticulitis was to prevent an 
emergency operation. More and more, however, surgical intervention aims at reducing 
the burden of recurrent disease and persistent abdominal complaints.
25-28
 For some 
patients persistent abdominal pain in between the overt flares of diverticulitis result into a 
more chronic illness known as symptomatic uncomplicated diverticular disease (SUDD). 
SUDD is a subtype of diverticular disease in which there are persistent abdominal 
symptoms attributed to diverticula in the absence of macroscopically overt colitis or 
diverticulitis.
29 
 
 
We concluded that elective colonic resection after two episodes of diverticulitis should no 
longer be advised. Since this conclusion was based on a Markov analytic model, results are 
affected by the validity of the data used in the analysis. Retrospective observational trials 
and epidemiologic studies accounted for nearly the entire evidence from which the data 
used in this study is derived. High quality multicenter randomized clinical trials assessing 
the optimal treatment strategy for patients with recurrent diverticulitis or persisting 
symptoms are needed to provide better evidence answering the question regarding the 
role of elective surgery. Currently a Dutch multicenter RCT is being conducted (DIRECT 
trial), in which patients presenting themselves with persisting abdominal complaints after 
an episode of diverticulitis and/or three or more recurrences within two years will be 
included and randomized between surgical resection or medical treatment. Patients 
randomized for conservative treatment are treated according to the current daily practice 
(antibiotics, analgetics and/or expectant management). Patients randomized for elective 
resection will undergo an elective resection of the affected colon segment, with health 
related quality of life as the primary outcome.
30
 Results of this trial are expected in the 
summer of 2015. Despite the importance of this trial trying to delineate the role of 
elective surgery in diverticulitis in a well-defined patient population, individual patient 
management may benefit less from results of this trial, particularly young patients with 
low risk and old patients with high risk of surgery. As mentioned before risk profiling and 
prediction of treatment success at the individual level using bio-information technology 
should gain more attention when aiming at improvements in personalized health. 
 
Although we tend towards a more conservative approach in patients with recurrent 
episode of diverticulitis, Chapter 7 revealed a potential benefit in laparoscopic surgery for 
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patients with recurrent diverticulitis. General quality of life and improvement in 
gastrointestinal symptoms was significantly improved after laparoscopic colonic resection 
as compared to conservative treatment. With evidence of a potential benefit, however 
based on a few high risk of bias studies, laparoscopic surgery should be further studied 
assessing HRQoL and PROs. Such studies also include undertaking Big Data research which 
prompts us to put more effort in diverticulitis registries comparable to colorectal cancer 
and hernia registries but with long term outcomes and PROs.  
 
Third question is what outcomes should be used in diverticulitis research? Many papers 
focus on short-term treatment results and physician derived outcomes. Fortunately, 
health status and quality of life are increasingly recognized as important in determining 
treatment results in diverticulitis. Papers often use the terms “quality of life” (QoL), 
“health status”, “functional status”, “health-related quality of life” (HRQoL) and “well-
being” interchangeably.
31
 PROs in patients with diverticulitis are not well defined and a 
confounding factor is the mixture of patients with diverticular disease and those with 
irritable bowel syndrome in series.
29, 32
 Guidance from the GRADE working group is 
relevant to optimize the utilization of PROs in systematic reviews. To improve reporting 
and to draw more meaningful conclusions for the individual patient from diverticulitis 
research we need to better define PROs. This process of defining research outcomes 
should include patients with recurrent episodes of diverticulitis and with persistent 
abdominal complaints. Patient participation in research design has shown surprising (for 
physicians) shifts in focus and relevant outcomes.
33 
For example fatigue or disutility from 
chronic medication use are seldom taking in to account in studies, but might be of crucial 
importance in patients with recurrent diverticulitis. Outcome measures relevant to 
patients are best derived by compiling focus groups to establish patient reported outcome 
measures (PROMS) and patient reported experience measures (PREMS) with in-depth 
interviewing.
34
 Not only are PROMS and PREMS important for assessing quality of care and 
for evaluating outcomes of specific interventions and clinical assessment, but also for 
decision support. If PROMS and PREMS are clearly defined and validated for patients with 
recurrent diverticulitis or persistent abdominal complaints, we are able to reduce costs by 
streamlining health care to only those treatments and techniques that improve outcome. 
In the end this will lead to better value of the healthcare system by patients with equal or 
lower costs.
34
 
 
Fourth question is what pathophysiology underlines persistence of abdominal pain and 
gastrointestinal symptoms in between recurrences and after surgical resection? With a 
better understanding of pain patterns in patients with diverticulitis we might be able to 
better intervene with medical treatment, further reducing the number of patients in need 
for resectional therapy. Results of the Markov analysis revealed that with a reduction of 
73% in symptoms, the optimal treatment strategy in case of recurrent diverticulitis is 
medical treatment with 5-ASA and a non-absorbable antibiotic. This large reduction in 
symptoms has been described in previous studies.
13, 14
 Although persistent abdominal 
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symptoms are increasingly recognized as a paramount problem in post-diverticulitis 
patients, we are unable to adequately define these patients because of lack of uniform 
definition and large variety of persistent abdominal symptoms. Persistent abdominal 
symptoms may reflect preexistent visceral hypersensitivity.
35
 Abdominal symptoms after 
surgery for example may be related to a shorter bowel (increased bowel movements), to a 
relative stenosis of the anastomosis (obstructive signs) or to the presence of a stoma 
(leakage).  
 
Diverticular disease is often defined as an acute attack of diverticulitis in a period of 
‘clinical silence’, but this is not applicable to everyone. Some patients have long-standing 
pain, discomfort, or IBS symptoms resembling a chronic bowel disorder.
29
 The possibility 
of chronic diverticular disease has recently received attention and a relation with altered 
gut microbiota and low-grade chronic inflammation has been hypothesized as cause of 
symptomatic diverticular disease and perhaps even as trigger for acute diverticulitis.
36 
Alterations in the colonic microbiota interacting with host tissue may generate pain, 
disturbed bowel movements or recurrent diverticulitis.
37
 Microbes in the human 
gastrointestinal tract contain 10
12
 to 10
14
 genes. The aggregate, multiorganismic, genetic 
code of those different microorganisms is referred to as the ‘microbiome’.
38
 Although the 
finding of altered microbiota in various disease states have been established, it is still 
unknown if these alterations cause the disease or are merely a consequence of the 
disease.
36
 Research on the effects of microorganisms in diverticular disease is in its 
infancy; results are mainly derived from studies in other gastrointestinal diseases.
39
 A 
recent Dutch study showed that the diagnosis diverticulitis can be made with relatively 
good accuracy based on microbiome analysis. The fecal microbiota diversity of patients 
with a first episode of acute uncomplicated diverticulitis significantly differed from control 
subjects, with the Proteobacteria phylum mainly determining this difference.
36
 A 
significantly higher occurrence of Bifidobacterium longum and Bifidobacterium animalis 
was found in another series of patients with diverticulitis. Unfortunately this series was 
small (nine patients) and healthy controls were not included.
40
 Establishing a causative 
role of gut microbiota in diverticular disease has great potential for disease prevention, 
diagnosis and treatment of disease and measuring therapy effect.
36
  
 
The last question to be answered is how to disperse guidelines regarding diagnosis and 
treatment of ACD in the surgical and gastroenterological community? Contemporary data 
has shown that despite recent guidelines recommending a delay in elective colon 
resection beyond two episodes of uncomplicated diverticulitis, the incidence of elective 
colectomy substantially increased in the last two decades.
20, 41, 42
 This can be partly 
explained by the lack of consensus regarding some topics between the different published 
guidelines and the often low quality of data. Very recently the evidence and consensus on 
diverticulitis in guidelines were systematically reviewed comparing all topics with 
recommendations.
43
 Analyzing all six guidelines (the American Society of Colon and Rectal 
Surgeons 2006, the association of Coloproctology of Great Britain and Ireland 2011, the 
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Association of Surgeons of The Netherlands 2012, the Danish Surgical Society 2011, the 
European Association for Endoscopic Surgery and the World Society for Emergency 
Surgery 2013) there was only consensus with high quality data on the following: 
• The need for imaging in addition to the clinical diagnosis 
• The consideration to use rifaximin and probiotics before elective surgery 
• Mild diverticulitis can be treated in an outpatient setting 
• Elective surgery is not routine treatment 
• When surgery is needed laparoscopic surgery in experienced hands is preferred 
• For failed conservative treatment of abscesses and Hinchey III perforated diverticulitis 
laparoscopic lavage is a treatment option 
 
Topics without consensus were the following: 
• Optimal classification to stage the severity of diverticulitis 
• Preferred imaging modality to diagnose diverticulitis 
• Intraluminal imaging (colonoscopy) after an episode of diverticulitis 
• Dietary restrictions and medical therapy 
• Antibiotic treatment 
• Surgical treatment for Hinchey III and IV perforated diverticulitis 
 
We may conclude that based on current international guidelines many topics in 
diverticulitis did not reach consensus or reached consensus but without sufficient 
supporting evidence, which hampers dispersion of guidelines. To achieve broader 
consensus with regard to the management of acute diverticulitis and to address areas of 
debate an International Acute Diverticulitis Delphi study has been proposed recently by 
Professor Des Winter and co-workers. Results of this Delphi rounds are to be awaited. 
 
This thesis had provided answers to important questions regarding diverticulitis and also 
raised questions for future research. In our opinion this research should focus on 
individual risk prediction for prognosis and treatment outcomes and outcomes relevant 
for the patient with diverticulitis. 
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Samenvatting en toekomstperspectief 
 
Dit proefschrift “Changing strategies in diverticulitis” beschrijft een systematische aanpak 
voor het diagnosticeren van acute diverticulitis van het colon, therapeutische vraag-
stukken bij patiënten met recidiverende diverticulitis, en patiënt gerapporteerde uit-
komstmaten en kwaliteit van leven na chirurgische of conservatieve behandeling van 
diverticulitis. Daarnaast wordt één hoofdstuk in dit proefschrift gewijd aan de richtlijn 
“Diagnostiek en behandeling van acute diverticulitis van het colon”.  
 
Hoofdstuk 1 is de inleiding van het proefschrift waarin een beschrijving van de 
ontstaanswijze en epidemiologie van diverticulosis coli en diverticulitis wordt beschreven. 
Daarnaast wordt de huidige diagnostiek en behandeling van acute diverticulitis uitgelegd. 
Dit hoofdstuk bevat tevens een overzicht van de hoofdstukken en doelstellingen van het 
proefschrift. 
 
DEEL I – Klinische besluitvorming in acute diverticulitis (Hoofdstuk 2 t/m 5) 
In het eerste deel van het proefschrift worden de huidige knelpunten en onvolkomen-
heden in het diagnosticeren van acute diverticulitis bediscussieerd. Diverticulitis is een 
veel voorkomende aandoening en komt vaak voor in de differentiaal diagnose bij 
patiënten die zich presenteren met acute buikpijn.
1
 Het is een uitdaging om patiënten met 
diverticulitis juist te diagnosticeren, omdat er vele oorzaken voor pijn links onder in de 
buik kunnen zijn die op het beeld van acute diverticulitis lijken. Het stellen van de 
diagnose diverticulitis op basis van de klinische blik van de dokter leidt dan ook frequent 
tot een foutieve diagnose.
2-5
 Om de diagnostische accuratesse van de anamnese, 
lichamelijk onderzoek en laboratorium parameters te verbeteren werd in dit proefschrift 
een klinisch beslismodel ontworpen. Externe validatie van dit beslismodel werd verricht in 
een tweetal andere cohorten van patiënten met diverticulitis. Ten slotte werd een 
systematische review verricht om tot een evidence-based advies te komen voor het 
diagnostische proces van patiënten met diverticulitis. In het laatste gedeelte van Deel I 
van het proefschrift worden de potentiële valkuilen in het diagnosticeren van rechtszijdige 
diverticulitis bediscussieerd.  
 
In Hoofdstuk 2 werden gegevens van patiënten die zich met acute buikpijn presenteerden 
op de SEH retrospectief verzameld en geanalyseerd. Gezocht werd naar individuele 
parameters in de anamnese, lichamelijk onderzoek en laboratorium parameters die 
voorspellend waren voor acute diverticulitis. Onafhankelijke voorspellende factoren voor 
het hebben van acute diverticulitis in het multivariabele logistische regressiemodel waren: 
leeftijd ouder dan 50 jaar, één of meerdere episodes van diverticulitis in de voor-
geschiedenis, pijn links onder in de buik zowel anamnestisch als bij lichamelijk onderzoek, 
vervoerspijn, en een CRP waarde van meer dan 50mg/l. Braken was een negatief 
voorspellende waarde voor het hebben van diverticulitis. Op basis van deze variabelen 
werd een beslismodel gemaakt, dat de kans op het hebben van een diverticulitis bij 
Chapter 10 
211 
patiënten met acute buikpijn kan voorspellen. De optimale sensitiviteit en specificiteit van 
het model was respectievelijk 75% en 84%. Een belangrijke klinische consequentie van het 
model is dat bij een hoge kans op acute diverticulitis in het model, aanvullende 
beeldvormende diagnostiek achterwege kan worden gelaten. Patiënten met een milde 
diverticulitis die door de huisarts werden behandeld en patiënten met een acute buik die 
direct werden geopereerd werden niet geïncludeerd in deze studie. Dit betekent dat het 
klinische beslismodel niet gebruikt kan worden in de huisartsenpraktijk, of bij kritiek zieke 
patiënten die van gecompliceerde diverticulitis worden verdacht.  
  
Externe validatie van het beslismodel werd verricht en beschreven in Hoofdstuk 3. De 
diagnostische waarde van het beslismodel werd vergeleken met een beslisregel voor de 
diagnose diverticulitis ontwikkeld door het Academisch Medisch Centrum in Amsterdam 
(AMC).
6
 Vanuit een subanalyse van patiënten die verdacht werden van acute diverticulitis 
in de OPTIMA studie, werden onafhankelijke variabelen geselecteerd die van waarde 
konden zijn voor het diagnosticeren van acute diverticulitis. In deze studie was de trias 
pijn links onder in de buik bij lichamelijk onderzoek, de afwezigheid van braken en een 
CRP waarde van meer dan 50mg/l geassocieerd met een positief voorspellende waarde 
van 97% voor het hebben van diverticulitis. Van alle patiënten met diverticulitis had 
ongeveer 25% een positieve trias en kon de diagnose diverticulitis alleen op basis van de 
trias gesteld worden zonder aanvullende beeldvormende diagnostiek. Met behulp van 
externe validatie werd de klinische toepasbaarheid van beide modellen getest en 
gevalideerd met behulp van een derde onafhankelijk cohort met patiënten met acute 
buikpijn.
7
 De positief voorspellende waarde van elke variabele in het beslismodel werd 
vergeleken met de positief voorspellende waarde van elke variabele in de twee validatie-
cohorten, om zo inzicht te krijgen in het discriminerende vermogen van de verschillende 
variabelen. Resultaten van de externe validatie laten zien dat de positief voorspellende 
waarde van ons beslismodel intact bleef (range 89%-92%), en dat de diagnose diverticulitis 
in één op de vijf patiënten met meer dan 90% zekerheid gesteld kon worden. Een nadeel 
van ons beslismodel was dat het alleen kon differentiëren tussen de aan- en afwezigheid 
van diverticulitis, maar dat het de andere diagnose niet kon specificeren. Daarnaast kon 
het model ook niet discrimineren tussen matig zieke en kritiek zieke patiënten. Als men 
deze tekortkomingen van het model in acht neemt, dan kan met ons model in één op de 
vijf patiënten met aan zekerheid grenzende waarschijnlijkheid de diagnose diverticulitis 
zonder aanvullende beeldvorming gesteld worden, vergelijkbaar met één op de vier 
patiënten met de trias van de AMC studie groep.  
 
In Hoofdstuk 4 werd de additionele waarde van beeldvorming in het diagnostische proces 
van patiënten met de verdenking diverticulitis beschreven. Er werd een systematische 
review van de literatuur verricht aangaande de diagnostische accuratesse van de klinische 
diagnose en beeldvormende technieken, om zo tot een evidence-based advies te komen 
voor het diagnostische proces van patiënten met diverticulitis. Met inachtneming van de 
matig tot slechte kwaliteit van de studies die rapporteerden over de diagnostische 
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accuratesse van de klinische diagnose, colon inloop foto en MRI scan, konden we 
concluderen dat van tweederde van de patiënten met de verdenking diverticulitis, de 
diagnose gesteld kon worden op basis van alleen de klinische evaluatie en dat aanvullende 
beeldvorming achterwege gelaten kon worden. De rol van de MRI scan in het 
diagnosticeren van diverticulitis is nog niet duidelijk. De sensitiviteit en specificiteit van de 
colon inloop foto bleek inferieur ten opzichte van graded compression echografie en CT 
scan en wordt beschouwd als een obsolete techniek voor het diagnosticeren van 
diverticulitis. De studies die de diagnostische accuratesse van de echografie en de CT scan 
beschreven waren van goede kwaliteit en konden gebruikt worden voor meta-analyse. 
Graded compression echografie en CT waren vergelijkbaar in het diagnosticeren van 
diverticulitis en superieur ten opzichte van de andere beeldvormende technieken. CT had 
het voordeel van een betere specificiteit en kon beter een alternatieve diagnose 
identificeren. Wij concludeerden op basis van deze studie dat de eerste stap in het 
diagnostische proces van acute diverticulitis een schatting moet zijn van de kans op 
diverticulitis op basis van de klinische evaluatie, bijgestaan door de klinische beslis-
modellen die voorhanden zijn. In geval van twijfel over de diagnose diverticulitis dient 
aanvullend een echografie verricht te worden. In het geval van een niet conclusieve of 
negatieve echografie, is een CT scan de volgende diagnostische stap om tot een diagnose 
te komen. Dit proces wordt de “step-up approach” genoemd, vergelijkbaar met het 
diagnostische proces van acute appendicitis.  
 
In Hoofdstuk 5 werden de verschillen tussen het klinische beloop van een rechtszijdige en 
linkszijdige diverticulitis vergeleken in een Westerse populatie. Rechtszijdige diverticulitis 
komt veel voor in Azië, maar minder vaak in de Westerse wereld.
8
 Kritische analyse van 
onze data leidde tot de conclusie dat rechtszijdige diverticulitis een lage incidentie kent en 
veelal een zelf limiterend karakter heeft. Het historische concept dat rechtszijdige 
diverticulitis een agressiever beloop kent dan linkszijdige diverticulitis in de Westerse 
populatie lijkt vooral te zijn gebaseerd op aannames vanuit het verleden, toen de diagnose 
rechtszijdige diverticulitis door een inadequate diagnostische work-up veelal pas 
peroperatief werd gesteld. Door de invoering van routinematige beeldvorming van 
patiënten met acute buikpijn, heeft er een belangrijke verschuiving plaatsgevonden, 
waarbij rechtszijdige diverticulitis meer een radiologische dan een chirurgische diagnose is 
geworden.  
 
DEEL II – Behandelstrategieën, risicofactoren en kwaliteit van leven bij patiënten met 
recidiverende diverticulitis (Hoofdstuk 6 t/m 8) 
Het tweede deel van het proefschrift beschrijft de verschillende behandelstrategieën voor 
patiënten met recidiverende diverticulitis en het effect van conservatieve of operatieve 
behandeling van diverticulitis op kwaliteit van leven (KvL) en andere patiënt gerapporteer-
de uitkomstmaten (patient reported outcomes – PROs). In dit deel van het proefschrift 
worden ook risicofactoren van een recidief diverticulitis na operatieve behandeling voor 
ongecompliceerde en gecompliceerde diverticulitis beschreven.  
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Algemeen geaccepteerde indicaties voor het ondergaan van een electieve sigmoid 
resectie na diverticulitis zijn obstructie, fistelvorming, of de verdenking van een maligniteit 
van het colon. Het hebben van recidiverende episodes van diverticulitis wordt ook 
beschouwd als een indicatie voor een sigmoid resectie. Het argument wat hier veelal voor 
gebruikt werd, was dat elke episode van diverticulitis het risico op een gecompliceerde 
diverticulitis vergrootte. Electieve sigmoidresectie kan de kans op een recidief diverti-
culitis, en daarmee ook de kans op een gecompliceerde diverticulitis verminderen, maar 
kan ook een oplossing zijn voor patiënten die persisterende pijnklachten houden na een 
episode van diverticulitis. Een electieve sigmoidresectie is echter niet geheel zonder risico. 
Patiënten riskeren de kans op morbiditeit, mortaliteit en de kans op een tijdelijk of 
permanent stoma, terwijl het risico op een recidief niet helemaal wordt weggenomen 
door een operatie. Bovendien kunnen er blijvende klachten van pijn optreden na een 
sigmoidresectie. Het wel of niet verrichten van een electieve sigmoidresectie in patiënten 
met recidiverende diverticulitis of peristerende pijn na een episode van diverticulitis blijft 
dan ook een therapeutisch dilemma. Om deze patiënten goed te adviseren, is het erg 
belangrijk patiënten te selecteren die waarschijnlijk hun voordeel doen bij een electieve 
sigmoidresectie om recidief (ongecompliceerde of gecompliceerde) diverticulitis en 
chronische abdominale pijnklachten te voorkomen en te behandelen. De beslissing om te 
opereren wordt beïnvloed  door de leeftijd en de comorbiditeit van de patiënt, de ernst en 
de frequentie van de aanvallen en de aanwezigheid van persisterende pijnklachten.  
 
Nieuwe theorieën over overeenkomsten tussen diverticulitis en inflammatoire darm-
aandoeningen hebben geleid tot nieuwe inzichten in de medicamenteuze behandeling van 
diverticulitis. Zo blijkt dat het gebruik van 5-aminosalicylic acid (5-ASA) in combinatie met 
een niet absorbeerbaar antibioticum, persisterende pijnklachten tussen episodes van 
diverticulitis kan doen verminderen. We hebben nog niet kunnen aantonen dat het 
gebruik van deze medicatie bij patiënten met diverticulitis ook kan leiden tot vermindering 
van het aantal recidieven.
9-12
 De resultaten van medicamenteuze behandeling zijn nog niet 
opgenomen in recente richtlijnen, maar kunnen wellicht een belangrijke rol gaan spelen in 
de beslissing om wel of niet over te gaan tot een operatieve behandeling. Om de beste 
strategie te bepalen bij patiënten met recidiverende diverticulitis hebben wij een Markov 
model ontworpen waarin verschillende behandelstrategieën met elkaar werden vergele-
ken met KvL als primaire uitkomstmaat. Resultaten van dit Markov model zijn beschreven 
in Hoofdstuk 6. Er werden vier concurrerende strategieën met elkaar vergeleken, 
gebaseerd op de huidige onzekerheid over de optimale behandeling van patiënten met 
recidiverende diverticulitis. De vier strategieën waren sigmoidresectie na twee episodes 
van diverticulitis sigmoidresectie, medicamenteuze behandeling of conservatieve behan-
deling na drie episodes van diverticulitis. Het model simuleerde de verschillen tussen de 
vier strategieën en op basis van sensitiviteitsanalyses werd bepaald welke variabelen 
effect hadden op de uitkomsten van het model. We concludeerden dat het verrichten van 
een sigmoidresectie na twee episodes van diverticulitis resulteerde in de minste Quality 
Adjusted Life Years (QALYs). Dit werd met name veroorzaakt, doordat een electieve 
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sigmoidresectie een kans op mortaliteit kent. Een electieve resectie alleen op basis van 
twee episodes van diverticulitis moet dan ook niet langer geadviseerd worden aan 
patiënten. Na een derde episode van diverticulitis, waren chirurgische, medicamenteuze 
en conservatieve behandeling vergelijkbaar wat betreft QALYs. Patiënten die medicamen-
teus werden behandeld voor recidiverende diverticulitis genereerden de laagste QALYs, 
vanwege het ongemak dat wordt geassocieerd met chronisch medicatiegebruik. Een 
belangrijke bevinding bij de medicamenteus behandelde groep was echter de relatief lage 
incidentie van persisterende abdominale klachten. Sensitiviteitsanalyse liet zien dat 
medicamenteuze behandeling voor recidiverende diverticulitis de strategie van keus werd 
als de persisterende abdominale klachten met meer dan 73% konden worden geredu-
ceerd. Dit percentage van symptoomreductie is beschreven in studies.
13, 14
 Resultaten van 
de Markov analyse doen ernstig twijfelen aan het oude dogma dat na twee episodes van 
diverticulitis een sigmoidresectie geïndiceerd is. In de beslissing om te opereren moet de 
patiënt centraal staan. De patiënt moet, bijgestaan door de behandelend arts, uiteindelijk 
de afweging maken of de ernst en de frequentie van de klachten opwegen tegen de 
risico’s van een chirurgische ingreep, maar pas nadat medicamenteuze behandeling is 
aangeboden aan de patiënt.  
 
Klinische trials incorporeren in toenemende mate zelf gerapporteerde uitkomsten van 
patiënten als belangrijke uitkomstmaat, dit wordt ook wel patiënt gerelateerde 
uitkomsten in de Nederlandse literatuur, of patient related outcomes (PROs) in de Angel-
saksische literatuur genoemd. Een PRO is gedefinieerd als elke uitkomst gerapporteerd 
door de patiënt, zonder tussenkomst of interpretatie van een arts of een willekeurige 
andere persoon. Veel recente initiatieven hebben opgeroepen in toenemende mate PROs 
te gaan gebruiken om de kwaliteit van onze zorg te meten, en PROs onderdeel te laten zijn 
in de keuze van een behandeling.
15
 De impact van conservatieve of operatieve 
behandeling van recidiverende diverticulitis  en persisterende klachten op de KvL en PROs 
werd geëvalueerd in Hoofdstuk 7. Een systematische review en meta-analyse werd 
verricht van de beschikbare literatuur over conservatieve en operatieve behandeling van 
diverticulitis, en relevante uitkomstmaten werden geselecteerd. In totaal werden acht 
PROs gedefinieerd en gerangschikt op basis van klinische relevantie, zoals voorgesteld 
door de GRADE working group. Klinische relevantie werd uitgedrukt in uitkomsten kritisch 
voor het nemen van een beslissing, belangrijk voor het nemen van een beslissing en 
uitkomsten met beperkte klinische relevantie.
16, 17
 Gastrointestinale KvL (GIQLI) en 
algemene KvL (SF-36, EORTC, CGQL), gemeten met gevalideerde vragenlijsten, werden 
gerangschikt als PROs kritisch voor het nemen van een beslissing. Disability, gedefinieerd 
door het onvermogen om aan dagelijkse activiteiten en het arbeidsproces deel te nemen, 
werden eveneens als kritisch voor het nemen van een beslissing geduid. Chronische 
abdominale pijn, fecale incontinentie en patiënt tevredenheid werden gerangschikt als 
PROs belangrijk voor het nemen van een beslissing. Chronische abdominale pijn werd 
gedefinieerd als pijnklachten langer dan drie maanden. Uitkomsten met beperkte klinische 
relevantie waren: darmklachten (i.e., opgeblazen gevoel, diarree, obstipatie, winderigheid, 
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koorts, pijnlijke defecatie, dyschesia, rectaal bloedverlies) en urogenitale klachten (i.e., 
impotentie, moeizame ejaculatie, libidoverlies). Patiënten die een laparoscopische sig-
moidresectie hadden ondergaan rapporteerden een betere algemene KvL in de SF-36 
vragenlijst in vergelijking met de conservatief behandelde patiëntengroep, maar dit 
verschil kon niet worden teruggevonden in de  studies die beide behandelmodaliteiten 
direct met elkaar vergeleken (head to head analysis). Patiënten die een laparoscopische 
sigmoidresectie hadden ondergaan rapporteerden minder gastrointestinale klachten in 
vergelijking met de conservatief behandelde groep, en dit verschil werd eveneens terug-
gevonden in de studies die beide behandelmodaliteiten direct met elkaar vergeleken. We 
concludeerden in deze studie dat electieve sigmoidresectie, meer dan conservatieve 
behandeling, is geassocieerd met een verbetering in de KvL en vermindering van de 
gastrointestinale klachten van patiënten met diverticulitis. Echter de kwaliteit en de 
power van de studies om deze conclusie te ondersteunen is laag. Een her-evaluatie van de 
rol van laparoscopische chirurgie of conservatieve behandeling van patiënten met een 
recidiverende diverticulitis lijkt noodzakelijk met als belangrijkste noemer voor een 
succesvolle behandeling patiëntgerapporteerde uitkomsten. Vooral voor de jonge patiënt 
met weinig comorbiditeit voor wie chronische gastrointestinale klachten veel sociale 
implicaties hebben, kan een chirurgische behandeling een waardevolle behandeloptie zijn. 
Resultaten van deze studie laten ook zien dat klinische besluitvorming vooral moet 
worden afgestemd op het individu en dat we af moeten stappen van one-size-fits-all 
richtlijnen over wel of niet opereren, maar per individuele patiënt het operatieve risico 
moeten afwegen tegen de potentiële winst in KvL.  
 
In Hoofdstuk 8 hebben we de incidentie en risicofactoren en morbiditeit en mortaliteit 
beschreven van patiënten die een electieve of acute sigmoidresectie ondergaan in 
verband met ongecompliceerde of gecompliceerde diverticulitis. Een recidief diverticulitis 
werd gezien bij 9% van de patiënten en bij twee derde van de patiënten ontstond het 
recidief binnen vijf jaar na de eerste operatie. Jonge patiënten en patiënten met 
persisterende abdominale klachten hadden significant meer risico op een recidief. Er kon 
geen relatie worden gevonden tussen het type operatie (electief of acuut), type 
anastomose en lengte van het preparaat en het ontstaan van een recidief. Eén op de vijf 
patiënten rapporteerde chronische abdominale pijn dat persisteerde na de resectie. 
Resultaten van deze studie en nieuw gepubliceerde data over het natuurlijk beloop van 
diverticulitis, ten tijde van publicatie van dit artikel, laten zien dat de meeste perforaties 
niet ontstaan bij een recidief diverticulitis, maar veelal een eerste presentatie zijn van de 
ziekte.
18
. Deze studie voegt meer bewijs toe aan het gegeven dat een chirurgische resectie 
na twee episodes van diverticulitis niet een gecompliceerd recidief, en daarmee een acute 
chirurgische interventie, voorkomt.   
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DEEL III – Samenvatting van de Nederlandse Richtlijn (Hoofdstuk 9) en toekomst-
perspectief (Hoofdstuk 10) 
Het derde deel van dit proefschrift is een samenvatting van de Nederlandse Richtlijn 
“Diagnostiek en behandeling van acute diverticulitis van het colon” en beschrijft het 
toekomstperspectief. Hoofdstuk 9 is een review artikel gebaseerd op deze Nederlandse 
richtlijn. Het idee voor een richtlijn over diverticulitis was ontstaan door het feit dat acute 
diverticulitis een veel voorkomende aandoening is, maar dat wetenschappelijk onderzoek 
naar diverticulitis wordt gekenmerkt door veel studies van lage tot matige kwaliteit. 
Hierdoor is het diagnosticeren en behandelen van patiënten met diverticulitis vooral 
gebaseerd op voorkeur van de behandelend arts en niet zo zeer op evidence-based 
medicine. De richtlijn is gebaseerd op de meest recente internationale literatuur en is 
daarom toepasbaar in elk Westers land. Het review artikel is een samenvatting van alle 
relevante onderwerpen aangaande epidemiologie, classificatie, diagnose en behandeling 
van acute linkszijdige diverticulitis van het colon, en geeft conclusies over de mate van 
bewijskracht van de literatuur en aanbevelingen gebaseerd op deze conclusies.  
 
De richtlijn concludeert dat het natuurlijk beloop van diverticulitis over het algemeen 
ongecompliceerd is en dat het overgrote deel van de patiënten met conservatieve 
maatregelen kan worden behandeld. Diverticulitis bij jonge patiënten behoeft geen 
andere behandeling dan bij oudere patiënten, maar kent wel een grotere recidiefkans. De 
grotere recidiefkans wordt vooral toegeschreven aan een groter “life-time”-risico op een 
recidief en niet aan een agressiever beloop van de ziekte. De combinatie van pijn links 
onder in de buik bij lichamelijk onderzoek, afwezigheid van braken en een CRP-waarde 
>50mg/l heeft een hoge voorspellende waarde voor de aanwezigheid van diverticulitis; 
beeldvormend onderzoek kan dan eventueel achterwege worden gelaten. Initieel 
echografie en alleen CT onderzoek als de uitslag van de echografie negatief of niet-
conclusief is, geeft het beste resultaat bij beeldvormend onderzoek. Er is geen bewijs dat 
het routinematig toedienen van antibiotica bij patiënten met een ongecompliceerde 
diverticulitis effectief is. Een pericolisch of pelvien abces kan antibiotisch behandeld 
worden, eventueel in combinatie met een percutane drainage. Chirurgisch ingrijpen is 
alleen nodig indien deze behandeling faalt. Patiënten met een peritonitis ten gevolge van 
een geperforeerde diverticulitis dienen geopereerd te worden, maar er is discussie over 
de optimale chirurgische strategie. Patiëntgerelateerde factoren, en niet zo zeer het 
aantal recidieven, spelen de belangrijkste rol in de beslissing om wel of niet over te gaan 
tot een electieve sigmoidresectie, zoals ook bediscussieerd in Deel II van dit proefschrift.  
 
Toekomstperspectief (Hoofdstuk 10) 
Diverticulitis is een veelvoorkomende aandoening met nog veel onbeantwoorde diagnos-
tische en therapeutische vraagstukken. In dit proefschrift wordt een deel van deze vraag-
stukken beantwoord, maar er worden ook nieuwe vraagstukken gegenereerd.  
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De eerste vraag die is ontstaan naar aanleiding van dit proefschrift is wat de bruikbaarheid 
van een klinisch scoresysteem is om daarmee het gebruik van potentieel schadelijke 
beeldvorming te kunnen verminderen. Zullen we in de toekomst beter in staat zijn om de 
diagnose diverticulitis te stellen zonder aanvullende beeldvorming? Ons klinische score-
systeem was bij één op de vijf patiënten in staat om de diagnose diverticulitis te stellen 
zonder aanvullende beeldvorming. Dit betekent dat bij het merendeel van de patiënten 
aanvullende beeldvorming noodzakelijk is om tot de juiste diagnose te komen. Om de 
diagnose diverticulitis te stellen zonder aanvullende beeldvorming, zullen we een beter 
begrip van de voorspellende waarde van de individuele klinische variabelen die bijdragen 
aan de diagnose diverticulitis moeten krijgen. Daarnaast moeten we beter het 
onderscheid kunnen maken tussen patiënten met ongecompliceerde en gecompliceerde 
diverticulitis op basis van klinische parameters zonder dat we daarmee de kwaliteit van 
zorg compromitteren. Een toename van de kennis van de voorspellende waarde van de 
klinische en laboratorium parameters in het diagnosticeren van diverticulitis kan leiden tot 
een vermindering van het aantal onnodige ziekenhuisopnames en daarmee kosten-
besparend zijn. In de afgelopen jaren is in Nederland een sterke stijging te zien van het 
aantal ziekenhuisopnames vanwege diverticulitis. Kosten voor deze ziekenhuisopnames in 
Nederland overstijgen reeds de 80 miljoen euro per jaar.
19
 Deze toename in ziekenhuis-
opnames is ook zichtbaar in andere landen. Een Amerikaanse studie liet eveneens een 
toename in het aantal ziekenhuisopnames zien voor diverticulitis, en dan vooral bij de 
jongere patiënten.
20
 Omdat diverticulitis een recidiefkans van ongeveer 25% kent, en 
meerdere recidieven bij één en dezelfde patiënt kunnen voorkomen, lopen patiënten met 
de recidiverende diverticulitis het risico om meerdere CT scans te moeten ondergaan. Dit 
brengt aanzienlijke kosten met zich mee die zijn geassocieerd met beeldvormende 
technieken, maar er zijn ook niet onbelangrijke risico’s voor de patiënt zoals de bloot-
stelling aan straling en de kans op contrast nefropathie. Verdere validatie van predictie 
modellen in verschillende subgroepen van patiënten met diverticulitis (i.e., eerste 
episode, recidief, ongecompliceerd, gecompliceerde diverticulitis, ziekenhuis-populatie, 
huisartsenpopulatie) is de volgende stap naar het individualiseren van het diagnostische 
proces van diverticulitis en daarmee de rol van aanvullende beeldvorming inzichtelijker te 
maken. De toenemende groei van mogelijkheden in “health monitoring”, “home 
biotechnology”, en informatietechnologie zullen waarschijnlijk in de nabije toekomst gaan 
bijdragen aan het zelfmanagement van patiënten met (recidiverende) diverticulitis. Dit 
zou kunnen leiden tot een reductie van (onnodige) ziekenhuisopnames en de daarmee 
geassocieerde kosten.
21
  
 
Een van de eerste stappen op dit moment in de reductie van de individuele risico’s en het 
beheersbaar houden van de kosten van patiënten met diverticulitis is het efficiënter 
gebruiken van de beschikbare diagnostische middelen zoals voorgesteld in de step-up 
approach, beschreven in dit proefschrift. De step- up approach is een conditionele strate-
gie, waarbij eerst een echografie wordt verricht en een CT scan alleen volgt na een 
negatieve of niet-conclusieve uitslag van de echografie. De eerste stap in het diagnos-
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tische proces is een schatting van de kans op de aanwezigheid van diverticulitis gebaseerd 
op een klinische evaluatie, en in het ideale geval een schatting van de kans op een 
gecompliceerde diverticulitis. In het geval van twijfel wordt een echografie verricht. Als de 
echografie geen duidelijke diagnose geeft of negatief is voor diverticulitis dan wordt een 
CT scan verricht om de diagnose te stellen. De step-up approach is aantrekkelijk vanuit 
patiënt- en kostenperspectief, echter geografische verschillen in het gebruik van aan-
vullende diagnostiek belemmeren algemeen internationaal gebruik hiervan. In een review 
studie naar het verschil in gebruik van echografie of CT scan voor het diagnosticeren van 
diverticulitis tussen Britse en Amerikaanse colorectaal chirurgen, kwam een duidelijk 
verschil naar voren.
22, 23
 Minder dan 10% van de Amerikaanse colorectaal chirurgen kozen 
echografie als de initiële beeldvormende techniek. Dit wordt waarschijnlijk veroorzaakt 
door de dreiging van medicolegale claims en de hoge prevalentie van obesitas in Amerika. 
Obese patiënten zijn minder geschikt om echografisch te onderzoeken. In het overgrote 
deel van Europa wordt echografie verricht door radiologen, maar met de toenemende 
technologische mogelijkheden van echoapparatuur en de toename van kennis van 
huisartsen en physician assistants met echografie, kan in de toekomst echografisch 
onderzoek buiten het ziekenhuis plaatsvinden. Dit kan een verbetering zijn van eerstelijns 
diagnostiek voor de patiënt, en een mogelijke verlaging van de kosten met zich 
meebrengen.
24
 
 
De tweede belangrijke vraag is wat de rol is van een chirurgische interventie bij patiënten 
met meerdere recidieven en chronische pijnklachten. In het verleden werd gedacht dat 
een chirurgische behandeling van recidief diverticulitis een gecompliceerd recidief en 
daarmee de kans op een acute operatie kon voorkomen. Tegenwoordig, gebaseerd op 
meer recentere inzichten, is een chirurgische interventie vooral bedoeld om de klachten 
die gepaard gaan met recidiverende diverticulitis en chronische pijnklachten tussen de 
aanvallen door te verminderen.
25-28
 Bij sommige patiënten resulteren de chronische 
pijnklachten tussen de duidelijke aanvallen van diverticulitis door in een soort van 
chronische ziekte die ook wel symptomatic uncomplicated diverticular disease wordt 
genoemd (SUDD). SUDD is een subtype van diverticulitis, waarbij er persisterende 
klachten zijn die worden toegeschreven aan diverticulosis coli zonder dat er een evident 
macroscopisch beeld van een colitis of diverticulitis is.
29
  
 
Wij concludeerden dat electieve resectie van het colon na twee episodes van diverticulitis 
niet meer standaard geadviseerd moet worden aan patiënten. Deze conclusie is echter 
gebaseerd op resultaten van een Markov model, en resultaten van dit model zijn 
onderhavig aan de validiteit van de data die in het model gebruikt wordt. Met name 
gegevens uit retrospectieve observationele studies en epidemiologische studies konden 
worden gebruikt als databron voor het Markov model. Helaas zijn er maar weinig 
kwalitatief goede studies waar we onze data input op konden baseren. We hebben in de 
toekomst kwalitatief goede multicentrische gerandomiseerde clinial trials nodig om te 
beoordelen wat de optimale behandelstrategie is bij patiënten met recidiverende diverti-
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culitis of persisterende klachten tussen de aanvallen van diverticulitis door. Met name de 
rol van electieve chirurgie moet duidelijker worden. Op het moment wordt er een 
Nederlandse studie uitgevoerd (DIRECT trial), waarbij patiënten met persisterende 
pijnklachten na een episode van diverticulitis en/of meer dan drie recidieven in twee jaar 
worden gerandomiseerd tussen chirurgische of conservatieve behandeling. Patiënten die 
gerandomiseerd worden voor de conservatieve behandeling worden behandeld volgens 
de nu gangbare protocollen (antibiotica en/of pijnstilling indien noodzakelijk geacht, of 
afwachtend beleid). Patiënten die gerandomiseerd worden voor een chirurgische behan-
deling ondergaan een resectie van het aangedane segment van het colon, met health 
related quality of life (HRQoL) als de primaire uitkomstmaat.
30
 Resultaten van deze studie 
worden in de zomer van 2015 verwacht. Ondanks het feit dat deze trial belangrijke data 
gaat opleveren over de rol van electieve chirurgie in een goed gedefinieerde studie-
populatie, zal de individuele patiënt waarschijnlijk minder profiteren van de resultaten van 
deze studie, met name jonge patiënten met een laag operatierisico en oudere patiënten 
met een hoog operatierisico. Zoals eerder vermeld, zal met name risicoprofilering en het 
voorspellen van het succes van de behandeling op individueel niveau met behulp van 
bioinformatietechnologie meer aandacht moeten gaan krijgen, wanneer we verbeteringen 
in de individuele patiëntenbehandeling willen nastreven. Ondanks dat we naar een meer 
conservatieve behandeling neigen bij patiënten met recidiverende diverticulitis, laat 
Hoofdstuk 7 van dit proefschrift zien dat patiënten die een laparoscopische sigmoidre-
sectie hebben ondergaan significante vermindering hebben van gastrointestinale 
symptomen, vergeleken met de conservatief behandelde patiëntengroep. Met het bewijs 
van een mogelijk voordeel van een laparoscopische sigmoidresectie, echter wel gebaseerd 
op een aantal high risk of bias studies, is het belangrijk om de uitkomsten in HRQoL en 
PROs bij laparoscopische chirurgie voor recidief diverticulitis verder te onderzoeken. Dit 
soort studies kunnen gedaan worden door grote groepen patiënten te verzamelen (Big 
Data research). Tegelijk moet dit een stimulans zijn om meer aandacht aan het registeren 
van patiënten met diverticulitis te besteden, analoog aan de registraties die er zijn voor 
colorectale maligniteiten gericht op lange termijn resultaten en PROs.  
 
De derde vraag is welke uitkomstmaten belangrijk zijn in het onderzoek naar diverticulitis. 
Veel gepubliceerde studies focussen op kortetermijnresultaten en uitkomstmaten bepaald 
door behandelaars en onderzoekers. Gelukkig worden health status en kwaliteit van leven 
steeds meer erkend als belangrijke uitkomstparameters om het succes van een behande-
ling voor diverticulitis te bepalen. Veel artikelen gebruiken echter de termen “kwaliteit 
van leven” (KvL), “health status”, “functionele status”, “health-related quality of life” 
(HRQoL) en “well-being” (welbevinden) door elkaar.
31
 PROs bij patiënten met diverticulitis 
zijn niet goed gedefinieerd en een belangrijke confounder is dat de patiëntengroep met 
sympto-matische diverticulosis coli geen homogene groep is, maar een zekere mate van 
overlap kent met het irritable bowel syndrome (IBS).
29, 32
 Begeleiding van de GRADE 
working group is essentieel voor het gebruik van PROs in systematic reviews. Om de 
kwaliteit van onderzoek te verbeteren en tot belangrijke conclusies te kunnen komen voor 
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de individuele patiënt is het essentieel dat  we PROs beter definiëren. Het proces van 
beter definiëren van PROs moet betrekking hebben op patiënten met recidiverende 
diverticulitis en met persisterende pijnklachten. Patiëntenparticipatie in het ontwikkelen 
van studie-protocollen heeft recent al geleid tot verrassende (voor behandelaars en 
onderzoekers) verschuivingen in studiefocus en relevante uitkomstmaten.
33
 Om een 
voorbeeld te geven, vermoeidheid en ongemak van chronisch medicatiegebruik wordt 
zelden meegenomen in studies, maar kan een cruciale rol spelen in patiënten met 
recidiverende diverticulitis. De uitkomstmaten die belangrijk zijn voor patiënten kunnen 
het best ontwikkeld worden door patiëntenfocusgroepen samen te stellen en diepte 
interviews te verrichten om zo patiënt reported outcome measures (PROMS) en patient 
reported experience measures (PREMS) te bepalen.
34
 PROMS en PREMS zijn niet alleen 
belangrijk om de kwaliteit van de patiëntenzorg en het evalueren van het effect van 
bepaalde behandelingen te bepalen, maar spelen ook een belangrijke rol in klinische 
besluitvorming. Zodra PROMS en PREMS goed gedefinieerd zijn voor patiënten met 
recidiverende diverticulitis of persisterende klachten, dan kunnen kosten worden 
bespaard door de gezondheidszorg zo in te richten dat we alleen die behandelingen 
uitvoeren die de uitkomstmaten van de patiënt daadwerkelijk verbeteren. Dit zal dan 
uiteindelijk leiden tot  een betere waardering van onze gezondheidszorg door patiënten, 
met een gelijke of mindere kosteninvestering.
34
 
 
De vierde vraag is welke pathofysiologische principes er aan persisterende abdominale 
pijnklachten en gastrointestinale symptomen na een episode van diverticulitis en na een 
chirurgische resectie ten grondslag liggen. Als we chronische pijnklachten bij diverticulitis 
beter gaan begrijpen kunnen we behandelingen daar op afstemmen, en daarmee het 
aantal chirurgische behandelingen voor diverticulitis verder verminderen. Resultaten van 
de Markov analyse lieten zien dat bij een vermindering van 73% van de persisterende 
klachten, 5-ASA en een antibioticum de optimale behandelstrategie in het geval van een 
recidief diverticulitis werd. Deze reductie in symptomen is beschreven in eerdere studies 
naar de medicamenteuze behandeling van persisterende klachten en recidief diverticu-
litis.
13, 14
 Ondanks het feit dat persisterende klachten in toenemende mate erkend worden 
als een belangrijk probleem bij patiënten na een episode van diverticulitis, zijn we nog 
steeds niet in staat om deze patiëntengroep adequaat te definiëren vanwege een gebrek 
aan uniformiteit van de definitie van persisterende klachten en een grote verscheidenheid 
aan gastrointestinale klachten. Persisterende abdominale klachten kunnen ontstaan door 
viscerale hypersensitiviteit.
35
 Abdominale klachten na een sigmoidresectie kunnen 
ontstaan door bijvoorbeeld een korter segment van de darm (toename van darmperistal-
tiek), door een relatieve stenose van de anastomose (obstructieve klachten) of door de 
aanwezigheid van een stoma (lekkage). 
  
De Angelsakische term “diverticular disease” wordt ook wel gedefinieerd als een acute 
aanval van diverticulitis in een periode van relatieve afwezigheid van de ziekte 
(diverticulitis), maar dit geldt zeker niet voor iedereen. Sommige patiënten ervaren 
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chronische pijn, gastrointestinale klachten, of IBS-achtige symptomen die passen bij een 
chronische darmaandoening.
29
 De mogelijkheid dat symptomatische diverticulosis coli 
beschouwd moet worden als een chronische aandoening  is recent in verband gebracht 
met een verandering in het microbioom van de darm. Een laag-gradige infectie van de 
mucosa van de darm kan een mogelijke oorzaak zijn voor de klachten die patiënten 
ervaren bij symptomatische diverticulosis coli en de infectie zelf kan een trigger zijn voor 
het ontstaan van diverticulitis.
36
 Veranderingen in het microbioom van het colon, kan 
resulteren in pijnklachten, verandering van de motiliteit van de darm of een recidief 
diverticulitis.
37
 Het microbioom in de tractus digestivus van de mens bevat 10
12
 tot 10
14
 
genen. De verzameling van deze micro-organismen en hun genetische code wordt het 
‘microbioom’ genoemd.
38
 Ondanks het feit dat een verandering in het microbioom bij 
verschillende aandoeningen is vastgesteld, is het nog niet duidelijk of dit de oorzaak is 
voor de ziekte of meer een gevolg daarvan.
36
 Onderzoek naar de rol van micro-organismen 
in symptomatische diverticulosis staat in de kinderschoenen.
39
 Een recente Nederlandse 
studie liet zien dat de diagnose diverticulitis met een redelijke goede diagnostische 
accuratesse kon worden aangetoond op basis van analyse van het microbioom. Het fecale 
microbioom van patiënten met een eerste episode van diverticulitis verschilde van die van 
gezonde vrijwilligers. Dit verschil werd vooral veroorzaakt door Proteobacteria phylum.
36
 
Een significant verschil in het voorkomen van Bifidobacterium longum en Bifidobacterium 
animalis werd gevonden in een andere serie patiënten met diverticulitis. Helaas was dit 
een kleine serie van slechts negen patiënten en werden de patiënten  in deze studie niet 
vergeleken met gezonde vrijwilligers.
40
 Het vaststellen van een oorzakelijke rol van het 
microbioom van de darm in symptomatische diverticulosis coli kan belangrijke gevolgen 
hebben voor de preventie, diagnostiek en behandeling van patiënten met diverticulitis en 
het meten van het effect van de ingestelde behandeling.
36
  
 
De laatste vraag die beantwoord moet gaan worden is de vraag hoe we richtlijnen 
aangaande de diagnostiek en behandeling van patiënten met diverticulitis verspreiden, 
naleven en up-to-date houden. Recente data hebben laten zien dat ondanks de nieuwe 
inzichten, gepresenteerd in recent gepubliceerde richtlijnen, waarin het advies wordt 
gegeven niet meer standaard een sigmoidresectie te verrichten na twee episodes van 
diverticulitis, weinig navolging vindt. Sterker nog, het aantal chirurgische interventies voor 
patiënten met diverticulitis is fors toegenomen in de laatste twee decennia.
20, 41, 42
 Dit kan 
deels worden verklaard door het gebrek aan consensus tussen richtlijnen onderling en de 
matige kwaliteit van de data waar de richtlijnen op zijn gebaseerd. Zeer recent is een 
systematische review verschenen waarin verschillende diverticulitis richtlijnen met elkaar 
zijn vergeleken.
43
 Na het analyseren van alle zes beschikbare richtlijnen (The American 
Society of Colon and Rectal Surgeons 2006, the Association of Coloproctology of Great 
Britain and Ireland 2011, de Nederlandse Vereniging voor Heelkunde 2012, the Danish 
Surgical Society 2011, the European Association for Endoscopic Surgery and the World 
Society for Emergency Surgery 2013) was er consensus op basis van kwalitatief goede data 
over: 
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• De noodzaak van aanvullende beeldvorming in aanvulling op de klinische diagnose 
• De overweging om medicamenteus te behandelen alvorens over te gaan op een 
chirurgische ingreep 
• De behandeling van milde diverticulitis  in een ambulante setting 
• Het gegeven dat electieve chirurgie  geen standaard behandeling is 
• De voorkeur voor een laparoscopische ingreep in ervaren handen indien er een 
indicatie is voor een chirurgische behandeling  
• Het gegeven dat een laparoscopische peritoneaal lavage tot de behandel-
mogelijkheden behoort indien conservatieve behandeling van abcesvorming of een 
Hinchey III diverticulitis faalt  
 
Onderwerpen zonder consensus: 
• Optimale classificatie voor de ernst van de diverticulitis 
• De eerste keus in diagnostiek voor het diagnosticeren van diverticulitis 
• Noodzaak voor coloscopie na een episode van diverticulitis 
• Dieetmaatregelen en medicamenteuze therapie 
• Antibiotische behandeling 
• Chirurgische behandeling voor Hinchey III en IV geperforeerde diverticulitis 
 
Gebaseerd op de systematische review van de verschillende internationale richtlijnen 
kunnen we concluderen dat over veel onderwerpen binnen diverticulitis nog geen 
consensus is bereikt of dat er consensus is bereikt maar zonder voldoende wetenschappe-
lijk onderbouwing op basis van kwalitatief goede studies. Dit staat het gebruik van 
richtlijnen in de weg. Om tot een betere overeenstemming te komen in de diagnostiek en 
behandeling van diverticulitis is recent een Internationale Diverticulitis Delphi studie 
voorgesteld door de onderzoeksgroep van Professor Des Winter. Resultaten van deze 
Delphi studie moeten nog gepubliceerd worden. 
 
Dit proefschrift geeft antwoorden op belangrijke vragen omtrent diagnostiek en behande-
ling van diverticulitis, maar genereert ook weer nieuwe onderzoeksvragen voor 
toekomstig onderzoek. Dit toekomstige onderzoek zal zich met name moeten toeleggen 
op het ontwikkelen van risicoprofielen voor individuele patiënten wat betreft prognose en 
behandeluitkomsten en uitkomsten die relevant zijn voor patiënten  met diverticulitis. 
Chapter 10 
223 
Reference list 
 
1  Rafferty J, Shellito P, Hyman NH, Buie WD, 
and Standards Committee of American 
Society of Colon and Rectal Surgeons. 
Practice parameters for sigmoid 
diverticulitis. Dis Colon Rectum. 2006, 
Jul;49(7):939-44. 
2  Wexner SD, and Dailey TH. The initial 
management of left lower quadrant 
peritonitis. Dis Colon Rectum. 1986, 
Oct;29(10):635-8. 
3  Cho KC, Morehouse HT, Alterman DD, and 
Thornhill BA. Sigmoid diverticulitis: 
diagnostic role of CT--comparison with 
barium enema studies. Radiology. 1990, 
Jul;176(1):111-5. 
4  Farag Soliman M, Wüstner M, Sturm J, 
Werner A, Diehl SJ, Düber C, and Post S. 
[Primary diagnostics of acute diverticulitis of 
the sigmoid]. Ultraschall Med. 2004, 
Sep;25(5):342-7. 
5  Toorenvliet BR, Bakker RF, Breslau PJ, 
Merkus JW, and Hamming JF. Colonic 
diverticulitis: a prospective analysis of 
diagnostic accuracy and clinical decision-
making. Colorectal Dis. 2010, Mar;12(3):179-
86. 
6  Laméris W, van Randen A, van Gulik TM, 
Busch OR, Winkelhagen J, Bossuyt PM, et al. 
A clinical decision rule to establish the 
diagnosis of acute diverticulitis at the 
emergency department. Dis Colon Rectum. 
2010, Jun;53(6):896-904. 
7  Laurell H, Hansson LE, and Gunnarsson U. 
Acute diverticulitis--clinical presentation and 
differential diagnostics. Colorectal Dis. 2007, 
Jul;9(6):496-501; discussion 501-2. 
8  Miura S, Kodaira S, Shatari T, Nishioka M, 
Hosoda Y, and Hisa TK. Recent trends in 
diverticulosis of the right colon in Japan: 
retrospective review in a regional hospital. 
Dis Colon Rectum. 2000, Oct;43(10):1383-9. 
9 Tursi A, Di Mario F, Brandimarte G, Elisei W, 
Picchio M, Loperfido S, et al. Intermittent 
versus every-day mesalazine therapy in 
preventing complications of diverticular 
disease: a long-term follow-up study. Eur Rev 
Med Pharmacol Sci. 2013, Dec;17(23):3244-
8. 
10  Maconi G, Barbara G, Bosetti C, Cuomo R, 
and Annibale B. Treatment of Diverticular 
Disease of the Colon and Prevention of Acute 
Diverticulitis: A Systematic Review. Dis Colon 
Rectum. 2011, Oct;54(10):1326-1338. 
11  Ünlü C, Daniels L, Vrouenraets BC, and 
Boermeester MA. A systematic review of 
high-fibre dietary therapy in diverticular 
disease. Int J Colorectal Dis. 2012, 
Apr;27(4):419-27. 
12  Raskin JB, Kamm MA, Jamal MM, Márquez J, 
Melzer E, Schoen RE, et al. Mesalamine did 
not prevent recurrent diverticulitis in phase 
3 controlled trials. Gastroenterology. 2014, 
Oct;147(4):793-802. 
13  Tursi A, Brandimarte G, Giorgetti GM, and 
Elisei W. Mesalazine and/or Lactobacillus 
casei in preventing recurrence of 
symptomatic uncomplicated diverticular 
disease of the colon: a prospective, 
randomized, open-label study. J Clin 
Gastroenterol. 2006, Apr;40(4):312-6. 
14 Brandimarte G, and Tursi A. Rifaximin plus 
mesalazine followed by mesalazine alone is 
highly effective in obtaining remission of 
symptomatic uncomplicated diverticular 
disease. Med Sci Monit. 2004, 
May;10(5):PI70-3. 
15  Richardson WS, and Detsky AS. Users' guides 
to the medical literature. VII. How to use a 
clinical decision analysis. A. Are the results of 
Summary and future perspectives / Samenvatting en toekomstperspectief 
224 
the study valid? Evidence-Based Medicine 
Working Group. JAMA. 1995, Apr 
26;273(16):1292-5. 
16  Basch E. New Frontiers in Patient-Reported 
Outcomes: Adverse Event Reporting, 
Comparative Effectiveness, and Quality 
Assessment. Annu Rev Med. 2013, Nov 20; 
17  Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-
Ytter Y, Schünemann HJ, and GRADE Working 
Group. What is "quality of evidence" and 
why is it important to clinicians? BMJ. 2008, 
May 3;336(7651):995-8. 
18  Chapman JR, Dozois EJ, Wolff BG, Gullerud 
RE, and Larson DR. Diverticulitis: a 
progressive disease? Do multiple recurrences 
predict less favorable outcomes? Ann Surg. 
2006, Jun;243(6):876-830; discussion 880-3. 
19  Draaisma WA, van de Wall BJ, Vermeulen J, 
Unlu C, de Korte N, and Swank HA. 
[Treatment for diverticulitis not thoroughly 
researched]. Ned Tijdschr Geneeskd. 
2009;153A648. 
20  Etzioni DA, Mack TM, Beart RW, and Kaiser 
AM. Diverticulitis in the United States: 1998-
2005: changing patterns of disease and 
treatment. Ann Surg. 2009, Feb;249(2):210-
7. 
21  Kohn MS, Sun J, Knoop S, Shabo A, Carmeli B, 
Sow D, et al. IBM's Health Analytics and 
Clinical Decision Support. Yearb Med Inform. 
2014;9(1):154-62. 
22  Schechter S, Mulvey J, and Eisenstat TE. 
Management of uncomplicated acute 
diverticulitis: results of a survey. Dis Colon 
Rectum. 1999, Apr;42(4):470-5; discussion 
475-6. 
23  Munikrishnan V, Helmy A, Elkhider H, and 
Omer AA. Management of acute diverticulitis 
in the East Anglian region: results of a United 
Kingdom regional survey. Dis Colon Rectum. 
2006, Sep;49(9):1332-40. 
24  Wong F, Franco Z, Phelan MB, Lam C, and 
David A. Development of a pilot family 
medicine hand-carried ultrasound course. 
WMJ. 2013, Dec;112(6):257-61. 
25  Ritz JP, Gröne J, Engelmann S, Lehmann KS, 
Buhr HJ, and Holmer C. [What is the actual 
benefit of sigmoid resection for acute 
diverticulitis? : Functional outcome after 
surgical and conservative treatment]. 
Chirurg. 2013, Aug;84(8):673-80. 
26  Forgione A, Leroy J, Cahill RA, Bailey C, 
Simone M, Mutter D, and Marescaux J. 
Prospective evaluation of functional 
outcome after laparoscopic sigmoid 
colectomy. Ann Surg. 2009, Feb;249(2):218-
24. 
27  Pasternak I, Wiedemann N, Basilicata G, and 
Melcher GA. Gastrointestinal quality of life 
after laparoscopic-assisted sigmoidectomy 
for diverticular disease. Int J Colorectal Dis. 
2012, Jun;27(6):781-7. 
28  Vermeulen J, Gosselink MP, Busschbach JJ, 
and Lange JF. Avoiding or reversing 
Hartmann's procedure provides improved 
quality of life after perforated diverticulitis. J 
Gastrointest Surg. 2010, Apr;14(4):651-7. 
29  Strate LL, Modi R, Cohen E, and Spiegel BM. 
Diverticular disease as a chronic illness: 
evolving epidemiologic and clinical insights. 
Am J Gastroenterol. 2012, Oct;107(10):1486-
93. 
30  Van de Wall BJ, Draaisma WA, Consten EC, 
van der Graaf Y, Otten MH, de Wit GA, et al. 
DIRECT trial. Diverticulitis recurrences or 
continuing symptoms: Operative versus 
conservative treatment. A multicenter 
randomised clinical trial. BMC Surg. 
2010;1025. 
31 Johnston BC, Patrick DL, Busse JW, 
Schünemann HJ, Agarwal A, and Guyatt GH. 
Patient-reported outcomes in meta-
analyses--Part 1: assessing risk of bias and 
Chapter 10 
225 
combining outcomes. Health Qual Life 
Outcomes. 2013;11(1):109. 
32  Cohen E, Fuller G, Bolus R, Modi R, Vu M, 
Shahedi K, et al. Increased risk for irritable 
bowel syndrome after acute diverticulitis. 
Clin Gastroenterol Hepatol. 2013, 
Dec;11(12):1614-9. 
33  Van Bruinessen IR, van Weel-Baumgarten 
EM, Snippe HW, Gouw H, Zijlstra JM, and van 
Dulmen S. Active patient participation in the 
development of an online intervention. JMIR 
Res Protoc. 2014;3(4):e59. 
34  Kaplan RS, and Porter ME. How to solve the 
cost crisis in health care. Harv Bus Rev. 2011, 
Sep;89(9):46-52, 54, 56-61 passim. 
35 Simpson J, Neal KR, Scholefield JH, and 
Spiller RC. Patterns of pain in diverticular 
disease and the influence of acute 
diverticulitis. Eur J Gastroenterol Hepatol. 
2003, Sep;15(9):1005-10. 
36 Daniels L, Budding AE, de Korte N, Eck A, 
Bogaards JA, Stockmann HB, et al. Fecal 
microbiome analysis as a diagnostic test for 
diverticulitis. Eur J Clin Microbiol Infect Dis. 
2014, Nov;33(11):1927-36. 
37  Quigley EM. Gut microbiota, inflammation 
and symptomatic diverticular disease. New 
insights into an old and neglected disorder. J 
Gastrointestin Liver Dis. 2010, Jun;19(2):127-
9. 
38  Mertz L. My Body, My Microbiome: Microbes 
outnumber cells, but what are they doing? 
IEEE Pulse. 2014;5(6):40-5. 
39  Hall JF. The microbiome and diverticulitis: a 
new target for medical therapy? Dis Colon 
Rectum. 2014, Apr;57(4):544-5. 
40  Gueimonde M, Ouwehand A, Huhtinen H, 
Salminen E, and Salminen S. Qualitative and 
quantitative analyses of the bifidobacterial 
microbiota in the colonic mucosa of patients 
with colorectal cancer, diverticulitis and 
inflammatory bowel disease. World J 
Gastroenterol. 2007, Aug 7;13(29):3985-9. 
41  Simianu VV, Bastawrous AL, Billingham RP, 
Farrokhi ET, Fichera A, Herzig DO, et al. 
Addressing the appropriateness of elective 
colon resection for diverticulitis: a report 
from the SCOAP CERTAIN collaborative. Ann 
Surg. 2014, Sep;260(3):533-8; discussion 
538-9. 
42  Masoomi H, Buchberg BS, Magno C, Mills SD, 
and Stamos MJ. Trends in diverticulitis 
management in the United States from 2002 
to 2007. Arch Surg. 2011, Apr;146(4):400-6. 
43  Vennix S, Morton DG, Hahnloser D, Lange JF, 
Bemelman WA, and research committee of 
the European Society of Coloproctocology. 
Systematic review of evidence and 
consensus on diverticulitis: an analysis of 
national and international guidelines. 
Colorectal Dis. 2014, Nov;16(11):866-78. 
  
  
 
  
 
 
 
 
 
List of publications  
 
 
   
 
 
 
 
List of publications 
229 
List of publications 
 
Recidivering en fistelvorming na incisie en drainage van cryptoglandulaire perianale 
abcessen.  
CS Andeweg, EJ Spillenaar Bilgen, JHG Klinkenbijl.  
NTvH 13, nummer 2, april 2004 39-43. 
 
Two patients with retroperitoneal paragangliomas.  
JA Wegdam, CS Andeweg, QH Leyten, CB Reuvers, EJ Spillenaar Bilgen.  
NTvG 2001 okt (20);145:2040-5. 
 
Damage control surgery in polytraumatized patients.  
CS Andeweg, N Vingerhoedt, M Haerkens, A van Vugt.  
NTvG 2006 jul (8);150:1503-7. 
 
Time to ‘rethink the diverticular rules’? 
M Cazemier, JA Wegdam, CS Andeweg, H van Goor, RP Bleichrodt.  
MAGMA jaargang 12, No 1, maart 2006. 
 
Diagnostic Image (318). A man with a non-healing preauricular wound. 
CS Andeweg, Th Wobbes.  
NTvG 2007 apr (7) ;151:814. 
 
Incidence and risk factors of recurrence after surgery for pathology proven diverticular 
disease. 
CS Andeweg, JH Peters, RP Bleichrodt, H van Goor.  
World J Surg. 2008 Jul;32(7):1501-6. 
 
A patient in haemorrhagic shock.  
CS Andeweg, AMM Kotsopoulos.  
Neth J Crit Care 2009:13(1):41-42. 
 
How to diagnose acute colonic diverticulitis? Proposal for a clinical scoring system. 
CS Andeweg, L Knobben, RP Bleichrodt, H van Goor.  
Ann Surg. 2011 May;253(5):940-6. 
 
Seroma formation after axillary lymph node dissection in breast cancer surgery: does 
timing of drain removal matter? 
CS Andeweg, MJ Schriek, J Heisterkamp, JA Roukema.  
The Breast Journal. 2011 Jul-Aug;17(4):359-64. Epub 2011 Jun 17. 
 
List of publications  
230 
 
The Transrectus Sheath Preperitoneal Approach (TREPP) for inguinal hernia repair. 
Rationale and technique.  
GG Koning, CS Andeweg, MWA van Tilburg, F Keus, CJM van Laarhoven, WL Akkersdijk.  
Hernia 2012 Jun;16(3):295-9. Epub 2011 Dec 1. 
 
Guidelines of diagnostics and treatment of acute colonic diverticulitis. 
CS Andeweg, IM Mulder, RJF Felt-Bersma, A Verbon, GJ van der Wilt, van Goor H, JF 
Lange, J Stoker, MA Boermeester, RP Bleichrodt. 
Dig Surg. 2013;30(4-6):278-92. 
 
Reply to letter: ‘The role of abdominal imaging in cases with a high probability of acute 
left-sided colonic diverticulitis based on a clinical scoring system’. 
CS Andeweg, RP Bleichrodt, H van Goor. 
Ann Surg. 2013 Aug;258(2). 
 
Summary of the practice guideline on diverticulitis in the colon: diagnostics and treatment 
in specialty care. 
CS Andeweg, R Felt-Bersma, A Verbon, J Stoker, MA Boermeester, RP Bleichrodt. 
NTvG. 2013;157(15):A6124. 
 
External validation of two tools for the clinical diagnosis of acute diverticulitis without 
imaging. 
JS Kiewiet, CS Andeweg, H Laurell, L Daniels, W Laméris, JB Reitsma, JCM Hendriks, RP 
Bleichrodt, H van Goor, MA Boermeester. 
Digestive and Liver Disease 2014 Feb;46(2):119-24. 
 
Toward an evidence approach to diagnose acute colonic diverticulitis. 
CS Andeweg, JA Wegdam, GJ van der Wilt, J Groenewoud, RP Bleichrodt., H van Goor. 
Scandinavian Journal of Gastroenterology 2014 Jul;49(7):775-84. 
 
The disease course of right- and left-sided diverticulitis in a Western population. 
JA Wegdam, CS Andeweg, TMAJ van Vuuren, TS de Vries Reilingh, HJ van der Zaag-van 
Loonen, H van Goor. 
Submitted  
 
Recurrent colonic diverticulitis: a Markov decision model to guide treatment. 
CS Andeweg, J Groenewoud, GJ van der Wilt, RP Bleichrodt, H van Goor 
Accepted in Clinical Gastroenterology and Hepatology, March 2015.  
 
Patient reported outcomes in diverticulitis: a systematic review and meta-analysis 
CS Andeweg, R Berg, B Staal, RPG van den Broek, H van Goor. 
Submitted 
  
 
 
 
 
 
Dankwoord 
 
 
   
 
 
 
 
Dankwoord 
233 
Dankwoord 
 
Als je eenmaal ergens aan begonnen bent dan moet je het ook afmaken, maar in dit geval 
had ik het van te voren toch niet helemaal overzien. Gelukkig heb ik het niet alleen hoeven 
doen, en zijn er veel mensen erg behulpzaam en betrokken geweest bij het tot stand 
komen van dit proefschrift. In een poging recht te doen aan wat een ieders bijdrage aan 
dit proefschrift is geweest en vooral wat iedereen daarin voor mij betekend heeft, is een 
dankwoord meer dan op zijn plaats. 
 
Prof. dr. H. van Goor, promotor, Beste Harry, zonder jou was dit proefschrift er niet 
geweest. Als het tempo weer eens verslofte, wist jij altijd op het juiste moment te 
motiveren en mij aan te sporen verder te gaan. Ik heb een enorme bewondering voor je 
als chirurg, opleider en mens. Je bent een echte inspirator, en criticaster, in de goede zin 
van het woord. Gezegend met een zeer sterk ontwikkeld analytisch vermogen wist je altijd 
het onderste uit de kan te halen. Soms werd ik er wel eens moedeloos van, alle rode 
pennenstreken, maar ik heb daarna altijd een goed gevoel gehad als het artikel er weer 
beter van was geworden. Dit heeft uiteindelijk geresulteerd in dit prachtige proefschrift. 
Heel veel dank daarvoor. 
 
Prof. dr. R.P. Bleichrodt, promotor en opleider, beste Rob, heel veel dank voor het 
vertrouwen, toentertijd nog als opleider in het UMC St. Radboud, om mij de fijne kneepjes 
van de colorectale- en buikwandchirurgie te leren. Tot op de dag van vandaag pluk ik de 
vruchten van wat u mij hebt geleerd. We zijn samen begonnen aan een eerste artikel over 
diverticulitis en al snel mondde dit uit in meer ideeën over een beetje het ondergeschoven 
kindje in de heelkunde. Ik heb met u samen de richtlijn over diverticulitis mogen schrijven, 
misschien is dat nog wel hetgeen het meest door anderen gelezen wordt, en waar ik het 
meest trots op ben. Al is het contact veel minder frequent sinds u in het buitenland werkt, 
ik kan altijd een beroep op u doen. Heel veel dank voor alles. 
 
Geachte leden van de leescommissie, hartelijk dank voor uw tijd en interesse in mijn 
proefschrift. 
 
Geachte leden van de promotiecommissie, hartelijk dank voor de aandacht en tijd die u 
aan mijn proefschrift heeft geschonken en voor uw bereidheid te willen opponeren. 
 
Beste Joost, 
Eindeloze grappen hebben we kunnen maken over het promoveren, de zin en onzin er van 
naast de gebruikelijke en vermakelijk anekdotes die we met elkaar delen over het chirurg 
zijn. Wat hebben we af en toe toch een raar vak, maar geen van ons beiden zou anders 
willen. Mijn dank is groot voor je onnavolgbare enthousiasme, praktische hulp en onvoor-
waardelijke steun als het even tegen zit. Carpe diem, we kunnen nu beiden achterover 
leunen, ik heb je alleen nog een laatste keer nodig als het om mijn proefschrift gaat. 
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Lieve Tanja, 
Opleidingsvriendinnetje uit Nijmegen, wie had gedacht dat onze levens zo synchroon 
zouden lopen. Lief en leed hebben we gedeeld in de opleiding en nog steeds. Ik bewonder 
je enorm voor je duidelijkheid in het maken van keuzes voor je gezin en voor jezelf. Al blijf 
ik het jammer vinden dat we niet dichter bij elkaar wonen, ik kan me geen lievere en 
attentere vriendin wensen dan jij. Ik weet dat me niets kan gebeuren als jij bij het 
verdedigen van mijn proefschrift achter me staat. 
 
Drs. J.A. Groenewoud, beste Hans, 
Ons gezamelijke kindje het Markov model heeft me zoveel hoofdbrekens gekost dat ik 
zowaar grijze haren bij mezelf begon te ontdekken. Of word ik gewoon echt een dagje 
ouder? Termen als “de toekomst gegeven het heden niet afhangt van het verleden" (zo-
genaamd makkelijke uitleg van een Markov keten) maakte het er voor mij niet makkelijker 
op. Terwijl ik er min of meer van overtuigd begon te raken dat ik een gendefect heb voor 
dit soort statistische tovertrucs, bleef jij volhouden en is het je toch gelukt mij het Markov-
model en aanverwante statistiek op een begrijpelijke manier uit te leggen. Hans, mijn 
dank is erg groot, dat weet je. 
 
Dr. H.J.M. Oostvogel, beste Henk, 
Jij bent voor mij in het tweede deel van mijn opleiding de drijvende kracht geweest achter 
mijn opleiding tot gastrointestinaal chirurg. Twee keer in de week stonden we gezellig een 
hele dag samen te opereren, goed op elkaar ingespeeld kon ik altijd met je sparren als het 
over diverticulitis of wat dan ook ging. “Zie vooral de echt belangrijke dingen in het leven 
niet over het hoofd” heb je vaak tegen me gezegd. Integer zijn als mens en chirurg met 
kwaliteit hoog in het vaandel heb ik van je mogen leren. Van jou heb ik de vlakken leren 
kennen, geleerd nooit de binnenbocht te nemen en een plan B te hebben als het anders 
loopt dan gepland. Mijn dank is groot. 
 
Opleiders, chirurgen en collega-assistenten uit het UMC St. Radboud in Nijmegen en het 
St. Elisabeth Ziekenhuis in Tilburg. Dank voor alles wat ik heb mogen leren tijdens mijn 
opleiding en vooral de gezellige sfeer waarin dit mocht plaatsvinden. Lang leve de 
gezellige borrels in het St. Anneke, pilsen op de Heuvel in Tilburg en de ongeëvenaarde 
skitripjes.  
 
Drs. J.A. Wegdam, beste Johannes, 
“Er ontbreekt een beetje wegdam-itis,” zeiden ze in Arnhem toen je daar weg was. Need I 
say more, met jou valt altijd wat te beleven, en jouw bijzondere avonturen werden door 
menig opleider naverteld. Door jouw enthousiasme en ons eerste gezamenlijke project 
over neuroendocriene tumoren, waar we allebei volgens mij niet zo veel van begrepen, 
ben ik verzeild geraakt in de wereld van de chirurgie. Dank daarvoor. 
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Beste mede auteurs, dank voor de prettige samenwerking bij de totstandkoming van de 
verschillende artikelen die bijgedragen hebben aan dit proefschrift. 
 
Lieve vrienden en vriendinnen, al hebben jullie inhoudelijk niet bijgedragen aan dit 
proefschrift, jullie onvoorwaardelijke steun en gezelligheid en luisterend oor waren voor 
mij super belangrijk. Ik heb wel vaak gehoord “ben je daar nou nog steeds mee bezig”, en 
ja, dan hoorde ik mezelf weer hetzelfde verhaaltje afsteken, maar dat is nu voorbij. Op 
naar een nieuw hoofdstuk, en dit keer eentje die niet opgeschreven hoeft te worden. 
 
Maatschap chirurgen Noord-West Veluwe, 
Lieve maten, Willem, Rene, Gerrit, Roberto, Marc, Ingjerd, Martin, Annet en Tjeerd. Toen 
ik in 2010 solliciteerde op een chef plek in jullie maatschap, had ik niet durven dromen zo 
zacht te landen. Voor toentertijd en nu al helemaal ondenkbaar, nog heel uitzonderlijk dat 
jullie mij hebben geschoold in de lacunes die ik had in het laparoscopisch opereren en mij 
in anderhalf jaar tijd tot een volwaardig maatschapslid hebben laten groeien. Ik kan me 
geen betere maatschap wensen! 
 
Mariska Scheuer, jij verdient een apart plaatsje, formeel geen lid meer van de maatschap 
en destijds aan mij de eer jou op te volgen. Jij was als een soort moeder voor de 
maatschap, kwaliteit hoog in het vaandel en koningin van de VIM meldingen. Niet zo gek 
dat je bij de inspectie bent gaan werken, het ga je goed, maar we houden contact (privé 
dan hè). 
 
Medewerkers St. Jansdal,  
Lieve dames van het secretariaat, OK-assistenten, verpleegkundigen, secretaresses van de 
afdeling, polimedewerkers, oncologie- en mammacare-verpleegkundigen, en natuurlijk 
collega-specialisten. Dank voor het altijd maar aanhoren van mijn verhalen over mijn 
promotie en de morele en soms fysieke ondersteuning die sommigen van jullie hebben 
geleverd. 
 
Lieve ouders, onvoorwaardelijk is jullie steun. We hadden ons de toekomst wel iets anders 
voorgesteld, maar desondanks zijn jullie samen een sterk team. Lieve mama, redder in 
nood, oppas als de vogeltjes nog niet fluiten, rots in de branding en bovenal superlieve 
oma (superoma) en moeder. Mijn doorzettingsvermogen heb ik van jou gekregen en heeft 
me gebracht tot waar ik vandaag ben. Lieve papa, ik moet een traantje wegpinken als ik 
denk aan hoe anders alles had kunnen zijn als het noodlot niet had toegeslagen die ene 
warme dag in de zomer. Van alle tegenslagen is dit wel de grootste en zijn we die nooit 
echt helemaal te boven gekomen, vooral jij niet. Dingen niet los kunnen laten, niet 
accepteren zoals het is zijn misschien de minder mooie eigenschappen die ik van jou heb 
gekregen, maar trots, eigenheid en vastberadenheid en altijd overal een oplossing voor 
vinden heb ik in overvloed van je gekregen.  
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Marike, lief zusje, je bent grappig, slim en vindingrijk. Wie had dat ooit gedacht dat jij als 
kleine Kiki altijd in de weer met moodboards (voor jou toen nog een plakboek, tijdschrift 
schaar en wat lijm) zou uitgroeien tot één van Nederlands meest vooraanstaande 
ontwerpers. Ik ben trots op je! Hoe fijn is het dat onze kinderen zo harmonieus met elkaar 
opgroeien als nu het geval is. Ik hoop dat we daar nog lang van mogen genieten. 
 
Lieve Chris, 
Love you, love you more, love you the most…….. 
 
Lieve Emma en Noor en ……. 
Jullie zijn mijn prachtige oogappeltjes, mijn mooie meisjes. Jullie zijn het mooiste wat me 
ooit is overkomen. 
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being admitted to medical school, she studied biomedical sciences at the University of 
Nijmegen (1993-1994). In 1994 she started her medical training at the University of 
Nijmegen Medical Centre and ended her last in hospital training courses in 2001. During 
this in hospital training the love for the surgical profession arose. In 2001, after graduating 
from medical school, she joined the Department of Surgery of the St. Elisabeth Hospital in 
Tilburg (prof. dr. J.A. Roukema) and later on the Department of Surgery in the Rijnstate 
Hospital in Arnhem (prof. dr. J.H.G. Klinkenbijl), as a surgical resident. In September 2003, 
she moved to the Radboud University Medical Centre (prof. dr. R.P. Bleichrodt), where she 
started her surgical training. At the third year of surgical training she started working on 
this PhD thesis, which primarily focused on the improvement of the clinical diagnosis and 
treatment strategies in patients with acute colonic diverticulitis. She is one of the authors 
of the guideline “Diagnostics and treatment of acute colonic diverticulitis” funded by the 
Association of Surgeons of the Netherlands in 2012. After completing the first three 
academic years in surgical training she continued her training in the St. Elisabeth Hospital 
in Tilburg (prof. dr. C.J.H.M. van Laarhoven and 
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registration as a surgeon she started working in 
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Stellingen behorende bij het proefschrift 
Changing strategies in diverticulitis 
 
1. “Diverticular disease” is een verwarrende Angelsaksische verzamelterm voor een groot 
aantal aandoeningen die betrekking hebben op diverticulosis van het colon. Vanwege 
deze verwarring moet de term worden vermeden in taal en geschrift. (dit proefschrift)  
2. Aanvullende beeldvorming bij patiënten met een ongecompliceerde diverticulitis leidt 
zelden tot een verandering in het beleid. (dit proefschrift)  
3. De combinatie van pijn links onder in de buik, de afwezigheid van braken en een CRP-
waarde boven de 50 mg/l heeft een hoge voorspellende waarde voor de aanwezigheid 
van diverticulitis. (dit proefschrift) 
4. De “step-up approach”, als eerste een echografie, bij negatieve of niet-conclusieve 
uitslag gevolgd door een CT scan, is de benadering van keuze voor beeldvorming bij 
verdenking op een diverticulitis. (dit proefschrift)   
5. Een electieve sigmoid resectie moet niet meer worden geadviseerd na twee episodes 
van diverticulitis. (dit proefschrift) 
6. In het geval van recidiverende diverticulitis moet met de patiënt een individuele 
afweging worden gemaakt tussen de frequentie en ernst van de klachten en de winst en 
risico’s van een operatieve behandeling. (dit proefschrift) 
7. De kwaliteit van leven van patiënten met recidiverende diverticulitis verbetert na een 
laparoscopische operatie in vergelijking met een conservatieve behandeling. (dit proef-
schrift) 
8. Een matig absorbeerbaar antibioticum zoals Ciprofloxacin is een goed alternatief voor 
chirurgie bij recidiverende klachten na een diverticulitis. (dit proefschrift)  
9. Jonge leeftijd en persisterende klachten na een chirurgische behandeling voor diverticu-
litis verhogen de kans op een recidief. (dit proefschrift) 
10. Artsen zijn nog niet goed in staat om het effect van ziekte en behandeling op kwaliteit 
van leven te beoordelen. Dit kan leiden tot een “geslaagde” operatie, maar een teleur-
gestelde patiënt. 
11. De kunst is zo te leven dat het je overkomt. (Martin Bril, 1959-2009)   
12. Nothing is so firmly believed as what we least know. (Michel de Montaigne, 1533-1592) 
13. Mastering others is strength. Mastering yourself is true power. (Lao Tzu, 6th century BC) 
 
Caroline Suzanne Andeweg 
30 april 2015 
  
 
 

